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Abstract 
 
 ii 
Studies towards the total synthesis of pyxidatol C I, isolated from the medicinal 
mushroom Clavicorona pyxidata, are described herein. Pyxidatol C I is a member of the 
africanane family of sesquiterpenes, which share a decahydro-1H-cyclopropa[e]azulene 
core structure. The synthetic strategy is shown below. 
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Chapter 1 provides an introduction while Chapter 2 outlines work on a desmethyl model 
system. A Cope rearrangement was used to prepare synthetic cycloheptadiene IX. 
Unfortunately, the analogous rearrangement using the gem-dimethyl substituted 
divinylcyclopropane X was unsuccessful. 
As such, the reactivity of a range of 
substituted divinylcyclopropanes towards 
the thermal Cope rearrangement was 
investigated (Chapter 3).  
 
The effects of gem-
dimethyl substitution on 
the cyclopropane, the 
alkene geometry, the relative stereochemistry of the cyclopropane and the steric and 
electronic effects of a range of functional groups were all examined, and the methods 
developed were used to synthesise a range of functionalised 1,4-cycloheptadienes in high 
yields.  
 
Chapters 4 and 5 describe studies towards the total synthesis of pyxidatol C. Advanced 
intermediates were prepared including ester XII and 
lactone XIII containing the requisite gem-dimethyl 
substituted 7-membered ring, the cyclopropane moiety 
and the methyl ketone side chain in place.  
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Chapter 1 
Introduction 
 
1.1 Pyxidatol C and the Africananes 
 
Clavicorona pyxidata is a wild mushroom used widely in traditional Chinese 
medicine for the treatment of gastric pain, dyspepsia, gout, and heat toxicity.1 In 2008, 
Zheng et al.1 reported the isolation of three novel sesquiterpene compounds from this 
medicinal mushroom, two belonging to the protoilludane family, pyxidatol A 1 and 
pyxidatol B 2, and one belonging to the africanane family, pyxidatol C 3 (Figure 1). 
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Figure 1 Structures of pyxidatol A 1, pyxidatol B 2 and pyxidatol C 3. 
 
The structure of pyxidatol C 3 is closely related to that of omphadiol 4 (Figure 2), first 
isolated by McMorris et al.2 in 2000 from cultures of Omphalutus illudens and also 
isolated from Clavicorona pyxidata by Zheng et al.1 Pyxidatol C belongs to the 
africanane family of sesquiterpenes, first found in africanol 53 and later in africanene 
6.4 The africananes are defined by their decahydro-1H-cyclopropa[e]azulene core 
structure (highlighted in red: Figure 2). 
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Figure 2 Structures of pyxidatol C 3, omphadiol 4, africanol 5 and africanene 6 with the common 
decahydro-1H-cyclopropa[e]azulene core structure highlighted in red. 
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1.2 Structural Elucidation of Pyxidatol C  
 
Pyxidatol C was isolated as a colourless oil. The molecular formula was determined 
as C15H26O2 using HRMS. The 13C NMR spectrum with DEPT revealed the presence 
of 15 signals: three CH3, six CH2 (one oxygenated), three CH, and three quaternary C-
atoms (one oxygenated). An IR absorption at 3281 cm-1 suggested the presence of an 
OH group, which was supported by the 1H NMR and HSQC spectra which showed 
signals corresponding to two OH groups.1 
 
A comparison of the 1H NMR and 13C NMR data of pyxidatol C, with the previously 
reported compound omphadiol 4, revealed that the compounds share the same core 
structure. However the Me group (12) and CH-OH (5) in 4 were replaced by a 
HOCH2 (12) substituent and CH2 (5) in 3 (Figure 3).1  
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Figure 3 Structures of pyxidatol C 3, omphadiol 4 and an acetylated derivative of omphadiol 7 
(Arbitrary atom numbering). 
 
The absolute configuration of omphadiol 4 was determined from the X-ray crystal 
structure of a 3,5-dinitrobenzoate derivative.2 Zheng et al.1 also obtained a crystal 
structure of an acetylated derivative of omphadiol, 7. The relative configuration of 
pyxidatol C was determined by comparison with 7. Further evidence was provided by 
the observation of a ROESY correlation between H-C (8) and H-C (4), and H-C (12) 
and H-C (15), supporting their assigned syn-relationship (Figure 3).1 
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1.3 Biological Activity of Pyxidatol C 
 
To date (other than the isolation paper) there have been no publications relating to 
pyxidatol C 3 (See Chapter 6: Addendum). However, the pharmacological activity of 
africanene 6 has been examined by Reddy et al.5 It was found to show mild CNS 
depressant activity, dose-dependant hypotensive activity, and anti-inflammatory 
activity. Furthermore, africanene was found to exhibit cytotoxic activity against the 
Ehrlich ascites carcinoma and Dalton’s lymphoma ascites tumour.5  
 
Pyxidatol C 3 shares a common tetrasubstituted cyclopentane ring (highlighted in 
blue: Figure 4) with a large family of sesquiterpenes and diterpenes, many of which 
display potent biological activities.6 Rossinone B 8, for example shows anti-
inflammatory, antiviral, and antiproliferative activities7,8 and tomeone F 9 displays 
significant cytotoxicity against KB cells.9 
 
H
H
O
OO
O
H
HOH
OH
O
O
O
OH
H
HO
3 8 9
HO
HO
 
 
Figure 4 Structures of pyxidatol C 3, rossinone B 8 and tomeone F 9 with the common tetrasubstituted 
cyclopentane ring highlighted in blue. 
 
1.4 Proposed Biosynthesis of the Africananes 
 
!-Humulene 10 is an important biogenetic precursor of a large number of 
sesquiterpenes, particularly in fungi.10 Although the biosynthesis of the africananes 
has not been established conclusively, biosynthetic pathways from !-humulene have 
been proposed.11,12 Braeckman et al.,11 for example, proposed a biogenesis of africanol 
in their original isolation paper (Scheme 1).  
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Scheme 1 Proposed biosynthesis of africanol 5 from !-humulene 10.11 
 
Bohlmann and Zderol12 reported the isolation and structural elucidation of the 
africanane sesquiterpene 12 (Scheme 2) and proposed a biogenetic derivation from !-
humulene derived epoxide 11. 
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Scheme 2 Proposed biosynthesis of sesquiterpene 12 from !-humulene 10.12 
 
1.5 The First Synthesis of a Natural Africanane: Shirahama’s Synthesis of (±)-
Africanol 
 
In 1980 Shirahama et al.13 used the !-humulene-derived epoxide 13 in their synthesis 
of (±)-africanol 5. This was the first example of a chemical synthesis of a natural 
africanane (Scheme 3). They began with a transannular cyclisation of epoxide 13 by 
treating with trimethylsilyl trifluoromethanesulfonate followed by desilylation with 
KI in MeOH, obtaining a mixture of alcohols 14 and 15 in a 2:1 ratio. Following the 
 5 
isolation of the desired isomer 15, it was treated with PBr3 to give bromide 16 
(retention is shown in the publication), which was then reduced using sodium in 
liquid ammonia furnishing olefin 17. Epoxidation using m-CPBA delivered epoxide 
18 and treatment with LDA afforded allylic alcohol 20. Hydrogenation with Adam’s 
catalyst concluded the synthesis of (±)-africanol 5. 
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Scheme 3 Synthesis of (±)-africanol 5 by Shirahama et al. 13 
 
1.6 White’s Synthesis of (±)-Africanol Using the Oxy-Cope rearrangement 
 
Africanol 5 has since been synthesised by many groups.14"18 The next racemic total 
synthesis was reported by Paquette et al. in 198616 and the first asymmetric synthesis 
was reported by Tai et al.17 in 1990. A six-step synthesis of (±)-africanol was 
developed by White and Fan in 1993,18 which used a key anionic oxy-Cope 
rearrangement step (Scheme 4). 
 
Conjugate addition of Bu3SnLi into 2,5,5-trimethylcyclohex-2-enone 21 (prepared in 
3 steps from commercially available dimedone),19 followed by in situ trapping of the 
intermediate enolate with the vinyl cation equivalent (phenylseleno)acetaldehyde 
started White’s synthesis of (±)-africanol.18 This afforded a 1:1 mixture of 
 6 
diastereomers 22 and 23. The desired isomer 23 was isolable by chromatography. 
Elimination followed by Grignard addition into the ketone then furnished a single 
diastereomer of divinylcyclohexanol 25. An anionic oxy-Cope rearrangement then led 
to the generation of compound 26, which was unstable and was used without further 
purification. Na/naphthalene in THF promoted the cyclisation to the fused ring system 
28 in 56% yield with only 6% of the unwanted diastereomer 27. Finally 
Simmons"Smith cyclopropanation completed the synthesis affording (±)-africanol 
with exclusive addition on the less hindered endo-face. 
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Scheme 4 Synthesis of (±) africanol 5 by White and Fan.18 
 
1.7 Recent Syntheses of Africananes: Romo’s Synthesis of Omphadiol 
 
More recent synthetic routes towards members of the africanane family include 
Nakata’s synthesis of epoxyafricanane20 and Romo’s synthesis of omphadiol,6 both of 
which were published in 2011. 
  
Romo et al.6 prepared (+)-omphadiol 4 in 10 steps and in 18% overall yield (Scheme 
5). Their elegant synthesis started with a [MnIII(dpm)3]-catalysed hydration of the 
 7 
enone moiety of (R)-carvone to afford hydroxy ketone 29. Oxidative cleavage by 
periodic acid delivered keto-acid 30. Upon activation of the carboxylic acid with tosyl 
chloride and the addition of 4-PPY as a nucleophilic catalyst, keto-acid 30 underwent 
an aldol lactonisation to give the unusual bicyclic lactone 31. DIBAL reduction gave 
the corresponding diol that was then converted into the C7 bromide. A 
tosylation/bromination sequence, and subsequent acylation provided ester 32. 
Alkylation using KHMDS, followed by quenching with excess MeI furnished the 
bicyclic #-lactone 33 bearing the requisite C6 gem-dimethyl moiety. The addition of 
allyllithium, which was derived from allyltriphenyltin, into lactone 33 gave the $,%-
unsaturated enone 34.  A tandem isomerisation/ring-closing metathesis (RCM) 
process using second generation Grubbs catalyst next gave cycloheptenone 35. 
Finally, DIBAL reduction furnished allylic alcohol 36, which underwent 
Simmons"Smith cyclopropanation to give synthetic (+)-omphadiol.6 
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Scheme 5 Synthesis of (+)-omphadiol 4 by Romo et al.6 
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1.8 Pyxidatol C: Retrosynthetic Analysis 
 
Our aim was to apply established Taylor group methodologies in the total synthesis of 
pyxidatol C. A modified Corey"Chaykovsky protocol, developed within the Taylor 
group,20"23 has been used previously to synthesise cyclopropane 41 where R = Et23 
which, it was hoped, could be readily converted into diester 40 via reduction followed 
by the group’s tandem oxidation procedure (TOP, tandem MnO2-Wittig reaction).23,24 
It was then anticipated that the Cope rearrangement of 40, would generate the 7-
membered ring meso-compound 39 which, upon partial reduction and alkene 
isomerisation (thermodynamically driven by moving the alkene into conjugation) may 
undergo a second Corey"Chaykovsky reaction to install the cyclopropane moiety of 
38. It was envisioned that a Wittig reaction followed by selective reduction would 
install the methyl ketone side chain, and a key SmI2-mediated ring closing reaction 
would complete the synthesis.  
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Scheme 6 Retrosynthetic strategy towards pyxidatol C. 
 
1.9 Asymmetric Synthesis 
 
It was planned that the synthesis could be rendered asymmetric by the 
desymmetrisation of either meso-compound 39 or meso-compound 40. There is good 
precedent for related reactions, for example, the selective hydrolysis of bisacetate 43 
using porcine pancreatic lipase (PPL) to generate enantio-enriched alcohol 44, which 
was first described by Von Langen and Tolman (Scheme 7).25 
 9 
OAcAcO OHAcO
44, 89%
>98% ee
PPL, pH 7 buffer
43
 
 
Scheme 7 The desymmetrisation of 43 using PPL.25 
 
We envisioned that a similar desymmetrisation could be applied to bisacetate 46, 
which should be easily prepared from cycloheptadiene 39 in 2 steps (Scheme 8). 
 
RO2C CO2R
39 45
OHHO
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OAcAcO
47
OHAcO
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Scheme 8 The planned desymmetrisation of 46 using PPL. 
 
The monohydrolysis of 40 using pig liver esterase enzyme (PLE) is an alternative 
strategy. The monohydrolysis of cyclopropyl meso-diesters has previously been 
reported in the literature (e.g. 48&49, Scheme 9).26 Note that the monohydrolysis of 
the olefinic diester 40 is preferable to the monohydrolysis of diester 41 (cf. 48), as this 
desymmetrisation comes at a later stage in the synthetic strategy. 
 
RO2C CO2R
MeO2C CO2Me
40
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HO2C CO2Me
49, 90%,
>99.5% ee
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RO2C CO2H
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Scheme 9 The desymmetrisation of 48 using PLE and the proposed desymmetrisation of 40 using 
PLE.26 
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1.10 Taylor Group Methodologies 
 
In 2007, the Taylor group reported a gem-dimethylcyclopropanation procedure using 
triisopropyl-sulfoxonium tetrafluoroborate.20"23 The cyclopropanation of diethyl 
fumarate (Scheme 10) has since been carried out to give 53,23 an intermediate in our 
retrosynthetic analysis of pyxidatol C. 
 
EtO2C CO2EtEtO2C CO2Et
53, 90%
NaH, DMF
Si-Pr i-Pri-Pr
O BF4
Si-Pr i-Pr
BF4i-Pr
i-Pr S i-Pr
Ba(OH)2•8H2O,
H2O2,
H2Oii) HBF4
i) IPA, MSA
SO2Cl
NO2
51, 69% 52, 60%
52
 
 
 
Scheme 10 Taylor Group modified Corey"Chaykovsky protocol.20"23 
 
The Taylor group’s tandem MnO2 oxidation then Wittig trapping process (TOP 
methodology) has been used previously to prepare 55.24 It was expected that this 
procedure could also be used to prepare the gem-dimethyl analogue, 57 (Scheme 11).  
 
EtO2C CO2EtOHHO
MnO2,
Ph3PCHCO2Et, 
CHCl3
55a, 75%54a
reflux, 18 h,
EtO2C CO2EtOHHO
MnO2,
 Ph3PCHCO2Et,
CHCl3
57a56a
reflux
 
 
 
Scheme 11 Taylor Group Tandem Oxidation Procedure (TOP).24 
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1.11 Preliminary Work on a Model System 
 
Preliminary work in the group carried out by Unsworth27 (Scheme 12), using a 
simplified desmethyl analogue, offered significant promise. Upon heating at 130 °C 
in xylene, the Cope rearrangement of 55 proceeded smoothly to give 58. Reduction, 
followed by mono-oxidation then yielded lactone 60, which was then isomerised to 61 
under basic conditions. Finally a Corey-Chaykovsky reaction afforded 62 as a single 
diastereomer, which was believed to possess the relative stereochemistry required for 
pyxidatol C based on n.O.e experiments (an n.O.e enhancement between the 
cyclopropane CH2 and the CHCH2O protons is observed, whereas no n.O.e 
enhancement is seen for the lactone CH2 protons with the cyclopropane CH2 protons). 
 
EtO2C CO2Et
xylene
130 °C, 16 h EtO2C CO2Et
LiAlH4, THF
58, 80% 59, 76%
OHHO
CH2Cl2
60, 40-60%
O O
DBU, THF
61, 59%
Me3S+O I-
NaH, DMF
O O
H
62, 21%
O O
H
H
55
 
 
Scheme 12 Preliminary work on a desmethyl model system.27 
 
1.12 Aims and objectives 
 
As outlined, a range of different approaches have been used to synthesise africanane 
natural products. We aimed to use established Taylor group methodologies in a total 
synthesis of the africanane, pyxidatol C.  
 
Initial work would involve optimising Unsworth’s preliminary work on the simplified 
desmethyl model system (Scheme 12) before applying this chemistry to the analogous 
gem-dimethyl pyxidatol C system. 
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Chapter 2 
From the Desmethyl Model System to the Gem-Dimethyl System 
 
2.1 Optimisation of Preliminary Work & Methyl Ketone Side-Chain Studies 
 
Initial work towards the synthesis of pyxidatol C involved repeating Unsworth’s27 
preliminary studies (Scheme 12) with a view to optimising the low yielding steps. The 
route to lactone 60 was easily reproducible and thus attention focused on improving 
its isomerisation. This preliminary work showed that the unwanted lactone 63 was 
obtained upon heating compound 60 for 1 h at 70 °C. Unsworth had also established 
that by lowering the temperature to RT and decreasing the reaction time to 40 min, a 
59% yield of lactone 61 along with a 30% yield of lactone 63 were isolated.27 
Lowering the temperature further to 0 °C was therefore considered a good starting 
point for further optimization and, pleasingly, after stirring lactone 60 for 2.5 h at 0 
°C, the desired lactone 61 was isolated in a yield of 74%, an improvement of 15%. A 
small amount of the unwanted !,$-%,#-unsaturated lactone 63 and the trans-epimer, 
lactone 64, were also obtained in low yields (11% and 6% respectively). 
 
O O
DBU, THF
0 °C, 2.5 h
61, 74%
O O
63, 11%
O O
64, 6%
O O
+ +
60  
 
Scheme 13 Optimised isomerisation conditions for the synthesis of lactone 61. 
 
Ratio of Productsa Entry Temperature 
(°C) 
Reaction 
Time 
(min) 
61 63 64 
127 70 60 0 1 0 
227 RT 60 1.75 1 0 
3 RT 40 1.75 0 1 
4 0 30 1 0 1 
5b 0 150 8 1.5 1 
 
aRatio determined by analysis of the 1H NMR spectra of the unpurified reaction mixtures. 
bThe compounds 61, 63 and 64 were separated by flash column chromatography and the isolated yields are shown in Scheme 
13. 
 
Table 1 Optimisation of the isomerisation of lactone 60 to lactone 61. 
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Unfortunately, the cyclopropanation of 61 was harder to optimise. Using the Taylor 
group modified Corey-Chaykovsky cyclopropanation conditions23 (61 was reacted 
with NaH and trimethylsulfoxonium iodide in DMF at RT), furnished 62 in only 21% 
yield during preliminary work.27 The same conditions were re-tested, but a similarly 
poor yield was obtained, with only 26% of cyclopropane 62 isolated. An alternative 
procedure28 was tested using MTBD in acetonitrile at 60 °C but unfortunately this 
protocol furnished cyclopropane 62 in only 19% yield. However on a more positive 
note both the NaH/DMF and MTBD/MeCN reaction conditions, yielded only one 
diastereomer; its relative stereochemistry determined as that required for pyxidatol C 
via n.O.e (Scheme 14).27 We were surprised by the low yields as the 1H NMR spectra 
of the unpurified reaction mixtures showed very little evidence of decomposition. We 
considered that the sulfoxonium ylide was also adding into the enone from the other 
face but, rather than closing to form the other diastereomer, material was being lost as 
the salt. However by taking the 1H NMR spectrum (D2O) of the aqueous extract no 
identifiable products were observed.   
 
61
O O
Me3S+O I-,
O O
H
62
NaH, DMF, RT, 16 h, 26%
MTBD, MeCN, 60 °C, 1 h, 19%
 
 
Scheme 14 Corey-Chaykovsky cyclopropanation reactions. 
 
Given the difficulties associated with the cyclopropanation of lactone 61 we planned 
instead to install the methyl ketone side-chain first with a view to testing the Corey-
Chaykovsky cyclopropanation on ester 65 (Scheme 15).  
 
CO2R
65
CO2RO O
66
R = alkyl
 
 
Scheme 15 Cyclopropanation of ester 65. 
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The initial strategy for installation of the side chain was via Wittig olefination, 
followed by selective reduction of the resulting !,$-unsaturated ketone. This strategy 
was tested using lactol 67, itself formed via the IBX oxidation of diol 59. However, 
clean material could not be recovered from the reaction, even after flash column 
chromatography. Based on analysis of the 1H NMR spectrum of the unpurified 
reaction mixture, we speculated that isomerisation of the C1, C2 double bond into 
conjugation with the newly formed !,$-unsaturated ketone was an unwanted side 
reaction (Scheme 16). We tentatively assigned the major component of the reaction 
mixture as 68 based on peaks at 7.12 (1H, d, J 16.0 Hz, H-4), 6.48 (1H, t, J 6.5 Hz, H-
2), 6.15 (1H, d, J 16.0 Hz, H-5) in the 1H NMR spectrum of the unpurified reaction 
mixture. 
 
HO OH
IBX,
DMSO
O
67, 60%
CH2Cl2
O
PPh3
HO OH
O 68
OH
O
1
2
59
RT, 2 h RT, 16 h
3
45
1
2
3
45
 
 
Scheme 16 Installation of side-chain Wittig-reduction route. 
 
An alternative strategy to introduce the side-chain was therefore tested on a model 
system. A cyclohexyl model system was chosen to test this alternative route. 
Iodination of cyclohexylmethanol using triphenylphosphine, imidazole and iodine in 
CH2Cl2 provided iodide 69 in 62% yield. Then $-ketoester 70 was prepared in 72% 
yield by refluxing iodide 69, NaH and tert-butyl 3-oxobutanoate in THF. 
Decarboxylation of $-ketoester 70 at reflux in benzene with p-TSA furnished ketone 
71 in 85% yield and completed the installation of the desired side-chain into the 
cyclohexyl model system. This sequence was not tested on our desmethyl analogue of 
pyxidatol C but this chemistry would later be trialled on the gem-dimethyl, pyxidatol 
C system (Chapter 4). 
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Scheme 17 Installation of the side-chain via a $-ketoester route. 
 
2.2 Further Studies on the Model System: A Simmons-Smith strategy 
 
Given that difficulties were encountered using the Corey-Chaykovsky 
cyclopropanation, it was decided that an alternative method of cyclopropanation 
should be examined. It is well known29 that in the Simmons-Smith reaction, the rate 
of cyclopropanation is faster for an allylic alcohol compared with an unfunctionalised 
alkene and we hoped to exploit this fact to achieve a regioselective cyclopropanation 
in our synthesis. DIBAL reduction of lactone 60 furnished diol 72 in 82% yield, 
providing a suitable test substrate for this Simmons-Smith reaction. However, 
treatment of diol 72 with diiodomethane and diethylzinc led only to a mixture of 
cyclopropanes 73, 74 and bis cyclopropane 75 in poor yield. The trace presence of 
cyclopropane 75 is supported by HRMS. (Scheme 18). 
 
O O
DIBAL, CH2Cl2
HO OH
60 72, 82%
HO OH HO OH
HO OHHO OH
74, 10%73, 13%
72, 33% 75, Trace
CH2I2 (4 eq)
Et2Zn (2 eq)
CH2Cl2 + +
+
!78 °C " RT, 4 h 0 °C " RT, 2 h
 
 
Scheme 18 Simmons-Smith reaction on diol 72.  
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The stereochemistry of cyclopropanes 73 and 74 in the Simmons-Smith reaction of 
diol 72 was confirmed by a comparison with the product of LiAlH4 reduction of 
lactone 62 (Scheme 19), where stereochemistry had already been confirmed by n.O.e 
(see Chapter 1.11, Scheme 12).  
 
O O
62
LiAlH4, THF
RT, 45 min
73, 44%
HO OH
 
 
Scheme 19 LiAlH4 reduction of lactone 62. 
 
Despite the poor yield and poor stereocontrol in the Simmons-Smith reaction of diol 
72, we could see sufficient scope for optimisation to believe that the reaction could be 
improved. For example zinc can coordinate to either alcohol of the diol 72 and we 
believed that protecting the non-allylic alcohol might improve the reaction.  
 
The efficient mono-silylation of symmetric diols was established in 1986 by 
McDougal et al.30 and was employed in the mono-TBS protection of diol 59 
furnishing 76 in 89% yield. As outlined in Scheme 20, Dess"Martin oxidation 
provided the corresponding aldehyde 77 in 97% yield, which was isomerised to !,$-
unsaturated aldehyde 78 under basic conditions. Pleasingly, no unwanted side 
products were obtained and after 20 min at 0 °C and the desired aldehyde 78 was 
obtained in 77% yield. DIBAL reduction then afforded alcohol 79, the required 
substrate for the Simmons-Smith reaction, in 64% yield.  
 
OHHO
TBSCl, NaH,
THF
OHTBSO OTBSO
DMP, 
CH2Cl2 DBU, THF
OTBSO
DIBAL, 
CH2Cl2
OHTBSO
76, 89% 77, 97%
78, 77% 79, 64%
59
0 °C ! RT, 
45 min
0 °C ! RT, 
1 h
0 °C, 20 min
0 °C, 30 min
 
 
Scheme 20 Mono-protection route to Simmons-Smith precursor 79. 
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The Simmons-Smith cyclopropanation of alcohol 79 was, unfortunately, less 
straightforward. As outlined in Scheme 21, initial conditions trialled used four 
equivalents of diiodomethane and two equivalents of diethylzinc in CH2Cl2 at RT. 
After 4 h, a ratio of 7:1 bis-cyclopropane 81 to cyclopropane 80 was observed by 
tentative analysis of the 1H NMR spectrum of the unpurified reaction mixture. 
Consumption of the peaks corresponding to the double bonds of diene 79 at 5.95 (1H, 
t, J 6.5 Hz), 5.78!5.72 (1H, m) and 5.47 (1H, ddt, J 12.0, 6.5, 1.5 Hz) was observed 
alongside the appearance of cyclopropyl peaks at 0.98!0.84 (2H, m) and 0.74!0.60 
(2H, m). 
 
TBSO OH
79
TBSO OH TBSO OH
CH2I2 (4 eq),
Et2Zn (2 eq),
CH2Cl2
80 81
0 °C ! RT, 4 h
1     :     7  
 
Scheme 21 Simmons-Smith reaction on TBS protected alcohol 79. 
 
Unfortunately cyclopropanes 80 and 81 are indistinguishable by thin layer 
chromatography (tlc) and so the reaction progress could not be followed using this 
method. The reaction time was decreased to 30 min, after which time a ratio of 3:1 81 
to 80 was observed (Entry 2, Table 2). Between 10 and 20 min predominantly starting 
material was recovered (Entry 3 and 4, Table 2). The reaction temperature was 
lowered to 0 °C as we thought it would be easier to control the reaction and after 4 h 
at this temperature a ratio of 2.5:1 81 to 80 was observed (Entry 5, Table 2), a 
promising result. However, reducing the reaction time had very little effect on the 
chemo-selectivity (Entry 6, Table 2). The reaction was attempted at "10 °C but even 
after 4 h there was no reaction (Entry 7, Table 2). Halving the number of equivalents 
of diiodomethane and diethylzinc, to two and one equivalents respectively, also 
resulted in no reaction after 4 h at RT (Entry 8, Table 2). 
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Ratio of Productsb Entrya Temperature 
(°C) 
Reaction 
Time 
(min) 
81 80 
 
79 
1 RT 240 7 1 0 
2 RT 30 3 1 0 
3 RT 10 trace 1 5 
4 RT 20 trace 1 4 
5 0 240 2.5 1 0 
6 0 30 2.5 1 0 
7 "10 °C 240 0 0 1 
8c RT 240 0 0 1 
 
aConditions (Entries 1"7): CH2I2 (4 eq), Et2Zn (2 eq), CH2Cl2. 
bRatio of 80 to 81 determined by analysis of the 1H NMR spectra of the unpurified reaction mixtures. 
cReaction carried out using only 2 equivalents of CH2I2 and 1 equivalent of Et2Zn. 
 
Table 2 Summary of the cyclopropanation of  79. 
 
 
Given that we were unable to achieve good chemo-selectivity using standard 
Simmons-Smith conditions, a Charette modification31 (which is also known to react 
faster with allylic alcohols than unfunctionalised alkenes) was trialled. The first step 
of the Simmons-Smith reaction using allylic alcohols is the generation of an 
iodomethylzinc alkoxide and computational studies by Nakamura et al.32 suggest that 
the reactive species is likely to be a multimetallic aggregate, either a dimer or a 
tetramer (Figure 5). A dioxaborolane additive is used in the Charette reaction and 
computational studies by Wang et al.33 suggest that the reactive species is a complex 
formed from dioxaboralane, Zn(CH2I)2 and the alcohol (Figure 5).  
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O Zn
Zn
O Zn
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I
IH2C
R CH2I
IH2C
R
Zn
O Zn
O
I
IH2C
R
O
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O
Me2NOC
O
OMe2N
Zn
I
dimer tetramer dioxabaorolane complex  
 
Figure 5 The proposed reactive species in the Simmons-Smith cyclopropanation of allylic alcohols.32,33 
 
It was hoped that this alternative reaction mechanism would improve the chemo-
selectivity of our reaction but unfortunately this procedure only led to decomposition 
of substrate 79 (Scheme 22). 
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Scheme 22 Simmons-Smith reaction on TBS protected alcohol 79 using a dioxaboralane additive. 
 
A TBDPS variant of the route shown in Scheme 20 was attempted. It was anticipated 
that the extra bulk may provide some additional steric hindrance to the unwanted 
cyclopropanation on the unfunctionalised alkene. Pleasingly the synthesis of TBDPS-
containing 85 proved as facile as its TBS analogue (Scheme 23), but unfortunately, 
the protecting group switch did not improve the chemo-selectivity for the 
cyclopropanation of 85, which was found to be similarly poor to that of TBS variant 
79; the best result was a 2:1 ratio of bis-cyclopropane 87 to cyclopropane 86 (Scheme 
23). The ratio of 87 to 86 was again determined by analysis of the 1H NMR spectra of 
the unpurified reaction mixtures. Consumption of the peaks corresponding to the 
double bonds of diene 85 at 5.97 (1H, dd, J 7.5, 5.5 Hz), 5.74!5.69 (1H, m) and 
5.51!5.45 (1H, m) was observed alongside the appearance of cyclopropyl peaks at 
1.01!0.91 (2H, m) and 0.77!0.62 (2H, m). 
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TBDPSCl, NaH,
THF
OHTBDPSO OTBDPSO
DMP, 
CH2Cl2
DBU, THF
OTBDPSO OHTBDPSO
82, 77% 83
84, 86% over 2 steps 85, 63%
59
0 °C ! RT, 
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0 °C, 20 min
DIBAL, 
CH2Cl2
0 °C, 30 min
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TBDPSO OH TBDPSO OH
86 87
1     :     2  
 
Scheme 23 TBDPS Mono-protection route to Simmons-Smith precursor 85 and subsequent Simmons-
Smith cyclopropanation.  
 
As shown, we were unable to achieve good chemo-selectivity when using Simmons-
Smith cyclopropanation on the desmethyl model system. However, we believed that 
the gem-dimethyl group on the analogous pyxidatol C system could influence this 
cyclopropanation. We thought it possible that the steric bulk of the cycloheptadiene 
dimethyl group might hinder the unwanted cyclopropanation on the unfunctionalised 
alkene (Figure 6) giving greater control over the regioselectivity of the 
cyclopropanation. Therefore, attention turned from the model system to preparation of 
the gem-dimethyl equivalent of alcohol 85. 
 
OHTBDPSO
IZn
I
 
 
Figure 6 Potential destabilising steric interaction of gem dimethyl group toward cyclopropanation of 
the unfunctionalised alkene. 
 
 
 
 
 21 
2.3 From the Desmethyl Model System to the Gem-Dimethyl System  
 
The requisite gem-dimethyl cyclopropane was made using a non-commercial 
sulfoxonium salt, necessitating the preparation of triisopropylsulfoxonium 
tetrafluoroborate 52, which was prepared in two steps from commercially available 
diisopropyl sulfide. Badet and Julia34 reported the synthesis of sulfonium salt 51 using 
IPA and MSA as a source of isopropyl cation to alkylate diisopropyl sulfide, which 
was followed by subsequent anion exchange with tetrafluoroboric acid. A protocol 
for the oxidation of this salt was developed within the Taylor group by Pugh,23 based 
on work by Ciba-Geigy.35 A sulfonoperoxic acid is formed in situ when ortho-
nitrobenzenesulfonyl chloride, hydrogen peroxide and barium hydroxide are mixed, 
which oxidizes sulfonium salt 51 to sulfoxonium salt 52 (Scheme 24). With the 
sulfoxonium salt 52 in hand, Corey-Chaykovsky type cyclopropanation of diethyl 
fumarate was then performed, which gave gem-dimethyl cyclopropane 53 in 73% 
yield, although yields of 90% have been obtained for this reaction under these 
conditions, within the Taylor group.23 LiAlH4 reduction followed in 86% yield and 
finally a TOP reaction, furnished E,E-diester 57a in 69% yield and E,Z-diester 57b in 
4% yield.  
 
EtO2C CO2EtEtO2C CO2Et
LiAlH4, THF HO OH
MnO2, 
Ph3PCHCO2Et,
CHCl3
EtO2C CO2Et
53 73%
57a, 69%
NaH, DMF
56a, 86%
EtO2C
CO2Et
Si-Pr i-Pr
BF4i-Pr
i-Pr S i-Pr ii) HBF4
i) IPA, MSA
reflux, 5 d
51, 56%
52, 63%
Ba(OH)2•8H2O,
H2O2, H2O
RT, 16 h SO2Cl
NO2
Si-Pr i-Pri-Pr
O BF4
reflux, 16 h
+
57b, 4%
0 °C ! RT, 2 h 0 °C ! reflux, 2 h
 
 
Scheme 24 The synthesis of gem-dimethyl diester 57a using Taylor group methodologies. 
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With diester 57a in hand, we could now test the key step in our retrosynthesis, the 
Cope rearrangement, which we hoped would introduce the 7 membered ring found in 
pyxidatol C. We were very disappointed to find that, after following the same 
procedure as that for its desmethyl analogue 55a, heating 57a in xylene at 130 °C, 
only starting material was observed along with significant decomposition products in 
the 1H NMR spectrum of the unpurified reaction mixture (Scheme 25).  
 
EtO2C CO2Et
EtO2C CO2Et
88a
xylene
X
57a 130 °C, 16 h
EtO2C CO2Et
EtO2C CO2Et
58a
xylene
55a 130 °C, 16 h
 
 
Scheme 25 The unsuccessful thermal Cope rearrangement of 57a. 
 
2.4 The Ethoxide-Promoted Cope Rearrangement 
 
Disappointingly, gem-dimethlydivinylcyclopropane 57a did not undergo the Cope 
rearrangement upon heating in xylene. We therefore considered an alternative strategy 
in which to encourage the Cope rearrangement. The Cope rearrangements of trans-
divinylcyclopropanes are understood to proceed by first epimerising to the cis-
cyclopropane before undergoing a rapid [3,3]-sigmatropic shift. With this in mind, it 
was thought that a base-catalysed epimerisation could facilitate the Cope 
rearrangement. DBU (pKaH in water ~12) in THF at 70 ˚C was attempted but there 
was no reaction. The stronger base, sodium ethoxide (pKaH in water ~16) in ethanol at 
90 °C, was tested and pleasingly the Cope rearrangement was successful. 
Unfortunately, subsequent isomerisation of the double bonds into conjugation with 
the ester groups also occurred in situ, providing cycloheptadiene 89 in 80% yield 
(Scheme 26). 
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Scheme 26 Ethoxide catalysed Cope rearrangement and isomerisation to give 89. 
 
In order to confirm that the ethoxide base was indeed catalyzing the Cope 
rearrangement, and that the change in solvent from xylene to ethanol was not 
responsible for the observed Cope rearrangement, the reaction was attempted in the 
absence of base, using EtOH as the solvent. Thus, diester 57a was heated in ethanol at 
90 °C and as expected there was no reaction, confirming that the base was responsible 
for the Cope rearrangement. Under otherwise identical conditions to the reaction with 
sodium ethoxide, but at 50 °C and 70 °C, incomplete conversion into cycloheptadiene 
89 was observed and so the initial conditions, using sodium ethoxide at 90 °C, were 
considered optimal for the synthesis of cycloheptadiene 89. 
 
 
Ratio of Productsa Entry Temperature 
(°C) 
Solvent Base 
89 57a 
1 130 xylene - 0 1b 
2 70 THF DBU 0 1 
3 90 EtOH NaOEt 1 0 
4 90 EtOH - 0 1 
5 50 EtOH NaOEt 1 20 
6 70 EtOH NaOEt 1 10 
 
aRatio determined by analysis of the 1H NMR spectra of unpurified reaction mixtures. 
bSome decomposition was also observed. 
 
Table 3 The base-catalysed Cope rearrangement of 57a. 
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While the Cope rearrangement of 57a was achieved using NaOEt as an additive, the 
in situ isomerisation of the double bonds into conjugation with the ester groups was 
an unwanted side reaction. However, the isomerisation of one of the double bonds 
was necessary in the retrosynthetic plan. We therefore planned to exploit this 
isomerisation by preparing an unsymmetrical divinylcyclopropane 90 that could be 
subjected to the optimized conditions for the base-catalysed Cope rearrangement in 
the expectation of obtaining unsymmetrical cycloheptadiene 91 (Scheme 27). It was 
then hoped to synthesise alcohol 90 by monohydrolysis of diester 57a, followed by 
borane reduction of the resulting acid 92. 
  
EtO2C CO2Et CO2EtHO2C
CO2Et
monohydrolysis BH3
CO2EtHO
NaOEt
57a 92
90
HO
CO2Et
90
HO
CO2EtHO
91
 
 
Scheme 27 The synthetic strategy towards cycloheptadiene 91. 
 
Unfortunately, monohydrolysis proved troublesome; unsuccessful attempts using 
lithium hydroxide in ethanol36 and sodium hydroxide in water/THF37 led only to di-
acid formation and an alternative strategy targeting protected hydroxyester 100 
(Scheme 28) was planned instead, and this proved straightforward. Mono-TBS 
protection of diol 56a furnished alcohol 93 in 65% yield which, following 
Dess"Martin oxidation, gave aldehyde 94 in 60% yield. Wittig olefination followed 
by DIBAL reduction afforded alcohol 96 in 79% yield. Benzyl protection with benzyl 
bromide gave 97 which was taken on crude to the next step. TBS cleavage with 
TBAF, then gave 98 in 44% over two steps. Dess"Martin oxidation (68% yield) 
followed by Wittig olefination (96% yield) furnished the required substrate 100 for 
testing the key mixed Cope reaction. We trialled the reaction using the established 
ethoxide conditions (Entry 3, Table 3) but, disappointingly, divinylcyclopropane 100 
was unreactive under these conditions and starting material 100 was recovered from 
the reaction unchanged. 
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Scheme 28 The synthesis of cyclopropane 100. 
 
In summary the Cope rearrangement of divinylcyclopropane 55 was successful 
(Scheme 25). However, under identical conditions, on the analogous gem-dimethyl 
pyxidatol C system it was unsuccessful (Scheme 25). The Cope rearrangement of a 
gem-dimethyl divinylcyclopropane was fundamental to the synthetic strategy for the 
synthesis of pyxidatol C and presented a significant challenge. Pleasingly, the Cope 
rearrangement was possible, using base-catalysed trans/cis-isomerisation, and despite 
leading to the unwanted cyclopheptadiene 89 (Scheme 26), this result provided reason 
to be optimistic that this challenge could be overcome (Chapter 3).  
 
 
 
 
 
 
 
 26 
Chapter 3 
The Cope Rearrangement of Gem-Dimethyl Substituted 
Divinylcyclopropanes 
 
3.1 Introduction 
 
3.1.1 The Cope rearrangement of divinylcylopropanes 
 
The thermal Cope rearrangement of divinylcyclopropanes was first described by 
Vogel in 1960, who reported the rearrangement of divinylcyclopropane 102a to 1,4-
cycloheptadiene 103 (Scheme 29).38"40 
 
102a 103
!50 °C
 
 
Scheme 29 The Cope rearrangement of cis-divinylcyclopropane 102a.  
 
The rearrangement of cis-divinylcyclopropane 102a to cycloheptadiene 103 is facile, 
even at "50 °C. However, the rearrangement of its trans-analogue 102b required 
temperatures of 190 °C (Scheme 30). The Cope rearrangements of trans-
divinylcyclopropanes are understood to proceed via epimerisation to the cis-
cyclopropane (at temperatures in the region of 120"200 °C) before undergoing a rapid 
[3,3]-sigmatropic shift.41  
 
190 °C
102b 102a 103  
 
Scheme 30 The Cope rearrangement of trans-divinylcyclopropane 102b first reported by Vogel et al. 
 
The Cope rearrangement of divinylcyclopropanes is symmetry allowed when it is 
suprafacial for all three components ['2S + (2S + '2S]. There are two possible 
transition state structures for an all-suprafacial reaction, one being chair-like and the 
other boat-like. The Cope rearrangement of divinylcyclopropanes proceeds via a boat-
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like transition state41 (Figure 7) because the chair-like transition state would lead to 
the formation of a highly strained ring containing two trans-double bonds. 
 
!2s
"2s
"2s"2s
!2s
"2s
boat-likechair-like  
 
Figure 7 The symmetry-allowed chair and boat-like transition state for the Cope rearrangement of 
divinylcyclopropanes. 
 
3.1.2 Steric Effects in the Cope Rearangement of Divinylcyclopropanes 
 
Literature precedent shows that the stability of this boat-like transition state is highly 
sensitive to steric interactions.41"51 Ohloff and Pickenhagen were the first to report 
this phenomenon (Scheme 31).42 They found that diene 104a underwent the Cope 
rearrangement at 15 °C whereas diene 104b required the higher temperature of 75 °C 
in order to react. This was attributed to a destabilising steric interaction between the 
cyclopropyl moiety and the butyl group in the boat-like transition state of 104b. Even 
higher temperatures (175 °C) were required before dienes 104c and 104d rearranged 
to generate cycloheptadiene 105, because in their cases epimerisation to the cis-
cyclopropane was also required. 
 
104a
105
n-Bu
n-Bu
104b
104c
n-Bu
n-Bu
104d
n-Bu
15 °C
75 °C
175 °C
175 °C
n-Bu
n-Bu
 
 
Scheme 31 Work by Ohloff and Pickenhagen on the thermal Cope rearrangement.42 Reactions were 
performed without solvent and yields and reaction times were not reported. 
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Baldwin et al.43,44 tested the Cope rearrangements of compounds 106a"106c (Scheme 
32). They found that the E,E-diene 106a, underwent the thermal Cope rearrangement 
at 178 °C giving cycloheptadiene 107a. The Cope rearrangement of the E,Z-diene 
106b was also successful, this time at 179 °C, affording cycloheptadiene 107b. 
Crucially, Z,Z-diene 106c, did not undergo a Cope rearrangement; Baldwin proposed 
that the boat-like transition state for this rearrangement is higher in energy than that of 
the analogous E,E/E,Z variants because of two destabilising steric interactions 
between the methyl substituents and the cyclopropyl moiety. As such, the 
rearrangement does not take place even though cis/trans-isomerisation of the 
cyclopropane takes place. 
 
178 °C
179 °C
106a
106b
106c
107b, 95%
107a, 99%
4.2 h
4.2 h
179 °C
4.2 h
106d
 
 
Scheme 32 Work by Baldwin et al. on the thermal Cope rearrangement.43"44 Reactions were performed 
without solvent. 
 
Work by Schneider and Rau,45 showed that the Cope rearrangement of diene 102a to 
cycloheptadiene 103 occurs at a rate 5800 times faster than the conversion of diene 
108 into cycloheptadiene 109 (Scheme 33). Again, a destabilising steric interaction 
between the methyl group in diene 108 and the cyclopropyl ring moiety in the 
transition state was used to explain this large difference in rate. 
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Scheme 33 Work by Schneider and Rau on the thermal Cope rearrangement.45 The solvent and the 
yields for the reactions were not reported. 
 
Sasaki et al.46,47 observed the profound effect a cyclopropyl gem-dimethyl group can 
have on the rearrangements of aza-divinylcyclopropanes. They found that the ‘aza-
divinylcyclopropane’ rearrangement (which is still a [3,3]-sigmatropic rearrangement 
but not strictly a Cope rearrangement) of isocyanate 110 was extremely facile; in fact, 
they could not isolate vinylcyclopropyl isocyanate 110, even when it was prepared at 
"45 °C, and instead rearranged product 111 was isolated. However, they found that 
the ‘aza-divinylcyclopropane’ rearrangement of the gem-dimethyl analogue 112 
required the far greater temperature of 144 °C before rearranged product 113 was 
observed even though the substituents are cis-orientated (Scheme 34).  
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Scheme 34 Work by Sasaki et al. on the ‘aza-divinylcyclopropane’ rearrangement.46 
 
Müller et al.48 report similar findings, in which a gem-dimethyl group had a similar 
effect on related ‘aza-divinylcyclopropane’ rearrangements; isocyanate 114 
underwent rearrangement to product 115 at 80 °C, whereas the gem-dimethyl 
analogue 116 did not rearrange, even upon heating to 144 °C.  
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Scheme 35 Work by Müller et al. on the ‘aza-divinylcyclopropane’ rearrangement.48 
 
Further work by Sasaki et al.46 showed that the cis-divinylcyclopropanes 118a and 
119a, bearing a gem-dimethyl group, did not undergo the Cope rearrangement when 
heated to 144 °C and instead underwent cis/trans-isomerisation at the cyclopropane. 
 
144 °C, xylene
118a R = H
119a R = Me
R
R
118b
119b
R
R
 
 
Scheme 36 Work by Sasaki et al. on the thermal Cope rearrangement.47 
 
An interesting Cope rearrangement of enone 120 was reported by Piers et al.,49"51 in 
which after 4 h at 69 °C diene 120 was converted into cycloheptadiene 121 in 97% 
yield. The analogue 122a, bearing a methyl substituent on the enone, was found to be 
far more stable, however; on heating diene 122a to a far greater temperature (144 °C) 
isomerisation to the trans-isomer 122b was found to compete with the Cope 
rearrangement and the ratio of the two products cycloheptadiene 123 and trans-diene 
122b was found to vary between 1.1:1 to 2.7:1.  
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O
O
O
O
O+
123, 48 % 122b, 17 %
48 h
144 °C, xylene
69 °C, hexane
4 h
121, 97 %
122a
120
 
 
Scheme 37 Work by Piers et al. on the thermal Cope rearrangement.49"51 
 
The examples described above all demonstrate that the energy of the boat-like 
transition state in the Cope rearrangement of divinylcyclopropanes is highly sensitive 
to steric interactions. This may explain why in the vast majority of literature 
examples, the cyclopropane is substituted only with the two alkene groups involved in 
the rearrangement. Limited examples of the Cope rearrangement of trisubstituted 
cyclopropanes have also been reported, but these are far less common (e.g. 123&124, 
Scheme 38).52 
 
200 °C, mesitylene
123
124, 57%
60 h
HO
OTBDPS
HO
H OTBDPS
 
 
Scheme 38 Work by Wollack et al. on the thermal Cope rearrangement.52 
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To the best of our knowledge, the only examples of tetrasubstituted cyclopropanes 
undergoing the Cope rearrangement, apart from the example described by Piers et al. 
(Scheme 37),49"51 are of fused bicyclic systems (e.g. 125&126, Scheme 39).53 In 
these systems the compound is much more rigid and the conformation of the starting 
material allows the Cope rearrangement to occur more readily. The relief of ring 
strain is likely to be an additional driving force in these cases.     
 
80 °C, toluene
125
O
Ph 44 h
Ph
O
126, 68%  
 
Scheme 39 Work by Kim et al. on the thermal Cope rearrangement on a fused bicyclic system.53 
 
3.2 The Cope Rearangement of Diester 57a 
 
As outlined in Chapter two, we were able to prepare cycloheptadiene 58a by heating 
diester 55a in xylene for 16 h but the analogous reaction of diene 57a was 
unsuccessful (Scheme 40). 
 
EtO2C CO2Et EtO2C CO2Et
58a
xylene
55a 130 °C, 16 h
EtO2C CO2Et
EtO2C CO2Et
88a
xylene
X
57a 130 °C, 16 h
 
 
Scheme 40 The Cope rearrangement of 55a to give 58a and the unsuccessful Cope rearrangement of 
57a. 
 
Based on the literature precedent described in section 3.1, this result is not altogether 
unexpected as it is known that bulky substituents typically inhibit the Cope 
rearrangements of divinylcyclopropanes41"51 by destabilising the boat-like transition 
state. A destabilising steric interaction between a geminal methyl group and the 
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double bond moiety in the transition state of diene 57a (A, Figure 8) rearranging to 
cycloheptadiene 88a is most likely the major obstacle to rearrangement explaining 
why the thermal Cope rearrangement is facile with the desmethyl substrate 55a (B, 
Figure 8), but not with its gem-dimethyl equivalent 57a (Scheme 40).  
 
EtO2CEtO2C
EtO2CEtO2C
A B  
 
Figure 8 A diagram showing the potential destabilising steric interactions when 57a adopts the 
required boat-like transition state (A).  
 
3.3 A Systematic Study into the Cope Rearrangement 
 
We were surprised to discover that a study comparing the Cope rearrangements of a 
gem-dimethyl divinylcyclopropane with its non-methylated analogue has, to the best 
of our knowledge, not been reported in the literature. Thus, in order to better 
understand how steric effects influence our system, we planned a systematic study 
into the Cope rearrangement of the gem-dimethyl substrate 57 and desmethyl 
substrate 55. We planned to prepare all of the possible cis/trans and E/Z isomers of 57 
and 55 (Figure 9) and determine how readily they undergo the Cope rearrangement.  
 
CO2Et
EtO2CCO2EtEtO2C
57b57a
EtO2C CO2Et
57c
CO2Et
EtO2CCO2EtEtO2C
57e57d
EtO2C CO2Et
57f
CO2Et
EtO2CCO2EtEtO2C
55b55a
EtO2C CO2Et
55c
CO2Et
EtO2CCO2EtEtO2C
55e55d
EtO2C CO2Et
55f
 
 
Figure 9 The target substrates for a systematic study into the Cope rearrangement.  
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3.4 Synthesis of Substrates (Divinylcyclopropanes 57a!57f and 55a!55f) 
 
3.4.1 Synthesis of Gem-Dimethyl Divinylcyclopropanes (57a!57f) 
 
Commercially available ethyl chrysanthemate was used to prepare diols 56a and 56b 
(which were separable by flash column chromatography) via ozonolysis followed by 
LiAlH4 reduction (Scheme 41).  
 
EtO2C
Ethyl chrysanthemate
mixture of cis and trans
in a ratio of 2:3
O3, CH2Cl2
EtO2C
O
127, 97%
!78 °C
OH
56b, 31%
HO
OHHO
56a, 49%
+
cis:trans 2:3
LiAlH4,
THF
0 °C " RT, 
10 min
 
 
Scheme 41 The synthesis of diols 56a and 56b. 
 
Trans-diol 56a was then subjected to Taylor group TOP chemistry (Section 1.10),24 
resulting in the preparation of two of the required substrates, E,E-diene 57a and E,Z-
diene 57b, in 69% and 4% yield respectively (Scheme 42). The double bond geometry 
of both compounds (and indeed throughout) was confirmed by analysis of their J3H-H 
alkene coupling constants. Note that an alternative preparation of diol 56a was also 
described earlier (see Scheme 24).  
 
OHHO
56a
CO2Et
EtO2CCO2EtEtO2C
57b, 4%57a, 69%
MnO2,
Ph3PCHCO2Et,
CHCl3
+
reflux, 18 h
J 3Ha-Hb = 15.5 Hz
a b a b
c
d
J 3Ha-Hb = 15.5 Hz
J 3Hc-Hd = 10 Hz  
Scheme 42 The synthesis of 57a and 57b. Previously described in Section 2.3. 
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The Still"Gennari modification54 of the HWE reaction was used to prepare 57c, 
following manganese dioxide oxidation of diol 56a to generate dialdehyde 128 
(Scheme 43).  
 
OHHO
56a
OO
EtO2C CO2Et
(F3CCH2O)2POCH2CO2Et,
KHMDS, 18-crown-6, 
THF, toluene
57c, 35%128, 72%
MnO2, 
CHCl3
reflux, 
16 h
!78 °C, 2 h
J 3Ha-Hb = 11.5 Hz
a
b
 
Scheme 43 The synthesis of 57c (> 20 : 1 Z : E). 
 
A stepwise strategy was necessary for the synthesis of the cis-variants, because the 
oxidation of cis-diols, for example 56b, results in lactone formation via lactol 129 
(Scheme 44). 
OHHO
MnO2, 
CHCl3
O O
130, 64%
56b HO O
129
rt, 16 h
 
 
Scheme 44 MnO2 oxidation of cis-cyclopropyl diols leads to lactone formation. 
 
Using the ethyl chrysanthemate-derived diol 56a, lactol 129 was prepared by IBX 
oxidation. Subsequent Wittig reaction furnished the desired compound 131. 
 
O
Ph3PCHCO2Et, 
CH2Cl2
EtO2C
OH
131, 47%
OH
56b
HO
IBX, DMSO
HO
129
RT, 2 h RT, 16 h
 
 
Scheme 45 The synthesis of 131 via lactol 129 (> 20 : 1 E : Z). 
 
However, poor yields and difficulties repeating the route shown above, led us to test 
an alternative synthesis of compound 131 (Scheme 46). Thus, the mono-TBS 
protection of 56b, followed by a TOP reaction was straightforward, affording 133 in 
good yield.  Unfortunately, TBS cleavage using TBAF led to oxy-Michael addition 
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giving rise to the unwanted tetrahydrofuran 134. Pleasingly, this unwanted side-
reaction was avoided by using an acidic source of fluoride (aqueous HF) furnishing 
the desired alcohol 131. A TOP reaction was then performed, completing the 
synthesis of two of the required substrates; E,E-diene 57d was obtained in 68% yield 
along with E,Z-diene 57e in 16% yield. (Scheme 46).  
 
OHHO
56b
NaH, TBSCl, 
THF
OTBSHO
132, 84%
OTBS
OH
EtO2C
EtO2C
CO2EtEtO2C
57d, 68%
131, 75%
133, 78%
HF(aq), MeCN
MnO2,
Ph3PCHCO2Et, 
CHCl3
CO2Et
57e, 16%
EtO2C
TBAF, THF
O
EtO2C
134, 76%, d.r 10 : 1
OTBSEtO2C 133
Ph3PCHCO2Et, 
CHCl3
0 °C ! RT, 
105 m
reflux, 2 d
RT, 17 h
RT, 16 h RT, 16 h
+
J 3Ha-Hb = 15 Hz J 3Ha-Hb = 15 Hz,
J 3Hc-Hd = 11.5 Hz
aba b c d
5 : 1 E : Z
5 : 1 E : Z 5 : 1 E : Z ; E-isomer 
was isolated by chromatography
  
 
Scheme 46 The synthesis of 57d and 57e. 
 
The oxidation of alcohol 132 using MnO2 followed by a Still"Gennari reaction, silyl 
deprotection using HF (again, this was necessary to avoid oxy-Michael addition) and 
another MnO2 oxidation/Still"Gennari sequence afforded the final gem-dimethyl 
substrate, Z,Z-diene 57f  (Scheme 47). 
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OTBSHO
132
OTBSO
OTBS
EtO2C
OH
EtO2C
O
EtO2C
EtO2C CO2Et
MnO2, CHCl3
(F3CCH2O)2POCH2CO2Et,
KHMDS, 18-crown-6, 
THF, toluene
57f, 56%
137, 53% 138, 85%
136, 55%
139, 53%
HF(aq), MeCN
MnO2,
CHCl3
(F3CCH2O)2POCH2CO2Et,
KHMDS, 18-crown-6, 
THF, toluene
RT, 16 h !78 °C, 30 min
RT, 16 h RT, 16 h
!78 °C, 1 h
J 3Ha-Hb = 12 Hz
a b
>20 : 1 Z : E
>20 : 1 Z : E
 
 
Scheme 47 The synthesis of 57f. 
 
3.4.2 Synthesis of Desmethyl Divinylcyclopropanes (55a!55f)  
 
The trans-desmethyl divinylcyclopropanes were prepared from commercially 
available diethyl trans-1,2-cyclopropanedicarboxylate; LiAlH4 reduction afforded 
diol 54a, and the Taylor group’s TOP chemistry was then used to prepare E,E-diene 
55a (Scheme 48).  
 
OHHO
54a, 71%
CO2EtEtO2C
EtO2C CO2Et
55a, 75%
MnO2,
Ph3PCHCO2Et, 
CHCl3
diethyl trans-1,2-
cyclopropanedicarboxylate
LiAlH4,THF
0 °C ! 70 °C 
! RT, 20 h
reflux, 18 h
J 3Ha-Hb = 15.5 Hz
a b
>20 : 1 E : Z
 
 
Scheme 48 The synthesis of 55a. Previously described in Section 1.10. 
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The synthesis of E,Z-diene 55b began with mono-TBS protection of 54a, followed by 
a TOP reaction furnishing ester 141. TBS cleavage using TBAF furnished 142 (oxy-
Michael addition cannot take place on the trans-cyclopropane system) and subsequent 
MnO2 oxidation to form aldehyde 143 and a Still"Gennari reaction completed the 
synthesis of E,Z-diene 55b  (Scheme 49).  
OHHO
54a
OTBSHO
140, 69%
NaH, TBSCl, THF
MnO2,
Ph3PCHCO2Et, 
CHCl3
OTBSEtO2C
TBAF, THF OHEtO2C
MnO2, CHCl3
O
EtO2C
(F3CCH2O)2POCH2CO2Et,
KHMDS, 18-crown-6, 
THF, toluene CO2Et
55b, 46%
EtO2C
141, 85% 142, 77%
143, 67% !78 °C, 2 h
0 °C " RT, 105 m reflux, 18 h
RT, 17 h RT, 20 h
J 3Ha-Hb = 15.5 Hz,
J 3Hc-Hd = 11.0 Hz
a b c d
>10 : 1 E : Z ; E-isomer 
was isolated by chromatography
>20 : 1 Z : E
 
 
Scheme 49 The synthesis of 55b. 
 
A double Still"Gennari modified HWE reaction was used to prepare 55c after the 
MnO2 oxidation of 54a was used to generate dialdehyde 144 (Scheme 50).  
 
OO
EtO2C CO2Et
55c, 63%144, 11%
OHHO
54a
(F3CCH2O)2POCH2CO2Et,
KHMDS, 18-crown-6, 
THF, toluene
MnO2, 
CHCl3
!78 °C, 2 hreflux, 16 h
J 3Ha-Hb = 11.5 Hz
a b
>20 : 1 Z : E
 
Scheme 50 The synthesis of 55c. 
 
The cis-desmethyl substrates were prepared from diol 54b, which was synthesised via 
the LiAlH4 reduction of commercially available 3-oxabicyclo[3.1.0]hexane-2,4-dione. 
Mono-TBS protection of diol 54b, followed by MnO2 oxidation and a Wittig reaction 
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furnished ester 146. TBS cleavage using aqueous HF provided alcohol 147 in good 
yield. MnO2 oxidation then afforded aldehyde 148. A Wittig reaction was then 
performed in an attempt to generate diester 55d; however, while the intermediate 
presumably formed, it could not be isolated and instead underwent Cope 
rearrangement spontaneously in situ, furnishing cycloheptadiene 58a in good yield 
(Scheme 51). 
 
O OO
OHHO
54b, 79%
NaH, TBSCl, 
THF
OTBSHO
OTBSO
145, 75%
OTBS
146, 63%
EtO2C
HF(aq), 
MeCN
OH
147, 94%
EtO2C
O
148, 81%
EtO2C CO2EtEtO2C
CO2Et
55d
58a, 79% from 148
EtO2C
144, quant.
3-oxabicyclo[3.1.0]
hexane-2,4-dione
LiAlH4, 
THF
MnO2, 
CHCl3
Ph3PCHCO2Et, 
CHCl3
MnO2, 
CHCl3
Ph3PCHCO2Et, 
CHCl3
reflux, 16 h 0 °C ! RT, 
105 m
RT, 16 h
RT, 16 h RT, 16 h
RT, 16 h RT, 16 h
10 : 1 E : Z ; E-isomer 
was isolated by chromatography
 
 
Scheme 51 The synthesis of 58a via 55d. 
 
A similar result was obtained during the attempted synthesis of E,Z-diene 55e; the 
Still"Gennari reaction of compound 148 also afforded the Cope rearranged product 
58b at RT, presumably via divinylcyclopropane 55e  (Scheme 52). 
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CO2Et
EtO2C
55e
(F3CCH2O)2POCH2CO2Et,
KHMDS, 18-crown-6, THF, 
toluene
!78 °C, 2 h
O
148
EtO2C
EtO2C CO2Et
58b, 75% from 148  
 
Scheme 52 The synthesis of 58b via 55e. 
 
A Still"Gennari reaction using aldehyde 145, HF mediated silyl deprotection and 
another MnO2 oxidation and Still"Gennari reaction again led to the Cope 
rearrangement product 58a at RT, presumably via the divinylcyclopropane 55f which 
could not be isolated (Scheme 53). 
 
OTBSO
145
OTBS
EtO2C
OH
EtO2C
O
EtO2C
149, 40%
150, 97% 151, 53%
EtO2C CO2Et
55f EtO2C CO2Et
58a, 81% from 151
!78 °C, 2 h
(F3CCH2O)2POCH2CO2Et,
KHMDS, 18-crown-6, THF, 
toluene
HF(aq), 
MeCN
(F3CCH2O)2POCH2CO2Et,
KHMDS, 18-crown-6, THF, 
toluene
MnO2, 
CHCl3
!78 °C, 2 h RT, 16 h
RT, 16 h
>20 : 1 Z : E
 
 
Scheme 53 The synthesis of 58a via 55f. 
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By considering the symmetry of the two diastereomeric cycloheptadienes 58a and 
58b, their stereochemistry could be inferred remarkably straightforwardly by analysis 
of their 1H NMR spectra. The spectrum of the cis-compound 58a has two distinct 
peaks for the characteristic diastereotopic protons (J = 20 Hz) shown in Figure 10.  
 
 
 
 
 
                                                                                         3.06"2.97 (1H, m) 
                                                                                     2.68 (1H, dt, J 20.0, 7.0) 
     
 
 
 
 
 
Figure 10 The 1H NMR spectrum of 58a with the peaks corresponding to the characteristic 
diastereotopic protons highlighted. 
 
Conversely, the corresponding protons in the trans-compound are homotopic and thus 
appear as a single two proton resonance (Figure 11).  
 
 
 
 
 
 
 
                                                                                 2.83"2.88 (2H, m) 
 
 
 
 
 
 
Figure 11 The 1H NMR spectrum of 58b with the characteristic homotopic protons highlighted. 
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3.5 A Study into the Effect of Gem-Dimethyl Substitution on the Cope 
Rearrangement of Divinylcyclopropanes 
 
We next tested the Cope rearrangements of all of the cis/trans and E/Z-isomers of 55 
and 57 as 0.19 mol dm-3 solutions in xylene at 5 different temperatures: RT, 40 °C, 70 
°C, 100 °C and 130 °C. Each substrate was stirred at these temperatures for 17 h 
before the percentage conversion was measured as a ratio of product to starting 
material, via analysis of the 1H NMR spectra of the unpurified reaction mixtures. The 
results are summarised in Table 4 and are discussed in more detail in the following 
section.  
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% Conversion (17 h)a 
Temperature  
Entry Reagent Product 
RT 40 °C 70 °C 100 °C 130 °C 
1 
E E55a  
 E E58a  
0 0 0 20 100b 
2 E
E 55b  E E
58b  
0 0 0 20 100b 
3 
55c
EE
 E E
58a  
0 0 0 0 80b 
4 
E E
55d  E E
58a  
100c - - - - 
5 E
E 55e  E E
58b  
100c - - - - 
6 
55f
EE
 E E
58a  
100c - - - - 
7 
E E
57a  E E
88a  
0 0 0 0 0b 
8 
E
E 57b  E E
88b  
0 0 0 0 0b 
9 
57c
EE
 E E
88a  
0 0 0 0 0b 
10 
E E
57d  E E
88a  
0 30 90 100d 100b 
11 
E
E 57e  E E
88b  
0 0 0 0 0b 
12 
57f
EE
 E E
88a  
0 0 0 0 0b 
 
aE = CO2Et. All reactions were carried out as 0.19 mol dm-3 solutions in xylene. All reactions were carried out for 17 h. % 
Conversion was determined via 1H NMR analysis of the unpurified reaction mixtures as a ratio of product to starting material. 
bSome decomposition was also evident. 
cThe divinylcyclopropane could not be isolated at RT; the cycloheptadiene shown was instead isolated during the attempted 
preparation of the diene. 
dCompound 88a was isolated in 78% yield after flash column chromatography. 
 
Table 4 The Cope rearrangement on test substrates 55 and 57. 
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CO2EtEtO2C
xylene
CO2EtEtO2C H HH H
The 1H NMR spectra for the key rearrangement of 57d into 88a at the 5 different 
temperatures are displayed in Figure 12. The spectra show that the reaction was 
complete after 17 h at 100 °C and show the decomposition that was evident after 17 h 
at 130 °C. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12 Following the conversion of 57a into 88a by 1H NMR spectroscopy at RT, 40 °C, 70 °C, 
100°C and 130°C, showing complete conversion at 100 °C and signs of decomposition at 130 °C. 
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The key findings of the study into the Cope rearrangement are: i) cis-
divinylcyclopropanes undergo the Cope rearrangement more readily than trans-
divinylcyclopropanes, ii) desmethyl divinylcyclopropanes undergo the Cope 
rearrangement more readily than their gem-dimethyl analogues, iii) divinyclopropanes 
with E-double bonds undergo the Cope rearrangement more readily than those with Z-
double bonds, and iv) there is an increased barrier to epimerisation between trans and 
cis-divinylcyclopropanes in the gem-dimethyl series. These observations are 
illustrated below: 
 
i) cis-Divinylcyclopropanes undergo the Cope rearrangement more readily than trans-
divinylcyclopropanes 
 
The desmethyl cis-divinylcyclopropanes 55d, 55e and 55f could not be isolated at RT, 
and instead they underwent spontaneous Cope rearrangement under the conditions 
used for their formation (a TOP reaction at RT or a Still"Gennari reaction at RT, 
Table 4, Entries 4, 5, 6 & Scheme 54). In contrast, the desmethyl trans-
divinylcyclopropanes 55a, 55b and 55c were stable at RT and required temperatures 
of 100"130 °C before they underwent the Cope rearrangement (Table 4, Entries 1, 2, 
3 & Scheme 54).   
 
EE
55d
E E
55f
E
E
55e
RT, 17 h
RT, 17 h
RT, 17 h
EE
55a
E E
55c
E
E
55b
130 °C, 17 h
130 °C, 17 h
130 °C, 17 h
100%
100%
80%
E E
58b
E E
58a
E E
58a
100%
100%
100% E = CO2Et
 
 
Scheme 54 The contrasting Cope rearrangements of divinylcyclopropane 55.  
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A single stereoisomer of product was observed in each case, with the stereochemical 
outcomes being consistent with a simple concerted thermal [3,3]-sigmatropic 
rearrangement in the cis-series of compounds (Table 4, entries 4–6) and trans to cis-
isomerisation, followed by a concerted thermal [3,3]-sigmatropic rearrangement, in 
the trans-series (Table 4, entries 1–3). Thus, the high temperatures necessary to 
induce rearrangement in the trans-series appear to be associated with overcoming the 
energy barrier for trans to cis-epimerisation of the cyclopropane and not with the 
energy of the transition state of the Cope rearrangement itself.  
 
A similar trend was seen in the analogous gem-dimethyl series: cis-
divinylcyclopropane 57d was fully converted into Cope product 88a after 17 h at 100 
°C (Table 4, Entry 10 & Scheme 55). In contrast, after 17 h at 130 °C trans-
divinylcyclopropane 57a did not undergo the Cope rearrangement (Table 4, Entry 7 & 
Scheme 55). 
EE
57a
EE
57d
100 °C, 17 h 130 °C, 17 h
100%
E = CO2Et
E E
88a
x
 
 
Scheme 55 The contrasting Cope rearrangements of 57a and 57d.  
 
ii) Desmethyl divinylcyclopropanes undergo the Cope rearrangement more readily 
than their gem-dimethyl analogues 
 
These results support the findings described in Chapter 2, in which the reactions of 
desmethyl diene 55a and gem-dimethyl diene 57a were compared. The desmethyl 
divinylcyclopropanes 55d, 55e and 55f all underwent the Cope rearrangement readily 
at RT. In contrast the corresponding gem-dimethyl variants 57e and 57f did not 
undergo the Cope rearrangement, even at 130 °C and while 57d was converted into 
88a, it required 17 h at 100 °C in order for the reaction to reach completion (Table 4, 
Entries 4, 5, 6, 10, 11, 12 & Scheme 56).  
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E E
57f
E
E
57e
EE
57d
130 °C, 
17 h
x
x
EE
55d
E E
55f
E
E
55e E E
58b
E E
58a
E E
58a
100%
100%
100%
E E
88a
E E
88a
E E
88b
E = CO2Et
100%
130 °C, 
17 h
130 °C, 
17 h
RT, 
17 h
RT, 
17 h
RT, 
17 h
   
 
Scheme 56 The contrasting Cope rearrangements of 55d, 55e, 55f, 57d, 57e and 57f.  
 
iii) Divinyclopropanes with E-double bonds undergo the Cope rearrangement more 
readily than those with Z-double bonds. 
 
The gem-dimethyl cis-divinylcyclopropane 57d was fully converted into Cope 
product after 17 h at 100 °C. However, the Z-isomers 57e and 57f did not undergo the 
Cope rearrangement, even after 17 h at 130 °C (Table 4, Entries 10, 11, 12 & Scheme 
57).   
 
EE
57d
100 °C, 17 h E E
57f
E
E
57e
100%
E E
88a
E E
88b
130 °C, 17 h
x
E = CO2Et
130 °C, 17 h
x
 
 
Scheme 57 The contrasting Cope rearrangements of 57d, 57e and 57f.  
 
The same trend (albeit less pronounced) was also observed in the desmethyl series. 
The Cope rearrangements of 55a and 55b were complete after 17 h at 130 °C. By 
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contrast, only 80% conversion into Cope product 58a was observed under the same 
conditions for 55c (Table 4, Entries 1, 2, 3 & Scheme 58). 
 
EE
55a
E
E
55b
130 °C, 17 h
130 °C, 17 h
E E
55c100%
100%
130 °C, 17 h
80%E E
58a
E E
58b
E = CO2Et
 
 
Scheme 58 The contrasting Cope rearrangements of 55a, 55b and 55c.  
 
iv) There is an increased barrier to epimerisation between trans and cis-
divinylcyclopropanes in the gem-dimethyl series. 
 
This is without question the most surprising conclusion to be drawn from these 
studies. The trans-dimethyl substrates 57a, 57b or 57c did not rearrange, even at 130 
°C (Table 4, entries 7–9, Scheme 59) and, importantly, epimerisation to the 
corresponding cis-diesters was also not observed. The cis-E,Z and cis-Z,Z-substrates 
57e and 57f also failed to react at 130 °C, with each remaining unchanged, again with 
no evidence of cyclopropane epimerisation (Table 4, entries 11–12). This suggests 
that the required transition state (Figure 8) is too high in energy for the Cope 
rearrangement to occur under the conditions screened, probably due to steric clashes, 
but also indicates that the cis/trans-epimerisation occurs less readily than in the non-
methylated series of compounds.  The cis-E,E-diester 57d was significantly more 
reactive than either of compounds 57e or 57f; this substrate began to rearrange at 
temperatures as low as 40 °C and the rearrangement was complete after 17 h at 100 
°C (Table 4, entry 10).  
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EE
57d
E E
57f
E
E
57e
100 °C, 17 h
RT, 17 h
RT, 17 h
EE
57a
E E
57c
E
E
57b
130 °C, 17 h
130 °C, 17 h
130 °C, 17 h
E E
88b
E E
88a
E E
88a
100%
E = CO2Et
x
x
x
xx
 
 
Scheme 59 The contrasting Cope rearrangements of 57a, 57b, 57c, 57d, 57e and 57f.  
 
This result sheds light on the reason why our original dimethyl trans-E,E-diester 57a 
(Table 4, entry 7) failed to react; given that the Cope rearrangement of cis-E,E-diester 
57d (Table 4, entry 10) proceeded at temperatures as low as 40 °C, and that there was 
no evidence of any cis/trans-epimerisation in any of the diesters 57a!57f, this 
suggests that the reaction of trans-E,E 57a failed at the cyclopropane epimerisation 
stage, and not because of the high energy of the Cope rearrangement transition state 
as originally thought (Figure 8). In addition, the complete lack of cis to trans-
epimerisation in any of the dimethyl substituted diesters 57a!57f is in contrast to the 
unsubstituted diesters 55a!55c (which must have epimerised otherwise their Cope 
rearrangements would not have taken place). Thus, we have shown that as well 
raising the energy of the Cope rearrangement transition state, gem-dimethyl 
substitution also retards the rate of cyclopropane epimerisation of the trans-
cyclopropane substrates screened. 
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3.6 Examining substituent effects on the Cope Rearrangement of Cis-Gem-
Dimethyl Divinylcyclopropanes 
 
It is clear that gem-dimethyl substitution significantly retards the Cope 
rearrangements of divinylcyclopropanes. However, it appears that its effect on the 
trans to cis-isomerisation of the cyclopropane, and not its effect on the [3,3]-
sigmatropic rearrangement itself, is the most significant barrier to reactivity. 
Pleasingly, from a synthetic viewpoint, the isomerisation problem is easily negated by 
starting from a cis-oriented divinylcyclopropane. To demonstrate this, we went on to 
synthesise a range of other gem-dimethyl-cis-E,E-functionalised cyclopropanes. 
Cyclopropane 154 was prepared using a tandem oxidation/Wittig reaction, followed 
by silyl cleavage using HF. Another tandem oxidation/Wittig reaction at RT afforded 
the cis-E,E-functionalised cyclopropane 154.  
 
OTBSHO OTBSMeO2C
152, 48%132
MnO2,
Ph3PCHCO2Me,
CHCl3
reflux, 2 d
HF(aq), MeCN
RT, 16 h
OH
MeO2C
153, 81%
MeO2C CO2Me
154, 49%
MnO2,
Ph3PCHCO2Me,
CHCl3
RT,16 h
>20 : 1 E : Z
>20 : 1 E,E : E,Z
 
 
Scheme 60 The synthesis of 154. 
 
The reduction of 154 using 2 equivalents of DIBAL gave a mixture of monoester 155 
and diol 156, which were easily separated by flash column chromatography. 
 
MeO2C CO2Me
154
DIBAL (2 eq.),
CH2Cl2
MeO2C
155, 9%
OH
156, 33%
OHHO
+
!78 °C, 30 min
 
 
Scheme 61 The synthesis of 155 and 156. 
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TBS protection of diol 156 using 1.5 equivalent of TBSCl generated a mixture of TBS 
compounds 157 and 158, which were easily separated by flash column 
chromatography.  
156
OHHO
TBSCl, imid, CH2Cl2
2 h, RT
157, 20%
OTBSHO
158, 35%
OTBSTBSO
+
 
 
Scheme 62 The synthesis of 157 and 158. 
 
Finally, the hydrolysis of diester 154 using NaOH in aq. THF (1:1) afforded 
cyclopropane 159. 
 
MeO2C CO2Me
154
NaOH, aq. THF (1:1)
RT, 16 h
HO2C CO2H
159, 100%  
 
Scheme 63 The synthesis of 159. 
 
We were pleased to find that all of these substrates 154"159 undergo the Cope 
rearrangement upon heating, generating 1,4-cycloheptadienes in high yields (78–97%, 
Table 5), with ester, alcohol, silyl ether and carboxylic acid substituents all being well 
tolerated. The rearrangements do not appear to be significantly affected by electronic 
effects, a point exemplified by the near-identical reactivity of the electron-deficient 
ester-substituted divinylcyclopropane 154 and the more electron-rich alcohol-
substituted divinylcyclopropane 156 (entries 1 and 3, Table 5). Note that the product 
isolated from the Cope rearrangement of substrate 155 (entry 2, Table 5) was a 
lactone, presumably, formed via an intramolecular transesterification following the 
Cope rearrangement. The size of the substituents appears to be more significant; the 
addition of one 157 and then two 158 tert-butyldimethyl silyl groups to diol 156 led to 
a decrease in reactivity in each case (entries 4 and 5, Table 5). Diacid-substituted 
divinylcyclopropane 159 reacts more slowly still (entry 6, Table 5), but this reaction 
should not be compared directly to the other entries, as it was only sparingly soluble 
in the reaction solvent. 
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% Conversion 
Temperature (°C) 
Entry Reagent Product 
40 70 100 
Isolated 
Yielda 
(%) 
1 
MeO2C CO2Me154  MeO2C CO2Me160  
30 100 100 83 
2 
MeO2C 155
OH
 
161
OO
 
0 100 100 84 
3 
156
OHHO
 
162
OHHO
 
30 90 100 83 
4 
157
OTBSHO
 
163
OHTBSO
 
30 70 100 86 
5 
158
OTBSTBSO
 
164
OTBSTBSO
 
0 30 100 88 
6 
HO2C CO2H159  HO2C CO2H165  
0 10 100 97 
 
aAll reactions were carried out as 0.19 mol dm-3 solutions in xylene. All reactions were carried out for 17 h. % Conversion was 
determined via analysis of the unpurified reaction mixtures. The isolated yields were obtained from the 100 °C experiments and 
include purification by column chromatography in each example except for diacid 165. 
 
Table 5 The Cope rearrangement on test substrates 154"159. 
 
In conclusion, the rate-retarding effect of gem-dimethyl substitution on the Cope 
rearrangements of divinylcyclopropanes has been demonstrated directly for the first 
time. An examination of the effects of alkene geometry and the relative 
stereochemistry of the cyclopropane have revealed that gem-dimethyl substitution 
significantly inhibits the trans to cis-isomerisation about the cyclopropyl ring, 
necessary for rearrangement to occur, relative to unsubstituted desmethyl analogues. 
Using the information accrued, a series of ideal substrates (cis-oriented on the 
cyclopropane with two E-alkenes) were synthesised and all underwent the desired 
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Cope rearrangement smoothly, affording a range of dimethylated substituted 1,4-
cycloheptadienes in high yields. The findings of this study were recently published in 
Organic and Biomolecular Chemistry55 (See Appendix for full paper).  
 
Significantly, with respect to the synthesis of pyxidatol C, we showed that by 
preparing the cis-divinylcyclopropane 57d we could access cycloheptadiene 88a, the 
gem-dimethyl-pyxidatol C analogue of cycoheptadiene 58a and therefore attention 
turned to completing its total synthesis (Chapter 4). 
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Chapter 4 
Towards the Total Synthesis of Pyxidatol C 
 
4.1 Corey!Chaykovsky Strategy 
 
A detailed study into the Cope rearrangements of gem-dimethyl divinylcyclopropanes 
revealed the importance of preparing a cis-divinylcyclopropane in the synthesis of 
gem-dimethyl substituted cycloheptadienes  (Chapter 3). This led to the optimized 
synthesis of 88a, an intermediate in the synthetic route towards pyxidatol C; the TOP 
reaction of 131 afforded 57d in 68% yield, which was then converted into 88a in 80% 
yield (Scheme 64). Toluene was used as the solvent in the Cope rearrangement of 
57d, in place of xylene, because it is easier to remove under vacuo. With the 7-
membered ring component of the decahydro-1H-cyclopropa[e]azulene core structure 
of pyxidatol C in place attention turned to the installation of the cyclopropane moiety. 
 
OHEtO2C
MnO2,
Ph3PCHCO2Et, 
CHCl3
EtO2C CO2Et
toluene
100 °C, 
16 h EtO2C CO2Et
88a, 82%
57d, 68%131
RT, 16 h
 
 
Scheme 64 Optimised synthesis of 88a. 
 
The general strategy devised for cyclopropanation was first to perform a partial 
reduction of diester 88a, followed by alkene isomerisation and cyclopropanation 
(Scheme 65) 
 
EtO2C CO2Et
88a
CO2R
166
RO CO2R
167
RO
CO2R
38
RO
partial reduction
alkene 
isomerisation
cyclopropanation
OH
H
HO
3
H
 
 
Scheme 65 General cyclopropanation strategy. 
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The Corey"Chaykovsky strategy trialled previously on the desmethyl model system 
was the first route to be tested on the gem-dimethyl system. LiAlH4 reduction of 88a 
was straightforward and was followed by TEMPO oxidation, affording lactone 161 
(Scheme 66). The 69% yield for this step was reproducible, which was pleasing 
because on the desmethyl model system yields were inconsistent, ranging from 
40"60% (Section 1.11). 
 
EtO2C CO2Et
88a
OHHO
TEMPO, PhI(OAc)2, 
CH2Cl2
OO
161, 69%162, 62%
LiAlH4, 
THF
0°C ! RT,
16 h
RT, 2 h
 
 
Scheme 66 Synthesis of lactone 161. 
 
Unfortunately, base-promoted isomerisation of lactone 161 was harder to optimise 
than on the desmethyl model system. The initial conditions trialled (1 equivalent of 
DBU in THF at 0 °C for 1.5 h) resulted in the formation of a mixture of the desired 
lactone 168 and !,$,%,#-unsaturated lactone 169 in 71% overall yield in a ratio of 
1:2.1 (Scheme 67).  
 
OO
DBU, THF
0 °C, 1.5 h
OO OO
71% 1:2.1
+
161 168 169
 
 
Scheme 67 Initial conditions trialled for the isomerisation of lactone 168. 
 
In order to avoid isomerisation into !,$,%,#-unsaturated lactone 169, the reaction time 
was reduced to 30 min affording !,$-unsaturated lactone 168 in 30% yield, epimer 
170 in 52% yield and starting material 161 in 7% yield.  Epimer 170 could in turn be 
converted into the desired lactone 168 in 39% yield, thus allowing reproducible 
quantities of the target compound 168 to be obtained (Scheme 68). 
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OO
DBU, THF
0 °C, 30 min
OO OO
168, 30% 170, 52%
+
DBU, THF
0 °C, 50 min, 39%
161
OO
161, 7%
+
 
 
Scheme 68 Optimised conditions for the synthesis of lactone 168. 
 
The Corey"Chaykovsky cyclopropanation of 168 was next attempted using 
trimethylsulfoxonium iodide (Corey’s salt) and sodium hydride in DMF. Pleasingly 
the desired cyclopropane 171 was formed as a single diastereomer (Scheme 69) with 
the relative stereochemistry shown to be that required for pyxidatol C by an n.O.e 
experiment (an n.O.e enhancement between the cyclopropane CH2 and the CHCH2O 
protons was observed, whereas no n.O.e enhancement was observed for the lactone 
CH2 protons with the cyclopropane CH2). Unfortunately the yield was low, ranging 
from 5"20% using sodium hydride as the base in DMF. The solvent was changed to 
DMSO and cyclopropane 171 was formed in 11% yield. Using MTBD as the base in 
acetonitrile, cyclopropane 171 was formed in only 8% yield. The low yields were 
particularly disappointing given that the 1H NMR spectra of the unpurified reaction 
mixtures were clean and contained no evidence of either starting materials or side 
products. The fate of the rest of the material remains unclear; efforts were made to 
examine the contents of the aqueous extracts but no tractable material was found. This 
is the same problem that we observed using the analogous desmethyl lactone 61 (See 
Chapter 2.1).  
 
Me3SO+I- DMSO/NaH - 11%
DMF/NaH - 5-20%
MeCN/MTBD - 8%
OO
168 171
O O
H
H
H
n.O.e
 
 
Scheme 69 Synthesis of cyclopropane 171 
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4.2 Installing the Side-Chain 
 
Despite the disappointing yields for the cyclopropanation leading to compound 171, 
we were able to continue the synthesis, with the aim of installing the methyl ketone 
side chain. We planned to install the side chain via reduction of lactone 171 to diol 
172, conversion of the less hindered alcohol into a leaving group, followed by 
alkylation (Scheme 70). This alkylation strategy had previously been tested on a 
cyclohexyl model system (Section 2.1).  
 
171
O O HO OH LG OH OH
O
172 174173  
 
Scheme 70 Installing the side chain to lactone 171. 
 
The reduction of lactone 171 with DIBAL was straightforward, affording diol 172. 
Unfortunately, the attempted iodination of 172 was unsuccessful affording a complex 
mixture of products (Scheme 71). The major component of this mixture was 
tentatively assigned as cyclic ether 176 based on peaks at 5.22"5.20 (2H, m, H-4 & 
H-5), 4.03 (1H, dd, J 11.5, 1.5 Hz, H-1a), 3.76 (2H, d, J 7.0 Hz, H-2), 2.96 (1H, dd, J 
11.5, 1.0 Hz, H-1b) and 2.41 (1H, t, J 7.0 Hz, H-3) in the 1H NMR spectrum of the 
unpurified reaction mixture, which are similar to those in a related compound 209 
(see later, Section 4.4). Attempts to tosylate and mesylate diol 172 were also 
unsuccessful with clean starting material recovered in both cases. Cyclic ether 
formation may well have followed had the mesylation and tosylation been successful; 
therefore an alternative approach was sought. 
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HO OH
172, 79%
I2, PPh3, imid, 
CH2Cl2
x
I OH OOO
HO OH
TsCl, pyr or
MsCl, Et3N, CH2Cl2
RO2SO OH
x
175 176171
172
12
3
5
4
177
DIBAL, 
CH2Cl2
!78 " RT, 
30 min
RT, 30 min
 
 
Scheme 71 Synthesis of diol 172 and attempts to install a leaving group. The numbering of 176 is for 
characterisation purposes only and does not conform to IUPAC rules.  
 
A lactone ring-opening strategy was tested as an alternative way of installing the 
leaving group, based on work by Olah et al. who reported the use of sodium iodide 
and methyltrichlorosilane to cleave a range of esters and lactones in good yield 
(Scheme 72).56 
O
O
O
O NaI, MeSiCl3, 
MeCN
CO2HI
I CO2H
178
180
181, 90%
179, 86%
NaI, MeSiCl3, 
MeCN
 
 
Scheme 72 Studies by Olah et al.56 into the dealkylative cleavage of esters and lactones using 
trichloromethylsilane and sodium iodide. 
 
This strategy had the advantage of affording a carboxylic acid (rather than an alcohol) 
containing iodide, thus negating the undesired THF formation. Unfortunately attempts 
to cleave lactone 161, !,$-unsaturated lactone 168 and cyclopropyl lactone 171 using 
trichloromethylsilane and sodium iodide were all unsuccessful (Scheme 73) and clean 
starting material was recovered in each case. A related ring-opening strategy using 
thionyl bromide was also examined,57 but again clean starting material was recovered 
when tested on lactones 168 and 171. The reaction with lactone 161 formed the trans-
epimer 170, although there was evidence of trace formation of product 185 by mass 
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spectrometry [m/z (ESI): [MH+] C12H1879BrO2, 273.0503 and C12H1881BrO2, 
275.0482]. Efforts were made to promote the ring-opening of lactone 161 by 
increasing the reaction time from 1 to 3 days and by heating to reflux instead of 
stirring at RT, but in each case only trace product formation was observed.   
 
OO
NaI, MeSiCl3
MeCN
CO2HI OO
MeOH
CO2MeBr
SOBr2
OO
NaI, MeSiCl3
MeCN
CO2HI OO
MeOH
CO2MeBr
SOBr2
OO CO2H CO2Me
NaI, MeSiCl3
MeCN MeOH
SOBr2
x
x
x
x
x
x
BrOOI
161
168
171
161
168
171
OO
170, 55%182
183
184
185
186
187
 
 
Scheme 73 A ring-opening strategy to introduce a leaving group. 
 
4.3 Simmons!Smith Strategy 
 
As an alternative to the Corey"Chaykovsky cyclopropanation, a Simmons"Smith 
strategy, previously tested on the desmethyl model system, was examined. The 
required substrate was formed easily via the mono-TBS protection of diol 162, 
oxidation to generate aldehyde 188 using DMP, DBU-promoted isomerisation to !,$-
unsaturated aldehyde 189 and sodium borohydride reduction, furnishing alcohol 190 
in a 62% yield over the four steps (Scheme 74).  
 
 60 
OHHO
TBSCl, NaH, 
THF
OHTBSO
DMP, 
CH2Cl2
OTBSO
OTBSO OHTBSO
163, 82%
190, 75% over 3 steps
162 188
189
NaBH4, 
MeOH
0 °C ! RT, 
45 min
0 °C ! RT, 
1 h
DBU, THF
0 °C, 20 min
0 °C, 30 min
 
 
Scheme 74 Synthesis of alcohol 190. 
 
As anticipated, the regioselectivity of the Simmons"Smith cyclopropanation was 
greater for the gem-dimethyl system relative to that of the desmethyl model system 
alcohol 79 (it was reasoned that the steric bulk of the cycloheptadiene dimethyl 
groups would hinder cyclopropanation on the unfunctionalised alkene, Section 2.2). 
Optimal conditions were found to be 4 equivalents of diidomethane and 2 equivalents 
of diethylzinc in CH2Cl2 at 0 °C for 40 min. This resulted in the synthesis of 
cyclopropane 191 in 32% yield and cyclopropane 192 in 27% yield, although trace 
impurities were evident in the 1H NMR spectrum of 191 and were attributed to the 
bis-cyclopropane 193 (supported by mass spectrometry [m/z (ESI): [MNa+] 
C19H36NaO2Si, 347.2362]). The relative stereochemistry of cyclopropanes 191 and 
192 was determined by TBS cleavage of cyclopropane 192 using TBAF to give diol 
194. The stereochemistry of diol 194 was confirmed by comparison with data for 
compound 172, which was prepared via the Corey"Chaykovsky route (Scheme 69). 
 
CH2I2, Et2Zn, 
CH2Cl2
OHTBSO OHTBSO OHTBSO
++
193, TRACE
OHTBSO
OHTBSO OHHO
TBAF, THF
190 191, 32% 192, 27%
192 194, quant.
0 °C, 40 Min
0 °C, 2 h
 
 
Scheme 75 Simmons"Smith cyclopropantion of alcohol 190. 
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4.4 Installing the Side-Chain; The Cyclic Ether Phenomenon 
 
Before installing the side chain, it was decided to protect the alcohol of 191 with a 
protecting group orthogonal to the TBS ether. It was hoped that this would allow 
cleavage of the TBS group followed by iodination without resulting in the unwanted 
formation of cyclic ether 176. Unfortunately efforts to protect the alcohol as its benzyl 
ether were unsuccessful (Scheme 76); starting material 191 was recovered when 
benzyl bromide and NaH were used and decomposition was observed using the 
Dudley reagent.58 Attempts to prepare the PMB ether 196, TIPS ether 197 and methyl 
ether 198 were also all unsuccessful, with starting material 191 recovered in each 
case.  
 
OHTBSO OBnTBSO
conditions
x
conditions
a) BnBr, NaH, THF or
b) Dudley reagent, MgO, 
!!!-trifluorotoluene
OHTBSO
TIPSOTf, 2,6-Lutidine, 
CH2Cl2
OTIPSTBSO
x
OHTBSO OPMBTBSO
PMBCl, NaH, THF
x
OHTBSO
MeI, NaH, THF
OMeTBSO
x
191
191
191
191
195
196
197
198
O N
OTf"
Dudley Reagent
 
 
Scheme 76 Attempts to protect alcohol 191. 
 
It was concluded that the alcohol must be extremely sterically hindered (it is neo-
pentyl). A new strategy of installing the side chain before carrying out the 
cyclopropanation was thus planned, so that protecting group manipulations could be 
carried out before the bulky cyclopropane was in place. Following protecting group 
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manipulations, we hoped to install the methyl ketone side chain to generate 
intermediate 201 (Scheme 77).  
 
OHTBSO
190
OPTBSO OPHO OP
199 200
O
201  
 
Scheme 77 Synthetic strategy to install the side chain before attempting the cyclopropanation. 
 
TIPS protection of TBS alcohol 190 was facile and TIPS containing compound 202 
was obtained in 66% yield, corroborating our theory that the cyclopropane in 191 was 
a steric encumbrance to the alcohol protection on that system. However, we were 
unable to selectively cleave the TBS ether of 202, and always observed the formation 
of a mixture of products (starting material was observed in the 1H NMR spectra of the 
unpurified reaction mixture and although clean material could not be isolated, HRMS 
indicated the presence of the corresponding diol in the unpurified reaction mixture).  
 
OHTBSO
TIPSOTf, 2,6-Lutidine, 
CH2Cl2
OTIPSTBSO OTIPSHO
x
190 202, 66% 203
TBAF, 
THF
RT, 2 h
 
 
Scheme 78 Attempt to selectively mono-deprotect TBS compound 202. 
 
We were also able to acetylate alcohol 190, forming acetate 204 in quantitative yield. 
Unfortunately, during cleavage of the TBS group of 204 with TBAF, acetate 
migration between the two alcohol groups was observed, resulting in the formation of 
an inseparable mixture of mono-acetate compounds 205 and 206 in a 1:0.8 ratio, 
based on HRMS data [m/z (ESI): [MNa+] C13H20NaO3, 247.1310] and the presence of 
two acetate methyl groups at 2.23 ppm and 2.38 ppm in the unpurified reaction 
mixture. 
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OHTBSO
Ac2O, Et3N, DMAP, 
CH2Cl2
OAcTBSO
190 204, quant.
OHAcO
+
 1:0.8 major:minor
206
OAcHO
205
TBAF, 
THF
RT, 30 min
 
 
Scheme 79 Attempt to selectively mono-deprotect TBS compound 204. 
 
In view of the various problems encountered during efforts to install orthogonal 
protecting groups, another change in the order of steps was planned. This involved the 
iodination of the alcohol of 163, and the installation of the methyl ketone side chain 
before isomerisation of the alkene and cyclopropanation.  
 
HO OTBS I OTBS OTBS
O
163 207 208
OH
O
174  
 
Scheme 80 Synthetic strategy to install the side chain before isomerisation of the alkene. 
 
Unfortunately the iodination of alcohol 163 did not go to plan. Surprisingly, the 
formation of the bis-TBS compound 164 and cyclic ether 209 were observed when 
alcohol 163 was treated with iodine, triphenylphosphine and imidazole (Scheme 81). 
The most likely explanation for this reactivity is that following iodination of the free 
alcohol, intramolecular nucleophilic attack from the oxygen of the TBS ether takes 
place generating an oxycation reactive intermediate, which can react with another 
molecule of alcohol 163 to form both the cyclic ether 209 and bis-TBS compound 164 
(Scheme 81). 
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I2, PPh3, imid, 
CH2Cl2
OTBSTBSO
+
O
209, 38% 164, 22%163
I OTBS O
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OHTBSO
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RT, 50 min
 
 
Scheme 81 Attempted iodination of alcohol 163. 
 
The mono-protection of diol 162 with the bulkier, more stable silyl protecting group 
TBDPS was therefore considered. Mono-TBDPS protection of diol 162 furnished 210 
in 95% yield, but under the same iodination conditions cyclic ether 209 and the bis-
TBDPS compound 211 were again formed (Cyclic ether 209 was seen in the 1H NMR 
spectrum of the unpurified reaction mixture and the formation of 211 was inferred by 
HRMS).  
 
OHHO
TBDPSCl, NaH, 
THF
HO OTBDPS
I2, PPh3, imid, 
CH2Cl2
OTBDPSTBDPSO
+
O
210, 95%162 209
211
0 °C, 45 min RT, 1 h
 
 
Scheme 82 Mono-TBDPS protection of diol 162 and attempted iodination of alcohol 210. 
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The mesylation of alcohol 210 was considered as an alternative to iodination. 
Pleasingly, mesylation was achieved in 83% yield using standard conditions but the 
subsequent alkylation with t-butyl acetoacetate and NaH in THF was unsuccessful 
and only starting material was recovered from the reaction after 16 h at reflux 
(Scheme 83).  
 
HO OTBDPS
MsCl, Et3N, 
CH2Cl2
MsO OTBDPS
NaH, t-butyl acetoacetate, 
THF
x
OTBDPS
O
O
t-BuO
210 212, 83%
213
RT, 1.5 h reflux, 16 h
 
 
Scheme 83 Mesylation and triflation approach to installing the sidechain. 
 
A Finkelstein reaction59 was therefore performed on mesylate 212 in an attempt to 
introduce the more reactive iodo-leaving group to facilitate the difficult alkylation. 
The desired iodide 214 is likely to have formed smoothly but unfortunately, only 
cyclic ether 209 was seen in the unpurified reaction mixture. Triflation of alcohol 210 
was also attempted and once again the cyclic ether 209 was the only product seen in 
the unpurified reaction mixture.  
 
MsO OTBDPS
HO OTBDPS
O
O
212 209
209210
NaI, 
DMF
(CF3SO2)2O, Et3N, 
CH2Cl2
I OTBDPS
214
 
 
Scheme 84 A Finkelstein and triflation approach to installing the sidechain.  
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In an effort to avoid cyclic ether formation during iodination, a PMB protecting group 
was considered. It was hoped that the PMB group would be more stable under the 
iodination reaction conditions than the TBS and TBDPS groups previously tested. 
Mono-protection of diol 162 as its PMB ether via the reduction of 215 was planned. 
Surprisingly under the acidic conditions necessary to prepare acetal 215, cyclic ether 
209 was formed again, presumably via an intramolecular SN2 reaction with loss of 
water. This result is particularly surprising given that H2O rarely acts as a leaving 
group in SN2 type processes. Mono-PMB ether 216 was therefore prepared using 
PMBCl and NaH in THF. Disappointingly (as judged by the analysis of the 1H NMR 
spectrum of the unpurified reaction mixture) the attempted iodination of alcohol 162 
led yet again to the predominant formation of cyclic ether 209.  
OHHO
PTSA, p-anisaldehyde, 
benzene
OHHO
PMBCl, NaH, 
THF
HO OPMB
I2, PPh3, imid, 
CH2Cl2
O
O
O O
OMe
162 209, 54%
215
162 216, 41% 209
x
RT, 1 hRT, 2h
 
 
Scheme 85 Mono-PMB protection of diol 162 and attempted iodination of alcohol 216. 
 
Given the previously described unwanted cyclic ether formations, this approach was 
abandoned. It was concluded that the alcohol groups are too prone to undergo THF 
formation for this strategy to succeed. It was surprising that the cyclic ether forms so 
readily such that the protecting groups, even PMB, are displaced. Given these 
setbacks the Wittig reaction, previously tested on the desmethyl system (Section 2.1) 
was re-examined.  
 
During previous studies on the desmethyl model system, a Wittig reaction on lactol 
67 was unsuccessful (Section 2.1, Scheme 16). However, we planned to investigate 
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the Wittig reaction using the gem-dimethyl aldehyde 217 (Scheme 86). Aldehyde 217 
was prepared from alcohol 210 using DMP, in an 80% yield. Unfortunately, the 
Wittig reaction using 1-(triphenylphosphoranylidene)acetone in CH2Cl2 at RT led to 
decomposition.  
HO OTBDPS
DMP,
CH2Cl2
O OTBDPS
Ph3PCHCOCH3, 
CH2Cl2
x
OTBDPS
O210 217, 80% 218
RT, 1h RT, 16 h
 
 
Scheme 86 A Wittig approach to installing the side chain using aldehyde 217. 
 
4.5 Installing the Side-Chain Before the Cope Rearrangement 
 
As outlined in Section 4.4, many difficulties were encountered when attempting to 
install the methyl ketone side chain on the cycloheptadiene system. This led to 
another re-ordering of the synthetic strategy and the installation of the methyl ketone 
side chain before the Cope rearrangement was considered. By carrying out the Cope 
rearrangement of 219, cycloheptadiene 220 could be prepared with the side chain 
already in place (Scheme 87). 
 
CO2Et
O CO2Et
220
O
219  
 
Scheme 87 The Cope rearrangement of 219. 
 
The alkylation strategy tested on the cyclohexyl model system (Section 2.1) was 
trialled on divinylcyclopropyl alcohol 221. DIBAL reduction of ester 133 furnished 
the requisite alcohol 221, necessary to apply this halogenation, alkylation strategy 
(Scheme 88). Unfortunately attempts to iodinate, using iodine, triphenylphosphine 
and imidazole were unsuccessful, leading to decomposition. Bromination using 
carbon tetrabromide and triphenylphosphine also led to decomposition. Therefore an 
alternative approach towards the installation of the side chain was tested using alcohol 
221. 
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Scheme 88 The attempted halogenation of alcohol 221. 
 
An alternative strategy for the introduction of the methyl ketone side chain was tested 
using Tsuji"Trost60,61 chemistry (Scheme 89). Carbonate 223 was prepared from 
alcohol 221 using ethyl chloroformate, DMAP and pyridine. Carbonate 223 was then 
used without purification in the key Tsuji-Trost step. The reaction of carbonate 223 
with tetrakis(triphenylphosphine)palladium(0) and tert-butyl 3-oxobutanoate afforded 
$-ketoester 224 in an excellent 92% yield over the two steps. Silyl cleavage was 
straightforward and furnished alcohol 225, a potential substrate for a Taylor group 
TOP reaction. Disappointingly, this TOP reaction was unsuccessful and clean starting 
material was recovered from the reaction.  
 
OTBSEtO2CO
DMAP,
pyridine,
ClCO2Et,
CH2Cl2
223
Pd(PPh3)4,
CH3COCH2CO2tBu,
THF
50 °C, 1 h
224, 92% over 2 steps
OTBSHO
OTBStBuO2C
OH
225, 72%
tBuO2C
OO
226
tBuO2C CO2Et
O
x
TBAF, 
CH2Cl2
MnO2, Ph3PCHCO2Et, 
CHCl3
RT, 30 min
RT, 16 h reflux, 16 h
221
 
 
Scheme 89 The Tsuji"Trost reaction of carbonate 223 and the attempted TOP reaction of alcohol 225. 
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The oxidation, Wittig sequence was therefore completed in a step-wise manner. The 
MnO2 oxidation of 225 was unsuccessful and once again clean starting material was 
recovered from the reaction (Scheme 90). Pleasingly, Dess"Martin oxidation 
generated aldehyde 227 (Scheme 91) which was used without purification in the 
Wittig reaction with (carbethoxymethylene)triphenylphosphorane affording 
divinylcyclopropane 226 in 72% yield over two steps. 
 
OH
225
tBuO2C
O MnO2, CHCl3
x O
227
tBuO2C
O
reflux, 16 h
 
 
Scheme 91 The unsuccessful MnO2 oxidation of alcohol 225. 
 
DMP, CH2Cl2
O
227
tBuO2C
226, 72% over 2 steps
tBuO2C CO2Et
O
O
OH
225
tBuO2C
O Ph3PCHCO2Et, CHCl3
RT, 16 h RT, 16 h
 
 
Scheme 92 The step-wise Dess-Martin oxidation and Wittig reaction. 
 
The decarboxylation of t-butyl ester 226 to furnish the desired divinylcyclopropane 
219, a substrate for the Cope rearrangement, was next planned (Scheme 92). 
However, attempts to promote decarboxylation of $-ketoester 226 using PTSA in 
benzene were unsuccessful, leading to decomposition of the material and when 226 
was stirred in TFA, only traces of ketone 219 were evident by HRMS. The Cope 
rearrangement of $-ketoester 226 was therefore tested. This substrate was not 
considered ideal for the Cope rearrangement given its relatively high steric bulk but 
pleasingly the rearrangement was successful affording cycloheptadiene 228. From 
here, decarboxylation of the $-ketoester using TFA was straightforward thus 
affording the key advanced cycloheptadiene intermediate 220 with the methyl ketone 
side chain already in place. 
 
 70 
226
tBuO2C CO2Et
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100 °C, 
16 h CO2Et
228
O
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O
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O 219
 
 
Scheme 92 The Cope rearrangement of 226.  
 
With cycloheptadiene 220 in hand and the methyl ketone side chain in place, 
cyclopropanation and a ketone-olefin coupling reaction would complete the synthesis 
of the decahydro-1H-cyclopropa[e]azulene core structure common to the africananes.  
 
The cyclopropane moiety has been successfully installed on related systems using 
both Corey"Chaykovsky chemistry and Simmons-Smith chemistry (Section 4.1 and 
Section 4.3). These established cyclopropanation conditions were next trialled on the 
more advanced cycloheptadiene intermediate 220. Base-promoted isomerisation of 
the alkene of 220 into conjugation with the ethyl ester afforded the !,$-unsaturated 
ester 229, substrate for the Corey"Chaykovsky cyclopropanation (Scheme 93). 
Unfortunately cyclopropanation was unsuccessful using both the NaH/DMF 
conditions and MTBD/MeCN conditions; a complex mixture of decomposition 
products was observed in each case. 
 
CO2Et
O
CO2Et
O O
CO2Et
DBU, THF
x
229, 91%
60 °C, 16 h
Me3SOI, NaH,
THF
0 °C ! RT, 1 h
220 230  
 
Scheme 93 The DBU promoted isomerisation of 220, and the failed Corey"Chaykovsky 
cyclopropanation of 229. 
 
It was considered possible that the free ketone in ester 229 was interfering with the 
reaction and as such, protection of the ketone as ketal 231 was attempted. Ketone 229 
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was heated at reflux in toluene/ethylene glycol/PTSA under Dean"Stark conditions 
for 16 h, (Scheme 94) but unfortunately unreacted starting material was recovered 
from the reaction. As such, attention turned towards Simmons"Smith 
cyclopropanation chemistry. 
 
CO2Et
O CO2Et
O O
x
HOCH2CH2OH, 
benzene
Dean-Stark reflux,
16 h
229 231  
 
Scheme 94 The unsuccessful ketal protection of ketone  229.  
 
DIBAL reduction of !,$-unsaturated ester 229 afforded diol 232, substrate for the 
Simmons-Smith cyclopropanation. However clean starting material was recovered 
from the reaction of allylic alcohol 232 with diethylzinc and diiodomethane. 
  
CO2Et
O
DIBAL, 
CH2Cl2
!78 °C, 2 h
HO
OH
CH2I2, Et2Zn,
CH2Cl2
HO
OH
x
232, 38%229 233
0 °C " RT, 
16 h
 
 
Scheme 95 DIBAL reduction of 229 afforded diol 232 as predominantly a single diastereomer 10:1. 
The major diastereomer was isolated by flash column chromatography. 
 
There is literature precedent for the high yielding and steroeselective Simmons-Smith 
cyclopropanation in the final step of the synthesis of other africananes.6,18 Therefore, 
given the difficulties with cyclopropanation on this system, it was decided that 
preparing the 5 membered ring before cyclopropanation would be tested. The 
synthetic strategy for installation of the 5 membered ring was via a samarium diiodide 
ketone-olefin ring closing reaction. 
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4.6 Samarium Diiodide Ketone-Olefin Ring Closing Reaction 
 
4.6.1 Background  
 
The samarium diiodide mediated ketone-olefin coupling reaction of 220 into 234 was 
planned (Scheme 96). This type of coupling reaction has been shown to proceed via 
single electron reduction of the ketone to give a ketyl anionic radical followed by 
addition into the olefin, subsequent single electron reduction and protonation (Scheme 
96).62  
SmI2
1 e
1 e
H
t-BuOH
CO2Et
O
CO2Et
O
I2Sm
CO2Et
O
I2Sm
CO2Et
O
I2Sm
CO2Et
HO
H
220 234
 
 
Scheme 96 Mechanism for the SmI2 mediated ketone-olefin coupling reaction. 
 
As such, 4 diastereomers of alcohol 234 are possible and it was expected, based on 
precedent for similar transformations, that the required trans-5/7 ring system with a 
trans-relationship between the relatively bulky methyl group (cf. the OH) and the 7 
membered ring would predominate.62 The four possible diastereomers are shown in 
Scheme 97 with the desired diastereomer 234a boxed. 
 
CO2Et
HO
H
CO2Et
HO
H
CO2Et
HO
H
CO2Et
HO
H
trans - between the methyl (cf. the OH) 
and the 7 membered ring
234d234c234a 234b
 
 
Scheme 97 The 4 possible diastereomers from the ketone-olefin ring closing reaction with the desired 
diastereomer boxed. 
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4.6.2 Preparing Samarium Diiodide  
 
A solution of SmI2 in THF was required to test this chemistry. Samarium diiodide is 
notoriously difficult to prepare and this proved to be the case in our hands. 
Fortunately, after several failed attempts at its preparation, a 2012 paper by Proctor et 
al. provided an answer. It describes how the major factor preventing the successful 
formation of SmI2 is an oxide layer on the samarium metal.63 By dry-stirring the 
samarium metal overnight under inert atmosphere the samarium is activated and the 
preparation of SmI2 becomes straightforward using standard conditions.63 
 
4.6.3 Results   
 
Clean starting material was recovered from the reaction of 220 with SmI2 and t-BuOH 
in THF. This result was not entirely unexpected as the vast majority of literature SmI2 
ketone-olefin coupling reactions use HMPA as an additive.62,64"67 Addition of HMPA 
to a solution of SmI2 in THF enhances the reduction potential of SmI2 by coordinating 
to the samarium metal center, producing the more powerful reductant 
[Sm(HMPA)6]2+2I".68 
 
CO2Et
O
CO2Et
HO
H
x
SmI2, t-BuOH,
THF
0 °C ! RT
234a220  
 
Scheme 98 The SmI2 ketone-olefin cyclisation of 220 without HMPA. 
 
The reaction of 220 with SmI2, HMPA and t-BuOH was attempted, but this led to the 
formation of unknown compound 235. Mass spectrometry suggests this compound is 
based on two molecules of the starting material (an unsymmetrical dimer) [m/z (ESI): 
[MNa+] C32H50NaO6, 553.3455], the IR shows a broad OH signal at 3400cm"1 and the 
1H NMR and 13C NMR spectra show that there are 4 alkene C-H environments and 
two ester C=0 environments. Efforts were made to grow a crystal of the unknown 
compound but these were unsuccessful. In an attempt to avoid this dimerisation, the 
reaction was carried out at high dilution (3.7)10"4 mol dm"3) but unfortunately the 
same product was recovered from this reaction.  
 74 
CO2Et
O
CO2Et
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Scheme 99 The SmI2 ketone-olefin cyclisation of 220 with HMPA. 
 
A much simpler, cyclohexyl model ketone-olefin compound 239 was prepared in the 
hope that it would shed light on the reaction of 220 with SmI2. Treatment of 
cylohexene 236 with Schlosser’s base69 furnished alcohol 236 in 75% yield. The 
iodination/alkylation/decarboxylation strategy, which was previously optimized on 
cyclohexanol (Section 2.1), was straightforward furnishing ketone-olefin 239 in good 
yield. 
CO2t-Bu
KOtBu,
BuLi,
H2CO
236, 75%
I2,
PPh3,
imid,
CH2Cl2
TFA,
CH2Cl2
237, 58% 238, 68% 239, 86%
MeCOCH2CO2tBu, 
NaH, 
THF
40 °C, 
16 h
reflux, 16 h 50 °C, 
16 h
RT, 16 h ! 
60 °C, 1h
OOI
cyclohexene
OH
 
 
Scheme 100 The preparation of model system ketone-olefin 239. 
 
The reaction of ketone-olefin 239 with SmI2 furnished an unidentifiable complex 
mixture of products. It had been hoped that this reaction would help in the elucidation 
of the unidentified dimer 235 but unfortunately, as there was no evidence of 
dimerisation by MS in the reaction of ketone-olefin 239 with SmI2 this was unhelpful.  
 
O
x
SmI2, t-BuOH, HMPA
THF
!78 °C, 10 min HO
239 240  
 
Scheme 101 The SmI2 ketone-olefin cyclisation of 239. 
 
However, the ring closing reaction of ketone-olefin 238, bearing the t-butyl ester 
group, furnished compound 241 as two isolable diastereomers in a yield of 43%. This 
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result is surprising as the steric bulk of the t-butyl ester moiety had been expected to 
hamper the reaction. The reaction was subsequently tested on the pyxidatol C 
analogue, t-butyl ester 228, but again dimerisation was evident in the MS and the 
NMR spectra suggested formation of a t-butyl ester substituted analogue of the 
unidentified compound 235. 
 
CO2Et
HO
H
CO2Et
O
tBuO2C tBuO2C
242228
x
SmI2, t-BuOH, HMPA
THF
!78 °C, 10 min
CO2t-Bu
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O
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Scheme 102 The SmI2 ketone-olefin cyclisation of t-butyl compound 238. 
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4.7 Conclusion 
 
Having successfully overcome the challenges associated with preparing the gem-
dimethyl cycloheptadiene (Chapter 3), there have been some frustrating setbacks in 
our efforts to synthesise pyxidatol C. We were unable to avoid cyclic ether formation 
when attempting to install the methyl ketone side chain to the cycloheptadiene 
(Scheme 103).  
O
209
HO OTBS
I2, PPh3, imid, 
CH2Cl2
HO OTBDPS
210
(CF3SO2)2O, Et3N, 
CH2Cl2
MsO OTBDPS
212
NaI, 
DMF
OHHO
162
PTSA, p-anisaldehyde, 
benzene
HO OPMB
216
I2, PPh3, imid, 
CH2Cl2
I2, PPh3, imid, 
CH2Cl2
HO OTBDPS
210
163
 
 
Scheme 103 A review of the formation of unwanted cyclic ether 209. 
 
More positively, Tsuji"Trost chemistry was used to prepare methyl ketone 220 
(Scheme 104), but the samarium diiodide promoted ketone-olefin cyclisation was 
unsuccessful.  
 77 
EtO2C
Ethyl chrysanthemate
mixture of cis and trans
in a ratio of 2:3
O3, CH2Cl2
EtO2C
O
127, 97%
!78 °C
OH
56b, 31%
HO
OHHO
56a, 49%
+
cis:trans 2:3
LiAlH4,
THF
0 °C " RT, 
10 min
NaH, TBSCl, 
THF
OTBSHO
132, 84%
OTBSEtO2C
133, 78%
MnO2,
Ph3PCHCO2Et, 
CHCl3
0 °C " RT, 
105 m
reflux, 2 d
5 : 1 E : Z
OTBSHO
221 82%
DIBAL, 
CH2Cl2
!78 °C
OTBSEtO2CO
DMAP,
pyridine,
ClCO2Et,
CH2Cl2
223
Pd(PPh3)4,
CH3COCH2CO2tBu,
THF
50 °C, 1 hRT, 30 min
224, 92% over 2 steps
OTBStBuO2C
OH
225, 72%
tBuO2C
OO
TBAF, 
CH2Cl2
RT, 16 h
DMP, CH2Cl2
O
227
tBuO2C
O Ph3PCHCO2Et, 
CHCl3
RT, 16 h
RT, 16 h
226, 72% over 2 steps
tBuO2C CO2Et
O
toluene
100 °C, 
16 h
CO2Et
228
O
tBuO2C
TFA, 
CH2Cl2
CO2Et
220, 51% over 2 steps
O50 °C,16 h CO2Et
HO
H
x
SmI2, t-BuOH, HMPA
THF
234a  
 
Scheme 104 A review of the synthetic route to the advanced intermediate 220. 
 
In light of these setbacks, a 2001 paper by Kerr et al.71 which uses Pauson"Khand 
chemistry in the synthesis of (+)-taylorione has led to the design of another alternative 
strategy for the installation of the 5 membered ring moiety, which is described in 
Chapter 5. 
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Chapter 5 
Future Approach and Preliminary Studies 
 
Studies into the Cope rearrangement enabled the synthesis of the gem-dimethyl 
containing 7-membered ring moiety present in the decahydro-1H-
cyclopropa[e]azulene core structure of pyxidatol C (Chapter 3). The cyclopropane of 
this core structure has been installed using both Corey-Chaykovsky cyclopropanation 
and Simons-Smith cyclopropanation (Sections 4.1 & 4.3). The methyl ketone side 
chain was installed using Tsuji"Trost chemistry but unfortunately, the planned SmI2 
ketone-olefin cyclisation reaction to form the 5-membered ring moiety present in 
pyxidatol C was unsuccessful (Scheme 104). Future work will focus on the 
development of a route to install this 5 membered ring moiety at an earlier stage in the 
synthesis. Preliminary scoping work and future plans are described below. 
 
5.1 A Pauson-Khand Strategy 
 
Kerr et al. used Pauson-Khand chemistry in their synthesis of the cyclopentenone-
containing compound (+)-taylorione (Scheme 105).70,71 Coordination of 
hexacarbonyldicobalt to the alkyne of 243 is followed by a [2+2+1]-cycloaddition 
which furnished cyclopentenone 245, an intermediate in the syntheisis of (+)-
taylorione. In one set of conditions, ethylene and carbon monoxide were used as 
reagents at 25 atm. In a second set of conditions, vinyl benzoate was used as an 
ethylene equivalent.70,71 
 
243 245, 60%
Ohex.
Co2(CO)6
244, 99%
Co2(CO)6
i) ethylene, CO
or
ii) vinyl benzoate,
NMO.H2O
O O O O O O
 
 
Scheme 105 Pauson-Khand chemistry used in the synthesis of (+)-taylorione 
 
It is expected that this methodology will be suitable for the preparation of the 5 
membered ring present in pyxidatol C (Scheme 106). The Cope rearrangement of 
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cyclopropane 248 bearing a cyclopentenone moiety would furnish cycloheptadiene 
249. Then, a selective reduction of the electron-deficient alkene of 249, followed by 
the addition of a methyl nucleophile into the ketone would furnish alcohol 234a. 
Alkene isomerisation/cyclopropanation would then complete the total synthesis of 
pyxidatol C 3. 
 
CO2Et
CO2Et
249
248
O
O
CO2Et
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H
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246 247
3
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H
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Scheme 106 The proposed Pauson-Khand approach towards pyxidatol C 3. 
 
The Pauson-Khand reaction was tested on ethynylbenzene 250 by Kerr et al.71 This 
chemistry was retested in order to confirm that it was reproducible in our hands 
(Scheme 107), and pleasingly it was easily repeated (using the vinyl benzoate, 
NMO.H2O conditions) both in terms of yield and purity. Alkynehexacarbonyldicobalt 
complex 251 was prepared in 95% yield, compared to 99% in the literature and 
cyclopentenone 252 was obtained in 75% yield compared to 80%.71 Attention 
therefore turned to the preparation of alkyne 246. 
hex.
Co2(CO)6
Co2(CO)6 vinyl benzoate, NMO.H2O,
CH2Cl2
O
251, 95% 252, 75%
RT, 16 h
250  
 
Scheme 107 The ethynylbenzene model system. 
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5.2 Preliminary Results Towards Alkyne 246 
 
Ohira-Bestmann chemistry72 was considered to be the simplest way to prepare alkyne 
246. Aldehyde 253 was prepared via the MnO2 oxidation of alcohol 131 but 
unfortunately the reaction with Ohira-Bestmann phosphonate 254 led only to a 
complex mixture of decomposition products (Scheme 108). 
 
O
CO2Et
O
P OCH3
O
OCH3N2
K2CO3, MeOH
CO2Et0 °C ! RT, 2 h
x
253, 72% 246
HO CO2Et
131
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reflux, 16 h
 
 
Scheme 108 Ohira-Bestmann reaction using aldehyde 253. 
 
The Ohira-Bestmann reaction was therefore trialled on aldehyde 136 with a view to 
building in the unsaturated ester of 246 once the alkyne was in place. However, once 
again a complex mixture of decomposition products was obtained (Scheme 109). 
Rather than test a multitude of Ohira-Bestmann conditions, Corey-Fuchs chemistry73 
was trialled in its place. 
OTBSO
O
P OCH3
O
OCH3N2
K2CO3, MeOH
OTBS0 °C ! RT, 2 h
x
136 255  
 
Scheme 109 Ohira-Bestmann reaction using aldehyde 136. 
 
Dibromoalkene 256 was prepared from the reaction of aldehyde 253 with carbon 
tetrabromide and triphenylphosphine, in a moderate 48% yield (Scheme 110). 
 
O
CO2Et CO2Et
Br
Br
CBr4, PPh3, CH2Cl2
253 256, 48%
0 °C, 20 min
 
 
Scheme 110 Corey-Fuchs reaction using aldehyde 253. 
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It was hoped that the reaction of dibromoalkene 256 with n-BuLi would afford the 
desired alkyne 246. However, a complex mixture of products, inseparable by flash 
column chromatography was obtained. A singlet at 1.95 ppm in the 1H NMR 
spectrum of the unpurified reaction mixture indicated that an alkyne was present but 
analysis of the HRMS indicated that the desired alkyne 246 was not present in the 
reaction mixture. It is postulated that addition of the nBu" nucleophile into the ester 
group instead afforded alkyne 257 which is supported by mass spectrometry [m/z 
(ESI): [MNa+]  C18H30NaO, 285.2917].  
 
OH
nBunBu
nBuLi, THF
257
CO2Et
Br
Br
256
CO2Et
246
x
!78 °C, 1 h
 
 
Scheme 111 Formation of alkyne 257. 
 
Preparation of dibromoalkene 258 from TBS aldehyde 136 was trialled with a view to 
preparing the alkyne before the ester was in place, thus avoiding addition of the nBu" 
nucleophile into the ethyl ester. Unfortunately, this reaction led to a complex mixture 
of decomposition products (Scheme 112) and so alternative strategies to avoid this 
addition were tested. 
 
OTBSO OHBr
Br
258
CBr4, PPh3, CH2Cl2
0 °C, 20 min
x
136  
 
Scheme 112 Corey-Fuchs reaction using aldehyde 136. 
 
It was hoped that reduction of the electrophilic ester moiety in 256 to give alcohol 259 
would stop the side-reactions during alkyne formation. DIBAL reduction of ester 256 
was straightforward but treatment with nBuLi again led to decomposition and no 
evidence of the formation of the desired product 260 (Scheme 113). 
 
Br
Br OH
DIBAL, 
CH2Cl2
259, 74% on small scale
CO2Et
Br
Br
OH
260
!78 °C, 
30 min
nBuLi, THF
x
!78 °C, 1 h
256  
 
Scheme 113 DIBAL reduction of 256. 
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Alcohol 259 was to be protected as a silyl ether in order to avoid deprotonation of the 
free alcohol group by nBuLi because the resulting alkoxide could be a reactive 
intermediate in decomposition pathways. Unfortunately, the DIBAL reduction of ester 
256 did not work well on scale up and only trace amounts of alcohol 259 were 
synthesized. With time limited, an alternative route towards silyl ether 265 was tested 
in place of optimizing the reduction of ester 256. This strategy relied on the use of 
orthogonal protecting groups in the synthesis of silyl ether 265 (Scheme 114). 
 
TBSO OH TBSO OTIPS HO OTIPS
HO OTIPS O OTIPS OTIPSBr
Br
OTIPS
221 261 262
263 264 265
266  
 
Scheme 114 Using TIPS as an orthogonal protecting group. 
 
TIPS protection of alcohol 221 proved to be straightforward. It was expected that 
TBAF would cleave the TBS ether of cyclopropane 261 selectively because the TIPS 
ether is more stable than TBS. However, desilylation using TBAF selectively cleaved 
the TIPS ether, in place of the desired TBS ether and TBS compound 221 was 
recovered from the reaction (Scheme 115).  
 
TBSO OH TBSO OTIPS
TBAF, THF
221 261, 92%
TIPSOTf, Lutidine,
CH2Cl2
0 °C ! RT, 16 h
0 °C, 1 h  
 
Scheme 115 TIPS protection of alcohol 221 followed by unsuccessful TBS cleavage. 
 
The relative stability of the TBS ether of cyclopropane 261 suggests that the silicon 
atom is more sterically hindered on the TBS than on the TIPS ether, probably due to 
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its proximity to the cyclopropane. With this in mind, it was hoped that the reaction of 
diol 267 with only 1 equivalent of TBSCl would give selectively mono-TBS protected 
compound 268, but unfortunately a mixture of diol and bis-TBS compound was 
recovered from this reaction. This suggests that the mono-TBS protected compound 
268 must silylate faster than diol 267. Speculatively, this could be due to differences 
in the solubility of the mono-TBS protected compound 268 and the starting material 
diol 267 (Scheme 116). 
 
TBSO OH
TBAF, THF
0 °C, 1 h HO OH
221 267, 84%
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RT, 2 h
HO OH
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Scheme 116 The unsuccessful mono-TBS protection of diol 267. 
 
Given the difficulties working with TIPS as an orthogonal protecting group, the use of 
a benzyl protecting group was planned. Pleasingly, benzyl protection of alcohol 221 
was straightforward, as was silyl cleavage furnishing alcohol 270 in 64% yield over 
the two steps. Unfortunately oxidation with MnO2 or DMP was unsuccessful (Scheme 
117).  
 
TBSO OH HO OBn
O OBn
i) NaH, benzyl bromide, CH2Cl2
ii) TBAF, THF
270, 64%221
MnO2, CH2Cl2 or
DMP, CH2Cl2
x
271  
 
 
Scheme 117 Benzyl protection followed by silyl deprotection of alcohol 221. 
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The focus of future work will be to build on these preliminary studies to find an 
efficient synthesis of alkyne 246, thus enabling us to test the proposed Pauson-Khand 
strategy towards pyxidatol C (Scheme 118).  
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Scheme 118 The proposed Pauson-Khand approach towards pyxidatol C 3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 85 
Chapter 6 
Addendum 
Total Synthesis of Pyxidatol C by G. Liang et al.74 
 
Having completed all of the experimental and written work contained in this thesis, 
the total synthesis of pyxidatol C 3 was reported by G. Liang et al.74 For 
completeness, details are given below. 
 
Commercially available ketone 272 was converted to trans-decalin 273 in 45% yield 
using the aldol"Henry reaction cascade and subsequent Parikh"Doering oxidation.75 
The stereochemistry of 273 was unambiguously confirmed by single-crystal X-ray 
crystallographic analysis. The carbonyl group in 273 was protected as its acetal 
allowing palladium-catalyzed hydrogenation of the nitro group to afford the 
corresponding amine 275 in nearly-quantitative yield. The Tiffeneau"Demjanov 
rearrangement generated the desired cis-fused 5,7-carbocycle 276 in 62% yield with 
complete diastereocontrol.76 A Corey"Chaykovsky epoxidation77 and epoxide 
isomerization sequence yielded alcohol 278 as the single regioisomer shown.78 Acetal 
hydrolysis with 1 N HCl in THF revealed ketone 279. Addition of methyllithium then 
afforded the diol 280 in 59% yield; this reaction furnished a pair of separable 
diastereomers, with the minor diasteromer, which is not depicted in scheme 119 
isolated in 15% yield. A Simmons"Smith cyclopropanation29 of 280 completed the 
synthesis of pyxidatol C in 68% yield with excellent stereo-chemical control (d.r. > 
19:1).74 
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Scheme 119 The total synthesis of pyxidatol C 3 by G.Liang et al. 
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Chapter 7 
Experimental 
 
7.1 General Experimental 
 
All reagents were purchased from commercial sources and were used without further 
purification. 
 
Unless otherwise stated, all procedures were carried out under an atmosphere of 
argon. Where necessary, solvents were dried on an MBraun SPS solvent purification 
system. Anhydrous THF was obtained by distillation over sodium benzophenone. 
Hexane refers to n-hexane and pet. ether refers to light petroleum ether, bp 40"60 °C. 
Ethanol was dried according to the method of Lund and Bjerrum.79 DMP was 
prepared using the procedure described by Boeckmann.80  
 
Flash column chromatography was performed using Fluka silica gel 60 under positive 
pressure. Analytical thin layer chromatography was performed on aluminium sheets 
pre-coated with Merck silica gel 60 F254 and visualised with ultraviolet light (254 
nm), aqueous potassium permanganate or anisaldehyde solutions where appropriate. 
 
1H NMR spectra were recorded on a JEOL ECX 400 (400 MHz) instrument. The 
chemical shift data is reported in parts per million (ppm) on the delta (#) scale relative 
to tetramethylsilane (TMS) where #TMS = 0.00 ppm. The number of protons (n) for a 
given resonance is indicated by nH. The multiplicity of each signal is indicated by: s 
(singlet), br s (broad singlet), d (doublet), t (triplet), q (quartet), m (multiplet). The 
coupling constants (J) are quoted to the nearest 0.5 Hz. The residual protic solvent 
(CHCl3) (#H=7.26 ppm) was used as an internal reference. 13C NMR spectra were 
recorded on a JEOL ECX 400 instrument at 100 MHz. The central signal of CDCl3 
(#C=77.0 ppm) was used as an internal reference. 13C spectra were verified using 
DEPT experiments and COSY and HSQC experiments were used for assignment 
purposes where necessary. Chemical shifts are reported to the nearest 0.01 ppm for 1H 
NMR and to the nearest 0.1 ppm for 13C NMR.  
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Infrared spectra were carried out on a ThermoNicolet IR100 spectrometer and are 
recorded as a thin film between NaCl discs. Absorption maxima are reported in 
wavenumbers (cm-1) and only selected absorbances are reported. Mass spectra and 
accurate mass measurements were obtained through the University of York mass 
spectrometry service and were recorded on a Bruker Daltonics, Micro-tof 
spectrometer. All melting points were taken on a Gallenkamp instrument.   
 
All numbering of structures is for characterisation purposes only and does not 
conform to IUPAC rules. 
 
7.2 Procedures & Compound Characterisation (Chapter 1 & Chapter 2) 
 
(±)-(1S,2S)-Cyclopropane-1,2-diyldimethanol (54a)24 
 
To a stirred suspension of LiAlH4 (4.17 g, 110 mmol) in THF 
(100 mL) at 0 °C was added a solution of diethyl trans-1,2-
cyclopropanedicarboxylate (13.6 g, 73.1 mmol) in THF (25 
mL), over a period of 1 h via a syringe pump. The reaction mixture was then heated at 
reflux at 70 °C for 2 h, before being cooled to RT and stirred for 18 h. After cooling to 
0 °C the mixture was diluted with EtOAc (30 mL) and washed cautiously with sat. 
NH4Cl (aq.) (30 mL). The resulting suspension was filtered, and the insoluble salts 
were washed with further portions of EtOAc (2 ) 50 mL). The filtrate was 
concentrated under reduced pressure, and the residue taken up in EtOAc (50 mL). The 
solution was then dried (MgSO4), filtered and concentrated under reduced pressure to 
afford to afford the title compound 54a as a colourless oil. (5.30 g, 71%); Rf (1:1 pet. 
ether:EtOAc) 0.34; 1H NMR (400 MHz; CDCl3) " 3.73"3.60 (2 H, m, H-1a), 
3.35"3.21 (2 H, m, H-1b), 0.99"1.07 (2 H, m, H-2), 0.46 (2 H, dt, J 7.0, 2.5 H-3). 
Data in agreement with those reported in the literature.24 
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(±)-(2E,2'E)-Diethyl 3,3'-cyclopropane-1R,2R-diyl)diprop-2-enoate (55a)24 
 
To a stirred solution of 54a (8.67 g, 85.0 mmol) in 
CHCl3 (510 mL) was added manganese oxide (148 g, 
1.7 mol) and (carbethoxymethylene) triphenyl 
phosphorane (71.1 g, 204 mmol). The resulting suspension was stirred vigorously 
with heating to maintain gentle reflux for 18 h. After cooling to room temperature, the 
suspension was filtered through Celite, and washed with CHCl3 (50 mL). The filtrate 
was concentrated under reduced pressure and diethyl ether (100 mL) was added to the 
yellow solid residue. This suspension was stirred at room temperature for 30 mins, 
and the resulting white precipitate (triphenylphosphine oxide) was removed by 
filtration and washed with pet. ether (75 mL). The filtrate was concentrated under 
reduced pressure to give the crude product. This was purified by flash column 
chromatography on silica gel, eluting with pet. ether:Et2O (4:1 & 2:1) to afford the 
title compound 55a as a white solid (15.2 g, 75%); Rf (4:1 pet. ether:Et2O) 0.41; 1H 
NMR (400 MHz; CDCl3) " 6.45 (2 H, dd, J 9.0, 15.5, H-2), 5.90 (2 H, d, J 15.5 H-1), 
4.17 (4 H, q, J 7.0 CH3CH2O), 1.79"1.82 (2 H, m, H-3), 1.23-1.31 (8 H, m, 
CH3CH2O & H-4). Data in agreement with those reported in the literature.24 
 
(±)-(1R,2S,3Z,6Z)-Diethyl cyclohepta-3,6-diene-1,2-dicarboxylate (58a) 
 
A stirred solution of 55 (5.01 g, 21.0 mmol) in xylene (50 mL) 
was heated at reflux at 130 °C for 16 h. After being cooled to RT 
the solution was concentrated under reduced pressure to give the 
crude product. This was purified by flash column 
chromatography on silica gel, eluting with pet. ether:Et2O (10:1 & 2:1) to afford the 
title compound 58a, as a colourless oil (3.96 g, 80%); Rf (20:1 pet. ether:EtOAc) 0.19; 
*max (thin film)/cm-1 2981, 2937, 1735; 1H NMR (400 MHz; CDCl3) " 6.08!6.02 
(2H, m, H-2), 5.82!5.76 (2H, m, H-3), 4.20!4.11 (4H, m, CH3CH2O), 3.86"3.84 (2H, 
m, H-1), 3.06"2.97 (1H, m, H-4a), 2.68 (1H, dt, J 20.0, 7.0 Hz H-4b), 1.25 (3H, t, J 
7.0, CH3CH2O); 13C NMR (101 MHz; CDCl3) # 172.1 (CH3CH2OC=O), 129.4 (C-
EtO2C CO2Et
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3), 127.5 (C-2), 61.1 (OCH2CH3), 45.1 (C-1), 28.3 (C-4), 14.2 (OCH2CH3); m/z (ESI) 
239 [MH+]; HRMS: calcd. for C13H19O4, 239.1278. Found: [MH+], 239.1271 (2.4 
ppm error). 
 
(±)-(1R,2S,3Z,6Z)-Cyclohepta-3,6-diene-1,2-diyldimethanol (59)  
 
To a stirred suspension of LiAlH4 (1.26 g, 33.2 mmol) in THF 
(75 mL) at RT was added 58 (3.96 g, 16.6 mmol) in THF (75 
mL) via cannula. After 2 h the reaction was cooled to 0 °C and 
Na2SO4.10H2O was cautiously added until on further addition 
fizzing could no longer be observed. The aluminium salts were removed by filtration 
and washed with EtOAc (200 mL). The filtrate was concentrated under reduced 
pressure to give the crude product. This was purified by flash column 
chromatography on silica gel, eluting with pet. ether:EtOAc (4:1 & 1:1) to afford the 
title compound 59 as a colourless oil (1.94 g, 76%); Rf (EtOAc) 0.44; *max (thin 
film)/cm-1 3315, 3013, 2926, 2876, 1655; 1H NMR (400 MHz; CDCl3) " 5.79!5.57 
(4H, m, H-3 & H-4), 3.77!3.58 (4H, m, H-1), 3.10!2.99 (1H, m, H-5a), 2.91!2.83 
(2H, m, H-2), 2.73!2.64 (1H, m, H-5b); 13C NMR (101 MHz; CDCl3) # 130.3 (C-3 
or C-4),  129.1 (C-3 or C-4), 64.0 (C-1), 44.1 (C-2), 29.8 (C-5); m/z (ESI): 177 
[MNa+]; HRMS (ESI): calcd. for C9H14NaO2, 177.0886. Found: [MNa+], 177.0886 
(0.0 ppm error). 
 
(±)-(3aR,4Z,7Z,8aS)-3,3a,6,8a-Tetrahydro-1H-cyclohepta[c]furan-1-one (60) 
   
To a stirred solution of 59 (500 mg, 3.25 mmol) in CH2Cl2 (18 mL) at 
RT was added PhI(OAc)2 (2.62 g, 8.13 mmol) and TEMPO (508 mg, 
0.325 mmol). After 2 h the reaction mixture was concentrated under 
reduced pressure to give the crude product. This was purified by flash 
column chromatography on silica gel, eluting with pet. ether:Et2O (10:1 & 1:1) to 
afford the title compound 60 as a colourless oil (240 mg, 49%); Rf (1:1 pet. 
ether:Et2O) 0.42; *max (thin film)/cm-1 3025, 2970, 2910, 1769; 1H NMR (400 MHz; 
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CDCl3) " 6.01!5.01 (2H, m, H-3 & H-5), 5.66 (1H, dddd, J 11.0, 5.0, 2.0, 1.0 Hz, H-
6), 5.52!5.48 (1H, m, H-2), 4.31 (1H, dd, J 9.0, 5.5 Hz, H-8a), 4.19 (1H, dd, J 9.0, 
3.5 Hz, H-8b), 3.52!3.44 (1H, m, H-1), 3.44!3.38 (1H, m, H-7), 2.98!2.87 (1H, m 
H-4a), 2.77!2.67 (1H, m H-4b); 13C NMR (101 MHz; CDCl3) # 176.4 (C-9), 133.4 
(C-3 or C-5), 132.3 (C-3 or C-5), 127.8 (C-6), 122.7 (C-2), 72.7 (C-8), 43.3 (C-1 or 
C-7), 39.0 (C-1 or C-7), 27.2 (C-4); m/z (ESI): 173 [MNa+]; HRMS (ESI): calcd. for 
C9H10NaO2, 173.0573. Found: [MNa+], 173.0574 (0.7 ppm error). 
 
(±)-(R,4Z,8E)-3,3a,6,7-Tetrahydro-1H-cyclohepta[c]furan-1-one, (61)  
& (±)-(Z)-3,6,7,8-Tetrahydro-1H-cyclohepta[c]furan-1-one (63) & (±)-
(3aR,4Z,7Z,8aR)-3,3a,6,8a-tetrahydro-1H-cyclohepta[c]furan-1-one (64) 
 
To a stirred solution of 60 (120 mg, 0.799 
mmol) in degassed THF (24 mL) at 0 °C 
was added DBU (0.12 mL, 0.799 mmol). 
After 2h the reaction was quenched with 
NH4Cl (aq.) (30 mL), the organic layer was 
separated and the aqueous layer extracted with portions of EtOAc (2 ) 50 mL). The 
combined organic extracts were dried (MgSO4), filtered and concentrated under 
reduced pressure. The resulting crude product was purified by flash column 
chromatography on silica gel, eluting with pet. ether:Et2O (4:1) to afford the title 
compound 61 as a white solid (89 mg, 74%), 63 as a colourless oil (13 mg, 11%) and 
64 (7 mg, 6%) as a colourless oil (assigned tentatively by 1H NMR spectroscopy); 61 
Rf (1:2 pet. ether:Et2O) 0.54; mp 55-58 °C; *max (thin film)/cm-1 3026, 2949, 2906, 
2854, 1754, 1678; 1H NMR (400 MHz; CDCl3) " 6.96 (1H, dd, J 4.5, 9.5 Hz, H-2), 
5.60 (1H, ddd, J 10.5, 2.5, 2.5 Hz, H-5), 5.98!5.90 (1H, m, H-6), 4.58 (1H, dd, J 9.0 
Hz, H-8a), 4.24!4.13 (1H, m, H-7), 3.96 (1H, dd, J 9.0 Hz, H-8b), 2.60!2.47 (2H, m, 
H-3), 2.39!2.28 (1H, m, H-4a), 2.25!2.16 (1H, m, H-4b); 13C NMR (101 MHz; 
CDCl3) # 171.0 (C-9), 140.9 (C-2), 132.3 (C-5 or C-6), 130.0 (C-5 or C-6), 128.7 (C-
1), 70.6 (C-8), 37.3 (C-7), 26.3 (C-3 or C-4), 25.0 (C-3 or C-4); m/z (ESI): 173 
[MNa+]; HRMS (ESI): calcd. for C9H10NaO2, 173.0573. Found: [MNa+], 173.0571 
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(1.5 ppm error). 63 Rf (1: 2 pet. ether: Et2O) 0.51; *max (thin film)/cm-1 3020, 2928, 
2850, 1752; 1H NMR (400 MHz; CDCl3) " 6.34 (1H, dt, J 11.5, 5.5 Hz, H-5), 5.86 
(1H, dt, J 11.5, 1.5 Hz, H-6), 4.66 (2H, t, J 2.5 Hz, H-8), 2.56!2.48 (4H, m, H-2 & H-
4), 1.90!1.84 (2H, m, H-3); 13C NMR (101 MHz; CDCl3) # 175.1 (C-9), 153.3 (C-1 
or C-7), 143.9 (C-5), 127.4 (C-1 or C-7), 119.0 (C-6), 70.9 (C-8), 32.0 (C-2 or C-4), 
26.8 (C-2 or C-4), 22.4 (C-3). m/z (ESI): 173 [MNa+]; HRMS (ESI): calcd. for 
C9H10NaO2, 173.0573. Found: [MNa+], 173.0575 (1.5 ppm error). 64 Rf (1: 2 pet. 
ether: Et2O) 0.49; 1H NMR (400 MHz; CDCl3) " 6.43!5.22 (2H, m, H-3 & H-5), 
5.97!5.76  (1H, m, H-6), 5.60!5.51 (1H, m, H-2), 4.43 (1H, dd, J 9.5, 5.0 Hz, H-8a), 
4.24 (1H, dd, J 9.5, 3.5 Hz, H-8b), 3.75!3.65 (1H, m, H-1), 3.50!3.47 (1H, m, H-7), 
3.01!2.84 (2H, m H-4). 
 
(±)-(31S,4aS,8aR,Z)-4,4a,5,6-Tetrahydro-1H-isochromen-3(8aH)-one (62) 
 
Procedure 1: To a suspension of NaH (27.0 mg, 0.675 mmol, 60% 
dispersion in mineral oil) in DMF (5 mL) at 0 °C was added 
trimethylsulfoxonium iodide (148 mg, 0.675 mmol). The reaction 
mixture was stirred for 5 min the dropwise addition of 61 (85 mg, 
0.567 mmol) in DMF (5 mL). The solution was stirred at 0 °C for 5 mins before 
warming to RT and stirring for 16 h. Sat. NH4Cl (aq.) (10 mL) was then added 
followed by H2O (50 mL). The organic layer was separated and the aqueous layer 
extracted with portions of Et2O (2 ) 60 mL). The combined organic extracts were 
dried (MgSO4), filtered and concentrated under reduced pressure. The resulting crude 
product was purified by flash column chromatography on silica gel, eluting with pet. 
ether:Et2O (4:1) to afford the title compound 62 as a colourless oil (24 mg, 26%); 
Procedure 2: To a stirred solution of MTBD (104 mg, 0.68 mmol) and 
trimethylsulfoxonium iodide (90 mg, 0.408 mmol) in MeCN (1 mL) was added 61 (51 
mg, 0.340 mmol) in MeCN (1 mL). The reaction mixture was stirred at RT overnight. 
It was then concentrated under reduced pressure and the resulting crude product was 
purified by flash column chromatography on silica gel, eluting with pet. ether:Et2O 
(4:1) to afford the title compound 62 as a colourless oil (11 mg, 19%); Rf (1:1 pet. 
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ether:Et2O) 0.46; *max (thin film)/cm-1 3002, 2919, 1767; 1H NMR (400 MHz; CDCl3) 
" 5.71!5.66 (1H, m, H-5), 5.37 (1H, dd, J 11.5, 4.0 Hz, H-6), 4.50 (1H, dd, J 9.0, 7.0 
Hz, H-8a), 4.28 (1H, dd, J 9.0, 1.0 Hz, H-8b), 3.14!3.10 (1H, m, H-7), 2.38!2.23 
(3H, m, H-2 & H-4), 1.77!1.69 (1H, m, H-3a), 1.34!1.25 (2H, m, H-3b & H-1a), 
0.99 (1H, dd, J 6.0, 4.0 Hz, H-1b); 13C NMR (101 MHz; CDCl3) # 179.7 (C-9), 
133.3 (C-5), 129.9 (C-6), 74.1 (C-8), 39.9 (C-2), 30.2 (C-10), 29.4 (C-3 or C-4), 29.3 
(C-3 or C-4), 24.3 (C-1), 22.9 (C-7); m/z (ESI): 187 [MNa+]; HRMS (ESI): calcd. for 
C10H12NaO2, 187.0730. Found: [MNa+], 187.0725 (2.7 ppm error). 
 
(±)-(3aR,4Z,7Z,8aS)-3,3a,6,8a-Tetrahydro-1H-cyclohepta[c]furan-1-ol (67) 
 
To a stirred solution of 59 (100 mg, 0.650 mmol) in anhydrous 
DMSO (2 mL) was added IBX (218 mg, 0.780 mmol) at RT. This 
was stirred for 2h before the addition of H2O (5 mL). The resulting 
mixture was filtered through celite, washed with CH2Cl2 (10 mL) 
and water (2 mL). The filtrate was dried (MgSO4), filtered and concentrated under 
reduced pressure. The resulting crude product was purified by flash column 
chromatography on silica gel, eluting with pet. ether:Et2O (2:1) to afford the title 
compound 67 as a colourless oil and mixture of diastereomers in a ratio of major (A): 
minor (B), 2:1 (60 mg, 60%); Rf (EtOAc) 0.63; *max (thin film)/cm-1 3397, 3017, 2941, 
2885; 1H NMR (400 MHz; CDCl3) " 5.99!5.91 (1H, m, H-2 or H-3 or H-5 or H-6, 
A), 5.89!5.82 (1H, m, H-2 or H-3 or H-5 or H-6, A), 5.81!5.74 (1H, m, H-2 or H-3 
or H-5 or H-6, A), 5.73!5.68 (1H, m, H-2 or H-3 or H-5 or H-6, B), 5.63!5.67 (1H, 
m, H-2 or H-3 or H-5 or H-6, B), 5.55!5.49 (1H, m, H-2 or H-3 or H-5 or H-6, A), 
5.48!5.43, (2H, m, H-2 or H-3 or H-5 or H-6, B), 5.33 (1H, d, J 2.0 Hz, H-9, A), 5.29 
(1H, dd, J 8.5, 5.0 Hz, H-9, B), 4.13 (1H, dd, J 8.0, 7.0 Hz, H-8a, A), 4.08 (1H, dd, J 
8.5, 1.5 Hz, H-8a, B), 3.90 (1H, dd, J 8.5, 5.5 Hz, H-8b, B), 3.69 (1H, dd, J 8.0, 8.0 
Hz, H-8b, A), 3.44 (1H, br s, OH, A), 3.36 (1H, br s, OH, B), 3.10!2.87 (4H, m, H-1 
& H-7, A & B) 2.63 (2H, dd, J 7.0, 7.0 Hz, H-4, A), 2.58 (2H, dd, J 7.0, 7.0 Hz, H-4, 
B); 13C NMR (101 MHz; CDCl3) # 134.2 (C-2 or C-3 or C-5 or C-6, B), 133.8 (C-2 
or C-3 or C-5 or C-6, A), 131.7 (C-2 or C-3 or C-5 or C-6, A), 130.7 (C-2 or C-3 or 
C-5 or C-6, B), 130.2, (C-2 or C-3 or C-5 or C-6, A) 127.8 (C-2 or C-3 or C-5 or C-6, 
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A), 127.6 (C-2 or C-3 or C-5 or C-6, B), 124.6 (C-2 or C-3 or C-5 or C-6, B), 103.8 
(C-9, A), 99.2 (C-9, B), 75.1 (C-8, B), 72.6 (C-8, A), 48.5 (C-1, A), 47.8 (C-1, B), 
40.1 (C-7, A), 38.8 (C-7, B), 27.7 (C-4, A), 27.4 (C-4, B); m/z (ESI): 175 [MNa+]; 
HRMS (ESI): calcd. for C9H12NaO2, 175.0730. Found: [MNa+], 175.0726 (2.6 ppm 
error). 
 
Iodomethyl(cyclohexane) (69)81 
 
To a stirred solution of cyclohexylmethanol (500 mg, 4.38 mmol) in 
CH2Cl2 (25 mL) at RT was added triphenylphosphine (1.72 g, 6.57 
mmol), imidazole (447 mg, 6.57 mmol) and iodine (667 mg, 5.26 
mmol). After stirring for 50 mins Na2S2O3 (aq.) (25 mL) was added, the organic layer 
was separated and the aqueous layer extracted with further EtOAc (2 ) 30 mL). The 
resulting crude product was purified by flash column chromatography on silica gel, 
eluting with pet. ether:EtOAc (30:1) to afford the title compound 69 as a colourless 
oil (608 mg, 62%); Rf (1:1 pet. ether:EtOAc) 0.78; 1H NMR (400 MHz; CDCl3) " 
3.10 (2H, d, J 6.5 Hz, CH2I), 1.88!1.84 (2H, m, CH-cyclohexyl), 1.72 (2H, m, CH-
cyclohexyl), 1.65!1.58 (1H, m, CH-cyclohexyl), 1.48!1.37 (1H, m, CH-cyclohexyl), 
1.31!1.07 (3H, m, CH-cyclohexyl), 0.94 (2H, m, CH-cyclohexyl) Data in agreement 
with those reported in the literature.81  
 
tert-Butyl 2-(cyclohexylmethyl)-3-oxobutanoate (70) 
 
To a stirring suspension of NaH (5 mg, 0.134 mmol) in THF 
(0.75 mL) at 0 °C was added t-butyl 3-oxobutanoate (18 µL, 
0.112 mmol). 69 (25 mg, 0.112 mmol) in THF (0.75 mL) was 
added to the reaction mixture dropwise over 1 minute before warming to RT over 1 h 
and heating for 16 h in a sealed tube wrapped in tin foil at 70 °C. The reaction was 
diluted with Et2O (5 mL), quenched with sat. NH4Cl (aq.) (3 mL) and the organic 
layer separated. The aqueous layer was extracted with further portions of Et2O (2 ) 5 
mL). The combined organic extracts were dried (MgSO4), filtered and concentrated 
under reduced pressure. The resulting crude product was purified by flash column 
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chromatography on silica gel, eluting with pet. ether:EtOAc (40:1) to afford the title 
compound 70 as a colourless oil (19 mg, 72%); Rf (20:1 pet. ether:EtOAc) 0.30; *max 
(thin film)/cm-1 2977, 2924, 2852, 1736, 1715; 1H NMR (400 MHz; CDCl3) " 3.41 
(1H, dd, J 8.0, 7.0 Hz, H-3), 2.19 (3H, s, H-1), 1.76!1.60 (7H, m, 3 # CH2 & CH), 
1.44 (9H, s, C(CH3)3), 1.24!1.12 (4H, m, 2 # CH2), 0.90!0.84 (2H, m, CH2); 13C 
NMR (101 MHz; CDCl3) # 204.0 (t-BuOC=O), 169.5 (C-2), 81.8 (C(CH3)3), 58.7 
(C-3), 35.7 (C-5), 35.6 (C-4), 33.3 (CH2), 33.0 (CH2), 28.6 (C-1), 28.0 (C(CH3)3), 
26.5 (CH2), 26.3 (CH2), 26.3 (CH2); m/z (ESI): 277 [MNa+]; HRMS (ESI): calcd. for 
C15H26NaO3, 277.1774. Found: [MNa+], 277.1772 (1.3 ppm error). 
 
4-Cyclohexylbutan-2-one (71)82 
 
To a stirred solution of (32) (44 mg, 0.173 mmol) in benzene 
(1.5 mL) was added p-TSA (7 mg, 0.035 mmol). This was 
heated at reflux for 2.5h before the addition of sat. NaHCO3 
(aq.) (2 mL) and Et2O (2 mL). The organic layer was separated and the aqueous layer 
extracted with further portions of Et2O (2 ) 5 mL). The combined organic extracts 
were dried (MgSO4), filtered and concentrated under reduced pressure to afford the 
title compound 71 as a colourless oil (22 mg, 85%); Rf (10:1 pet. ether:EtOAc) 0.22; 
1H NMR (400 MHz; CDCl3) " 2.42 (2H, t, J 8.0 Hz, H-3), 2.13 (3H, s, H-1), 
1.70!1.64 (5H, m, CH), 1.48!1.42 (2H, m, CH), 1.21!1.15 (4H, m, CH), 0.91!0.82 
(2H, m, CH); Data in agreement with those reported in the literature.82  
 
(±)-(R,2E,6Z)-Cyclohepta-2,6-diene-1,2-diyldimethanol (72) 
 
To a stirred solution of 60 (99 mg, 0.666 mmol) in CH2Cl2 (3 
mL) at "78 °C was added DIBAL (3.33 mL, 3.33 mmol, 1M in 
hexanes). After 10 mins the reaction was warmed to RT. After 4 
h the reaction mixture was diluted with CH2Cl2 (5 mL) followed 
by the addition of sat. aq. Rochelle’s salt (5 mL). The mixture was stirred overnight 
after which time, the organic layer was separated and the aqueous layer extracted with 
O
2 1
5 4 3
1
2
3
4
OHHO
5
6
7
98
 96 
further portions of CH2Cl2 (2 ) 10 mL). The combined organic extracts were dried 
(MgSO4), filtered and concentrated under reduced pressure to afford the title 
compound 72 as a colourless oil (84 mg, 82%); Rf (1:2 pet. ether:Et2O) 0.21; *max (thin 
film)/cm-1 3306, 3010, 2925, 2877, 1660; 1H NMR (400 MHz; CDCl3) " 5.95 (1H, t, 
J 6.5 Hz, H-2), 5.78!5.72 (1H, m, H-5), 5.47 (1H, ddt, J 12.0, 6.5, 1.5 Hz, H-6), 
4.14!3.81 (2H, br s, OH), 3.97!3.96 (2H, m, H-9), 3.77 (1H, dd, J 10.5, 8.5, H-8a), 
3.70 (1H, dd, J 10.5, 5.0, H-8b), 3.03!2.97 (1H, m, H-7), 2.54!2.43 (1H, m H-3a), 
2.16!2.08 (3H, m, H-3b, H-4); 13C NMR (101 MHz; CDCl3) # 142.4 (C-1), 132.4 
(C-5), 130.7 (C-2), 126.7 (C-6), 68.8 (C-9), 65.1 (C-8), 45.6 (C-7), 26.2 (C-3 or C-4), 
25.5 (C-3 or C-4); m/z (ESI): 177 [MNa+]; HRMS (ESI): calcd. for C9H14NaO2, 
177.0886. Found: [MNa+], 177.0885 (0.1 ppm error). 
 
(±)-(1S,2R,7S,Z)-Bicyclo[5.1.0]oct-3-ene-1,2-diyldimethanol (73) &  
(±)-(1R,2R,7R,Z)-Bicyclo[5.1.0]oct-3-ene-1,2-diyldimethanol (74) 
 
To a stirred solution of Et2Zn (0.65 mL, 1 mol 
in hexanes, 0.650 mmol) in CH2Cl2 (0.2 mL) 
at 0 °C was added diiodomethane (100 µL, 
1.30 mmol). This was stirred for 10 mins 
before the addition of 72 (45 mg, 0.292 mmol) 
in CH2Cl2 (0.2 mL) via cannula. The reaction was stirred at 0 °C for 10 mins, before 
warming to RT. After 2h the reaction was quenched by the addition of sat. NH4Cl 
(aq.) (2mL). The organic layer was separated and the aqueous layer extracted with 
further portions of CH2Cl2 (2 ) 5 mL). The combined organic extracts were dried 
(MgSO4), filtered and concentrated under reduced pressure to afford the title 
compound 73 as a colourless oil (6 mg, 13%) and 74 as a colourless oil (5 mg, 10%); 
73 Rf (1:2 pet. ether:Et2O) 0.19; *max (thin film)/cm-1 3301, 3012, 2928, 2880, 1640; 
1H NMR (400 MHz; CDCl3) " 5.54!5.49 (1H, m, H-5), 5.41!5.36 (1H, ddt, J 11.5, 
4.0, 2.0 Hz, H-6), 3.97 (1H, dd, J 11.5, 1.0 Hz, H-9a), 3.79!3.73 (2H, m, H-8), 3.22 
(2H, br s, OH), 3.01 (1H, d, J 11.5 Hz, H-9b), 2.58!2.49 (1H, m, H-7), 2.39!2.20 
(2H, m, H-4), 2.05!1.98 (1H, m, H-3a), 1.65!1.53 (1H, m, H-3b), 0.78 (1H, dd, J 8.5, 
4.5 Hz, H-10a), 0.73!0.65 (1H, m, H-10b), 0.48 (1H, td, J 4.5, 1.0 Hz, H-2). 13C 
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NMR (101 MHz; CDCl3) # 134.4 (C-5), 129.7 (C-6), 65.8 (C-9), 63.1 (C-8), 41.1 (C-
7), 30.2 (C-3 or C-4), 29.5 (C-3 or C-4), 22.1 (C-1), 21.4 (C-2), 20.0 (C-10); 191 
[MNa+]; HRMS (ESI): calcd. for C10H16NaO2, 191.1048. Found: [MNa+], 191.1050 
(0.3 ppm error); 74 Rf (1:2 pet. ether:Et2O) 0.17; *max (thin film)/cm-1 3300, 3004, 
2928, 2880, 1643;   1H NMR (400 MHz; CDCl3) " 5.66!5.50 (1H, m, H-5), 5.46 
(1H, dddd, J 12.0, 6.5, 2.5, 1.5 Hz, H-6), 3.69!3.65 (1H, m, H-8a), 3.59 (1H, dd, J 
11.0, 1.5 Hz, H-9a), 3.50!3.44 (1H, m, H-8b), 3.10 (1H, d, J 11.0 Hz, H-9b), 
3.01!2.96 (1H, m, H-7), 2.4 (2H, br s, OH), 2.30!2.17 (2H, m, H-4), 1.96!1.86 (1H, 
m, H-3a), 1.50!1.39 (1H, m, H-3b), 0.87!0.82 (1H, m, H-10a), 0.67 (1H, td, J 5.0, 
1.5 Hz, H-2), 0.60 (1H, dd, J 9.0, 5.0 Hz, H-10b). 13C NMR (101 MHz; CDCl3) # 
135.2 (C-5), 130.3 (C-6), 69.5 (C-9), 65.1 (C-8), 38.1 (C-7), 30.0 (C-3 or C-4), 29.2 
(C-3 or C-4), 23.3 (C-1), 20.9 (C-2), 20.3 (C-10); 191 [MNa+]; HRMS (ESI): calcd. 
for C10H16NaO2, 191.1048. Found: [MNa+], 191.1055 (1.4 ppm error) 
 
(±)-(1R,2R,7R,Z)-Bicyclo[5.1.0]oct-3-ene-1,2-diyldimethanol (73) 
 
To a stirred solution of LiAlH4 (16 mg, 0.426 mmol) in THF (2 
mL) at 0 °C was added a solution of 62 (35 mg, 0.213 mmol) in 
THF (2 mL), via cannula. The reaction mixture was warmed to 
RT and stirred for 45 mins. After being cooled to 0 °C, 
Na2SO4.10H2O was cautiously added until on further addition fizzing could no longer 
be observed. The aluminium salts were removed by filtration and washed with EtOAc 
(15 mL). The filtrate was concentrated under reduced pressure to give the crude 
product. This was purified by flash column chromatography on silica gel, eluting with 
pet. ether:Et2O (4:1 & 1:1) to afford the title compound 73 as a colourless oil (16 mg, 
44%); For data see page 96. 
 
(±)-((1S,2Z,5Z,7R)-7-((tert-Butyldimethylsilyloxy)methyl)cyclohepta-2,5-
dienyl)methanol (76) 
 
To a stirred solution of 59 (500 mg, 3.25 mmol) in THF (6 
mL) was added NaH (156 mg, 3.90 mmol, 60% dispersion in 
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mineral oil) at RT and the reaction mixture stirred for 45 mins before the addition of 
TBSCl (588 mg, 3.90 mmol). After 2h the reaction was quenched with sat. K2CO3 
(aq.) (5 mL) followed by Et2O (5 mL). The organic layer was separated and the 
aqueous layer extracted with further portions of Et2O (2 ) 5 mL). The combined 
organic extracts were dried (MgSO4), filtered and concentrated under reduced pressure. 
The resulting crude product was purified by flash column chromatography on silica 
gel, eluting with pet. ether:EtOAc (40:1 & 5:1) to afford the title compound 76 as a 
colourless oil (775 mg, 89%); Rf (1:1 pet. ether:EtOAc) 0.72; *max (thin film)/cm-1 
3430, 3014, 2955, 2929, 2884, 2858; 1H NMR (400 MHz; CDCl3) " 5.77!5.69 (2H, 
m, H-2 or H-3 or H-5 or H-6), 5.66!5.64 (2H, m, H-2 or H-3 or H-5 or H-6), 
3.84!3.80 (1H, m, H-8a or H-9a), 3.74 (1H, dd, J 10.5, 8.0 Hz, H-8a or H-9a), 
3.68!3.64 (1H, m, H-8b or H-9b), 3.56 (1H, dd, J 10.5, 3.0 Hz, H-8b or H-9b), 
3.07!3.00 (1H, m, H-4a), 2.89!2.85 (1H, m, H-1 or H-7), 2.80!2.76 (1H, m, H-1 or 
H-7), 2.71!2.62 (1H, m, H-4b), 0.91 (9H, s, C(CH3)3), 0.10 (6H, s, SiCH3); 13C NMR 
(101 MHz; CDCl3) # 130.8 (C-2 or C-3 or C-5 or C-6), 130.2 (C-2 or C-3 or C-5 or 
C-6), 129.1 (C-2 or C-3 or C-5 or C-6), 128.8 (C-2 or C-3 or C-5 or C-6), 64.5 (C-8 
or C-9), 64.4 (C-8 or C-9), 44.4 (C-1 or C-7), 44.2 (C-1 or C-7), 29.8 (C-4), 26.0 
(C(CH3)3), 18.4 (C(CH3)3), !5.4 (SiCH3), !5.4 (SiCH3); m/z (ESI): 291 [MNa+]; 
HRMS (ESI): calcd. for C15H28NaO2Si, 291.1751. Found: [MNa+], 291.1745 (2.2 
ppm error). 
 
(±)-(1S,2Z,5Z,7R)-7-((tert-Butyldimethylsilyloxy)methyl)cyclohepta-2,5-
dienecarbaldehyde (77) 
 
To a stirred solution of 76 (725 mg, 2.70 mmol) in CH2Cl2 (27 
mL), at 0 °C was added Dess-Martin Periodinane (1.72 g, 4.05 
mmol). The reaction mixture was warmed to RT and allowed to 
stir for 1 h. It was then diluted with CH2Cl2 (20 mL), and 
quenched with a 1:1 solution of sat. Na2CO3 (aq.) and sat. Na2S2O3 (aq.) (40 mL). 
After vigorous stirring for 30 mins, the organic layer was separated and the aqueous 
layer extracted with further portions of CH2Cl2 (2 ) 50 mL). The combined organic 
extracts were dried (MgSO4), filtered and concentrated under reduced pressure to 
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afford the title compound 77 as a colourless oil (699 mg, 97%); Rf (5:1 pet. 
ether:EtOAc) 0.63; *max (thin film)/cm-1 2954, 2930, 2885, 2858, 1725, 1692; 1H 
NMR (400 MHz; CDCl3) " 9.62 (1H, br s, H-9) 6.00 (1H, ddd, J 11.0, 5.5, 2.5,  Hz, 
H-3 or H-5), 5.89!5.84 (1H, m, H-3 or H-5), 5.72!5.63 (2H, m, H-2 & H-6), 3.57 
(2H, m, H-8), 3.41!3.38 (1H, m, H-1 or H-7), 3.18!3.14 (1H, m, H-1 or H-7), 
3.10!3.02 (1H, m, H-4a), 2.78 (1H, dt, J 21.0, 5.5 Hz, H-4b), 0.91 (9H, s, C(CH3)3), 
0.10 (6H, s, SiCH3); 13C NMR (101 MHz; CDCl3) # 201.1 (C-9), 130.2 (C-2 or C-3 
or C-5 or C-6), 129.2 (C-2 or C-3 or C-5 or C-6), 128.8 (C-2 or C-3 or C-5 or C-6), 
125.1 (C-2 or C-3 or C-5 or C-6), 63.9 (C-8), 53.25 (C-1), 42.7 (C-7), 30.1 (C-4), 
26.0 (C(CH3)3), 18.4 (C(CH3)3), !5.5 (SiCH3), !5.5 (SiCH3). 
 
(±)-(R,1E,5Z)-7-((tert-Butyldimethylsilyloxy)methyl)cyclohepta-1,5-
dienecarbaldehyde (78) 
 
To a solution of 77 (685 mg, 2.57 mmol) in THF (24 mL) at 0 
°C was added DBU (0.38 mL, 2.57 mmol). After 20 mins the 
reaction was quenched with NH4Cl (aq.) (30 mL), the organic 
layer was separated and the aqueous layer extracted with 
portions of EtOAc (2 ) 50 mL). The combined organic extracts were dried (MgSO4), 
filtered and concentrated under reduced pressure. The resulting crude product was 
purified by flash column chromatography on silica gel, eluting with pet. ether:EtOAc 
(20:1) to afford the title compound 78 as a colourless oil (525 mg, 77%); Rf (5:1 pet. 
ether:EtOAc) 0.59; *max (thin film)/cm-1 2954, 2929, 2887, 2857, 1689, 1649; 1H 
NMR (400 MHz; CDCl3) " 9.32 (1H, s, H-9), 6.95 (1H dd, J 7.5, 5.5 Hz, H-2), 
5.87!5.82 (1H, m, H-5), 5.66!5.60 (1H, m, H-6), 3.69!3.65 (2H, m, H-8), 3.64!3.61 
(1H, m, H-7), 2.91!2.82 (1H, m, H-4a), 2.46!2.33 (2H, m, H-4b & H-3a), 2.22!2.14 
(1H, m, H-3b), 0.86 (9H, s, C(CH3)3), 0.02 (3H, s, SiCH3), 0.01 (3H, s, SiCH3); 13C 
NMR (101 MHz; CDCl3) # 194.4 (C-9), 156.8 (C-2), 144.7 (C-1), 130.8 (C-5 or C-
6), 128.6 (C-5 or C-6), 66.0 (C-8), 40.0 (C-7), 27.7 (C-3 or C-4), 26.1 (C(CH3)3), 25.5 
(C-3 or C-4), 18.4 (C(CH3)3), !5.4 (SiCH3), !5.4 (SiCH3); m/z (ESI): 289 [MNa+]; 
HRMS (ESI): calcd. for C15H26NaO2Si, 289.1594. Found: [MNa+], 289.1583 (3.7 
ppm error). 
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(±)-((R,1E,5Z)-7-((tert-Butyldimethylsilyloxy)methyl)cyclohepta-1,5-
dienyl)methanol (79) 
 
To a stirred solution of 78 (14 mg, 0.053 mmol) in CH2Cl2 (2 
mL) at 0 °C was added DIBAL (0.208 mL, 1M in hexanes). 
After 30 mins the reaction mixture was diluted with CH2Cl2 (5 
mL) and washed with Rochelle’s salt (5 mL). The organic layer 
was separated and the aqueous layer extracted with portions of EtOAc (2 ) 10 mL). 
The combined organic extracts were dried (MgSO4), filtered and concentrated under 
reduced pressure. The resulting crude product was purified by flash column 
chromatography on silica gel, eluting with pet. ether:Et2O (1:2) to afford the title 
compound 79 as a colourless oil (9 mg, 64%); Rf (1:1 pet. ether:EtOAc) 0.75; *max 
(thin film)/cm-1 3337, 3010, 2927, 2856; 1H NMR (400 MHz; CDCl3) " 5.96!5.92 
(1H, m, H-2), 5.79!5.73 (1H, m, H-6), 5.52!5.45 (1H, m, H-5), 4.01 (1H, dd, J 11.5, 
4.0 Hz, H-9a), 3.94 (1H, dd, J 11.5, 6.0 Hz, H-9b), 3.83 (1H, dd, J 9.5, 9.5 Hz, H-8a), 
3.72 (1H, dd, J 9.5, 5.0 Hz, H-8b), 3.21!3.16 (1H, m, H-7), 3.07!3.02 (1H, m, H-3 or 
H-4), 2.56!2.47 (1H, m, H-3 or H-4), 2.17!2.05 (3H, m, OH + H-3 or H-4), 0.91 (s, 
9H, C(CH3)3), 0.09 (3H, s, SiCH3), 0.09 (3H, s, SiCH3); 13C NMR (101 MHz; 
CDCl3) # 143.6 (C-1), 132.4 (C-6), 128.5 (C-5), 124.6 (C-2), 68.3 (C-8), 64.8 (C-9), 
42.9 (C-7), 26.4 (C-3 or C-4), 26.1 (C(CH3)3), 25.0 (C-3 or C-4), 18.4 (C(CH3)3),  
!5.5 (SiCH3), !5.5 (SiCH3) m/z (ESI): 291 [MNa+]; HRMS (ESI): calcd. for 
C15H28NaO2Si, 291.1751 Found: [MNa+], 291.1746 (1.1 ppm error). 
 
(±)-((1S,2Z,5Z,7R)-7-((tert-Butyldiphenylsilyloxy)methyl)cyclohepta-2,5-
dienyl)methanol (82) 
 
To a solution of 59 (100 mg, 0.650 mmol) in THF (3 mL) 
was added NaH (31 mg, 0.280 mmol, 60% dispersion in 
mineral oil) at RT and the reaction mixture stirred for 45 
mins before the addition of TBDPSCl (0.17 mL, 0.650 
mmol). After 45 mins the reaction was quenched with K2CO3 (aq.) (5 mL) followed 
by Et2O (5 mL). The organic layer was separated and the aqueous layer extracted with 
TBSO OH
1
2
3
4
5
6
7
8 9
TBDPSO OH
1
2
3
4
5
6
7
8 9
 101 
further portions of Et2O (2 ) 5 mL). The combined organic extracts were dried 
(MgSO4), filtered and concentrated under reduced pressure. The resulting crude 
product was purified by flash column chromatography on silica gel, eluting with pet. 
ether:EtOAc (40:1 & 5:1) to afford the title compound 82 as a colourless oil (196 mg, 
77%); Rf (1:1 pet. ether:EtOAc) 0.73; *max (thin film)/cm-1 3364, 3071, 3015, 2931, 
2858, 1471, 1428; 1H NMR (400 MHz; CDCl3) " 7.71 (4H, ddd, J 8.0, 1.5, 0.5 Hz, 
Ar-H), 7.48!7.40 (6H, m, Ar-H), 5.82!5.71 (2H, m, H-2 or H-3 or H-5 or H-6), 
5.63!5.51 (2H, m, H-2 or H-3 or H-5 or H-6), 3.84!3.71 (3H, m, H-8 or H-9), 3.61 
(1H, dd, J 10.5, 4.0 Hz, H-8 or H-9), 3.07!2.96 (2H, m, H-1 or H-7 & H-4a), 
2.88!2.80 (1H, m, H-1 or H-7), 2.64 (1H, ddd, J 20.5, 6.0, 6.0 Hz, H-4b), 1.09 (9H, s, 
C(CH3)3); 13C NMR (101 MHz; CDCl3) # 135.7 (Ar-CH), 135.7 (Ar-CH), 133.0 (Ar-
CH), 133.0 (Ar-C), 130.9 (CH), 130.3 (CH), 130.0 (CH), 129.2 (CH), 128.8 (CH), 
127.9 (CH), 65.2 (C-8 or C-9), 64.8 (C-8 or C-9), 43.8 (C-1 or C-7), 43.5 (C-1 or C-
7), 29.7 (C-4), 26.9 (C(CH3)3), 19.2 (C(CH3)3); m/z (ESI): 415 [MNa+]; HRMS (ESI): 
calcd. for C25H32NaO2Si, 415.2069. Found: [MNa+], 415.2076 (2.5 ppm error). 
 
(±)-(1S,2Z,5Z,7R)-7-((tert-Butyldiphenylsilyloxy)methyl)cyclohepta-2,5-
dienecarbaldehyde (83) 
 
To a stirred solution of 82 (510 mg, 1.30 mmol) in CH2Cl2 
(13 mL), at 0 °C was added Dess-Martin Periodinane (827 
mg, 1.95 mmol). The reaction mixture was warmed to RT 
and allowed to stir for 1 h. It was then diluted with CH2Cl2 
(15 mL), and quenched with a 1:1 solution of sat. Na2CO3 (aq.) and sat. Na2S2O3 (aq.) 
(30 mL). After vigorous stirring for 30 mins, the organic layer was separated and the 
aqueous layer extracted with further portions of CH2Cl2 (2 ) 30 mL). The combined 
organic extracts were dried (MgSO4), filtered and concentrated under reduced pressure 
to afford the title compound 83 as a colourless oil (511 mg, 100%) which was used in 
the next step without purification; Rf (5:1 pet. ether:EtOAc) 0.81; 1H NMR (400 
MHz; CDCl3) " 9.76 (1H, s, H-9), 7.63 (4H, ddd, J 8.0, 6.0, 1.5 Hz, Ar-H), 7.45!7.36 
(6H, m, Ar-H), 6.06 (1H, ddd, J 11.0, 5.5, 3.0 Hz, H-2 or H-3 or H-5 or H-6), 
5.88!5.83 (1H, m, H-2 or H-3 or H-5 or H-6), 5.62!5.60 (2H, m, H-2 or H-3 or H-5 
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or H-6), 3.65!3.52 (2H, m, H-8), 3.50!3.45 (1H, m, H-1), 3.24!3.20 (1H, m, H-7), 
3.07!3.00 (1H, m, H-4a), 2.78!2.70 (1H, m, H-4b), 1.01 (9H, s, C(CH3)3); m/z (ESI): 
391 [MH+]; HRMS (ESI): calcd. for C25H31O2Si, 391.2088. Found: [MH+], 391.2089 
(0.3 ppm error). 
 
(±)-(R,1E,5Z)-7-((tert-Butyldiphenylsilyloxy)methyl)cyclohepta-1,5-
dienecarbaldehyde (84) 
 
To a solution of 83 (480 mg, 1.23 mmol) in THF (40 mL) at 0 
°C was added DBU (0.184 mL, 1.23 mmol). After 20 mins 
the reaction was diluted with EtOAc (30 mL), quenched with 
NH4Cl (aq.) (30 mL) and the organic layer separated. The 
aqueous layer was extracted with further portions of EtOAc (2 ) 50 mL). The 
combined organic extracts were dried (MgSO4), filtered and concentrated under 
reduced pressure. The resulting crude product was purified by flash column 
chromatography on silica gel, eluting with pet. ether:Et2O (10:1) to afford the title 
compound 84 as a colourless oil (413 mg, 86%); Rf (5:1 pet. ether:EtOAc) 0.72; *max 
(thin film)/cm-1 3070, 3049, 3014, 2930, 2857, 1687, 1649, 1471, 1427; 1H NMR 
(400 MHz; CDCl3) " 9.30 (1H, s, H-9), 7.65 (4H, ddd, J 8.0, 6.0, 1.5 Hz, Ar-H), 
7.43!7.35 (6H, m, Ar-H), 6.89 (1H, dd, J 7.5, 5.5 Hz, H-2), 5.86!5.81 (1H, m, H-5), 
5.69!5.64 (1H, m, H-6), 3.78!3.75 (1H, m, H-7), 3.72!3.70 (2H, m, H-8), 2.81!2.73 
(1H, m, H-3a), 2.38!2.26 (2H, m H-3b & H-4a), 2.18!2.14 (1H, m, H-4b), 1.02 (9H, 
s, C(CH3)3); 13C NMR (101 MHz; CDCl3) # 194.1 (C-9), 156.3 (C-2), 144.8 (C-1), 
135.9 (C-5), 133.7 (Ar-C), 131.0 (Ar-CH), 129.7 (Ar-CH), 128.4 (C-6), 127.7 (Ar-
CH), 66.4 (C-8), 39.3 (C-7), 27.5 (C-3 or C-4), 27.0 (C(CH3)3), 25.4 (C-3 or C-4), 
19.4 (C(CH3)3); m/z (ESI): 413 [MNa+]; HRMS (ESI): calcd. for C25H30NaO2Si, 
413.1907. Found: [MNa+], 413.1907 (0.8 ppm error). 
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(±)-((R,1E,5Z)-7-((tert-Butyldiphenylsilyloxy)methyl)cyclohepta-1,5-
dienyl)methanol (85) 
 
To a stirred solution of 84 (380 mg, 0.973 mmol) in CH2Cl2 
(11 mL) at 0 °C was added DIBAL (1.46 mL, 1M in 
hexanes). After 30 mins the reaction mixture was diluted 
with CH2Cl2 (10 mL) and washed with Rochelle’s salt (10 
mL). The organic layer was separated and the aqueous layer extracted with portions of 
EtOAc (2 ) 10 mL). The combined organic extracts were dried (MgSO4), filtered and 
concentrated under reduced pressure. The resulting crude product was purified by 
flash column chromatography on silica gel, eluting with pet. ether:EtOAc (10:1) to 
afford the title compound 85 as a colourless oil (240 mg, 63%); Rf (5:1 pet. 
ether:EtOAc) 0.39; *max (thin film)/cm-1 3378, 3071, 3013, 2920, 2857, 1472, 1427; 
1H NMR (400 MHz; CDCl3) " 7.71 (4H, ddd, J 8.0, 6.0, 1.5 Hz, Ar-H), 7.47!7.38 
(6H, m, Ar-H), 5.97 (1H, dd, J 7.5, 5.5 Hz, H-2), 5.74!5.69 (1H, m, H-5), 5.51!5.45 
(1H, m, H-6), 4.10 (1H, d, J 12.0 Hz, H-9a), 4.00 (1H, d, J 12.0 Hz, H-9b), 3.86 (1H, 
dd J 9.5, 9.5 Hz, H-8a), 3.73 (1H, dd, J 9.5, 5.5 Hz, H-8b), 3.13 (1H, m, H-7), 2.78 
(1H, br s, OH), 2.44!2.37 (1H, m H-3a), 2.11!2.01 (3H, m, H-3b + H-4), 1.08 (9H, s, 
C(CH3)3); 13C NMR (101 MHz; CDCl3) # 143.0 (C-1), 135.8 (Ar-CH), 135.8 (Ar-
CH), 133.1 (Ar-C), 132.4 (C-5), 129.9 (Ar-CH), 128.5 (C-2), 127.9 (Ar-CH), 126.6 
(C-6), 68.8 (C-8 or C-9), 66.5 (C-8 or C-9), 44.6 (C-7), 26.9 (C(CH3)3), 26.4 (C-3 or 
C-4), 25.2 (C-3 or C-4), 19.2 (C(CH3)3); m/z (ESI): 415 [MNa+]; HRMS (ESI): calcd. 
for C25H32NaO2Si, 415.2064. Found: [MNa+], 415.2058 (1.5 ppm error). 
 
Triisopropylsulfonium tetrafluoroborate (51)23 
 
To a stirring solution of diisopropyl sulfide (7.3 mL, 0.049 mol) in iso-
propyl alcohol (15 mL) was added methanesulfonic acid (32 mL, 500 
mmol). The reaction was heated to reflux and held at temperature for 5 
days. The brown solution was cooled to RT and tetrafluroboric acid (31.5 mL, 500 
mmol) added. The mixture was stirred for 15 mins, water (150 mL) and CH2Cl2 (150 
mL) were added and the organic layer separated. The aqueous layer was extracted with 
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further portions of CH2Cl2 (2 ) 150 mL). The combined organic extracts were dried 
(MgSO4), filtered and concentrated under reduced pressure to give an orange solid. 
This was suspended in Et2O (100 mL) and filtered. The filtrand was washed with 
Et2O (2 x 50 mL) to give a white precipitate, which was recrystallised from 
MeOH/Et2O to afford the title compound 51 as a white solid (6.90 g, 56%); 1H NMR 
(400 MHz; D2O) " 3.88 (3H, septet, J 7.0 Hz, CH), 1.54 (18H, d, J 7.0 Hz, 18H, 
CH3); Data in agreement with those reported in the literature.23 
 
Triisopropylsulfoxonium tetrafluoroborate (52)23 
 
To a stirring solution of 51 (4.96 g, 20.0 mmol) in water (400 mL) at 0 
°C was added 2-Nitrobenzenesulfonyl chloride (8.86 g, 40.0 mmol) 
followed by barium hydroxide octahydrate (18.9 g, 60.0 mmol) to give 
a cream suspension. Hydrogen peroxide (12.3 mL, 120.0 mmol) was added drop-wise 
over 1 h. The suspension was stirred for a further 1 h at 0 °C, warmed to RT and 
stirred for 18 h. The reaction mixture was filtered through celite, washed with water 
(100 mL) and concentrated under reduced pressure. CH2Cl2 (250 mL) and (MgSO4) 
were added, the suspension filtered and the filtrate concentrated under reduced 
pressure to give the crude product. This was recrystallised from MeOH/Et2O to 
afford the title compound 52 as a white solid (3.31 g, 63%); 1H NMR (400 MHz; 
D2O) " 4.43 (3H, septet, J 7.0 Hz, CH), 1.61 (18H, d, J 7.0 Hz, CH3); Data in 
agreement with those reported in the literature.23 
 
(±)-(1R,2R)-Diethyl 3,3-dimethylcyclopropane-1,2-dicarboxylate (53) 
 
To a stirred solution of NaH (920 mg, 23.0 mmol, 60% 
dispersion in mineral oil) in DMF (150 mL) at 0 °C was added 
52 (6.08 g, 23.0 mmol). This solution was allowed to stir for 5 
mins before the drop-wise addition of a solution of diethyl fumarate (3.31 g, 19.2 
mmol) in DMF (35 mL). The reaction mixture was allowed to stir at 0 °C for 5 mins 
before being warmed to RT and stirred for a further 2 h. It was diluted with Et2O (115 
SiPr iPriPr
O BF4
EtO2C CO2Et
1
2
 105 
mL), washed with sat. NH4Cl (aq.) (100 mL), the organic layer separated and the 
aqueous layer extracted with further portions of Et2O (2 ) 150 mL). The combined 
organic extracts were dried (MgSO4), filtered and concentrated under reduced pressure. 
The resulting crude product was purified by flash column chromatography on silica 
gel, eluting with pet. ether:Et2O (7:1 & 4:1) to afford the title compound 53 as a 
colourless oil (3.01 g, 73%); Rf (3:1 pet. ether:EtOAc) 0.59; *max (thin film)/cm-1 2982, 
1723; 1H NMR (400 MHz; CDCl3) " 4.20!4.08 (4H, m, CH3CH2O), 2.21 (2H, s, H-
1), 1.29 (6H, s, CH3), 1.27 (6H, t, J 7.0, CH3CH2O); 13C NMR (101 MHz; CDCl3) # 
170.6 (C=O), 60.9 (CH3CH2O), 33.7 (C-1), 30.4 (C-2), 20.5 (CH3), 14.4 (CH3CH2O); 
m/z (ESI): 215 [MH+]; HRMS (ESI): calcd. for C11H19O4, 215.1278. Found: [MH+], 
215.1283 (2.3 ppm error). 
 
(±)-((1R,2R)-3,3-Dimethylcyclopropane-1,2-diyl)dimethanol (56a) 
 
To a stirred solution of LiAlH4 (963 mg, 25.4 mmol) in THF (25 
mL) at 0 °C was added a solution of 53 (3.63 g, 16.9 mmol) in 
THF (9 mL), over a period of 1 h via a dropping syringe. The 
reaction mixture was then heated at reflux at 70 °C for 2 h, before being cooled to RT 
and stirred for 18 h. After being cooled to 0 °C the mixture was diluted with EtOAc (6 
mL), washed cautiously with sat. NH4Cl (aq.) (6 mL). The resulting suspension was 
filtered, and the insoluble salts were washed with further portions of EtOAc (2 ) 10 
mL). The filtrate was concentrated under reduced pressure, and the residue taken up 
in EtOAc (10 mL). The solution was then dried (MgSO4), filtered and concentrated 
under reduced pressure to afford to afford the title compound 56a as a colourless oil. 
(1.89 g, 86%); Rf (EtOAc) 0.23; *max (thin film)/cm-1 3337, 2926, 2874; 1H NMR (400 
MHz; CDCl3) # 3.77"3.69 (2H, m, H-1a), 3.59"3.50 (2H, m, H-1b), 2.23 (2H, broad 
s, OH), 1.13 (6H, s, CH3), 0.85"0.79 (2H, m, H-2); 13C NMR (101 MHz; CDCl3) # 
63.1 (C-1), 32.1 (C-2), 21.9 (CH3), 20.8 (C-3); m/z (ESI): 153 [MNa+]; HRMS (ESI): 
calcd. for C7H14NaO2, 153.0886. Found: [MNa+], 153.0888 ("1.5 ppm error).  
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Diethyl (±)-(2E,2'E)-3,3'-[(1R,2R)-3,3-dimethylcyclopropane-1,2-diyl]bisprop-2-
enoate (57a) & Diethyl (±)-(2Z,2'E)-3,3'-[(1R,2R)-3,3-dimethylcyclopropane-1,2-
diyl]bisprop-2-enoate (57b) 
 
To a stirred solution 
of 56a (934 mg, 7.17 
mmol) in CHCl3 (70 
mL) was added manganese (IV) dioxide (12.4 g, 143 mmol) and (carbethoxymethylene) 
triphenyl phosphorane (5.99 g, 17.2 mmol). The resulting suspension was stirred 
vigorously with heating to maintain gentle reflux for 18 h. After cooling to room 
temperature, the suspension was filtered through Celite, and washed with CHCl3 (25 
mL). The filtrate was concentrated under reduced pressure to give the crude product. 
This was purified by flash column chromatography on silica gel, eluting with pet. 
ether:EtOAc (20:1) to afford the title compound 57a as a white solid (1.31 g, 69%), 
and 57b as a colourless oil (85 mg, 4%); 57a Rf (1:1 pet. ether:Et2O) 0.38; mp 49"52 
°C; *max (thin film)/cm-1 2934, 1687, 1616; 1H NMR (400 MHz; CDCl3) "; 6.73!6.63 
(2H, m, H-2), 5.91 (2H, d, J 15.5, H-1), 4.17 (4H, q, J 7.0, CH3CH2O), 1.77"1.72 
(2H, m, H-3), 1.27 (6H, t, J 7.0, CH3CH2O), 1.23 (6H, s, H-5 & H-6); 13C NMR (101 
MHz; CDCl3) # 166.4 (C=O), 147.5 (C-2), 121.5 (C-1), 60.3 (CH3CH2O), 38.5 (C-3), 
30.3 (C-4), 22.4 (2 ) CH3), 14.4 (CH3CH2O); m/z (ESI): 267 [MH+]; HRMS: calcd. 
for C15H23O4, 267.1591. Found: [MH+], 267.1581 (3.6 ppm error); 57b Rf (1:1 pet. 
ether:Et2O) 0.39; *max (thin film)/cm-1 2934, 1688, 1615; 1H NMR (400 MHz; CDCl3) 
" 6.74 (1H, dd, J 15.5, 10.0, H-6), 5.91 (1H, d, J 15.5, H-5), 5.87!5.77 (2H, m, H-2 & 
H-1), 4.21!4.14 (4H, m, CH3CH2O), 3.08 (1H, dd, J 10.0, 5.0, H-5), 1.65 (1H, dd, J 
10.0, 5.0, H-3), 1.31-1.27 (6H, m, CH3CH2O), 1.26 (3H, s, CH3), 1.21 (3H, s, CH3); 
13C NMR (101 MHz; CDCl3) # 166.8 (C=O), 166.5 (C=O), 148.3 (C-6 or C-2) 148.1 
(C-6 or C-2), 121.2 (C-7 or C-1), 119.9 (C-7 or C-1), 60.3 (CH3CH2O), 60.0 
(CH3CH2O), 39.7 (C-5), 35.6 (C-3), 30.6 (C-4), 22.6 (CH3), 22.3 (CH3), 14.5 
(CH3CH2O), 14.4 (CH3CH2O); m/z (ESI): 267 [MH+]; HRMS: calcd. for C15H23O4, 
267.1591. Found: [MH+], 267.1587 (1.1 ppm error). 
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(±)-1,2-Diethyl 5,5 dimethylclcyclohepta-1 (7),2-diene-1,2-dicarboxylate (89) 
 
Sodium ethoxide (1 mL, 0.563 M), prepared in situ by the 
addition of sodium (129 mg, 5.63 mmol) to ethanol (10 mL) and 
stirring under argon for ~10 mins, was added to 57a (100 mg, 
0.375 mmol). The reaction mixture was heated to 90 °C and 
allowed to reflux for 18 h. After cooling to RT, the reaction mixture was concentrated 
under reduced pressure and CH2Cl2 (10 mL) added. This was washed with sat. NH4Cl 
(aq.) (5 mL), the organic layer separated and the aqueous layer extracted with further 
portions of CH2Cl2 (2 ) 10 mL). The combined organic extracts were dried (MgSO4), 
filtered and concentrated under reduced pressure. The resulting crude product was 
purified by flash column chromatography on silica gel, eluting with pet. ether:EtOAc 
(9:1) to afford the title compound 89 as a colourless oil (80 mg, 80%) Rf (1:1 pet. 
ether:EtOAc) 0.66; *max (thin film)/cm-1 2956, 1724; 1H NMR (400 MHz; CDCl3) " 
7.40!7.37 (2H, m, H-2), 4.18 (4H, q, J 7.0, CH3CH2O), 1.86 (4H, d, J 7.5, H-3), 1.26 
(6H, t, J 7.0, CH3CH2O), 1.03 (6H, s, CH3); 13C NMR (101 MHz; CDCl3) # 166.1 
(C=O), 145.1 (C-2), 132.3 (C-1), 60.8 (CH3CH2O), 52.2 (C-4), 40.9 (C-3), 29.4 
(CH3), 14.3 (CH3CH2O); m/z (ESI) 267 [MH+]; HRMS: calcd. for C15H23O4, 
267.1591. Found: [MH+], 267.1586 (0.6 ppm error). 
 
(±)-((1R,3R)-3-((tert-Butyldimethylsilyloxy)methyl)-2,2-
dimethylcyclopropyl)methanol (93) 
 
To a stirred solution of 56a (824 mg, 6.33 mmol) in THF (13 
mL) at RT was added NaH (253 mg, 6.33 mmol, 60% 
dispersion in mineral oil). After 45 mins, by which time a 
large amount of white precipitate had formed, TBSCl (954 mg, 6.33 mmol) was 
added. The reaction mixture was allowed to stir for a further 1 h before dilution with 
Et2O (15 mL). It was then washed with sat. K2CO3 (aq.) (10 mL) and brine (10 mL), 
the organic layer separated and the aqueous layer extracted with further portions of 
Et2O (2 ) 20 mL). The combined organic extracts were dried (MgSO4), filtered and 
concentrated under reduced pressure. The resulting crude product was purified by 
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flash column chromatography on silica gel, eluting with pet. ether:EtOAc (7:1 & 1:1) 
to afford the title compound 93 as a colourless oil (1.55 g, 65%); Rf (1:1 pet. 
ether:EtOAc) 0.46; *max (thin film)/cm-1 3392, 2954, 2929, 2858; 1H NMR (400 
MHz; CDCl3) " 3.63!3.59 (4H, m, H-1 & H-5), 1.12 (3H, s, CH3), 1.11 (3H, s, CH3), 
0.89 (9H, s, C(CH3)3), 0.80!0.70 (2H, m, H-2 & H-4), 0.05 (6H, s, SiCH3); 13C NMR 
(101 MHz; CDCl3) # 63.5 (C-1 or C-5), 63.4 (C-1 or C-5), 32.0 (C-2 or C-4), 31.9 
(C-2 or C-4), 26.1 (C(CH3)3), 21.9 (CH3), 21.8 (CH3), 20.8 (C-3), 18.4 (C(CH3)3), 
"5.0 (SiCH3), "5.0 (SiCH3); m/z (ESI) 267 [MNa+]; HRMS: calcd. for C13H28NaO2Si, 
267.1751. Found: [MNa+], 267.1748 (1.0 ppm error). 
 
(±)-(1R,3R)-3-((tert-Butyldimethylsilyloxy)methyl)-2,2-
dimethylcyclopropanecarbaldehyde (94) 
 
To a stirred solution of 93 (980 mg, 4.00 mmol) in CH2Cl2 (40 
mL), at 0 °C was added DMP (5.09 g, 12.0 mmol). The 
reaction mixture was warmed to RT and allowed to stir for 2 h. 
It was then diluted with CH2Cl2 (15 mL), and quenched with a 1:1 solution of sat. 
Na2CO3 (aq.) and sat. Na2S2O3 (aq.) (15 mL). After vigorous stirring for 30 mins, the 
organic layer was separated and the aqueous layer extracted with further portions of 
CH2Cl2 (2 ) 20 mL). The combined organic extracts were dried (MgSO4), filtered and 
concentrated under reduced pressure. The resulting crude product was purified by 
flash column chromatography on silica gel, eluting with pet. ether:EtOAc (5:1 & 2:1) 
to afford the title compound 94 as a colourless oil (580 mg, 60%); Rf (1:1 pet. 
ether:EtOAc) 0.58; *max (thin film)/cm-1 2954, 2930, 2858, 1705; 1H NMR (400 
MHz; CDCl3) " 9.35 (1H, d, J 5.5, H-5), 3.77 (1H, dd, J 11.0, 6.0, H-1a), 3.60 (1H, 
dd, J 11.0, 8.0, H-1b), 1.93!1.88 (1H, m, H-4), 1.60!1.56 (1H, m, H-2), 1.30 (3H, s, 
CH3), 1.22 (3H, s, CH3), 0.89 (9H, s, C(CH3)3), 0.05 (3H, s, SiCH3), 0.05 (3H, s, 
SiCH3); 13C NMR (101 MHz; CDCl3) # 201.3 (C-5), 61.9 (C-1), 41.3 (C-4), 36.6 (C-
2), 26.1 (C-3) 26.0 (C(CH3)3), 22.2 (CH3), 21.4 (CH3), 18.4 (C(CH3)3), "5.0 (SiCH3), 
"5.1 (SiCH3); m/z (ESI) 243 [MH+]; HRMS: calcd. for C13H27O2Si, 243.1775. Found: 
[MH+], 243.1770 (1.6 ppm error). 
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(±)-(E)-Ethyl 3-((1R,3R)-3-((tert-butyldimethylsilyloxy)methyl)-2,2-
dimethylcyclopropyl)prop-2-enoate (95) 
 
To a stirred solution of 94 (550 mg, 2.27 mmol) in 
CH2Cl2 (25 mL) at RT was added carbethoxymethylene 
triphenylphosphorane (1.58 g, 4.54 mmol). After 18 h 
the solution was concentrated under reduced pressure and the crude product purified 
by flash column chromatography on silica gel, eluting with pet. ether:EtOAc (9:1) to 
afford the title compound 95 as a colourless oil (709 mg, 82%); Rf (5:1 pet. 
ether:EtOAc) 0.63; *max (thin film)/cm-1 2954, 2930, 2858, 1724, 1641; 1H NMR (400 
MHz; CDCl3) " 6.69 (1H, dd, J 15.5, 10.0 Hz, H-5), 5.84 (1H, d, J 15.5 Hz, H-6) 
4.20!4.10 (2H, m, CH3CH2O), 3.76 (1H, dd, J 11.0, 6.0 Hz, H-1a), 3.57 (1H, dd, J 
11.0, 7.5 Hz, H-1b), 1.30!1.25 (2H, m, H-2 & H-4) 1.27 (3H, t, J 7.0 Hz, CH3CH2O), 
1.17 (3H, s, CH3), 1.06 (3H, s, CH3),  0.87 (9H, s, C(CH3)3), 0.04 (3H, s, SiCH3), 0.03 
(3H, s, SiCH3); 13C NMR (101 MHz; CDCl3) # 166.8 (C=O), 150.6 (C-5), 120.0 (C-
6), 62.8 (C-1), 60.1 (CH3CH2O), 37.3 (C-2 or C-4), 33.1 (C-2 or C-4), 26.5 (C-3), 
26.0 (C(CH3)3), 23.0 (CH3), 21.3 (CH3), 18.4 (C(CH3)3), 14.5 (CH3CH2O), !5.0 
(SiCH3), !5.1 (SiCH3); m/z (ESI) 313 [MH+]; HRMS: calcd. for C17H33O3Si, 
313.2193. Found: [MH+], 313.2185 (2.7 ppm error). 
 
(±)-(E)-3-((1R,3R)-3-((tert-Butyldimethylsilyloxy)methyl)-2,2-
dimethylcyclopropyl)prop-2-en-1-ol (96) 
 
To a stirred solution of 95 (460 mg, 1.47 mmol) in 
CH2Cl2 (15 mL) at 0 °C was added DIBAL (5.88 mL, 
5.88 mmol, 1M in hexanes). After 30 mins the reaction 
mixture was diluted with CH2Cl2 (35 mL) and washed with sat. aq. Rochelle’s salt (20 
mL). The organic layer was separated and the aqueous layer extracted with further 
portions of CH2Cl2 (2 ) 20 mL). The combined organic extracts were dried (MgSO4), 
filtered and concentrated under reduced pressure to afford the title compound 96 as a 
colourless oil (360 mg, 96%); Rf (1:1 pet. ether:EtOAc) 0.67; *max (thin film)/cm-1 
3368, 2929, 2859; 1H NMR (400 MHz; CDCl3) " 5.73!5.67 (1H, dt, J 15.5, 6.0 Hz, 
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H-6), 5.44 (1H, dd, J 15.5, 9.0, H-5), 4.09 (2H, dd, J 6.0, 6.0 Hz, H-7), 3.79 (1H, dd, 
J 11.0, 6.0 Hz, H-1a), 3.52 (1H, dd, J 11.0, 8.5 Hz, H-1b), 1.26!1.08 (2H, m, H-2 & 
H-4), 1.23-1.18 (1H, t, J 6.0 Hz, OH), 1.11 (3H, s, CH3), 1.07 (3H, s, CH3), 0.89 (9H, 
s, C(CH3)3), 0.05, (3H, s, SiCH3) 0.04 (3H, s, SiCH3); 13C NMR (101 MHz; CDCl3) # 
133.4 (C-6), 128.8 (C-5), 64.0 (C-1), 63.4 (C-7), 34.7 (C-2 or C-4), 32.0 (C-2 or C-4), 
26.1 (C(CH3)3), 23.1 (C-3), 22.7 (CH3), 21.3 (CH3), 18.4 (C(CH3)3), "4.9 (SiCH3), 
"5.0 (SiCH3); m/z (ESI) 293 [MNa+]; HRMS: calcd. for C15H30NaO2Si, 293.1907. 
Found: [MNa+], 293.1905 (0.1 ppm error). 
 
(±)-((1R,3R)-3-((E)-3-(Benzyloxy)prop-1-enyl)-2,2-dimethylcyclopropyl)methanol 
(98) 
 
To a stirred solution of 96 (440 mg, 1.72 mmol) in THF 
(9 mL) at 0 °C was added NaH (103 mg, 2.58 mmol, 60% 
dispersion in mineral oil). This was warmed to RT and 
allowed to stir for 45 mins. This was re-cooled to 0 °C, benzyl bromide (307 µL, 2.58 
mmol) was added and the reaction mixture was allowed to stir at RT for 18 h. The 
reaction mixture was diluted with Et2O (20 mL) and washed with sat. NH4Cl (aq.) (10 
mL), the organic layer separated and the aqueous layer extracted with further portions 
of Et2O (2 ) 20 mL). The combined organic phases were dried (MgSO4), filtered and 
concentrated under reduced pressure. The resulting crude product was dissolved in 
THF (17 mL) and the solution cooled to 0 °C before the addition of TBAF (3.4 mL, 1 
M in THF). After 2 h the reaction mixture was diluted with Et2O (20 mL) and washed 
with sat. NH4Cl (aq.) (10 mL), the organic layer separated and the aqueous layer 
extracted with further portions of Et2O (2 ) 20 mL). The combined organic extracts 
were dried (MgSO4), filtered and concentrated under reduced pressure. The resulting 
crude product was purified by flash column chromatography on silica gel, eluting with 
pet. ether:EtOAc (9:1 & 1:1) to afford the title compound 98 as a colourless oil (188 
mg, 44%); Rf (1:1 pet. ether:EtOAc) 0.44; *max (thin film)/cm-1 3398, 2922, 2866, 
1661; 1H NMR (400 MHz; CDCl3) " 7.36!7.26 (5H, m, Ar-CH), 5.68 (1H, ddd, J 
15.5, 6.5, 6.5 Hz, H-6), 5.47 (1H, dd, J 15.5, 9.0 Hz, H-5), 4.50 (2H, s, C6H5CH2), 
3.98 (2H, d, J 6.5 Hz, H-7), 3.75 (1H, dd, J 11.5, 6.5 Hz H-1a), 3.55 (1H, dd, J 11.5, 
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8.5 Hz, H-1b), 1.42 (1H, br s, OH), 1.21!0.94 (2H, m, H-2 & H-4), 1.14 (3H, s, CH3), 
1.10 (3H, s, CH3); 13C NMR (101 MHz; CDCl3) # 138.5 (Ar-C), 134.2 (C-6), 128.5 
(Ar-CH), 127.9 (C-5), 127.7 (Ar-CH), 126.5 (Ar-CH) 72.0 (C6H5CH2), 70.9 (C-7), 
63.3 (C-1), 34.6 (C-2 or C-4), 32.3 (C-2 or C-4), 23.2 (C-3), 22.6 (CH3), 21.3 (CH3); 
m/z (ESI): 269 [MNa+]; HRMS (ESI): calcd. for C16H22NaO2, 269.1512. Found: 
[MNa+], 269.1519 (1.4 ppm error). 
 
(±)-(1R,3R)-3-((E)-3-(Benzyloxy)prop-1-enyl)-2,2-
dimethylcyclopropanecarbaldehyde (99) 
 
To a stirred solution of 98 (140 mg, 0.568 mmol) in CH2Cl2 
(6 mL), at 0 °C was added DMP (721 mg, 1.7 mmol). The 
reaction mixture was warmed to RT and allowed to stir for 
18 h. It was then diluted with CH2Cl2 (14 mL), and quenched with a 1:1 solution of 
sat Na2CO3 (aq.) and sat. Na2S2O3 (aq.) (10 mL). After vigorous stirring for 30 mins, 
the organic layer was separated and the aqueous layer extracted with further portions 
of CH2Cl2 (2 ) 10 mL). The combined organic extracts were dried (MgSO4), filtered 
and concentrated under reduced pressure. The resulting crude product was purified by 
flash column chromatography on silica gel, eluting with pet. ether:EtOAc (4:1) to 
afford the title compound 99 (139 mg, 68%); Rf (2:1 pet. ether:EtOAc) 0.63; *max 
(thin film)/cm-1 2923, 2852, 1699; 1H NMR (400 MHz; CDCl3) " 9.40 (1H, d, J 5.0 
Hz, H-1), 7.37!7.26 (5H, m, Ar-CH), 5.80 (1H, ddd, J 15.5, 6.0, 6.0 Hz, H-6), 5.49 
(1H, dd, J 15.5, 8.5 Hz, H-5), 4.51 (2H, s, C6H5CH2), 3.99 (2H, d, J 6.0 Hz, H-7), 2.33 
(1H, dd, J 8.5, 5.0 Hz, H-4), 1.78 (1H, dd, J 5.0, 5.0 Hz, H-2), 1.32 (3H, s, CH3), 1.20 
(3H, s, CH3); 13C NMR (101 MHz; CDCl3) # 200.3 (C-1), 138.3 (Ar-C), 130.0 (C-6), 
129.3 (Ar-CH), 128.5 (Ar-CH), 127.9 (C-5), 127.79 (Ar-CH), 72.3 (C6H5CH2), 70.4 
(C-7), 44.1 (C-4), 37.5 (C-2), 31.8 (C-3), 22.2 (CH3), 21.6 (CH3); m/z (ESI): 267 
[MNa+]; HRMS (ESI): calcd. for C16H20NaO2, 267.1356. Found: [MNa+], 267.1355 
(0.9 ppm error). 
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(±)-(E)-Ethyl 3-((1R,3R)-3-((E)-3-(benzyloxy)prop-1-enyl)-2,2-
dimethylcyclopropyl)prop-2-enoate (100) 
 
To a stirred solution of 99 (80 mg, 0.327 mmol) in 
CH2Cl2 (25 mL) at RT was added 
carbethoxymethylene triphenylphosphorane (227 
mg, 0.654 mmol). After stirring for 2 days the solution was concentrated under 
reduced pressure and the crude product purified by flash column chromatography on 
silica gel, eluting with pet. ether:EtOAc (9:1) to afford the title compound 100 as a 
colourless oil (99 mg, 96%); Rf (5:1 pet. ether:EtOAc) 0.41; *max (thin film)/cm-1 2926, 
1712, 1638; 1H NMR (400 MHz; CDCl3) " 7.38!7.26 (5H, m, Ar-CH), 6.69 (1H, dd, 
J 15.5, 10.5 Hz, H-2), 5.88 (1H, d, J 15.5 Hz, H-1), 5.73 (1H, ddd, J 15.5, 6.0, 6.0 Hz, 
H-7), 5.48 (1H, dd, J 15.5, 9.0 Hz, H-6), 4.50 (2H, s, C6H5CH2), 4.21!4.11 (2H, m, 
CH3CH2O), 3.99 (2H, d, J 6.0 Hz, H-8), 1.65 (1H, dd, J 9.0, 5.0 Hz, H-5), 1.48 (1H, 
dd, J 10.5, 5.0, Hz, H-3), 1.27 (3H, t, J 7.0 Hz, CH3CH2O), 1.19 (3H, s, CH3), 1.15 
(3H, s, CH3); 13C NMR (101 MHz; CDCl3) # 166.7 (C=O), 149.4 (C-1 or C-2 or C-6 
or C-7), 138.4 (Ar-C), 132.1 (C-1 or C-2 or C-6 or C-7), 128.5 (Ar-CH), 127.9 (Ar-
CH), 127.8 (Ar-CH), 127.7 (C-1 or C-2 or C-6 or C-7), 120.4 (C-1 or C-2 or C-6 or 
C-7), 72.2 (C6H5CH2), 70.7 (C-8), 60.2 (CH3CH2O), 38.4 (C-3 or C-5), 36.7 (C-3 or 
C-5), 28.3 (C-4), 22.5 (CH3), 22.2 (CH3), 14.5 (CH3CH2O); m/z (ESI): 337 [MNa+]; 
HRMS (ESI): calcd. for C20H26NaO3, 337.1774. Found: [MNa+], 337.1772 (0.7 ppm 
error). 
 
7.3 Procedures & Compound Characterisation (Chapter 3) 
 
Ethyl (±)-(1S,3R)-3-formyl-2,2-dimethylcyclopropanecarboxylate (127cis)& 
Ethyl (±)-(1R,3R)-3-formyl-2,2-dimethylcyclopropanecarboxylate (127trans)83 
 
Oxygen was bubbled through a solution of 
ethyl chrysanthemate (10.0 g, 0.0510 mmol) 
in CH2Cl2 (500 mL) at "78 °C for 5 min. 
Ozone was then bubbled through the 
solution until a sky blue colour could be seen (55 min), after which time oxygen was 
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bubbled through the solution for a further 5 min. DMS (37.4 mL, 0.510 mmol) was 
next added to the solution, which was then allowed to stir at RT overnight. The 
solution was concentrated under reduced pressure to give the crude product, which 
was purified by flash column chromatography on silica gel, eluting with pet. 
ether:EtOAc (10:1) to afford the title compound as a mixture of diastereomers 
(127cis:127trans 2:3)  and as a colourless oil (8.23 g, 97%); Rf (20:1 pet. ether:EtOAc) 
0.21; 1H NMR (400 MHz; CDCl3) 127cis " 9.70 (1H, d, J 6.5, H-1), 4.08!4.16 (2H, 
m, CH3CH2O), 2.08 (1H, d, J 8.5, H-2 or H-6), 1.79 (1H, dd, J 6.5, 6.5, H-2 or H-6), 
1.56 (3H, s, H-4), 1.24 (3H t, J 7.0, CH3CH2O), 1.23 (3H, s, H-5); 127trans " 9.53 (1H, 
d, J 3.5, H-1), 4.08!4.16 (2H, m, CH3CH2O), 2.35!2.45 (2H, m, H-2 & H-6), 1.30 (3H, 
s, H-4), 1.26 (3H, s, H-5), 1.23 (3H, t J 7.0, CH3CH2O). Data in agreement with those 
reported in the literature.83 
 
[(1R,2R)-3,3-Dimethylcyclopropane-1,2-diyl]dimethanol (56a) & (±)-[(1R,2S)-3,3-
Dimethylcyclopropane-1,2-diyl]dimethanol (56b)  
 
To a stirred suspension of LiAlH4 (7.30 g, 
192 mmol) in THF (500 mL) at 0 °C was 
added 127 (16.4 g, 96.3 mmol) in THF (500 
mL) via cannula. The reaction was warmed 
to RT and stirred for 10 min.  The reaction was cooled to 0 °C and water (7.3 mL) 
was added cautiously, followed by NaOH (aq. 15%) (7.3 mL) and water (21.9 mL). 
The aluminium salts were removed by filtration and washed with EtOAc (500 mL). 
The filtrate was concentrated under reduced pressure to give the crude product. This 
was purified by flash column chromatography on silica gel, eluting with EtOAc to 
afford the title compound 56a as a colourless oil (6.22 g, 49%) and 56b as a colourless 
oil (3.93 g, 31%); 56a For data see page 105; 56b Rf (EtOAc) 0.34; *max (thin 
film)/cm-1 3342, 2987, 2929, 2887; 1H NMR (400 MHz; CDCl3) # 3.97 (2H, dd, J 
11.5, 5.5, H-1a), 3.50"3.46 (2H, m, H-1b), 2.83 (2H, broad s, OH), 1.10"1.05 (2H, 
m, H-2), 1.07 (3H, s, H-4), 1.05 (3H, s, H-5); 13C NMR (101 MHz; CDCl3) # 59.7 
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(C-1), 29.2 (C-4), 29.1 (C-5), 20.2 (C-3), 15.6 (C-2); m/z (ESI): 153 [MNa+]; HRMS 
(ESI): calcd. for C7H14NaO2, 153.0886. Found: [MNa+], 153.0884 (1.3 ppm error). 
 
(2Z,2'Z)-Diethyl (±)-3,3'-((1R,2R)-3,3-dimethylcyclopropane-1,2-diyl)diprop-2-
enoate (57c) 
 
To a stirred solution of 56a (1.80 g, 13.8 mmol) in CHCl3 
(150 mL) was added manganese (IV) dioxide (24.0 g, 
276 mmol). The suspension was heated at reflux gently 
and after 16 h, the suspension was filtered through Celite, 
and washed with CHCl3 (250 mL). The filtrate was concentrated under reduced 
pressure to give (1.25 g, 72%) of unpurified dialdehyde. (195 mg, 1.55 mmol) of the 
resulting dialdehyde was diluted with THF (8 mL). This was added, via cannula, to a 
solution of ethyl [bis(2,2,2-trifluoroethoxy)phosphoryl]acetate (1.33 mg, 4.00 mmol), 
18-crown-6 (2.34 g, 9.02 mmol) and KHMDS (5.80 mL, 0.7 M in toluene, 3.45 
mmol)  at "78 °C. After 2 h the reaction was quenched with sat. NH4Cl (aq.) (15 mL), 
Et2O (25 mL) added and the organic layer separated. The aqueous layer was extracted 
with further portions of Et2O (2 ) 25 mL) and the combined organic extracts were 
dried (MgSO4), filtered and concentrated under reduced pressure. The resulting crude 
product was purified by flash column chromatography on silica gel, eluting with pet. 
ether:EtOAc (10:1) to afford the title compound 57c as a colourless oil (144 mg, 
35%); Rf (1:1 pet. ether:Et2O) 0.41; *max (thin film)/cm-1 2934, 1688, 1604; 1H NMR 
(400 MHz; CDCl3) " 5.98"5.90 (2H, m, H-2), 5.80 (2H, d, J 11.5, H-1), 4.17 (4H, q, 
J 7.0, CH3CH2O), 3.04"3.00 (2H, m, H-3), 1.27 (6H, t, J 7.0, CH3CH2O), 1.23 (6H, 
s, H-5 & H-6); 13C NMR (101 MHz; CDCl3) # 167.0 (C=O), 149.3 (C-2), 119.3 (C-
1), 59.9 (CH3CH2O), 37.0 (C-3), 30.9 (C-4), 22.5 (C-5 & C-6), 14.4 (CH3CH2O); m/z 
(ESI): 267 [MH+]; HRMS: calcd. for C15H23O4, 267.1591. Found: [MH+], 267.1583 
(2.8 ppm error). 
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(±)-(1S,5R)-6,6-Dimethyl-3-oxabicyclo[3.1.0]hexan-2-one (130)84 
 
To a stirred solution of 56b (180 mg, 1.38 mmol) in CHCl3 (10 mL) 
was added manganese (IV) dioxide (2.40 g, 27.6 mmol). The 
suspension was stirred for 16 h, filtered through Celite and washed 
with CHCl3 (20 mL). The filtrate was concentrated under reduced 
pressure to afford the title compound 130 (111 mg, 64%); Rf (1:1 pet. ether:EtOAc) 
0.38; 1H NMR (400 MHz; CDCl3) " 4.36 (1H, dd, J 10.0, 5.5 Hz, H-1a), 4.15 (1H, d, 
J 10 Hz, H-1b), 2.04 (1H, dd, J 6.0, 5.5 Hz, H-2), 1.95 (1H, d, J 6.0 Hz, H-6), 1.18 
(3H, s, H-4), 1.17 (3H, s, H-5). Data in agreement with those reported in the 
literature.84  
 
Ethyl (±)-(2E)-3-[(1S,3R)-3-(hydroxymethyl)-2,2-dimethylcyclopropyl]prop-2-
enoate (131) 
 
To a stirred solution of 56b (3.93 g, 30.2 mmol) in 
anhydrous DMSO (150 mL) at RT was added IBX (10.1 
g, 36.1 mmol). After 2 h the reaction was quenched with 
water (100 mL), filtered through celite and the filtrand 
washed with CH2Cl2 (400 mL). The organic layer was separated and the aqueous layer 
extracted with portions of CH2Cl2 (2 ) 250 mL). The combined organic extracts were 
dried (MgSO4), filtered and concentrated under reduced pressure to give a colourless 
oil. This oil was diluted with CH2Cl2 (200 mL) before the addition of  
(carbethoxymethylene)triphenylphosphorane (9.84 g, 28.2 mmol). The reaction was  
stirred at RT and after 16 h the solution was concentrated under reduced pressure and 
the crude product purified by flash column chromatography on silica gel, eluting with 
pet. ether:EtOAc (5:1) to afford the title compound 131 as a colourless oil (2.36 g, 
47%); Rf (5:1 pet. ether:EtOAc) 0.14; *max (thin film)/cm-1 3372, 2938, 2910, 1683, 
1613; 1H NMR (400 MHz; CDCl3) "; 6.76 (1H, dd, J 15.0, 11.0, H-7), 5.97 (1H, d, J 
15.0, H-8), 4.17 (2H, q, J 7.0, CH3CH2O), 3.83 (1H, dd, J 11.5, 7.5, H-1a), 3.75 (1H, 
dd, J 11.5, 8.0, H-1b), 1.57 (1H, dd, J 11.0, 8.5, H-6), 1.50 (1H, br. s, OH), 1.42 (1H, 
dd, J 11.0, 8.0, H-2), 1.27 (3H, t, J 7.0, CH3CH2O), 1.19 (3H, s, H-5), 1.17 (3H, s, H-
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4); 13C NMR (101 MHz; CDCl3) # 166.6 (C=O), 146.7 (C-7), 122.0 (C-8), 60.3 
(CH3CH2O), 60.0 (C-1) 35.5 (C-2), 31.1 (C-6), 28.9 (C-5), 25.5 (C-3), 15.9 (C-4), 
14.5, (CH3CH2O); m/z (ESI): 221 [MNa+]; HRMS: calcd. for C11H18NaO3, 221.1148. 
Found: [MNa+], 221.1150 ("1.0 ppm error).  
 
(±)-[(1S,3R)-3-({[tert-Butyl(dimethyl)silyl]oxy}methyl)-2,2-
dimethylcyclopropyl]methanol (132) 
 
To a stirred solution of 56b (276 mg, 2.12 mmol) in THF (4 
mL) at 0 °C was added NaH (102 mg, 2.54 mmol, 60% 
dispersion in mineral oil). After 45 mins, by which time a 
large amount of white precipitate had formed, TBSCl (319 
mg, 2.12 mmol) was added. The reaction mixture was warmed to RT and allowed to 
stir for a further 1 h before dilution with Et2O (15 mL). It was then washed with sat. 
NH4Cl (aq.) (10 mL) and brine (10 mL), the organic layer separated and the aqueous 
layer extracted with further portions of Et2O (2 ) 20 mL). The combined organic 
extracts were dried (MgSO4), filtered and concentrated under reduced pressure. The 
resulting crude product was purified by flash column chromatography on silica gel, 
eluting with pet. ether:EtOAc (20:1 & 10:1) to afford the title compound 132 as a 
colourless oil (506 mg, 84%); Rf (1:1 pet. ether:EtOAc) 0.48; *max (thin film)/cm-1 
3346, 2885, 2842, 22816; 1H NMR (400 MHz; CDCl3) " 4.07!3.98 (1H, m, H-1a or 
H-7a), 3.89!3.80 (1H, m, H-1a or H-7a), 3.57!3.45 (2H, m, H-1b & H-7b), 2.97 (1H, 
br s, OH), 1.16!1.08 (1H, m, H-2 or H-6), 1.06 (3H, s, H-4), 1.04 (3H, s, H-5), 
1.03!0.93 (1H, m, H-2 or H-6), 0.90 (9H, s, SiC(CH3)3), 0.10 (3H, s, SiCH3), 0.08 
(3H, s, SiCH3); 13C NMR (101 MHz; CDCl3) # 60.6 (C-1 or C-7), 59.7 (C-1 or C-7), 
29.9 (C-4), 29.2 (C-2 or C-6), 29.0 (C-2 or C-6), 26.0 (SiC(CH3)3), 20.3 (C-3), 18.3 
(SiC(CH3)3), 15.7 (C-5) "5.1 (SiCH3), "5.3 (SiCH3); m/z (ESI) 267 [MNa+]; HRMS: 
calcd. for C13H28NaO2Si, 267.1751. Found: [MNa+], 267.1742 (3.1 ppm error).  
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Ethyl (±)-(2E)-3-[(1S,3R)-3-({[tert-butyl(dimethyl)silyl]oxy}methyl)-2,2-
dimethylcyclopropyl]prop-2-enoate (133E) & Ethyl (±)-(2Z)-3-[(1S,3R)-3-({[tert-
butyl(dimethyl)silyl]oxy}methyl)-2,2-dimethylcyclopropyl]prop-2-enoate (133Z) 
 
To a stirred solution of 132 
(18.0 g, 73.5 mmol) in CHCl3 
(300 mL) was added 
manganese (IV) dioxide (63.9 
g, 735 mmol) and (carbethoxymethylene) triphenyl phosphorane (30.7 g, 88.2 mmol). 
The resulting suspension was stirred vigorously with heating to maintain gentle reflux 
for 18 h. After cooling to room temperature, the suspension was filtered through 
Celite, and washed with CHCl3 (500 mL). The filtrate was concentrated under reduced 
pressure to give the crude product. This was purified by flash column 
chromatography on silica gel, eluting with pet. ether:EtOAc (20:1) to afford the title 
compound as an inseparable mixture of 133E/133Z isomers in a ratio of 5:1 and as a 
colourless oil (17.94 g, 78%); Rf (20:1 pet. ether:EtOAc) 0.31; *max (thin film)/cm-1 
2910, 2884, 2813, 1690; 1H NMR (400 MHz; CDCl3) 133E " 6.75 (1H, dd, J 15.0, 
11.0, H-7), 5.93 (1H, d, J 15.0, H-8), 4.19!4.13 (2H, m, OCH2CH3), 3.77 (1H, dd, J 
11.0, 7.5, H1a), 3.72 (1H, dd, J 11.0, 7.0, H-1b), 1.51 (1H, dd, J 11.0, 9.0, H-6), 
1.39!1.32 (1H, m, H-2), 1.27 (3H, t, J 7.0, OCH2CH3),  1.16 (3H, s, H-4), 1.15 (3H, s, 
H-5), 0.87 (9H, s, SiC(CH3)3), 0.05 (3H, s, SiCH3), 0.04 (3H, s, SiCH3); 133Z " 5.98 
(1H, dd, J 11.5, 11.5, H-7), 5.79 (1H, d, J 11.5, H-8), 4.19!4.13 (2H, m, OCH2CH3), 
3.75!3.69 (1H, m, H-1a), 2.75 (1H, dd, J 11.0, 9.0, H-1b), 1.71!1.66 (1H, m, H-6 or 
H-2), 1.39!1.32 (1H, m, H-6 or H-2), 1.28 (3H, t, J 7.0, OCH2CH3), 1.16 (3H, s, H-
4), 1.15 (3H, s, H-5), 0.87 (9H, s, SiC(CH3)3), 0.05 (3H, s, SICH3), 0.04 (3H, s, 
SICH3); 13C NMR (101 MHz; CDCl3) 133E # 166.6 (CH3CH2OC=O), 147.7 (C-7), 
121.3 (C-8), 60.1 (C-1), 60.1 (CH3CH2O), 35.6 (C-6 or C-2), 31.2 (C-4), 28.9 (C-6 or 
C-2), 26.0 (SiC(CH3)3), 25.4 (C-3), 18.4 (SiC(CH3)3), 15.9 (C-5), 14.5 (CH3CH2O), 
"5.0 (SiCH3), "5.1 (SiCH3) 133Z # 167.1 (CH3CH2OC=O), 148.1 (C-7), 119.5 (C-8), 
60.0 (C-1), 59.8 (OCH2CH3), 35.6 (C-2), 29.0 (C-4), 28.1 (C-3), 26.0 (SiC(CH3)3), 
25.6 (C-6), 18.4 (SiC(CH3)3), 15.6 (C-5), 14.5 (OCH2CH3), "5.0 (SiCH3), "5.0 
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(SiCH3); m/z (ESI) 335 [MNa+]; HRMS: calcd. for C17H32NaO3Si, 335.2013. Found: 
[MNa+], 335.2014 ("0.9 ppm error).  
 
Ethyl (±)-[(1S,5R)-6,6-dimethyl-3-oxabicyclo[3.1.0]hex-2-yl]acetate (134) 
 
To a solution of 133 (102 mg, 0.327 mmol) in THF (5 mL) at 0 
°C was added TBAF (0.491 mL, 1 M in THF, 0.491 mmol). 
After 17 h the reaction mixture was diluted with Et2O (5 mL) and 
washed with sat. NH4Cl (aq.) (5 mL), the organic layer separated 
and the aqueous layer extracted with further portions of Et2O (2 x 10 mL). The 
combined organic extracts were dried (MgSO4), filtered and concentrated under 
reduced pressure to to give the crude product. This was purified by flash column 
chromatography on silica gel, eluting with pet. ether:EtOAc (5:1) to afford the title 
compound 88 as a colourless oil and in a diastereomeric ratio of 1:0.1 134major:134minor 
(49 mg, 76%); Rf (1:1 pet. ether: Et2O) 0.47; *max (thin film)/cm-1 2876, 2825, 1710; 
1H NMR (400 MHz; CDCl3) 134major " 4.28 (1H, dd, J 6.5, 6.5, H-7), 4.17 (1H, q, J 
7.0, OCHaHbCH3), 4.16 (1H, q, J 7.0, OCHaHbCH3), 3.93 (1H, dd, J 8.5, 4.0, H-1a), 
3.75 (1H, d, J 8.5, H-1b), 2.54!2.42 (2H, m, H-8), 1.45 (1H, dd, J 7.5, 4.0, H-2), 1.32 
(1H, d, J 7.5, H-6), 1.26 (3H, t, J 7.0, OCH2CH3), 1.05 (3H, s, H-4), 1.01 (3H, s, H-5); 
134minor " 4.49!4.43 (1H, m, H-7), 4.21!4.11 (2H, m, OCH2CH3), 3.89!3.84 (2H, m, 
H-1), 2.67 (1H, dd, J 15.0, 7.5, H-8a), (1H, dd, J 15.0, 6.0 (H-8b), 1.42!1.35 (2H, m, 
H-6 & H-2), 1.28 (3H, t, J 7.0, OCH2CH3), 1.20 (3H, s, H-4), 0.99 (3H, s, H-5); 13C 
NMR (101 MHz; CDCl3) 134major # 171.4 (CH3CH2OC=O), 75.4 (C-7) 67.2 (C-1), 
60.6 (CH3CH2O), 41.1 (C-8), 34.3 (C-6), 29.8 (C-2), 26.2 (CH3CH2O), 19.5 (C-3), 
14.4 (C-4), 13.0 (C-5); 134minor # 171.4 (CH3CH2OC=O), 75.4 (C-7) 68.3 (C-1), 60.6 
(CH3CH2O), 37.7 (C-8), 32.3 (C-6), 29.5 (C-2), 26.9 (CH3CH2O), 19.8 (C-3), 15.3 
(C-4), 13.0 (C-5); m/z (ESI): 221 [MNa+]; HRMS: calcd. for C11H18NaO3, 221.1148. 
Found: [MNa+], 221.1154 ("2.2 ppm error). 
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Ethyl (±)-(2E)-3-[(1S,3R)-3-(hydroxymethyl)-2,2-dimethylcyclopropyl]prop-2-
enoate (131)  
 
To a stirred solution of 133 (5:1 E:Z) (2.06 g, 6.59 mmol) 
in MeCN (65 mL) in a plastic container was added HF 
(0.41 mL, 48 wt % in water, 9.9 mmol). This was stirred 
at RT for 16 h before the addition of sat. NaHCO3 (aq.) (50 mL). The solution was 
diluted with CH2Cl2 (200mL), the organic layer was separated and the aqueous layer 
extracted with further portions of CH2Cl2 (2 ) 200 mL). The combined organic 
extracts were dried (MgSO4), filtered and concentrated under reduced pressure. The 
resulting crude product was purified by flash column chromatography on silica gel, 
eluting with pet. ether:EtOAc (2:1) to afford the title compound 131 as a colourless 
oil (0.984 g, 75%); For data see page 115 
 
(2E,2'E)-diethyl 3,3'-((1R,2R)-3,3-dimethylcyclopropane-1,2-diyl)diprop-2-
enoate (57d) & (±)-(2E,2'Z)-diethyl 3,3'-((1R,2S)-3,3-dimethylcyclopropane-1,2-
diyl)diprop-2-enoate (57e) 
 
To a stirred solution 
of 131 (8.10 g, 40.9 
mmol) in CHCl3 (400 
mL) was added 
manganese dioxide (35.6 g, 409 mmol), 4Å molecular sieves (35.6 g) and 
(carbethoxymethylene) triphenyl phosphorane (17.1 g, 49.1 mmol). After 16 h, the 
suspension was filtered through Celite, and washed with CHCl3 (500 mL). The filtrate 
was concentrated under reduced pressure to give the crude product. This was purified 
by flash column chromatography on silica gel, eluting with pet. ether:EtOAc (40:1 & 
20:1) to afford the title compound 57d  as a colourless oil (7.4 g, 68%) and 57e as a 
colourless oil (1.73 g, 16%); 57d Rf (1:1 pet. ether:EtOAc) 0.62; *max (thin film)/cm-1 
2936, 2876, 1691, 1613; 1H NMR (400 MHz; CDCl3) " 6.90!6.76 (2H, m, H-2), 
5.95 (2H, d, J 15.0, H-1), 4.17 (4H, q, J 7.0, OCH2CH3), 1.91!1.85 (2H, m, H-3), 
1.28 (6H, t, J 7.0, OCH2CH3), 1.25 (3H, s, H-5), 1.21, (3H, s, H-6); 13C NMR (101 
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MHz; CDCl3) # 166.2 (CH3CH2OC=O), 145.4 (C-2), 123.0 (C-1), 60.3 (CH3CH2O), 
36.6 (C-3), 29.6 (C-4), 28.6 (C-5), 16.7 (C-6), 14.4 (CH3CH2O); m/z (ESI) 289 
[MNa+]; HRMS: calcd. for C15H22NaO4, 289.1410. Found: [MNa+], 289.1403 (2.3 
ppm error); 57e Rf (15:1 pet. ether:EtOAc) 0.41; *max (thin film)/cm-1 2936, 2913, 
2881, 1688, 1612; 1H NMR (400 MHz; CDCl3) " 6.82 (1H, dd, J 15.0, 11.0, H-8), 
6.10 (1H, dd, J 11.5, 11.5, H-2), 5.95 (1H, d, J 15.0, H-9), 5.87 (1H, d, J 11.5, H-1), 
4.17 (2H, q, J 7.0, OCH2CH3), 4.16 (2H, q, J 7.0, OCH2CH3), 3.17 (1H, dd, J 11.5, 
9.0, H-3), 1.94 (1H, dd, J 11.0, 9.0, H-7), 1.28 (3H, t, J 7.0, OCH2CH3), 1.27 (3H, t, J 
7.0, OCH2CH3), 1.24 (3H, s, H-5), 1.23, (3H, s, H-6); 13C NMR (101 MHz; CDCl3) # 
166.7 (CH3CH2OC=O), 166.4 (CH3CH2OC=O), 146.0 (C-2 or C-8), 145.9 (C-2 or C-
8), 122.6 (C-0), 121.1 (C-1), 60.3 (OCH2CH3), 60.0 (OCH2CH3), 36.7 (C-7), 33.7 (C-
3), 29.9 (C-4), 28.6 (C-5), 16.5 (C-6), 14.4 (OCH2CH3), 14.4 (OCH2CH3); m/z (ESI) 
289 [MNa+]; HRMS: calcd. for C15H22NaO4, 289.1410. Found: [MNa+], 289.1406 
(1.0 ppm error).  
 
(±)-(1S,3R)-3-({[tert-Butyl(dimethyl)silyl]oxy}methyl)-2,2-
dimethylcyclopropanecarbaldehyde (136) 
 
To a stirred solution of 132 (304 mg, 1.24 mmol) in CH2Cl2 
(10 mL) was added manganese (IV) dioxide (1.08 g, 12.4 
mmol). and 4Å molecular sieves (1.08 g). After 16 h the 
suspension was filtered through Celite, and washed with 
CHCl3 (50 mL). The filtrate was concentrated under reduced pressure to give the 
crude product. This was purified by flash column chromatography on silica gel, 
eluting with pet. ether:EtOAc (15:1) to afford the title compound 136 as a colourless 
oil (166 mg, 55%); Rf (15:1 pet. ether:EtOAc) 0.17; *max (thin film)/cm-1 2909, 2885, 
2841, 1676; 1H NMR (400 MHz; CDCl3) " 9.50 (1H, d, J 5.5, H-7), 4.06 (1H, dd, J 
11.5, 7.5, H-1a), 3.90 (1H, dd, J 11.5, 7.0, H-1b), 1.74!1.62 (2H, m, H-6 & H-2), 
1.36 (3H, s, H-5), 1.20 (3H, s, H-4), 0.88 (9H, s, SiC(CH3)3), 0.05 (3H, s, SiCH3), 
0.05 (3H, s, SiCH3); 13C NMR (101 MHz; CDCl3) # 201.3 (C-7), 58.6 (C-1), 39.0 (C-
2 or C-6), 38.8 (C-2 or C-6), 29.8 (C-3), 29.1 (C-4), 26.0 (SiC(CH3)3), 18.4 
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(SiC(CH3)3), 15.3 (C-5), "5.1 (SiCH3); m/z (ESI) 265 [MNa+]; HRMS: calcd. for 
C13H26NaO2Si, 265.1594. Found: [MNa+], 265.1593 (0.1 ppm error).  
 
Ethyl (±)-(2Z)-3-[(1S,3R)-3-({[tert-butyl(dimethyl)silyl]oxy}methyl)-2,2-
dimethylcyclopropyl]prop-2-enoate (137) 
 
To a solution of ethyl [bis(2,2,2-
trifluoroethoxy)phosphoryl]acetate (285 mg, 0.859 mmol) 
in THF (6 mL) was added 18-crown-6 (507 mg, 1.92 
mmol). The solution was cooled to 0 °C and KHMDS 
(1.23 mL, 0.7 M in toluene, 0.859 mmol) was added cautiously. After 15 min the 
solution was cooled to "78 °C and 136 (160 mg, 0.661 mmol) in THF (3 mL) was 
added via cannula. After 30 min the reaction was quenched with sat. NH4Cl (aq.) (5 
mL), Et2O (10 mL) added and the organic layer separated. The aqueous layer was 
extracted with further portions of Et2O (2 ) 10 mL) and the combined organic extracts 
were dried (MgSO4), filtered and concentrated under reduced pressure. The resulting 
crude product was purified by flash column chromatography on silica gel, eluting with 
pet. ether:EtOAc (40:1) to afford the title compound 137 as a colourless oil (109 mg, 
53%); Rf (10:1 pet. ether:EtOAc) 0.57; *max (thin film)/cm-1 2909, 2883, 2814, 1690, 
1601; 1H NMR (400 MHz; CDCl3) " 5.98 (1H, dd J 11.5, 11.5, H-7), 5.79 (1H, d, J 
11.5, H-8), 4.16 (2H, q, J 7.0, OCH2CH3), 3.74!3.71 (2H, m, H-1), 2.75 (1H, dd, J 
11.5, 9.0, H-6), 1.40!1.34 (1H, m, H-2), 1.28 (3H, t, J 7.0, OCH2CH3), 1.18 (3H, s, 
H-4), 1.12 (3H, s, H-5), 0.87 (9H, s, SiC(CH3)3), 0.04 (6H, s, SICH3); 13C NMR (101 
MHz; CDCl3) # 167.1 (CH3CH2OC=O), 148.1 (C-7), 119.5 (C-8), 60.0 (C-1), 59.8 
(OCH2CH3), 35.6 (C-2), 29.0 (C-4), 28.1 (C-3), 26.0 (SiC(CH3)3), 25.6 (C-6), 18.4 
(SiC(CH3)3), 15.6 (C-5), 14.5 (OCH2CH3), "5.0 (SiCH3), "5.0 (SiCH3); m/z (ESI) 335 
[MNa+]; HRMS: calcd. for C17H32NaO3Si, 335.2013. Found: [MNa+], 335.2006 (1.4 
ppm error).  
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Ethyl (±)-(2Z)-3-[(1S,3R)-3-(hydroxymethyl)-2,2-dimethylcyclopropyl]prop-2-
enoate (138) 
 
To a stirred solution of 137 (136 mg, 0.435 mmol) in MeCN 
(10 mL) in a plastic container was added HF (2 drops, 48 wt 
% in water). This was stirred at RT for 16 h before the 
addition of sat. NaHCO3 (aq.) (5 mL). The solution was diluted with CH2Cl2 (10 mL), 
the organic layer was separated and the aqueous layer extracted with further portions 
of CH2Cl2 (2 ) 10 mL). The combined organic extracts were dried (MgSO4), filtered 
and concentrated under reduced pressure. The resulting crude product was purified by 
flash column chromatography on silica gel, eluting with pet. ether:EtOAc (2:1) to 
afford the title compound 138 as a colourless oil (73 mg, 85%); Rf (1:1 pet. 
ether:EtOAc) 0.38; *max (thin film)/cm-1 3372, 2939, 2883, 2827, 1689, 1601; 1H 
NMR (400 MHz; CDCl3) " 6.02 (1H, dd, J 11.5 10.5, H-7), 5.85 (1H, d, J 11.5, H-
8), 4.17 (2H, q, J 7.0, OCH2CH3), 3.79 (1H, dd, J 11.5, 7.5, H-1a), 3.65 (1H, dd, J 
11.5, 8.0, H-1b), 2.73!2.68 (1H, m, H-6), 1.47!1.39 (1H, m, H-2), 1.28 (3H, t, J 7.0, 
OCH2CH3), 1.19 (3H, s, H-4), 1.14 (3H, s, H-5); 13C NMR (101 MHz; CDCl3) # 
167.1 (CH3CH2OC=O), 147.0 (C-7), 120.5 (C-8), 60.0 (C-1), 60.0 (OCH2CH3), 35.5 
(C-2), 28.8 (C-6), 28.0 (C-5), 25.4 (C-3), 15.6 (C-4), 14.4 (OCH2CH3); m/z (ESI) 221 
[MNa+]; HRMS: calcd. for C11H18NaO3, 221.1148. Found: [MNa+], 221.1140 (3.5 
ppm error).  
 
Ethyl (±)-(2Z)-3-[(1S,3R)-3-formyl-2,2-dimethylcyclopropyl]prop-2-enoate (139) 
 
To a stirred solution of 138 (73 mg, 0.368 mmol) in CHCl3 (5 
mL) was added manganese (IV) dioxide (320 mg, 3.68 mmol) 
and 4Å molecular sieves (320 mg). After 12 h the suspension 
was filtered through Celite, and washed with CHCl3 (25 mL). The filtrate was 
concentrated under reduced pressure to give the crude product. This was purified by 
flash column chromatography on silica gel, eluting with pet. ether:EtOAc (5:1) to 
afford the title compound 139 as a colourless oil (38 mg, 53%); Rf (5:1 pet. 
ether:EtOAc) 0.34; *max (thin film)/cm-1 2911, 2876, 1689, 1610; 1H NMR (400 
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MHz; CDCl3) " 9.72 (1H, d, J 4.0, H-1), 6.55 (1H, dd, J 11.5, 10.5, H-7), 5.88 (1H, 
d, J 11.5, H-8), 4.16 (2H, q, J 7.0, OCH2CH3), 3.49!3.44 (1H, m, H-6), 2.21 (1H, dd, 
J 8.5, 4.0, H-2), 1.34 (3H, s, H-4), 1.30 (3H, s, H-5), 1.28 (3H, t, J 7.0, OCH2CH3); 
13C NMR (101 MHz; CDCl3) # 199.9 (C-1), 166.7 (CH3CH2OC=O), 143.7 (C-7), 
121.3 (C-8), 60.1 (OCH2CH3), 43.1 (C-2), 36.2 (C-6), 33.3 (C-3), 28.8 (C-4), 15.1 (C-
5), 14.4 (OCH2CH3); m/z (ESI) 197 [MH+]; HRMS: calcd. for C11H17O3, 197.1172. 
Found: [MH+], 197.1167 (2.8 ppm error).  
 
Diethyl (2Z,2'Z)-3,3'-[(1R,2S)-3,3-dimethylcyclopropane-1,2-diyl]bisprop-2-
enoate (57f) 
 
To a solution of ethyl [bis(2,2,2-
trifluoroethoxy)phosphoryl]acetate (80 mg, 0.246 mmol) 
in THF (3 mL) was added 18-crown-6 (145 mg, 0.548 
mmol). The solution was cooled to 0 °C and KHMDS 
(350 µL, 0.7 M in toluene, 0.246 mmol) was added cautiously. After 15 min the 
solution was cooled to "78 °C and 139 (37 mg, 0.189 mmol) in THF (2 mL) was 
added via cannula. After 1 h the reaction was quenched with sat. NH4Cl (aq.) (5 mL), 
Et2O (10 mL) added and the organic layer separated. The aqueous layer was extracted 
with further portions of Et2O (2 ) 10 mL) and the combined organic extracts were 
dried (MgSO4), filtered and concentrated under reduced pressure. The resulting crude 
product was purified by flash column chromatography on silica gel, eluting with pet. 
ether:EtOAc (20:1) to afford the title compound 57f as a colourless oil (28 mg, 56%); 
Rf (1:1 pet. ether:Et2O) 0.71; *max (thin film)/cm-1 2935, 2913, 2874, 1691, 1627; 1H 
NMR (400 MHz; CDCl3) " 6.08!6.01 (2H, m, H-2), 5.85 (2H, d, J 12.0, H-1), 4.16 
(4H, q, J 7.0, OCH2CH3), 3.17!3.11 (2H, m, H-3), 1.28 (3H, s, H-5), 1.28 (6H, t, J 
7.0, OCH2CH3), 1.17 (3H, s, H-6); 13C NMR (101 MHz; CDCl3) # 166.7 
(CH3CH2OC=O), 146.0 (C-2), 121.0 (C-1), 60.0 (OCH2CH3), 33.7 (C-3), 30.2 (C-4), 
28.8 (C-5), 16.3 (C-6), 14.4 (OCH2CH3); m/z (ESI) 267 [MH+]; HRMS: calcd. for 
C15H23O4, 267.1591. Found: [MH+], 267.1587 (1.1 ppm error). 
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(±)-[(1S,2S)-2-({[tert-Butyl(dimethyl)silyl]oxy}methyl)cyclopropyl]methanol 
(140) 
 
To a stirred solution of 54a (1.00 g, 9.80 mmol) in THF (20 
mL) at 0 °C was added NaH (472 mg, 11.8 mmol, 60% 
dispersion in mineral oil). After 45 mins, by which time a 
large amount of white precipitate had formed, TBSCl (1.48 g, 9.80 mmol) was added. 
The reaction mixture was warmed to RT and allowed to stir for a further 1 h before 
dilution with Et2O (25 mL). It was then washed with sat. NH4Cl (aq.) (20 mL) and 
brine (10 mL), the organic layer separated and the aqueous layer extracted with 
further portions of Et2O (2 ) 20 mL). The combined organic extracts were dried 
(MgSO4), filtered and concentrated under reduced pressure. The resulting crude 
product was purified by flash column chromatography on silica gel, eluting with pet. 
ether:EtOAc (20:1 & 4:1) to afford the title compound 140 as a colourless oil (1.46 g, 
69%); Rf (EtOAc) 0.89; *max (thin film)/cm-1 3315, 2909, 2884, 2842; 1H NMR (400 
MHz; CDCl3) " 3.59 (1H, dd, J 10.5, 6.0) and 3.51!3.42 (3H, m, H-1 & H-5), 
1.06!0.90 (2H, m, H-4 & H-2), 0.89 (9H, s, SiC(CH3)3), 0.53!0.40 (2H, m, H-3), 0.05 
(6H, s, SICH3); 13C NMR (101 MHz; CDCl3) # 66.6 (C-1 or C-5), 65.9 (C-1 or C-5), 
26.0 (SiC(CH3)3), 19.5 (C-2 or C-4), 19.4 (C-2 or C-4), 18.4 (SiC(CH3)3), 7.9 (C-3), 
"5.1 (SiCH3); m/z (ESI) 217 [MH+]; HRMS: calcd. for C11H25O2Si, 217.1618. Found: 
[MH+], 217.1622 ("2.3 ppm error).  
 
Ethyl (±)-(2E)-3-[(1R,2S)-2-({[tert-
butyl(dimethyl)silyl]oxy}methyl)cyclopropyl]prop-2-enoate (141) 
 
To a stirred solution of 140 (1.46 g, 6.75 mmol) in 
CHCl3 (70 mL) was added manganese (IV) dioxide 
(5.87 g, 67.5 mmol) and (carbethoxymethylene) 
triphenyl phosphorane (2.82 g, 8.10 mmol). The resulting suspension was stirred 
vigorously with heating to maintain gentle reflux for 18 h. After cooling to room 
temperature, the suspension was filtered through Celite, and washed with CHCl3 (100 
mL). The filtrate was concentrated under reduced pressure to give the crude product. 
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This was purified by flash column chromatography on silica gel, eluting with pet. 
ether:EtOAc (40:1 & 10:1) to afford the title compound 141 as a colourless oil (1.63 
g, 85%); Rf (10:1 pet. ether:EtOAc) 0.24; *max (thin film)/cm-1 2909, 2886, 2814, 
1691, 1621; 1H NMR (400 MHz; CDCl3) " 6.48 (1H, dd, J 15.5, 10.0, H-5), 5.85 
(1H, d, J 15.5), 4.17 (2H, q, J 7.0, CH3CH2O), 3.65"3.54 (2H, m, H-1), 1.54"1.47 
(1H, m, H-4), 1.33"1.25 (1H, m, H-2), 1.27 (3H, t, J 7.0 CH3CH2O), 0.96"0.90 (1H, 
m, H-3a), 0.88 (9H, s, SiC(CH3)3), 0.84"0.79 (1H, m H-3b), 0.04 (6H, s, SICH3); 13C 
NMR (101 MHz; CDCl3) # 166.9 (CH3CH2OC=O), 152.8 (C-5), 118.4 (C-6), 64.6 
(C-1), 60.2 (OCH2CH3), 26.1 (SiC(CH3)3), 24.8 (C-2 or C-4), 19.6 (C-2 or C-4), 18.5 
(SiC(CH3)3), 14.5 (OCH2CH3), 13.1 (C-3), "5.1 (SiCH3); m/z (ESI) 285 [MH+]; 
HRMS: calcd. for C15H28O3Si, 285.1880. Found: [MH+], 285.1877 (1.2 ppm error).  
 
Ethyl (±)-(2E)-3-[(1R,2S)-2-(hydroxymethyl)cyclopropyl]prop-2-enoate (142) 
 
To a solution of 141 (1.60 g, 5.40 mmol) in THF (50 mL) 
at 0 °C was added TBAF (6.48 mL, 1 M in THF, 6.48 
mmol). After 17 h the reaction mixture was diluted with 
Et2O (50 mL) and washed with sat. NH4Cl (aq.) (50 mL), the organic layer separated 
and the aqueous layer extracted with further portions of Et2O (2 ) 50 mL). The 
combined organic extracts were dried (MgSO4), filtered and concentrated under 
reduced pressure to to give the crude product. This was purified by flash column 
chromatography on silica gel, eluting with pet. ether:EtOAc (2:1) to afford the title 
compound 142 as a colourless oil (704 mg, 77%); Rf (1:1 pet. ether:EtOAc) 0.59; *max 
(thin film)/cm-1 3374, 2938, 2893, 2830, 1687, 1670; 1H NMR (400 MHz; CDCl3) " 
6.47 (1H, dd, J 15.5, 10.0, H-5), 5.88 (1H, d, J 15.5, H-6), 4.17 (2H, q, J 7.0, 
CH3CH2O), 3.60 (1H, dd, J 11.5, 6.5, H-1a), 3.53 (1H, dd, J 11.5, 7.0, H-1b), 
1.57"1.49 (1H, m, H-2 or H-4), 1.43"1.35 (1H, m, H-2 or H-4), 1.27 (3H, t, J 7.0 
CH3CH2O), 0.96"0.86 (2H, m, H-3); 13C NMR (101 MHz; CDCl3) # 166.8 
(CH3CH2OC=O), 152.0 (C-5), 118.9 (C-6), 65.6 (C-1), 60.3 (OCH2CH3), 24.8 (C-2 
or C-4), 20.0 (C-2 or C-4), 14.4 (OCH2CH3), 13.4 (C-3); m/z (ESI) 171 [MH+]; 
HRMS: calcd. for C9H15O3, 171.1016. Found: [MH+], 171.1010 (3.8 ppm error). 
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Ethyl (±)-(2E)-3-[(1R,2S)-2-formylcyclopropyl]prop-2-enoate (143) 
 
To a stirred solution of 142 (704 mg, 4.14 mmol) in CHCl3 
(40 mL) was added manganese (IV) dioxide (3.60 g, 41.4 
mmol) and 4Å molecular sieves (3.60 g). After 20 h the 
suspension was filtered through Celite, and washed with CHCl3 (100 mL). The filtrate 
was concentrated under reduced pressure to afford the title compound 143 as a 
colourless oil (468 mg, 67%); Rf (1:1 pet. ether:EtOAc) 0.72; *max (thin film)/cm-1 
2937, 2893, 2796, 1681, 1624; 1H NMR (400 MHz; CDCl3) " 9.31 (1H, d, J 4.0, H-
1), 6.42 (1H, dd, J 15.5, 9.5, H-5), 5.97 (1H, d, J 15.5, H-6), 4.17 (2H, q, J 7.0, 
CH3CH2O), 2.28"2.20 (1H, m, H-4), 2.17"2.10 (1H, m, H-2), 1.68"1.63 (1H, m, H-
3a), 1.35"1.29 (1H, m, H-3b), 1.27 (3H, t, J 7.0 CH3CH2O); 13C NMR (101 MHz; 
CDCl3) # 198.7 (C-1), 166.2 (CH3CH2OC=O), 147.4 (C-5), 121.7 (C-6), 60.6 
(OCH2CH3), 31.8 (C-2), 24.8 (C-4), 16.3 (C-3), 14.4 (OCH2CH3); m/z (ESI) 169 
[MH+]; HRMS: calcd. for C9H13O3, 169.0859. Found: [MH+], 169.0861 ("0.9 ppm 
error).  
 
Diethyl (±)-(2E,2'Z)-3,3'-(1R,2R)-cyclopropane-1,2-diylbisprop-2-enoate (55b) 
 
To a solution of ethyl [bis(2,2,2-
trifluoroethoxy)phosphoryl]acetate (257 mg, 0.774 
mmol) in THF (6 mL) was added 18-Crown-6 (457 
mg, 1.73 mmol). The solution was cooled to 0 °C and KHMDS (1.10 mL, 0.7 M in 
toluene, 0.774 mmol) was added cautiously. After 15 min the solution was cooled to 
"78 °C and 143 (100 mg, 0.595 mmol) in THF (3 mL) was added via cannula. After 2 
h the reaction was quenched with sat. NH4Cl (aq.) (10 mL), Et2O (20 mL) added and 
the organic layer separated. The aqueous layer was extracted with further portions of 
Et2O (2 ) 20 mL) and the combined organic extracts were dried (MgSO4), filtered and 
concentrated under reduced pressure. The resulting crude product was purified by 
flash column chromatography on silica gel, eluting with pet. ether:EtOAc (20:1) to 
afford the title compound 55b as a colourless oil (65 mg, 46%); Rf (1:1 pet. 
ether:Et2O) 0.56; *max (thin film)/cm-1 2938, 2893, 2862, 1688, 1618; 1H NMR (400 
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MHz; CDCl3) " 6.50 (1H, dd, J 15.5, 10.0, H-6), 5.88 (1H, d, J 15.5, H-7), 5.73 (1H, 
d, J 11.0, H-1), 5.50 (1H, dd, J 11.0, 11.0, H-2), 4.17 (2H, q, J 7.0, CH3CH2O), 4.15 
(2H, q, J 7.0, CH3CH2O) 3.24"3.13 (1H, m, H-3), 1.78"1.68 (1H, m, H-5), 1.31"1.26 
(1H, m, H-4a), 1.28 (3H, t, J 7.0 CH3CH2O), 1.26 (3H, t, J 7.0 CH3CH2O), 1.18"1.09 
(1H, m, H-4b); 13C NMR (101 MHz; CDCl3) # 166.8 (CH3CH2OC=O), 166.4 
(CH3CH2OC=O), 150.7 (C-2), 150.0 (C-6), 119.8 (C-7), 118.8 (C-1), 60.3 
(OCH2CH3), 60.1 (OCH2CH3), 25.5 (C-5), 23.0 (C-3), 18.0 (C-4), 14.4 (OCH2CH3); 
m/z (ESI) 239 [MH+]; HRMS: calcd. for C13H19O4, 239.1278. Found: [MH+], 
239.1276 (0.5 ppm error). 
 
(±)-(1S,2S)-Cyclopropane-1,2-dicarbaldehyde (144)85 
 
To a stirred solution of 54a (2.00 g, 19.6 mmol) in CHCl3 (150 
mL) was added manganese (IV) dioxide (34.1 g, 392 mmol). 
The suspension was heated at reflux gently and after 16 h, the 
suspension was filtered through Celite, and washed with CHCl3 (250 mL). The filtrate 
was concentrated under reduced pressure to afford the title compound 144 as a 
colourless oil (205 mg, 11%), which was used in the next step without further 
purification; Rf (1:1 pet. ether:EtOAc) 0.54; 1H NMR (400 MHz; CDCl3) " 
9.34!9.32 (2H, m, H-1), 2.57!2.49 (2H, m, H-2), 1.71!1.65 (2H, m, H-3). Data in 
agreement with those reported in the literature.85 
 
Diethyl (±)-(2'Z)-3,3'-(1R,2R)-cyclopropane-1,2-diylbisprop-2-enoate (55c) 
 
To a solution of ethyl [bis(2,2,2-
trifluoroethoxy)phosphoryl]acetate (1.32 mg, 3.98 mmol) 
in THF (15 mL) was added 18-crown-6 (2.30 g, 8.87 
mmol). The solution was cooled to 0 °C and KHMDS (5.70 mL, 0.7 M in toluene, 
3.98 mmol) was added cautiously. After 15 min the solution was cooled to "78 °C 
and 144 (150 mg, 1.53 mmol) in THF (8 mL) was added via cannula. After 2 h the 
reaction was quenched with sat. NH4Cl (aq.) (15 mL), Et2O (25 mL) added and the 
organic layer separated. The aqueous layer was extracted with further portions of 
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Et2O (2 ) 25 mL) and the combined organic extracts were dried (MgSO4), filtered and 
concentrated under reduced pressure. The resulting crude product was purified by 
flash column chromatography on silica gel, eluting with pet. ether:EtOAc (10:1) to 
afford the title compound 55c as a colourless oil (192 mg, 63%); Rf (10:1 pet. 
ether:EtOAc) 0.37; *max (thin film)/cm-1 2935, 2885, 1691, 1612; 1H NMR (400 
MHz; CDCl3) " 5.73 (2H, d, J 11.5, H-1), 5.60!5.53 (2H, m, H-2), 4.17 (4H, q, J 7.0, 
CH3CH2O), 3.18!3.10 (2H, m, H-3), 1.28 (6H, t, J 7.0, CH3CH2O), 1.20 (2H, t, J 7.0, 
H-4); 13C NMR (101 MHz; CDCl3) # 167.0 (CH3CH2OC=O), 151.4 (C-2), 118.4 (C-
1), 60.0 (OCH2CH3), 23.4 (C-3), 18.3 (C-4), 14.4 (OCH2CH3); m/z (ESI) 239 [MH+]; 
HRMS: calcd. for C13H19O4, 239.1278. Found: [MH+], 239.1285 ("3.2 ppm error). 
 
(1R,2S)-Cyclopropane-1,2-diyldimethanol (54b)86 
 
To a stirred suspension of LiAlH4 (510 mg, 13.4 mmol) in THF 
(25 mL) at 0 °C was added 3-oxabicyclo[3.1.0]hexane-2,4-dione 
(1.00 g, 8.92 mmol) in THF (20 mL) via cannula. The reaction 
was heated to reflux and stirred for 16 h.  The reaction was cooled to 0 °C and 
Na2SO4.10H2O was cautiously added until on further addition fizzing was no longer 
observed. The aluminium salts were removed by filtration and washed with EtOAc 
(100 mL). The filtrate was concentrated under reduced pressure to give the crude 
product. This was purified by flash column chromatography on silica gel, eluting with 
EtOAc to afford the title compound 54b as a colourless oil. (723 mg, 79%); Rf 
(EtOAc) 0.23; 1H NMR (400 MHz; CDCl3) " 4.15!4.08 (2H, m, H-1a), 3.31!3.21 
(2H, m, H-1b), 2.20 (2H, br s, OH), 1.39!1.28 (2H, m, H-2), 0.81 (1H, dt, J 8.0, 5.0, 
H-3a), 0.22 (1H, dt, J 5.0, 5.0, H-3b). Data in agreement with those reported in the 
literature.86 
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(±)-[(1R,2S)-2-({[tert-Butyl(dimethyl)silyl]oxy}methyl)cyclopropyl]methanol 
(144)87 
 
To a stirred solution of 54b (720 mg, 7.06 mmol) in THF (14 
mL) at 0 °C was added NaH (339 mg, 8.47 mmol, 60% 
dispersion in mineral oil). After 45 mins, by which time a 
large amount of white precipitate had formed, TBSCl (1.06 g, 7.06 mmol) was added. 
The reaction mixture was warmed to RT and allowed to stir for a further 1 h before 
dilution with Et2O (25 mL). It was then washed with sat. NH4Cl (aq.) (20 mL) and 
brine (10 mL), the organic layer separated and the aqueous layer extracted with 
further portions of Et2O (2 ) 20 mL). The combined organic extracts were dried 
(MgSO4), filtered and concentrated under reduced pressure to afford the title 
compound 144 as a colourless oil (1.53 g, 100%), which was used in the next step 
without further purification; Rf (EtOAc) 0.81; 1H NMR (400 MHz; CDCl3) # 4.15 
(1H, dd, J 11.5, 5.5, H-1a or H-5a), 3.97 (1H, dd, J 12.0, 5.5, H-1a or H-5a), 
3.26"3.20 (2H, m, H-1 & H-5) 1.43-1.30 (1H, m, H-4 or H-2), 1.30-1.18 (1H, m, H-4 
or H-2), 0.92 (9H, s, SiC(CH3)3), 0.80"0.71 (1H, m, H-3a), 0.23"0.16 (1H, m, H-3b), 
0.12 (3H, s, SiCH3), 0.10 (3H, s, SiCH3). Data in agreement with those reported in the 
literature.87 
 
(±)-(1R,2S)-2-({[tert-Butyl(dimethyl)silyl]oxy}methyl)cyclopropanecarbaldehyde 
(145)87 
 
To a stirred solution of 144 (1.61 g, 7.44 mmol) in CHCl3 (75 
mL) was added manganese (IV) dioxide (6.47 g, 74.4 mmol) 
and 4Å molecular sieves (6.47 g). After 16 h the suspension 
was filtered through Celite, and washed with CHCl3 (150 mL). The filtrate was 
concentrated under reduced pressure to afford the title compound 145 as a colourless 
oil (1.20 g, 75%), which was used in the next step without further purification; Rf (1:1 
pet. ether:EtOAc) 0.86; 1H NMR (400 MHz; CDCl3) # 9.41 (1H, d, J 5.0, H-5), 3.97 
(1H, dd, J 11.0, 5.5, H-1a), 3.62 (1H, dd, J 11.0, 7.5, H-1b), 2.02"1.91 (1H, m, H-4 or 
H-2), 1.82"1.73 (1H, m, H-4 or H-2), 1.37"1.32 (1H, m, H-3a), 1.25"1.20 (1H, m, H-
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3b), 0.87 (9H, s, SiC(CH3)3), 0.04 (3H, s, SiCH3), 0.03 (3H, s, SiCH3). Data in 
agreement with those reported in the literature.87 
 
Ethyl (±)-(2E)-3-[(1S,2S)-2-({[tert-
butyl(dimethyl)silyl]oxy}methyl)cyclopropyl]prop-2-enoate (146)87 
 
To a stirred solution of 145 (534 mg, 2.50 mmol) in 
CHCl3 (25 mL) at RT was added 
(carbethoxymethylene) triphenyl phosphorane (1.04 g, 
3.00 mmol). After 16 h the solution was concentrated under reduced pressure and the 
crude product purified by flash column chromatography on silica gel, eluting with pet. 
ether:EtOAc (40:1) to afford the title compound 146 as a colourless oil (471 mg, 
63%); Rf (20:1 pet. ether:EtOAc) 0.31; 1H NMR (400 MHz; CDCl3) # 6.72 (1H, dd, J 
15.5, 10.5, H-5), 5.92 (1H, d, J 15.5, H-6), 4.17 (2H, q, J 7.0, CH3CH2O), 3.82 (1H, 
dd, J 11.0, 5.6, H-1a), (1H, dd, J 11.0 7.5, H-1b), 1.67"1.78 (1H, m, H-4 or H-2), 
1.49"1.58 (1H, m, H-4 or H-2), 1.28 (3H, t, J 7.1, CH3CH2O), 1.09"1.16 (1H, m, H-
3a), 0.89 (9H, s, SiC(CH3)3), 0.68"0.75 (1H, m, H-3b), 0.06 (3H, s, SiCH3), 0.05 (3H, 
s, SiCH3). Data in agreement with those reported in the literature.87 
 
Ethyl (±)-(2E)-3-[(1S,2S)-2-(hydroxymethyl)cyclopropyl]prop-2-enoate (147)86 
 
To a stirred solution of 146 (471 mg, 1.59 mmol) in 
MeCN (15 mL) in a plastic container was added HF (130 
µL, 48 wt % in water, 3.18 mmol). This was stirred at RT 
for 16 h before the addition of sat. NaHCO3 (aq.) (15 mL). The solution was diluted 
with CH2Cl2 (10 mL), the organic layer was separated and the aqueous layer extracted 
with further portions of CH2Cl2 (2 ) 20 mL). The combined organic extracts were 
dried (MgSO4), filtered and concentrated under reduced pressure to afford the title 
compound 147 as a colourless oil (254 mg, 94%), which was used in the next step 
without further purification; Rf (1:1 pet. ether: EtOAc) 0.42; 1H NMR (400 MHz; 
CDCl3) " 6.69 (1H, dd, J 15.5, 10.0, H-5), 5.95 (1H, d, J 15.5, H-6), 4.17 (2H, q, J 
7.0, CH3CH2O), 3.82 (1H, ddd, J 11.5, 6.0, 1.5 H-1a), 3.50 (1H, dd, J 11.5, 8.5, H-
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1b), 1.98 (1H, br s, OH), 1.81"1.70 (1H, m, H-4 or H-2), 1.63"1.52 (1H, m, H-4 or 
H-2), 1.25 (3H, t, J 7.0, CH3CH2O), 1.20"1.13 (1H, m, H-3a), 0.72"0.65 (1H, m, H-
3b). Data in agreement with those reported in the literature.86 
 
Ethyl (±)-(2E)-3-[(1S,2S)-2-formylcyclopropyl]prop-2-enoate (148)86 
 
To a stirred solution of 147 (281 mg, 1.65 mmol) in CHCl3 
(15 mL) was added manganese (IV) dioxide (1.43 g, 16.5 
mmol) and 4Å molecular sieves (1.43 g). After 16 h the 
suspension was filtered through Celite, and washed with CHCl3 (50 mL). The filtrate 
was concentrated under reduced pressure to afford the title compound 148 as a 
colourless oil (224 mg, 81%), which was used in the next step without further 
purification; Rf (1:1 pet. ether: EtOAc) 0.57; 1H NMR (400 MHz; CDCl3) " 9.47 
(1H, d, J 4.5, H-1), 6.82 (1H, dd, J 15.5, 9.5, H-5), 6.02 (1H, d, J 15.5, H-6), 4.17 
(2H, q, J 7.0, CH3CH2O), 2.37!2.21 (2H, m, H-4 & H-2), 1.68!1.63 (1H, m, H-3a), 
1.60!1.53 (1H, m, H-3b), 1.28 (3H, t, J 7.0, CH3CH2O). Data in agreement with those 
reported in the literature.86 
 
Diethyl (1R,2S)-cyclohepta-3,6-diene-1,2-dicarboxylate (58a) 
 
To a stirred solution of 148 (132 mg, 0.786 mmol) in CHCl3 (10 
mL) was added (carbethoxymethylene)triphenylphosphorane 
(329 mg, 0.943 mmol) at RT. After 16 h the solution was 
concentrated under reduced pressure at RT and the crude product 
purified by flash column chromatography on silica gel, eluting with pet. ether:EtOAc 
(20:1) to afford the title compound 58a as a colourless oil (148 mg, 79%); For data 
see page 89. 
 
Diethyl (±)-(1S,2S)-cyclohepta-3,6-diene-1,2-dicarboxylate (58b) 
 
To a solution of ethyl [bis(2,2,2-
trifluoroethoxy)phosphoryl]acetate (236 mg, 0.712 mmol) in 
THF (7 mL) was added 18-crown-6 (420 mg, 1.59 mmol). The 
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solution was cooled to 0 °C and KHMDS (1.02 mL, 0.7 M in toluene, 0.712 mmol) 
was added cautiously. After 15 min the solution was cooled to "78 °C and 148 (92 
mg, 0.548 mmol) in THF (7 mL) was added via cannula. After 2 h the reaction was 
quenched with sat. NH4Cl (aq.) (10 mL), Et2O (20 mL) added and the organic layer 
separated. The aqueous layer was extracted with further portions of Et2O (2 ) 20 mL) 
and the combined organic extracts were dried (MgSO4), filtered and concentrated under 
reduced pressure at RT. The resulting crude product was purified by flash column 
chromatography on silica gel, eluting with pet. ether:EtOAc (20:1) to afford the title 
compound 58b as a colourless oil (98 mg, 75%); Rf (10:1 pet. ether:EtOAc) 0.27; *max 
(thin film)/cm-1 2978, 2936, 2893, 2862, 1710 1H NMR (400 MHz; CDCl3) " 
5.89!5.81 (2H, m, H-3), 5.66!5.60 (2H, m, H-2), 4.17 (4H, q, J 7.0, OCH2CH3), 
3.83"3.77 (2H, m, H-1), 2.88"2.83 (2H, m, H-4), 1.26 (6H, t, J 7.0, CH3CH2O); 13C 
NMR (101 MHz; CDCl3) # 173.3 (CH3CH2OC=O), 130.8 (C-3), 127.0 (C-2), 61.1 
(OCH2CH3), 45.5 (C-1), 27.5 (C-4), 14.3 (OCH2CH3); m/z (ESI) 239 [MH+]; HRMS: 
calcd. for C13H19O4, 239.1278. Found: [MH+], 239.1267 (3.8 ppm error). 
 
Ethyl (±)-(2Z)-3-[(1S,2S)-2-({[tert-
butyl(dimethyl)silyl]oxy}methyl)cyclopropyl]prop-2-enoate (149) 
 
To a solution of ethyl [bis(2,2,2-
trifluoroethoxy)phosphoryl]acetate (1.31 g, 4.04 mmol) in 
THF (40 mL) was added 18-crown-6 (2.38 g, 9.02 mmol). 
The solution was cooled to 0 °C and KHMDS (5.80 mL, 0.7 M in toluene, 4.04 
mmol) was added cautiously. After 15 min the solution was cooled to "78 °C and 145 
(665 mg, 3.11 mmol) in THF (40 mL) was added via cannula. After 2 h the reaction 
was quenched with sat. NH4Cl (aq.) (50 mL), Et2O (50 mL) added and the organic 
layer separated. The aqueous layer was extracted with further portions of Et2O (2 ) 
50 mL) and the combined organic extracts were dried (MgSO4), filtered and 
concentrated under reduced pressure. The resulting crude product was purified by 
flash column chromatography on silica gel, eluting with pet. ether:EtOAc (50:1) to 
afford the title compound 149 as a colourless oil (883 mg, 40%); Rf (50:1 pet. 
ether:EtOAc) 0.18; *max (thin film)/cm-1 2910, 2886, 2814, 1690, 1608; 1H NMR (400 
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MHz; CDCl3) " 5.91 (1H, dd, J 11.5, 11.5, H-5), 5.75 (1H, d, J 11.5, H-6), 4.17 (2H, 
q, J 7.0, OCH2CH3), 3.78 (1H, dd, J 11.0, 6.0, H-1a), 3.69 (1H, dd, J 11.0, 7.0, H-1b), 
3.04!2.95 (1H, m, H-4), 1.59!1.49 (1H, m, H-2), 1.29 (3H, t, J 7.0, CH3CH2O), 
1.24!1.15 (1H, m, H-3a), 0.88 (9H, s, (SiC(CH3)3)), 0.70!0.63 (1H, m, H-3b), 0.05 
(6H, s, SiCH3); 13C NMR (101 MHz; CDCl3) # 167.2 (CH3CH2OC=O), 151.3 (C-5), 
118.7 (C-6), 62.6 (C-1), 59.8 (OCH2CH3), 26.1 (SiC(CH3)3), 23.7 (C-2), 18.5 
(SiC(CH3)3), 17.0 (C-4), 14.5 (OCH2CH3), 14.4 (C-3), "5.1 (SiCH3), "5.1 (SiCH3); 
m/z (ESI) 285 [MH+]; HRMS: calcd. for C15H29O3Si, 285.1880. Found: [MH+], 
285.1880 (0.0 ppm error). 
 
Ethyl (±)-(2Z)-3-[(1S,2S)-2-(hydroxymethyl)cyclopropyl]prop-2-enoate (150) 
 
To a stirred solution of 149 (339 mg, 1.14 mmol) in MeCN 
(10 mL) in a plastic container was added HF (90 µL, 48 wt 
% in water, 2.28 mmol). This was stirred at RT for 16 h 
before the addition of sat. NaHCO3 (aq.) (15 mL). The solution was diluted with 
CH2Cl2 (15 mL), the organic layer was separated and the aqueous layer extracted with 
further portions of CH2Cl2 (2 ) 20 mL). The combined organic extracts were dried 
(MgSO4), filtered and concentrated under reduced pressure to afford the title 
compound 150 as a colourless oil (188 mg, 97%), which was used in the next step 
without further purification; Rf (1:1 pet. ether: EtOAc) 0.43; *max (thin film)/cm-1 
3365, 2937, 2912, 2874, 1687, 1607; 1H NMR (400 MHz; CDCl3) " 5.89 (1H, dd, J 
11.5, 10.0, H-5), 5.83 (1H, d, J 11.5, H-6), 4.19 (2H, q, J 7.0, OCH2CH3), 3.85 (1H, 
dd, J 11.5, 6.0, H-1a), 3.55 (1H, dd, J 11.5, 8.5, H-1b), 3.03!2.95 (1H, m, H-4), 
1.69!1.39 (1H, m, H-2), 1.29 (3H, t, J 7.0, CH3CH2O), 1.28"1.23 (1H, m, H-3a), 
0.67"0.62 (1H, m, H-3b); 13C NMR (101 MHz; CDCl3) # 167.0 (CH3CH2OC=O), 
149.8 (C-5), 120.0 (C-6), 63.1 (C-1), 60.0 (OCH2CH3), 23.8 (C-2), 16.5 (C-4), 14.5 
(C-3), 14.4 (OCH2CH3); m/z (ESI) 193 [MNa+]; HRMS: calcd. for C9H14NaO3, 
193.0835. Found: [MNa+], 193.0833 (0.6 ppm error). 
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Ethyl (±)-(2Z)-3-[(1S,2S)-2-formylcyclopropyl]prop-2-enoate (151) 
 
To a stirred solution of 150 (185 mg, 1.09 mmol) in CHCl3 
(10 mL) was added manganese (IV) dioxide (948 mg, 10.9 
mmol) and 4Å molecular sieves (948 mg). After 16 h the 
suspension was filtered through Celite, and washed with CHCl3 (50 mL). The filtrate 
was concentrated under reduced pressure. The resulting crude product was purified by 
flash column chromatography on silica gel, eluting with pet. ether:EtOAc (20:1) to 
afford the title compound 151 as a colourless oil (97 mg, 53%); Rf (20:1 pet. 
ether:EtOAc) 0.18; *max (thin film)/cm-1 2938, 2894, 2861, 2803, 2699, 1685, 1613; 
1H NMR (400 MHz; CDCl3) " 9.67 (1H, d, J 3.5, H-1), 6.09 (1H, dd, J 11.5, 10.5, 
H-5), 5.83 (1H, d, J 11.5, H-6), 4.18 (2H, q, J 7.0, OCH2CH3), 3.67!3.56 (1H, m, H-
4), 2.50!2.42 (1H, m, H-2), 1.60!1.52 (2H, m, H-3), 1.29 (3H, t, J 7.0, CH3CH2O); 
13C NMR (101 MHz; CDCl3) # 200.0 (C-1), 166.7 (CH3CH2OC=O), 146.0 (C-5), 
121.1 (C-6), 60.2 (OCH2CH3), 31.1 (C-2), 23.9 (C-4), 17.3 (C-3), 14.4 (OCH2CH3); 
m/z (ESI) 191 [MNa+]; HRMS: calcd. for C9H12NaO3, 191.0679. Found: [MNa+], 
191.0676 (0.3 ppm error). 
 
Diethyl (1R,2S)-cyclohepta-3,6-diene-1,2-dicarboxylate (58a) 
 
To a solution of ethyl [bis(2,2,2-
trifluoroethoxy)phosphoryl]acetate (244 mg, 0.735 mmol) in 
THF (7 mL) was added 18-crown-6 (433 mg, 1.64 mmol). The 
solution was cooled to 0 °C and KHMDS (1.05 mL, 0.7 M in 
toluene, 0.735 mmol) was added cautiously. After 15 min the solution was cooled to 
"78 °C and 151 (95 mg, 0.565 mmol) in THF (7 mL) was added via cannula. After 2 
h the reaction was quenched with sat. NH4Cl (aq.) (10 mL), Et2O (20 mL) added and 
the organic layer separated. The aqueous layer was extracted with further portions of 
Et2O (2 ) 20 mL) and the combined organic extracts were dried (MgSO4), filtered and 
concentrated under reduced pressure. The resulting crude product was purified by 
flash column chromatography on silica gel, eluting with pet. ether:EtOAc (20:1) to 
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afford the title compound 58a as a colourless oil (109 mg, 81%); For data see page 
89 
 
Methyl (±)-(E)-3-((1S,3R)-3-((tert-butyldimethylsilyloxy)methyl)-2,2-
dimethylcyclopropyl)prop-2-enoate (152) 
 
To a stirred solution of 132 (200 mg, 0.818 mmol) in 
CHCl3 (8 mL) was added manganese (IV) dioxide (711 
mg, 8.18 mmol) and (methoxycarbonylmethylen)-
triphenylphosphorane (328 mg, 0.982 mmol). The resulting suspension was stirred 
vigorously with heating to maintain gentle reflux for 48 h. After cooling to room 
temperature, the suspension was filtered through Celite, and washed with CHCl3 (20 
mL). The filtrate was concentrated under reduced pressure to give the crude product. 
This was purified by flash column chromatography on silica gel, eluting with pet. 
ether:EtOAc (50:1) to afford the title compound 152 as a colourless oil E:Z < 20:1 
(118 mg, 48%); Rf (10:1 pet.ether:EtOAc) 0.56; *max (thin film)/cm-1 2908, 2814, 
1696, 1242, 1066; 1H NMR (400 MHz; CDCl3) E " 6.76 (1H, dd, J 15.0, 11.0, H-7), 
5.93 (1H, d, J 15.0, H-8), 3.81!3.69 (2H, m, H-1), 3.71 (3H, s, OCH3), 1.57!1.48 
(1H, m, H-6), 1.39!1.32 (1H, m, H-2), 1.16 (3H, s, H-4), 1.15 (3H, s, H-5), 0.87 (9H, 
s, SiC(CH3)3), 0.05 (3H, s, SiCH3), 0.04 (3H, s, SiCH3) Z " 5.99 (1H, dd, J 11.5, 11.5, 
H-7), 5.80 (1H, d, J 11.5, H-8), 4.00!3.86 (2H, m, H-1), 3.71 (3H, s, OCH3), 
1.50!1.44 (2H, m, H-6 & H-2), 1.20 (3H, s, H-4), 1.19 (3H, s, H-5), 0.89 (9H, s, 
SiC(CH3)3), 0.06 (6H, s, SICH3); 13C NMR (101 MHz; CDCl3) E # 167.0 
(CH3OC=O), 148.1 (C-7), 120.8 (C-8), 60.1 (C-1), 51.4 (CH3O), 35.7 (C-6 or C-2), 
31.2 (C-4), 28.9 (C-6 or C-2), 26.0 (SiC(CH3)3), 25.6 (C-3), 18.4 (SiC(CH3)3), 15.9 
(C-5), "5.1 (SiCH3), "5.1 (SiCH3); m/z (ESI): 321 [MNa+]; HRMS: calcd. for 
C16H30NaO3Si, 321.1856. Found: [MNa+], 321.1852 (1.1 ppm error). 
 
Methyl (±)-(E)-3-((1S,3R)-3-(hydroxymethyl)-2,2-dimethylcyclopropyl)prop-2-
enoate (153) 
 
To a stirred solution of 152 (100 mg, 0.335 mmol) in 
MeCN (4 mL) in a plastic container was added HF (23 
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µL, 48 wt % in water, 0.531 mmol). This was stirred at RT for 16 h before the 
addition of sat. NaHCO3 (aq.) (5 mL). The solution was diluted with CH2Cl2 (10 mL), 
the organic layer was separated and the aqueous layer extracted with further portions 
of CH2Cl2 (2 ) 10 mL). The combined organic extracts were dried (MgSO4), filtered 
and concentrated under reduced pressure to afford the title compound 153 as a 
colourless oil E:Z < 20:1  (50 mg, 81%), which was used in the next step without 
further purification; Rf (1:1 pet.ether:EtOAc) 0.47; *max (thin film)/cm-1 3373, 2907, 
1690, 1416; 1H NMR (400 MHz; CDCl3) E " 6.78 (1H, dd, J 15.0, 11.0, H-7), 5.98 
(1H, d, J 15.0, H-8), 3.87!3.73 (2H, m, H-1), 3.71 (3H, s, OCH3), 1.58 (1H, dd, J 
11.0, 9.0, H-6), 1.43 (1H, dd, J 9.0, 7.5, H-2), 1.19 (3H, s, H-4), 1.18 (3H, s, H-5); Z 
" 6.78 (1H, dd, J 11.5, 10.5, H-7), 5.87 (1H, d, J 11.5, H-8), 3.87!3.73 (2H, m, H-1), 
3.72 (3H, s, OCH3), 1.60!1.39 (2H, m, H-6 & H-2), 1.19 (3H, s, H-4), 1.18 (3H, s, H-
5); 13C NMR (101 MHz; CDCl3) # 167.0 (CH3OC=O), 147.1 (C-7), 121.5 (C-8), 
59.9 (C-1), 51.5 (CH3O), 35.5 (C-6 or C-2), 31.1 (C-4), 28.9 (C-6 or C-2), 25.7 (C-3), 
15.9 (C-5); m/z (ESI): 207 [MNa+]; HRMS: calcd. for C10H16NaO3, 207.0992. Found: 
[MNa+], 207.0989 (1.0 ppm error). 
 
Dimethyl (2E,2'E)-3,3'-((1R,2S)-3,3-dimethylcyclopropane-1,2-diyl)diprop-2-
enoate (154) 
 
To a stirred solution of 153 (50 mg, 0.272 mmol) 
in CHCl3 (3 mL) at RT was added 
(methoxycarbonylmethylen)-triphenylphosphorane 
(109 mg, 0.326 mmol). After 16 h the solution was 
concentrated under reduced pressure and the crude product purified by flash column 
chromatography on silica gel, eluting with pet. ether:EtOAc (20:1) to afford the title 
compound 154 as a colourless oil (32 mg, 49%); Rf (20:1 pet.ether:EtOAc) 0.18; *max 
(thin film)/cm-1 2908, 2873, 1689, 1610, 1413; 1H NMR (400 MHz; CDCl3) " 
6.89!6.78 (2H, m, H-2), 5.96 (2H, d, J 15.5, H-1), 3.72 (6H, s, OCH3), 1.93!1.86 
(2H, m, H-3), 1.26 (3H, s, H-5), 1.21, (3H, s, H-6); 13C NMR (101 MHz; CDCl3) # 
166.6 (CH3OC=O), 145.7 (C-2), 122.5 (C-1), 51.6 (CH3O), 36.7 (C-3), 29.7 (C-4), 
CO2MeMeO2C
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28.5 (C-5), 16.7 (C-6); m/z (ESI): 261 [MNa+]; HRMS: calcd. for C13H18NaO3, 
261.1097. Found: [MNa+], 261.1096 (0.4 ppm error). 
 
Methyl (±)-(E)-3-((1S,3R)-3-((E)-3-hydroxyprop-1-enyl)-2,2-
dimethylcyclopropyl)prop-2-enoate (155) & (2E,2'E)-3,3'-((1R,2S)-3,3-
Dimethylcyclopropane-1,2-diyl)diprop-2-en-1-ol (156) 
 
To a stirred 
solution of 154 
(250 mg, 1.06 
mmol) in 
CH2Cl2 (10 mL) at "78 °C was added DIBAL (2.10 mL, 2.10 mmol, 1M in hexanes). 
After 30 mins, MeOH (1 mL) was added and the reaction was warmed to RT, sat. aq. 
Rochelle’s salt (5 mL) was added and the mixture was stirred overnight. The organic 
layer was separated and the aqueous layer extracted with further portions of CH2Cl2 
(2 x 20 mL). The combined organic extracts were dried (MgSO4), filtered and 
concentrated under reduced pressure to afford the crude compound, which was 
purified by flash column chromatography on silica gel, eluting with pet. ether: EtOAc 
(2: 1) to afford 155 as a colourless oil (21 mg, 9%) and 156 as a colourless oil (64 mg, 
33%); 155 Rf (2:1 pet.ether:EtOAc) 0.55; *max (thin film)/cm-1 3357, 2906, 2876, 
1689, 1610; 1H NMR (400 MHz; CDCl3) " 6.81 (1H, dd, J 15.0, 11.0, H-2), 5.94 
(1H, d, J 15.0, H-1), 5.83 (1H, dt, J 15.0, 6.0, H-9), 5.60 (1H, ddt, J 15.0, 9.5, 1.5, H-
8), 4.13 (2H, dd, J 6.0, 1.5, H-10), 3.72 (3H, s, OCH3), 1.81 (1H, dd, J 9.5, 8.5, H-7), 
1.68 (1H, dd, J 11.0, 8.5, H-3), 1.19 (3H, s, H-5), 1.17 (3H, s, H-6); 13C NMR (101 
MHz; CDCl3) # 167.0 (CH3OC=O), 147.7 (C-2), 132.0 (C-1), 128.2 (C-9), 121.3 (C-
8), 63.8 (C-10), 51.5 (CH3O), 36.5 (C-7), 34.4 (C-3), 28.6 (C-5), 27.6 (C-4), 16.6 (C-
6); m/z (ESI): 233 [MNa+]; HRMS: calcd. for C12H18NaO3, 233.1148. Found: 
[MNa+], 233.1143 (2.1 ppm error); 156 Rf (2:1 pet.ether:EtOAc) 0.18; *max (thin 
film)/cm-1 3284, 2954, 2899, 2821, 1356; 1H NMR (400 MHz; CDCl3) " 5.79 (2H, 
dt, J 15.0, 6.0, H-3), 5.56!5.48 (2H, m, H-2), 4.10 (4H, dd, J 6.0, 1.5, H-1), 
1.58!1.52 (2H, m, H-4), 1.12 (3H, s, H-5), 1.09 (3H, s, H-6); 13C NMR (101 MHz; 
CDCl3) # 130.7 (C-3), 129.5 (C-2), 63.9 (C-1), 33.4 (C-4), 28.6 (C-7), 24.4 (C-5), 
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16.3 (C-6); m/z (ESI): 205 [MNa+]; HRMS: calcd. for C11H18NaO2, 205.1199. Found: 
[MNa+], 205.1192 (3.0 ppm error). 
  
(±)-(E)-3-((1S,3R)-3-((E)-3-(tert-butyldimethylsilyloxy)prop-1-enyl)-2,2-
dimethylcyclopropyl)prop-2-en-1-ol (157) & (2E,2'E)-3,3'-((1R,2S)-3,3-
Dimethylcyclopropane-1,2-diyl)bis(prop-2-ene-3,1-diyl)bis(oxy)bis(tert-
butyldimethylsilane) (158) 
 
To a stirred 
solution of 
diol 156 
(122 mg, 
0.669 mmol) in CH2Cl2 (10 mL) was added TBSCl (150 mg, 1.00 mmol) and 
imidazole (68 mg, 1.00 mmol). After 2 h aq. HCl (10 mL) was added. The organic 
layer was separated and the aqueous layer extracted with further portions of CH2Cl2 
(2 x 20 mL). The combined organic extracts were dried (MgSO4), filtered and 
concentrated under reduced pressure to afford the crude compound, which was 
purified by flash column chromatography on silica gel, eluting with pet. ether: Et2O 
(10: 1) to afford 157 as a colourless oil (40 mg, 20%) and 158 as a colourless oil (96 
mg, 35%); 157 Rf (10:1 pet.ether:Et2O) 0.28; *max (thin film)/cm-1 3346, 2882, 2813, 
1441; 1H NMR (400 MHz; CDCl3) " 5.78 (1H, dt, J 15.0, 6.0, H-2 or H-10), 5.69 
(1H, dt, J 15.0, 5.0, H-2 or H-10), 5.56!5.43 (2H, m, H-3 & H-9), 4.15 (2H, br d, J 
5.0, H-1 or H-11), 4.09 (2H, br d, J 6.0, H-1 or H-11), 1.58!1.50 (1H, m, H-4 or H-8), 
1.11 (3H, s, H-5), 1.09 (3H, s, H-6), 0.94!0.85 (1H, m H-4 or H-8), 0.905 (9H, s, 
SiC(CH3)3), 0.06 (6H, s, SiCH3); 13C NMR (101 MHz; CDCl3) # 131.0 (C-2 or C-
10), 130.5 (C-2 or C-10), 130.1 (C-3 or C-9), 127.4 (C-3 or C-9), 64.1 (C-1 or C-11), 
64.1 (C-1 or C-11), 33.4 (C-4 or C-8), 33.3 (C-4 or C-8), 28.7 (C-7), 26.1 
(SiC(CH3)3), 24.3 (C-5), 18.6 (SiC(CH3)3), 16.3 (C-6), !5.0 (SiCH3) m/z (ESI): 319 
[MNa+]; HRMS: calcd. for C17H32NaO2Si, 319.2064. Found: [MNa+], 319.2047 (4.9 
ppm error); 158 Rf (10:1 pet.ether:Et2O) 0.75; *max (thin film)/cm-1 2909, 2885, 2813; 
1H NMR (400 MHz; CDCl3) " 5.68 (2H, dt, J 15.0, 5.5, H-3), 5.53!5.42 (2H, m, H-
2), 4.18!4.08 (4H, m, H-1), 1.58!1.52 (2H, m, H-4), 1.12 (3H, s, H-5), 1.09 (3H, s, 
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H-6), 0.90 (18H, s, SiC(CH3)3), 0.06 (12H, s, SICH3); 13C NMR (101 MHz; CDCl3) # 
130.8 (C-3), 127.8 (C-2), 64.2 (C-1), 33.3 (C-4), 28.7 (C-7), 26.1 (SiC(CH3)3), 24.0 
(C-5), 18.6 (SiC(CH3)3), 16.4 (C-6), "5.0 (SiCH3); m/z (ESI): 433 [MNa+]; HRMS: 
calcd. for C23H46NaO2Si2, 433.2929. Found: [MNa+], 433.2916 (3.2 ppm error). 
 
(2E,2'E)-3,3'-((1R,2S)-3,3-dimethylcyclopropane-1,2-diyl)diprop-2-enoic acid 
(159) 
 
To a solution of 154 (71 mg, 0.298 mmol) in 
THF:H2O 1:1 (6 mL) was added NaOH (83 mg, 
2.09 mmol). This was stirred at RT for 16 h before 
the addition of Et2O (10 mL). The Et2O layer was 
removed and the aq. layer was acidified with 10% aq. HCl (20 mL). The aqueous 
layer was extracted with of EtOAc (2 x 20 mL) and the combined organic extracts 
were dried (MgSO4), filtered and concentrated under reduced pressure to afford title 
compound 159, without further purification as a light brown solid (62 mg, 100%); 
*max (thin film)/cm-1 2879, 2600 (br), 1679, 1627, 1421; 1H NMR (400 MHz; DMSO) 
" 5.93!5.85 (2H, m, H-2), 5.10 (2H, d, J 15.0, H-1), 1.21"1.14 (2H, m, H-3), 0.34 
(3H, s, H-5), 0.30 (3H, s, H-6) 13C NMR (101 MHz; DMSO) # 167.1 (C=O), 146.0 
(C-2), 123.8 (C-1), 36.3 (C-3), 29.8 (C-5), 28.4 (C-4), 16.8 (C-6); m/z (ESI): 433 
[MNa+]; HRMS: calcd. for C11H14NaO4, 233.0790. Found: [MNa+], 233.0797 (2.2 
ppm error). 
 
General Procedure for the Cope Rearrangement 
 
A solution of divinylcyclopropane in xylene (0.19 mol dm-3) was heated to the 
temperature indicated and held at that temperature for 17 h.  The solution was then 
concentrated in vacuo.  The products in Table 5 were purified, by flash column 
chromatography, except for diacid 165.  
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Diethyl (1R,2S)-5,5-dimethylcyclohepta-3,6-diene-1,2-dicarboxylate (88a) 
 
Synthesised from compound 57d using the general procedure at 
100 °C, affording the title compound 88a as a colourless oil 
(78%); Rf (10:1 pet. ether: EtOAc) 0.25; *max (thin film)/cm-1 
2961, 2920, 1735; 1H NMR (400 MHz; CDCl3) # 5.93 (2H, dd, 
J 12.0, 6.0, H-2), 5.50 (2H, d, J 12.0, H-3), 4.12"4.18 (4H, m, OCH2CH3), 3.79 (2H, 
d, J 6.0, H-1), 1.25 (6H, t, J 7.0, OCH2CH3), 1.16 (3H, s, H-5), 1.13 (3H, s, H-6); 13C 
NMR (101 MHz; CDCl3) # 172.0 (C=O), 140.0 (C-2), 123.2 (C-3), 61.1 (OCH2CH3), 
45.1 (C-1), 39.1 (C-4), 32.4 (OCH2CH3), 29.3 (C-6), 14.3 (C-5); m/z (ESI): 289 
[MNa+]; HRMS: calcd. for C15H22NaO4, 289.1410. Found: [MNa+], 289.1411 (0.3 
ppm error). 
 
Dimethyl (1R,2S)-5,5-dimethylcyclohepta-3,6-diene-1,2-dicarboxylate (160) 
 
Synthesised from compound 154 using the general procedure at 
100 °C, affording the title compound 160 as a colourless oil (36 
mg, 83%); Rf (10:1 pet. ether: EtOAc) 0.23; *max (thin film)/cm-
1 2974, 2912, 1718; 1H NMR (400 MHz; CDCl3) # 5.93 (2H, 
dd, J 11.5, 6.5, H-2), 5.50 (2H, d, J 11.5, H-3), 3.82 (2H, d, J 6.5, H-1), 3.70 (6H, s, 
OCH3), 1.16 (3H, s, H-6), 1.12 (3H, s, H-5); 13C NMR (101 MHz; CDCl3) # 172.5 
(C=O), 140.1 (C-2), 123.1 (C-3), 52.3 (C-1), 44.9 (OCH3), 39.1 (C-4), 32.5 (C-6), 
29.3 (C-5); m/z (ESI): 239 [MH+]; HRMS: calcd. for C13H19O4, 239.1278. Found: 
[MH+], 239.1269 (3.2 ppm error). 
 
(±)-(3aR,8aS)-6,6-Dimethyl-3,3a,6,8a-tetrahydro-1H-cyclohepta[c]furan-1-one 
(161) 
 
Synthesised from compound 155 using the general procedure at 100 
°C, affording the title compound 161 as a light yellow solid (32 mg, 
84%); Rf (EtOAc) 0.72; mp 29"32 °C; *max (thin film)/cm-1 2917, 
2880, 2824, 1744; 1H NMR (400 MHz; CDCl3) " 5.67 (1H, ddd, J 
12.0, 2.0, 2.0, H-7 or H-3), 5.61 (1H, ddd, J 12.0, 2.0, 2.0, H-7 or H-
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3), 5.46 (1H, dd, J 12.0, 5.0, H-8 or H-2), 5.31 (1H, dd, J 12.0, 4.5, H-8 or H-2), 4.31 
(1H, dd, J 8.5, 6.0, H-10a), 4.12 (1H, dd, J 8.5, 4.5, H-10b), 3.47!3.39 (2H, m, H-9 & 
H-1), 1.19 (3H, s, H-5), 1.15 (3H, s, H-6); 13C NMR (101 MHz; CDCl3) # 176.8 (C-
11), 143.4 (C-7 or C-3), 142.6 (C-7 or C-3), 123.6 (C-8 or C-2), 118.6 (C-8 or C-2), 
73.2 (C-10), 44.0 (C-9 or C-1), 39.7 (C-4), 38.2 (C-9 or C-1), 32.0 (C-5), 30.1 (C-6); 
m/z (ESI): 179 [MH+]; HRMS: calcd. for C11H15O2, 179.1067. Found: [MH+], 
179.1065 (1.0 ppm error). 
 
((1R,2S)-5,5-Dimethylcyclohepta-3,6-diene-1,2-diyl)dimethanol (162) 
 
 Synthesised from compound 156 using the general procedure at 
100 °C, affording the title compound 162 as a colourless oil (15 
mg, 83%); Rf (EtOAc) 0.43; mp 42"44 °C; *max (thin film)/cm-1 
3304, 3008, 2958, 2923, 2871; 1H NMR (400 MHz; CDCl3) " 
5.57 (2H, dd, J 12.0, 6.5, H-2), 5.43 (2H, d, J 12.0, H-3), 3.72 (2H, dd, J 11.0, 7.0, H-
7a), 3.66 (2H, br s, OH), 3.59 (2H, dd, J 11.0, 3.0, H-7b), 2.81!2.76 (2H, m, H-1), 
1.13 (3H, s, H-5), 1.08 (3H, s, H-6); 13C NMR (101 MHz; CDCl3) # 139.9 (C-3), 
126.0 (C-2), 63.9 (C-7), 43.8 (C-1), 39.9 (C-4), 32.9 (C-5), 29.8 (C-6); m/z (ESI): 205 
[MNa+]; HRMS: calcd. for C11H18NaO2, 205.1199. Found: [MNa+], 205.1195 (0.7 
ppm error). 
 
(±)-((1R,7S)-7-((tert-Butyldimethylsilyloxy)methyl)-4,4-dimethylcyclohepta-2,5-
dienyl)methanol (163)  
 
Synthesised from compound 157 using the general procedure 
at 100 °C, affording the title compound 163 as a colourless oil 
(10 mg, 86%); Rf (10:1 pet.ether:EtOAc) 0.52; *max (thin 
film)/cm-1 3373, 2962, 2911, 2885, 2815; 1H NMR (400 MHz; 
CDCl3) " 5.58 (1H, dd, J 11.5, 6.0, H-8 or H-2), 5.50 (1H, dd, 
J 12.0, 6.5, H-8 or H-2), 5.45!5.37 (2H, m, H-7 & H-3), 3.74 (1H, dd, J 10.5, 8.0, H-
11a or H-10a), 3.65 (1H, dd, J 11.5, 7.0, H-11a or H-10a), 3.57!3.51 (2H, m, H-11b 
& H-10b), 2.86!2.79 (1H, m, H-9 or H-1), 2.75!2.68 (1H, m, H-9 or H-1), 1.13 (3H, 
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s, H-6), 1.08 (3H, s, H-5), 0.91 (9H, s, SiC(CH3)3), 0.10 (6H, s, SiCH3); 13C NMR 
(101 MHz; CDCl3) # 140.1 (C-8 or C-2), 139.5 (C-8 or C-2), 126.5 (C-7 or C-3), 
125.9 (C-7 or C-3), 64.4 (C-11 or C-10), 64.3 (C-11 or C-10), 44.0 (C-9 or C-1), 44.0 
(C-9 or C-1), 39.8 (C-4), 33.0 (C-6), 29.7 (C-5), 26.0 (SiC(CH3)3), 18.4 (SiC(CH3)3), 
!5.4 (SiCH3); m/z (ESI): 319 [MNa+]; HRMS: calcd. for C17H32NaO2Si, 319.2064. 
Found: [MNa+], 319.2053 (2.4 ppm error). 
 
((1R,2S)-5,5-Dimethylcyclohepta-3,6-diene-1,2- 
diyl)bis(methylene)bis(oxy)bis(tert-butyldimethylsilane) (164) 
 
Synthesised from compound 158 using the general 
procedure at 100 °C, affording the title compound 164 as a 
colourless oil (17 mg, 88%); Rf (40:1 pet. ether: Et2O) 0.76; 
*max (thin film)/cm-1 2911, 2883, 2852, 2814; 1H NMR (400 
MHz; CDCl3) # 5.48 (2H, dd, J 11.5, 6.0, H-3), 5.35 (2H, d, 
J 11.5, H-4), 3.66 (2H, dd, J 10.0, 7.0, H-1a), 3.58 (2H, dd, J 10.0, 7.0, H-1b), 2.73 
(2H, ddd, J 7.0, 7.0, 6.0, H-2), 1.14 (3H, s, H-6), 1.09 (3H, s, H-7), 0.88 (18H, s, 
SiC(CH3)3), 0.03 (12H, s, SiCH3); 13C NMR (101 MHz; CDCl3) # 139.1 (C-4), 128.0 
(C-3), 65.5 (C-1), 42.8 (C-2), 39.8 (C-5), 32.9 (C-6), 29.9 (C-7), 26.1 (SiC(CH3)3), 
18.5 (SiC(CH3)3), "5.2 (SiCH3). m/z (ESI): 411 [MH+]; HRMS: calcd. for 
C23H47O2Si2, 411.3109. Found: [MH+], 411.3100 (1.1 ppm error). 
 
 (1R,2S)-5,5-Dimethylcyclohepta-3,6-diene-1,2-dicarboxylic acid (165) 
 
Synthesised from compound 159 using the general procedure at 
100 °C, without chromatography, affording the title compound 
165 as a light brown solid (22 mg, 97%); mp 130"132 °C; *max 
(thin film)/cm-1 2963, 2927, 2600 (br), 1693; 1H NMR (400 
MHz; DMSO) # 5.87"5.80 (2H, m, H-2), 5.40 (2H, d, J 12.0, H-3), 3.67 (2H, d, J 5.5, 
H-1), 1.12 (3H, s, H-6), 1.06 (3H, s, H-5); 13C NMR (101 MHz; DMSO) # 172.8 
(C=O), 138.4 (C-2), 124.4 (C-3), 44.1 (C-1), 38.2 (C-4), 32.1 (C-6), 28.8 (C-5); m/z 
(ESI): 211 [MH+]; HRMS: calcd. for C11H15O4, 211.0965. Found: [MH+], 211.0971 
(2.8 ppm error). 
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7.4 Procedures & Compound Characterisation (Chapter 4) 
 
Diethyl (1R,2S)-5,5-dimethylcyclohepta-3,6-diene-1,2-dicarboxylate (88a) 
A stirred solution of 57d (5.49 g, 20.6 mmol) in toluene (200 mL) 
was heated to 100 °C for 16 h. After being cooled to RT the 
solution was concentrated under reduced pressure to afford the 
title compound cis-37, as a colourless oil (4.50 g, 82%); For data 
see page 140 
 
[(1R,2S)-5,5-Dimethylcyclohepta-3,6-diene-1,2-diyl]dimethanol (162) 
 
To a stirred suspension of LiAlH4 (86 mg, 2.26 mmol) in THF (5 
mL) at 0 °C was added 88a (300 mg, 1.13 mmol) in THF (5 mL) 
via cannula. The reaction was warmed to RT and stirred for 16 h.  
The reaction was cooled to 0 °C and Na2SO4.10H2O was 
cautiously added until on further addition fizzing could no longer be observed. The 
aluminium salts were removed by filtration and washed with EtOAc (20 mL). The 
filtrate was concentrated under reduced pressure to give the crude product. This was 
purified by flash column chromatography on silica gel, eluting with pet. ether:EtOAc 
(5:1 & 1:1) to afford the title compound 162 as a white solid (127 mg, 62%); For data 
see page 141 
 
(±)-(3aR,8aS)-6,6-Dimethyl-3,3a,6,8a-tetrahydro-1H-cyclohepta[c]furan-1-one 
(161) 
   
To a stirred solution of 162 (100 mg, 0.549 mmol) in CH2Cl2 (5 mL) at 
RT was added PhI(OAc)2 (441 mg, 1.37 mmol) and TEMPO (9 mg, 
0.0576 mmol). After 2h the reaction mixture was concentrated under 
reduced pressure to give the crude product. This was purified by flash 
column chromatography on silica gel, eluting with pet. ether:Et2O (10:1 & 2:1) to 
afford the title compound 161 as a light yellow solid (68 mg, 69%); For data see page 
140 
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(±)-(3aR)-6,6-Dimethyl-3,3a,6,7-tetrahydro-1H-cyclohepta[c]furan-1-one (168) 
& (±)-(3aR,8aR)-6,6-Dimethyl-3,3a,6,8a-tetrahydro-1H-cyclohepta[c]furan-1-one 
(170) 
 
To a stirred solution of 161 (624 mg, 3.50 mmol) in THF 
(175 mL) at 0 °C was added DBU (0.52 mL, 3.50 mmol). 
After 30 min the reaction was quenched with NH4Cl 
(aq.) (100 mL), EtOAc (100 mL) was added, the organic 
layer was separated and the aqueous layer extracted with 
portions of EtOAc (2 ) 100 mL). The combined organic extracts were dried (MgSO4), 
filtered and concentrated under reduced pressure. The resulting crude product was 
purified by flash column chromatography on silica gel, eluting with pet. ether:Et2O 
(4:1) to afford the title compound 168 as a colourless oil (185 mg, 30%) and 170 as a 
colourless oil (322 mg, 52%); 168 Rf (1:1 pet. ether:Et2O) 0.48; *max (thin film)/cm-1 
2915, 1731, 1663; 1H NMR (400 MHz; CDCl3) " 7.00!6.95 (1H, m, H-2), 5.44 (1H, 
ddd, J 12.0, 3.0, 1.5, H-8 or H-7), 5.18, (1H, dd, J 12.0, 2.0, H-8 or H-7), 4.56 (1H, 
dd, J 9.5, 8.5, H-10a), 4.00!3.92 (1H, m, H-9), 3.85 (1H, dd, J 8.5, 8.5, H-10b), 2.57 
(1H, dddd, J 14.5, 6.0, 2.5, 0.5, H-3a), 2.22 (1H, dddd, J 14.5, 7.5, 1.0, 1.0, H-3b), 
1.08 (3H, s, H-6), 1.01 (3H, s, H-5); 13C NMR (101 MHz; CDCl3) # 170.3 (C-11), 
141.6 (C-8 or C-7), 139.2 (C-2), 131.8 (C-1), 122.5 (C-8 or C-7), 71.1 (C-10), 39.5 
(C-3), 37.5 (C-9), 35.4 (C-4), 31.4 (C-6), 29.1 (C-5); m/z (ESI): 179 [MH+]; HRMS: 
calcd. for C11H15O2, 179.1067. Found: [MH+], 179.1066 (0.1 ppm error); 170 Rf (1:1 
pet. ether:Et2O) 0.45; *max (thin film)/cm-1 2969, 2916, 2878, 2824, 1754; 1H NMR 
(400 MHz; CDCl3) " 5.89 (1H, ddd, J 11.0, 3.0, 0.5, H-7 or H-3), 5.55!5.45 (3H, m, 
H-8, H-2 & H-7 or H-3), 4.44 (1H, ddd, J 8.5, 7.0, 0.5, H-10a), 3.92!3.85 (1H, m, H-
10b), 3.26!3.13 (2H, m, H-9 & H-1), 1.17 (6H, s, H-5 & H-6); 13C NMR (101 MHz; 
CDCl3) # 176.7 (C-11), 141.1 (C-7 or C-3), 140.2 (C-7 or C-3), 122.3 (C-8 or C-2), 
121.1 (C-8 or C-2), 70.4 (C-10), 44.3 (C-9 or C-1), 41.5 (C-9 or C-1), 41.1 (C-4), 31.6 
(C-5), 31.5 (C-6); m/z (ESI): 179 [MH+]; HRMS: calcd. for C11H15O2, 179.1067. 
Found: [MH+], 179.1068 ("1.4 ppm error). 
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(±)-(3aS,4aS,8aR)-6,6-Dimethyl-1,4,4a,5,6,8a-
hexahydrocyclopropa[1,7]cyclohepta[1,2-c]furan-3-one (171) 
 
Procedure 1: To a suspension of NaH (33 mg, 0.815 mmol, 60% 
dispersion in mineral oil) in DMF (1.5 mL) at 0 °C was added 
trimethylsulfoxonium iodide (179 mg, 0.815 mmol). The reaction 
mixure was stirred for 5 min before the dropwise addition of 168 (121 
mg, 0.679 mmol) in DMF (1.5 mL). The solution was stirred at 0 °C 
for a further 5 min before warming to RT and stirring for 16 h. Sat. NH4Cl (aq.) (5 
mL) was then added followed by H2O (5 mL) and Et2O (15 mL). The organic layer 
was separated and the aqueous layer extracted with portions of Et2O (2 ) 15 mL). 
The combined organic extracts were dried (MgSO4), filtered and concentrated under 
reduced pressure. The resulting crude product was purified by flash column 
chromatography on silica gel, eluting with pet. ether:Et2O (4:1) to afford the title 
compound 171 as a colourless oil (26 mg, 20%); Procedure 2: To a suspension of NaH 
(29 mg, 0.734 mmol, 60% dispersion in mineral oil) in DMSO (1 mL) at 0 °C was 
added trimethylsulfoxonium iodide (162 mg, 0.734 mmol). The reaction mixure was 
stirred for 5 min before the dropwise addition of 168 (109 mg, 0.612 mmol) in DMSO 
(1 mL). The solution was stirred at RT for 16 h. Sat. NH4Cl (aq.) (5 mL) was then 
added followed by H2O (5 mL) and Et2O (2 mL). The organic layer was separated and 
the aqueous layer extracted with portions of Et2O (2 ) 2 mL). The combined organic 
extracts were dried (MgSO4), filtered and concentrated under reduced pressure. The 
resulting crude product was purified by flash column chromatography on silica gel, 
eluting with pet. ether:Et2O (4:1) to afford the title compound 171 as a colourless oil 
(15 mg, 11%); Procedure 3: To a stirred solution of MTBD (208 mg, 1.36 mmol) and 
trimethylsulfoxonium iodide (179 mg, 0.815 mmol) in MeCN (2 mL) was added 168 
(121 mg, 0.679 mmol) in MeCN (2 mL). The reaction mixture was stirred at RT 
overnight. It was then concentrated under reduced pressure and the resulting crude 
product was purified by flash column chromatography on silica gel, eluting with pet. 
ether:Et2O (4:1) to afford the title compound 171 as a colourless oil (10 mg, 8%); Rf 
(1:1 pet. ether:EtOAc) 0.43; *max (thin film)/cm-1 2956, 2915, 2871, 2825, 1740; 1H 
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NMR (400 MHz; CDCl3) " 5.37 (1H, dd, J 12.0, 2.5, H-8 or H-7), 5.19 (1H, dd, J 
12.0, 2.0, H-8 or H-7), 4.49 (1H, dd, J 9.0, 6.5, H-10a), 4.28 (1H, dd, J 9.0, 1.0, H-
10b), 3.04!2.99 (1H, m, H-9), 2.05 (1H, ddd, J 14.0, 4.5, 2.5, H-3a), 1.82!1.73 (1H, 
m, H-2), 1.34 (1H, dd, J 9.0, 4.0, H-12a), 1.28 (1H, dd, J 14.0, 12.0, H-3b), 1.11 (3H, 
s, H-6), 1.01-0.98 (1H, m, H-12b), 0.99 (3H, s, H-5); 13C NMR (101 MHz; CDCl3) # 
177.4 (C-11), 143.9 (C-8 or C-7), 126.5 (C-8 or C-7), 74.3 (C-10), 42.5 (C-3), 39.3 
(C-9), 37.9 (C-4), 32.4 (C-2), 30.4 (C-1), 26.9 (C-6), 24.8 (C-12), 19.3 (C-5); m/z 
(ESI): 193 [MH+]; HRMS: calcd. for C12H17O2, 193.1223. Found: [MH+], 193.1222 
(0.5 ppm error). 
 
(±)-([(1S,2R,7S)-5,5-Dimethylbicyclo[5.1.0]oct-3-ene-1,2-diyl]dimethanol (172) 
 
To a stirred solution of 171 (19 mg, 0.0990 mmol) in CH2Cl2 (1 
mL) at "78 °C was added DIBAL (0.50 mL, 0.495 mmol, 1M in 
hexanes). After 10 mins the reaction was warmed to RT and after 
30 min the reaction mixture was diluted with CH2Cl2 (2 mL) 
followed by the careful addition of sat. aq. Rochelle’s salt (3 mL). The mixture was 
stirred overnight after which time, the organic layer was separated and the aqueous 
layer extracted with further portions of CH2Cl2 (2 ) 3 mL). The combined organic 
extracts were dried (MgSO4), filtered and concentrated under reduced pressure to 
afford the crude compound, which was purified by flash column chromatography on 
silica gel, eluting with pet. ether:Et2O (1:1) to afford the title compound 172 as a 
colourless oil (15 mg, 79%); Rf (1:1 pet. ether:Et2O) 0.36; *max (thin film)/cm-1 3285, 
2951, 2909, 2873, 2807; 1H NMR (400 MHz; CDCl3) " 5.27!5.19 (2H, m, H-8 & H-
7), 3.98 (1H, dd, J 11.5, 1.5, H-10a), 3.80!3.77 (2H, m, H-11), 3.04 (1H, dd, J 11.5, 
1.0, H-10b), 2.46!2.39 (1H, m, H-9), 2.23 (2H, br s, OH), 1.78 (1H, ddd, J 14.5, 5.0, 
2.0, H-3a), 1.57 (1H, dd, J 14.5, 11.5, H-3b), 1.05 (3H, s, H-6), 0.97 (3H, s, H-5), 
0.94!0.73 (3H, m, H-12 & H-2); 13C NMR (101 MHz; CDCl3) # 141.2 (C-8 or C-7), 
125.0 (C-8 or C-7), 69.1 (C-10), 64.8 (C-11), 42.8 (C-3), 40.0 (C-9), 38.9 (C-4), 32.3 
(C-2), 31.0 (C-1), 27.7 (C-6), 19.0 (C-12), 18.1 (C-5); m/z (ESI): 219 [MNa+]; 
HRMS: calcd. for C12H20NaO2, 219.1356. Found: [MNa+], 219.1357 ("0.5 ppm 
error). 
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(±)-[(1S,7R)-7-({[tert-Butyl(dimethyl)silyl]oxy}methyl)-4,4-dimethylcyclohepta-
2,5-dien-1-yl]methanol (163) 
 
To a stirred solution of 162 (370 mg, 2.03 mmol) in THF (4 
mL) was added NaH (100 mg, 2.44 mmol, 60% dispersion in 
mineral oil) at RT and the reaction mixture was stirred for 45 
min before the addition of TBSCl (306 mg, 2.03 mmol). After 
2 h the reaction was quenched with sat. NH4Cl (aq.) (5 mL) followed by Et2O (5 mL). 
The organic layer was separated and the aqueous layer extracted with further portions 
of Et2O (2 ) 5 mL). The combined organic extracts were dried (MgSO4), filtered and 
concentrated under reduced pressure. The resulting crude product was purified by 
flash column chromatography on silica gel, eluting with pet. ether:EtOAc (40:1 & 1:1) 
to afford the title compound 163 as a colourless oil (495 mg, 82%); For data see page 
141 
 
(±)-(1S,7R)-7-({[tert-Butyl(dimethyl)silyl]oxy}methyl)-4,4-dimethylcyclohepta-
2,5-diene-1-carbaldehyde (188) 
 
To a stirred solution of 163 (220 mg, 0.743 mmol) in CH2Cl2 
(10 mL), at 0 °C was added Dess"Martin Periodinane (636 mg, 
1.50 mmol). The reaction mixture was warmed to RT and 
allowed to stir for 16 h. It was then diluted with CH2Cl2 (10 
mL), and quenched with a 1:1 solution of sat. Na2CO3 (aq.) and sat. Na2S2O3 (aq.) (40 
mL). After vigorous stirring for 30 mins, the organic layer was separated and the 
aqueous layer extracted with further portions of CH2Cl2 (2 ) 25 mL). The combined 
organic extracts were dried (MgSO4), filtered and concentrated under reduced pressure 
to afford 200 mg of unpurified aldehyde 188, which was used in the next step without 
further purification; Rf (10:1 pet.ether:EtOAc) 0.71; 1H NMR (400 MHz; CDCl3) " 
9.59 (1H, s, H-11) 5.86 (1H, dd, J 11.5, 5.0, H-8 or H-2), 5.60 (1H, ddd, J 11.5, 2.0, 
2.0 H-7 or H-3), 5.56 (1H, dd, J 11.5, 6.5, H-8 or H-2), 5.42 (1H, ddd, J 11.5, 2.0, 2.0 
H-7 or H-3), 3.56!3.53 (2H, m, H-10), 3.33!3.51 (1H, m, H-9 or H-1), 3.12!3.05 
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(1H, m, H-9 or H-1), 1.14 (3H, s, H-6), 1.12 (3H, s, H-5), 0.85 (9H, s, SiC(CH3)3), 
0.00 (3H, s, SiCH3), !0.01 (3H, s, SiCH3). 
 
(±)-(7R)-7-({[tert-Butyl(dimethyl)silyl]oxy}methyl)-4,4-dimethylcyclohepta-1,5-
diene-1-carbaldehyde (189) 
 
To a solution of 188 (200 mg, 0.675 mmol) in THF (20 mL) at 0 
°C was added DBU (111 µL, 0.748 mmol). After 20 mins the 
reaction was quenched with NH4Cl (aq.) (20 mL), EtOAc (50 
mL) was added and the organic layer was separated. The 
aqueous layer was extracted with portions of EtOAc (2 ) 50 mL). The combined 
organic extracts were dried (MgSO4), filtered and concentrated under reduced pressure 
to afford 233 mg of unpurified aldehyde 189, which was used in the next step without 
further purification; Rf (5:1 pet. ether:Et2O) 0.53; 1H NMR (400 MHz; CDCl3) " 
9.37 (1H, s, H-11) 6.87 (1H, dd, J 9.0, 5.5, H-2), 5.54 (1H, d, J 12.0, H-8 or H-7), 
5.42 (1H, dd, J 12.0, 5.5, H-8 or H-7), 3.70!3.56 (3H, m, H-10 & H-9), 3.00 (1H, dd, 
J 13.5, 5.5 H-3a), 2.17 (1H, ddd, J 13.5, 9.0, 2.0 H-3b), 1.10 (3H, s, H-6), 1.00 (3H, s, 
H-5), 0.86 (9H, s, SiC(CH3)3), 0.02 (3H, s, SiCH3), 0.01 (3H, s, SiCH3). 
 
(±)-[(7R)-7-({[tert-Butyl(dimethyl)silyl]oxy}methyl)-4,4-dimethylcyclohepta-1,5-
dien-1-yl]methanol (190) 
 
To a stirred solution of 189 (233 mg of crude material) in 
MeOH (10 mL) at 0 °C was added NaBH4 (28 mg, 0.748 
mmol). After 30 min the reaction mixture was diluted with 
CH2Cl2 (25 mL) and quenched with NaHCO3 (aq.) (5 mL). 
The organic layer was separated and the aqueous layer extracted with portions of 
CH2Cl2 (2 ) 25 mL). The combined organic extracts were dried (MgSO4), filtered and 
concentrated under reduced pressure. The resulting crude product was purified by 
flash column chromatography on silica gel, eluting with pet. ether:Et2O (5:1) to afford 
the title compound 190 as a colourless oil (165 mg, 75% over 3 steps); Rf (5:1 pet. 
ether:Et2O) 0.18; *max (thin film)/cm-1 3298, 2909, 2883, 2815; 1H NMR (400 MHz; 
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CDCl3) " 5.83 (1H, ddd, J 8.5, 6.0, 1.0, H-2), 5.43 (1H, ddd, J 12.0, 2.0, 1.0, H-8 or 
H-7), 5.32 (1H, dd, J 12.0, 7.0, H-8 or H-7), 4.06!3.94 (2H, m, H-10 or H-11), 3.79 
(1H, dd, J 9.5, 9.5, H-10a or H-11a), 3.68 (1H, dd, J 9.5, 5.0, H-10a or H-11a), 
3.04!2.97 (1H, m, H-9), 2.52 (1H, dd, J 14.0, 6.0, H-3a), 1.90 (1H, ddd, J 14.0, 8.5, 
2.0, H-3b), 1.00 (3H, s, H-6), 0.98 (3H, s, H-5), 0.91 (9H, s, SiC(CH3)3), 0.10 (3H, s, 
SiCH3), 0.09 (3H, s, SiCH3); 13C NMR (101 MHz; CDCl3) # 142.9 (C-7), 140.4 (C-
1), 127.4 (C-8), 121.6 (C-2), 68.5 (C-10), 65.0 (C-11), 44.1 (C-3), 43.1 (C-4), 33.3 
(C-6),  29.8 (C-9), 28.9 (C-5), 26.1 (C(CH3)3), 18.5 (C(CH3)3),  !5.5 (SiCH3), !5.5 
(SiCH3); m/z (ESI): 319 [MNa+]; HRMS: calcd. for C17H32NaO2Si, 319.2064. Found: 
[MNa+], 319.2063 (0.2 ppm error). 
 
(±)-[(1S,2R,7S)-2-({[tert-Butyl(dimethyl)silyl]oxy}methyl)-5,5-
dimethylbicyclo[5.1.0]oct-3-en-1-yl]methanol (191) & (±)-[(1R,2R,7R)-2-({[tert-
Butyl(dimethyl)silyl]oxy}methyl)-5,5-dimethylbicyclo[5.1.0]oct-3-en-1-
yl]methanol (192) 
 
To a stirred solution of Et2Zn (170 µL, 1 
M in hexanes, 0.170 mmol) in CH2Cl2 (1 
mL) at 0 °C was added diiodomethane 
(27 µL, 0.340 mmol). This was stirred 
for 10 min before the addition of 139 (25 
mg, 0.0850 mmol) in CH2Cl2 (1 mL) via cannula. The reaction was stirred at 0 °C for 
30 min before it was quenched by the addition of sat. NH4Cl (aq.) (5 mL). The organic 
layer was separated and the aqueous layer extracted with further portions of CH2Cl2 
(2 ) 10 mL). The combined organic extracts were dried (MgSO4), filtered and 
concentrated under reduced pressure. The resulting crude product was purified by 
flash column chromatography on silica gel, eluting with pet. ether:Et2O (15:1) to 
afford the title compound 191 as a colourless oil (8 mg, 32%) and 192 as a colourless 
oil (7 mg, 27%); 191 Rf (4:1 pet. ether:Et2O) 0.21; *max (thin film)/cm-1 3340, 2909, 
2886, 2816; 1H NMR (400 MHz; CDCl3) " 5.25!5.15 (2H, m, H-7 & H-8), 
3.82!3.73 (3H, m, H-10 & H-11), 3.04 (1H, d, J H-10b or H-11b), 2.37!2.31 (1H, m, 
H-9), 1.80!1.74 (1H, m, H-3a), 1.57!1.43 (1H, m, H-3b), 1.06 (3H, s, H-5), 0.98 (3H, 
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s, H-6), 0.92 (9H, s, SiC(CH3)3), 0.90!0.88 (1H, m, H-12a), 0.82!0.77 (2H, m, H-12b 
& H2), 0.10 (3H, s, SiCH3), 0.10 (3H, s, SiCH3); 13C NMR (101 MHz; CDCl3) # 
140.9 (C-8), 125.0 (C-7), 68.9 (C-10 or C-11), 65.3 (C-10 or C-11), 48.2 (C-9), 42.7 
(C-2), 40.2 (C-3), 39.0 (C-4), 32.3 (C-6), 30.7 (C-1), 27.7 (C-5), 25.9 (C(CH3)3), 19.3 
(C-12), 18.3 (C(CH3)3), "5.3 (SiCH3), "5.3 (SiCH3); m/z (ESI): 333 [MNa+]; HRMS: 
calcd. for C18H34NaO2Si, 333.2220. Found: [MNa+], 333.2220 (0.0 ppm error); 192 
Rf (4:1 pet. ether:Et2O) 0.16; *max (thin film)/cm-1 3354, 2910, 2884, 2814; 1H NMR 
" 5.38"5.28 (2H, m, H-7 & H-8), 3.54"3.50 (2H, m, H-10), 3.36 (1H, dd, J 10.0, 8.5, 
H-11a), 3.06 (1H, d, J 10.0, H-11b), 2.93"2.88 (1H, m, H-9), 1.84 (1H, ddd, J 14.0, 
5.0, 2.0, H-3a), 1.44"1.22 (2H, m, H-3b & H-2), 1.09 (3H, s, H-5), 0.93 (3H, s, H-6), 
0.89 (9H, s, SiC(CH3)3), 0.63!0.53 (2H, m, H-12), 0.06 (6H, s, SiCH3); 13C NMR 
(101 MHz; CDCl3) # 142.5 (C-8), 124.7 (C-7), 77.4 (C-9) 73.5 (C-11), 66.5 (C-10), 
42.5 (C-2), 41.4 (C-3), 38.0 (C-4), 32.7 (C-5), 28.4 (C-1), 27.0 (C-6), 26.0 (C(CH3)3), 
18.3 (C(CH3)3), 16.1 (C-12), "5.2 (SiCH3); m/z (ESI): 333 [MNa+]; HRMS: calcd. for 
C18H34NaO2Si, 333.2220. Found: [MNa+], 333.2222 (0.3 ppm error). 
 
(±)-[(1R,2R,7R)-5,5-Dimethylbicyclo[5.1.0]oct-3-ene-1,2-diyl]dimethanol (194) 
 
To a solution of 192 (6 mg, 0.0195 mmol) in THF (0.5 mL) at 0 
°C was added TBAF (23 µL, 1 M in THF, 0.0230 mmol). After 
2 h the reaction mixture was diluted with Et2O (5 mL) and 
washed with sat. NH4Cl (aq.) (2 mL), the organic layer separated 
and the aqueous layer extracted with further portions of Et2O (2 ) 5 mL). The 
combined organic extracts were dried (MgSO4), filtered and concentrated under 
reduced pressure to afford the title compound 194 as a colourless oil (4 mg, 100%) 
which was assigned tentatively using 1H NMR spectroscopy and HRMS; Rf (EtOAc) 
0.47; 1H NMR (400 MHz; CDCl3) " 5.42!5.29 (2H, m, H-8 & H-7), 3.60!3.55 (2H, 
m, H-10a & H-11a), 3.30 (1H, dd, J 10.5, 9.0, H-10b or H-11b), 3.12 (1H, d, J 11.0, 
H-10b or H-11b), 2.99!2.90 (1H, m, H-9), 1.86 (1H, ddd, J 14.5, 6.5, 1.5, H-3a), 1.34 
(1H, dd, J 14.5, 12.0, H-3b), 1.09 (3H, s, H-6), 0.94 (3H, s, H-5), 0.93!0.84 (1H, m, 
H-2), 0.67 (1H, dd, J 9.0, 5.0, H-12a), 0.59 (1H, dd, J 5.0, 5.0, H-12b); m/z (ESI): 219 
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[MNa+]; HRMS: calcd. for C12H20NaO2, 219.1356. Found: [MNa+], 219.1358 ("1.0 
ppm error). 
 
(±)-tert-Butyl{[(1R)-5,5-dimethyl-2-{[(tripropan-2-ylsilyl)oxy]methyl}cyclohepta-
2,6-dien-1-yl]methoxy}dimethylsilane (202) 
 
To a stirred solution of 190 (25 mg, 0.0850 mmol) in 
CH2Cl2 (1.5 mL) at RT was added lutidine (25 µL, 0.213 
mmol) and TIPSOTf (30 µL, 0.111 mmol). After 2 h the 
reaction was quenched by the addition of water (2 mL). The 
organic layer was separated and the aqueous layer extracted with further portions of 
CH2Cl2 (2 ) 5 mL). The combined organic extracts were dried (MgSO4), filtered and 
concentrated under reduced pressure. The resulting crude product was purified by 
flash column chromatography on silica gel, eluting with pet. ether:Et2O (40:1) to 
afford the title compound 202 as a colourless oil (25 mg, 66%) which was assigned 
tentatively using 1H NMR spectroscopy and HRMS; Rf (40:1 pet. ether:Et2O) 0.36; 
1H NMR (400 MHz; CDCl3) " 5.85!5.79 (1H, m, H-2), 5.43!5.38 (2H, m, H-7 & H-
8), 4.18!4.06 (2H, m, H-11), 3.77 (1H, dd, J 9.5, 7.0, H-10a), 3.71 (1H, dd, J 9.5, 7.0, 
H-10b), 2.78!2.70 (1H, m, H-9), 2.52 (1H, dd, J 14.0, 5.5, H-3a), 1.88 (1H, dd, J 
14.0, 8.5, H-3b), 1.06 (18H, s, CH(CH3)2), 1.05 (3H, s, CH(CH3)2), 0.99 (3H, s, H-5), 
0.98 (3H, s, H-6), 0.89 (9H, s, SiC(CH3)3), 0.04 (3H, s, SiCH3), 0.04 (3H, s, SiCH3); 
m/z (ESI): 475 [MNa+]; HRMS: calcd. for C26H52NaO2Si2, 475.3404. Found: [MNa+], 
475.3409 (2.1 ppm error). 
 
(±)-[(7R)-7-({[tert-Butyl(dimethyl)silyl]oxy}methyl)-4,4-dimethylcyclohepta-1,5-
dien-1-yl]methyl acetate (204) 
 
To a stirred solution of 190 (25 mg, 0.0850 mmol) in CH2Cl2 
(1 mL) at RT was added triethylamine (23 µL, 0.168 mmol), 
acetic anhydride (16 µL, 0.168 mmol) and DMAP (2 mg, 
0.0170 mmol). After 30 min the reaction was quenched by the 
addition of sat. NH4Cl (aq.) (2 mL). The organic layer was 
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separated and the aqueous layer extracted with further portions of CH2Cl2 (2 x 5 mL). 
The combined organic extracts were dried (MgSO4), filtered and concentrated under 
reduced pressure to afford the title compound 204 as a colourless oil (29 mg, 100%), 
which was assigned tentatively using 1H NMR spectroscopy and HRMS; Rf (4:1 pet. 
ether: Et2O) 0.77; 1H NMR (400 MHz; CDCl3) " 5.87!5.81 (1H, m, H-2), 5.46!5.41 
(1H, m, H-7), 5.38 (1H, dd, J 12.0, 6.0, H-8), 4.55!4.45 (2H, m, H-10), 3.77 (1H, dd, 
J 9.50, 7.5, H-11a), 3.71 (1H, dd, J 9.5, 7.0, H-11b), 3.14!3.06 (1H, m, H-9), 2.52 
(1H, dd, J 14.0, 6.5, H-3a), 2.06 (3H, s, OCOCH3), 1.88 (1H, ddd, J 14.0, 9.0, 1.5, H-
3b), 1.00 (6H, s, H-5 & H-6), 0.88 (9H, s, SiC(CH3)3), 0.04 (3H, s, SiCH3), 0.04 (3H, 
s, SiCH3); m/z (ESI): 361 [MNa+]; HRMS: calcd. for C19H34NaO3Si, 361.2175. 
Found: [MNa+], 361.2179 (1.3 ppm error). 
 
(3aR,8aS)-6,6-Dimethyl-3,3a,6,8a-tetrahydro-1H-cyclohepta[c]furan (209) & 
{[(1R,2S)-5,5-Dimethylcyclohepta-3,6-diene-1,2-
diyl]bis(methanediyloxy)}bis[tert-butyl(dimethyl)silane] (164)  
 
To a stirred solution of 163 (100 mg, 0.340 
mmol) in CH2Cl2 (3 mL) at RT was added 
triphenylphosphine (134 mg, 0.510 mmol), 
imidazole (35 mg, 0.510 mmol) and iodine (52 
mg, 0.408 mmol). After stirring for 50 min, 
Na2S2O3 (aq.) (5 mL) was added, the organic layer was separated and the aqueous 
layer extracted with portions of CH2Cl2 (2 x 10 mL). The resulting crude product was 
purified by flash column chromatography on silica gel, eluting with pet. ether:Et2O 
(30:1) to afford the title compound 164 as a colourless oil (31 mg, 22%) and 209 as a 
colourless oil (53 mg, 38%) 209 Rf (15:1 pet. ether:Et2O) 0.32; 1H NMR (400 MHz; 
CDCl3) " 5.49 (2H, d, J 12.0, H-4), 5.32 (2H, dd, J 12.0, 4.0, H-3), 3.93 (2H, dd, J 
7.5, 6.5, H-1a), 3.67 (2H, dd, J 7.5, 6.0, H-1b), 3.07!2.99 (2H, m, H-2), 1.20 (3H, s, 
H-6), 1.12 (3H, s, H-7); 13C NMR (101 MHz; CDCl3) # 140.9 (C-4), 125.4 (C-3), 
74.6 (C-1), 42.5 (C-2), 38.2 (C-5), 32.7 (C-6), 30.0 (C-7); m/z (ESI): 165 [MH+]; 
HRMS: calcd. for C11H17O, 165.1274. Found: [MH+], 165.1280 (3.5 ppm error). 
164 For data see page 142 
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(±)-[(1S,7R)-7-({[tert-Butyl(diphenyl)silyl]oxy}methyl)-4,4-dimethylcyclohepta-
2,5-dien-1-yl]methanol (210) 
 
To a solution of 162 (200 mg, 1.10 mmol) in THF (3 mL) 
was added NaH (53 mg, 1.32 mmol, 60% dispersion in 
mineral oil) at 0 °C and the reaction mixture stirred for 45 
mins before the addition of TBDPSCl (285 µL, 1.10 mmol). 
After 45 mins the reaction was quenched with K2CO3 (aq.) (10 mL) followed by Et2O 
(20 mL). The organic layer was separated and the aqueous layer extracted with further 
portions of Et2O (2 ) 20 mL). The combined organic extracts were dried (MgSO4), 
filtered and concentrated under reduced pressure. The resulting crude product was 
purified by flash column chromatography on silica gel, eluting with pet. ether:EtOAc 
(40:1 & 1:1) to afford the title compound 210 as a colourless oil (440 mg, 95%); Rf 
(4:1 pet. ether:Et2O) 0.32; *max (thin film)/cm-1 3301, 3024, 3003, 2964, 2913, 2887, 
2815; 1H NMR (400 MHz; CDCl3) # 7.70"7.64 (4H, m, Ar-H), 7.48"7.35 (6H, m, 
Ar-H), 5.61 (1H, dd, J 11.5, 6.0, H-2 or H-8), 5.44 (1H, d, J 11.5, H-3 or H-7), 5.35 
(1H, dd, J 12.0, 6.0, H-2 or H-8), 5.30 (1H, d, J 12.0, H-3 or H-7), 3.77 (1H, dd, J 
10.5, 8.5, H-10a or H-11a), 3.74 (1H, dd, J 11.5, 6.5, H-10a or H-11a), 3.68 (1H, dd, J 
11.5, 4.5, H-10b or H-11b), 3.55 (1H, dd, J 10.5, 4.0, H-10b or H-11b), 2.93"2.84 
(1H, m, H-1 or H-9), 2.77"2.70 (1H, m, H-1 or H-9), 1.11 (3H, s, H-5), 1.07 (9H, s, 
SiC(CH3)3), 1.03 (3H, s, H-6); 13C NMR (101 MHz; CDCl3) # 139.9 (C-8 or C-2), 
139.9 (C-7 or C-3), 135.8 (Ar-CH), 135.7 (Ar-CH), 134.9 (C-8 or C-2), 133.0 (Ar-C), 
132.9 (Ar-C), 130.0 (Ar-CH), 130.0 (Ar-CH), 129.8 (C-7 or C-3), 127.9 (Ar-CH), 
127.9 (Ar-CH), 66.0 (C-11 or C-10), 65.0 (C-11 or C-10), 43.1 (C-9 or C-1), 39.7 (C-
4), 32.9 (C-5), 29.7 (C-6), 27.0 (SiC(CH3)3), 26.7 (C-9 or C-1), 19.3 (SiC(CH3)3). m/z 
(ESI): 443 [MNa+]; HRMS: calcd. for C27H36NaO2Si, 443.2377. Found: [MNa+], 
443.2357 (4.4 ppm error). 
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(±)-[(1S,7R)-7-({[tert-Butyl(diphenyl)silyl]oxy}methyl)-4,4-dimethylcyclohepta-
2,5-dien-1-yl]methyl methanesulfonate (212) 
 
To a stirred solution of 210 (50 mg, 0.119 mmol) in 
CH2Cl2 (2 mL) at RT was added triethylamine (50 µL, 
0.357 mmol) and MsCl (14 µL, 0.179 mmol). After 1.5 h 
the reaction was quenched by the addition of sat. NH4Cl 
(aq.) (5 mL). The organic layer was separated and the 
aqueous layer extracted with further portions of CH2Cl2 (2 ) 10 mL). The combined 
organic extracts were dried (MgSO4), filtered and concentrated under reduced pressure. 
The resulting crude product was purified by flash column chromatography on silica 
gel, eluting with pet. ether:Et2O (4:1) to afford the title compound 212 as a colourless 
oil (49 mg, 83%); Rf (4:1 pet. ether:Et2O) 0.29; *max (thin film)/cm-1 2967, 2914, 2887, 
2850, 2815; 1H NMR (400 MHz; CDCl3) " 7.69"7.63 (4H, m, Ar-H), 7.46"7.35 
(6H, m, Ar-H), 5.52 (1H, dd, J 12.0, 5.5, H-2 or H-8), 5.46 (1H, d, J 12.0, H-3 or H-
7), 5.37 (1H, d, J 12.0, H-3 or H-7), 5.31 (1H, dd, J 12.0, 5.5, H-2 or H-8), 4.38"4.31 
(2H, m, H-11), 3.71 (1H, dd, J 10.5, 9.0, H-10a), 3.60 (1H, dd, J 10.5, 5.5, H-10b), 
3.16"3.08 (1H, m, H-1), 2.89 (3H, s, SO2CH3), 2.87"2.79 (1H, m, H-9), 1.13 (3H, s, 
H-5), 1.07 (3H, s, H-6), 1.06 (9H, s, SiC(CH3)3); 13C NMR (101 MHz; CDCl3) # 
140.8 (C-8 or C-2), 140.2 (C-7 or C-3), 135.7 (Ar-CH), 135.7 (Ar-CH), 135.3 (C-8 or 
C-2), 134.9 (C-7 or C-3), 133.5 (Ar-C), 133.5 (Ar-C), 129.9 (Ar-CH), 129.8 (Ar-CH), 
127.9 (Ar-CH), 127.9 (Ar-CH), 72.6 (C-11), 65.1 (C-10), 42.3 (C-1), 40.0 (C-4), 37.3 
(SO2CH3), 32.6 (C-5), 29.6 (C-6), 27.0 (SiC(CH3)3), 26.7 (C-9), 19.3 (SiC(CH3)3). 
m/z (ESI): 521 [MNa+]; HRMS: calcd. for C28H38NaO4SSi, 521.2152. Found: 
[MNa+], 521.2153 (0.1 ppm error). 
 
(±)-[(1R,7S)-7-{[(4-Methoxybenzyl)oxy]methyl}-4,4-dimethylcyclohepta-2,5-dien-
1-yl]methanol (216) 
 
To a stirred solution of 162 (200 mg, 1.10 mmol) in THF (10 
mL) was added NaH (53 mg, 1.32 mmol, 60% dispersion in 
mineral oil) at 0 °C After 30 min PMBCl (149 µL, 1.10 mmol) 
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was added and the reaction mixture was warmed to RT. After 2h the reaction was 
quenched with sat. NH4Cl (aq.) (10 mL) followed by Et2O (20 mL). The organic layer 
was separated and the aqueous layer extracted with further portions of Et2O (2 ) 20 
mL). The combined organic extracts were dried (MgSO4), filtered and concentrated 
under reduced pressure. The resulting crude product was purified by flash column 
chromatography on silica gel, eluting with pet. ether:Et2O (3:1 & 2:1) to afford the 
title compound 216 as a colourless oil (123 mg, 41%); Rf (2:1 pet. ether:Et2O) 0.34; 
*max (thin film)/cm-1 3349, 2959, 2912, 2858, 2822; 1H NMR (400 MHz; CDCl3) " 
7.25 (2H, d, J 9.0, Ar-H), 6.88 (2H, d, J 9.0, Ar-H), 5.88!5.48 (2H, m, H-2 & H-8), 
5.44!5.35 (2H, m, H-3 & H-7), 4.46 (2H, s, C6H4CH2), 3.80 (3H, s, C6H4OCH3), 3.64 
(1H, dd, J 11.5, 7.0, H-10a or H-11a), 3.58 (1H, dd, J 9.5, 8.0, H-10a or H-11a), 3.54 
(1H, dd, J 11.5, 4.0, H-10b or H-11b), 3.39 (1H, dd, J 9.5, 3.5, H-10b or H-11b), 
2.87!2.76 (2H, m, H-1 & H-9), 1.13 (3H, s, H-5), 1.07 (3H, s, H-6); 13C NMR (101 
MHz; CDCl3) # 159.5 (Ar-C), 139.9 (C-3 or C-7), 139.7 (C-3 or C-7), 129.7 (Ar-
CH), 129.5 (Ar-C), 126.3 (C-2 or C-8), 126.2 (C-2 or C-8), 114.0 (Ar-CH), 73.2 
(C6H4CH2), 71.1 (C-10 or C-11), 64.5 (C-10 or C-11), 55.5 (C6H4OCH3), 43.7 (C-1 or 
C-9), 41.6 (C-1 or C-9), 39.8 (C-4), 32.9 (C-5), 29.7 (C-6); m/z (ESI): 325 [MNa+]; 
HRMS: calcd. for C19H26NaO3, 325.1774. Found: [MNa+], 325.1770 (1.1 ppm error). 
 
(±)-(1S,7R)-7-({[tert-Butyl(diphenyl)silyl]oxy}methyl)-4,4-dimethylcyclohepta-
2,5-diene-1-carbaldehyde (217) 
 
To a stirred solution of 210 (99 mg, 0.235 mmol) in CH2Cl2 
(5 mL), at 0 °C was added Dess"Martin periodinane (199 
mg, 0.470 mmol). The reaction mixture was warmed to RT 
and allowed to stir for 1 h. It was then diluted with CH2Cl2 
(15 mL), and quenched with a 1: 1 solution of sat. Na2CO3 (aq.) and sat. Na2S2O3 (aq.) 
(30 mL). After vigorous stirring for 30 mins, the organic layer was separated and the 
aqueous layer extracted with further portions of CH2Cl2 (2 ) 30 mL). The combined 
organic extracts were dried (MgSO4), filtered and concentrated under reduced pressure 
to afford the title compound 217 as a colourless oil (78 mg, 80%) which was assigned 
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tentatively using 1H NMR spectroscopy; Rf (2:1 pet. ether:Et2O) 0.48; 1H NMR 
(400 MHz; CDCl3) " 9.76 (1H, s, H-11), 7.69!7.61 (4H, m, Ar-H), 7.47!7.35 (6H, 
m, Ar-H), 5.94 (1H, dd, J 11.5, 5.0, H-2 or H-8), 5.60 (1H, d, J 11.5, H-3 or H-7), 
5.50 (1H, dd, J 12.0, 6.5, H-2 or H-8), 5.37 (1H, d, J 12.0, H-3 or H-7), 3.62 (1H, dd, 
J 9.5, 9.5, H-10a), 3.52 (1H, dd, J 9.5, 4.5, H-10b), 3.43"3.39 (1H, m, H-1 or H-9), 
3.20"3.13 (1H, m, H-1 or H-9), 1.13 (3H, s, H-5), 1.08 (3H, s, H-6) 1.01 (9H, s, 
SiC(CH3)3). 
 
(±)-(E)-3-((1S,3R)-3-((tert-Butyldimethylsilyloxy)methyl)-2,2-
dimethylcyclopropyl)prop-2-en-1-ol (221) 
 
To a stirred solution of 133 (1.00 g, 3.20 mmol) in 
CH2Cl2 (30 mL) at "78 °C was added DIBAL (12.8 
mL, 12.8 mmol, 1M in hexanes). After 10 mins the 
reaction was warmed to RT and after 30 min the 
reaction mixture was diluted with CH2Cl2 (50 mL) followed by the careful addition of 
sat. aq. Rochelle’s salt (30 mL). The mixture was stirred for 2 h after which time, the 
organic layer was separated and the aqueous layer extracted with further portions of 
CH2Cl2 (2 ) 100 mL). The combined organic extracts were dried (MgSO4), filtered and 
concentrated under reduced pressure to afford the crude compound, which was 
purified by flash column chromatography on silica gel, eluting with pet. ether:EtOAc 
(10:1) to afford the title compound 221 as a colourless oil (710 mg, 82%); Rf (10:1 
pet. ether:EtOAc) 0.24; *max (thin film)/cm-1 3346, 2929, 2858; 1H NMR (400 MHz; 
CDCl3) " 5.83!5.74 (1H, m, H-2), 5.49!5.41 (1H, m, H-3), 4.08 (2H, d, J 6.0, H-1), 
3.70!3.66 (2H, m, H-9), 1.37 (1H, t, J 9.5, H-4), 1.10 (3H, s, H-6), 1.08-1.01 (1H, m, 
H-8), 1.06 (3H, s, H-7), 0.88 (9H, s, SiC(CH3)3), 0.04 (6H, s, SiCH3); 13C NMR (101 
MHz; CDCl3) # 131.5 (C-3), 130.2 (C-2), 64.1 (C-1), 60.5 (C-9), 32.3 (C-6), 30.0 (C-
4 or C-8), 28.9 (C-4 or C-8), 26.1 (SiC(CH3)3), 21.7 (C-5), 18.4 (SiC(CH3)3), 15.6 (C-
7), "5.0 (SiCH3), "5.0 (SiCH3); m/z (ESI): 293 [MNa+]; HRMS: calcd. for 
C15H30NaO2Si, 293.1907. Found: [MH+], 293.1900 (2.6 ppm error). 
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(±)-(E)-3-((1S,3R)-3-((tert-Butyldimethylsilyloxy)methyl)-2,2-
dimethylcyclopropyl)allyl ethyl carbonate (223) 
 
To a solution of alcohol 221 (420 mg, 1.55 mmol) 
in CH2Cl2 (30 mL) at 0 °C was added DMAP (38 
mg, 0.31 mmol) and pyridine (499 µL, 6.2 mmol). 
This was stirred at 0 °C for 10 min before the 
addition of ethylchloroformate (505 mg, 4.65 mmol). The reaction was warmed to RT 
and after 30 min was quenched with a solution of sat. NH4CL (aq.) (30 mL). The 
organic layer was separated and the aqueous layer extracted with further portions of 
CH2Cl2 (2 ) 50 mL). The combined organic extracts were dried (MgSO4), filtered and 
concentrated under reduced pressure to afford the title compound 223 as a colourless 
oil which was used in the next step without further purification; Rf (30:1 pet. 
ether:EtOAc) 0.31; *max (thin film)/cm-1 2954, 2930, 2858, 1745; 1H NMR (400 
MHz; CDCl3) " 5.73 (1H, dt, J 15.0, 6.5,  H-8), 5.56 (1H, dd, J 15.0, 10.0, H-7), 4.58 
(1H, dd, J 13.5, 6.5, H-9a), 4.55 (1H, dd, J 13.5, 6.5, H-9b), 4.18 (2H, q, J 7.0, 
CH3CH2O), 3.68 (1H, d, J 7.5 H-1a), 3.67 (1H, d, J 7.5 H-1b), 1.30 (3H, t, J 7.0, 
CH3CH2O), 1.11"1.08 (2H, m, H-2 & H-6),  1.10 (3H, s, H-5), 1.07 (3H, s, H-4), 
0.88 (9H, s, SiC(CH3)3), 0.04 (6H, s, SiCH3); 13C NMR (101 MHz; CDCl3) # 155.2 
(C=O), 134.3 (C-2), 124.3 (C-7), 68.7 (C-1), 64.0 (C-9), 60.4 (CH3CH2O), 32.7 (C-
4), 30.1 (C-6 or C-2), 28.9 (C-6 or C-2), 26.1 (SiC(CH3)3),  22.1 (C-3), 18.4 
(SiC(CH3)3), 15.7 (C-5), 14.4 (CH3CH2O), "5.0 (SiCH3), "5.0 (SiCH3); m/z (ESI): 
365 [MNa+]; HRMS: calcd. for C18H34NaO4Si, 365.2119. Found: [MNa+], 365.2108 
(2.1 ppm error). 
 
(±)-(E)-tert-Butyl 5-((1S,3R)-3-((tert-butyldimethylsilyloxy)methyl)-2,2-
dimethylcyclopropyl)-2-ethanoylpent-4-enoate (224) 
 
To a solution of carbonate 223 (1.55 mmol) in 
degassed THF at 0 °C was added tert-butyl 3-
oxobutanoate (308 µL, 1.86 mmol) and 
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tetrakis(triphenylphosphine)palladium(0) (179 mg, 0.155 mmol). This reaction 
mixture was warmed to 45 °C and stirred for 1h. It was then concentrated under 
reduced pressure and the resulting crude product was purified by flash column 
chromatography on silica gel, eluting with pet. ether:EtOAc (30:1) to afford the title 
compound 224 as a colourless oil (584 mg, 92%) as a mixture of diastereomers in a 
ratio of ~ 1:1; Rf (30:1 pet. ether:EtOAc) 0.19; *max (thin film)/cm-1 2954, 2930, 2858, 
1745, 1716; 1H NMR (400 MHz; CDCl3) " 5.50!5.40 (1H, m,  H-8), 5.29!5.21 (1H, 
m, H-7), 3.70!3.57 (2H, m, H-1), 3.38!3.32 (1H, m, H-10), 2.53"2.47 (2H, m, H-9), 
2.20 (3H, s, H-12), 1.45 (9H, s, C(CH3)3), 1.28 (1H, dt, J 9.0, 1.5, H-2), 1.06 (3H, s, 
H-5), 1.02 (3H, s, H-4), 1.00"0.96 (1H, m, H-6), 0.88 (9H, s, SiC(CH3)3), 0.04 (6H, s, 
SiCH3); 13C NMR (101 MHz; CDCl3) # 203.3, and 203.3 (CH3C=O), 168.7, and 
168.7 ((CH3)3COC=O), 129.6, and 129.6 (C-8), 127.1, and 127.0 (C-7), 82.0, and 82.0 
(C(CH3)3), 61.2, and 61.1 (C-10), 60.6, and 60.6 (C-1), 31.9, and 31.9 (C-5), 31.8, and 
31.7 (C-9), 30.1, and 30.0 (C-6 or C-2), 29.2, and 29.1 (C-6 or C-2), 28.1, and 28.1 
(C(CH3)3), 26.1, and 26.1 (SiC(CH3)3), 21.2, and 21.2 (C-3), 18.4, and 18.4 
(SiC(CH3)3), 15.7, and 15.7 (C-4), "4.9, and "4.9 (SiCH3), "5.0, and "5.0 (SiCH3); 
m/z (ESI): 433 [MNa+]; HRMS: calcd. for C23H42NaO4Si, 433.2745. Found: [MNa+], 
433.2733 (2.9 ppm error). 
 
(±)-(E)-tert-Butyl 2-ethanoyl-5-((1S,3R)-3-(hydroxymethyl)-2,2-
dimethylcyclopropyl)pent-4-enoate (225) 
 
To a solution of 224 (167 mg, 0.421 mmol) in THF 
(4 mL) at 0 °C was added TBAF (505 µL, 1 M in 
THF, 0.505 mmol). After 2 h the reaction mixture 
was diluted with Et2O (5 mL) and washed with sat. NH4Cl (aq.) (5 mL), the organic 
layer separated and the aqueous layer extracted with further portions of Et2O (2 ) 10 
mL). The combined organic extracts were dried (MgSO4), filtered and concentrated 
under reduced pressure. The resulting crude product was purified by flash column 
chromatography on silica gel, eluting with pet. ether:EtOAc (1:1) to afford the title 
compound 225 as a colourless oil (86 mg, 72%) as a mixture of diastereomers and 
OHtBuO2C
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enol/keto tautomers; Rf (1:1 pet. ether:Et2O) 0.24; *max (thin film)/cm-1 3444, 2980, 
1714; 1H NMR (400 MHz; CDCl3) "  5.58!5.24 (2H, m,  H-8 & H-7), 3.77!3.47 
(2H, m, H-1), 3.41!3.35 (1H, m, H-10), 2.81!2.47 (2H, m, H-9), 2.22, 2.21, 2.20 
(3H, s, H-12), 1.47, 1.44 (9H, s, C(CH3)3), 1.12-1.02 (2H, m, H-6 & H-2), 1.08 (3H, 
s, H-5), 1.06 (3H, s, H-4); m/z (ESI): 319 [MNa+]; HRMS: calcd. for C17H28NaO4, 
319.1180. Found: [MNa+], 319.1868 (3.7 ppm error). Note that the compound exists 
as a mixture of diastereoisomers and enol/keto tautomers, therefore assignment of the 
13C NMR spectrum was complex and could not be assigned with confidence. 
 
(±)-(4E)-tert-Butyl 2-ethanoyl-5-((1S,3R)-3-(3-ethoxy-3-oxoprop-1-enyl)-2,2-
dimethylcyclopropyl)pent-4-enoate (226) 
 
To a stirred solution of 225 (58 mg, 0.198 
mmol) in CH2Cl2 (2 mL), at 0 °C was added 
Dess-Martin periodinane (126 mg, 0.297 
mmol). The reaction mixture was warmed to RT and allowed to stir overnight. It was 
then diluted with CH2Cl2 (5 mL), and quenched with a 1:1 solution of sat. Na2CO3 
(aq.) and sat. Na2S2O3 (aq.) (3 mL). After vigorous stirring for 30 mins, the organic 
layer was separated and the aqueous layer extracted with further portions of CH2Cl2 
(2 ) 10 mL). The combined organic extracts were dried (MgSO4), filtered and 
concentrated under reduced pressure to afford aldehyde 227. This was dissolved in 
CHCl3 (5 mL) and (carbethoxymethylene) triphenyl phosphorane (83 mg, 0.238 
mmol) was added. After 16 h the solution was concentrated under reduced pressure 
and the crude product purified by flash column chromatography on silica gel, eluting 
with pet. ether:EtOAc (5:1) to afford the title compound 226 as a colourless oil (52 
mg, 72%) as a mixture of diastereomers and enol/keto tautomers; Rf (5:1 pet. 
ether:EtOAc) 0.29; *max (thin film)/cm-1 2980, 2954, 2930, 1714; 1H NMR (400 
MHz; CDCl3) " 6.83"6.61 (1H, m, olefinic CH), 6.04"5.77 (1H, m, olefinic CH), 
5.58"5.21 (2H, m, olefinic CH), 4.25"4.12 (2H, m, CH3CH2O), 3.42"3.30 (1H, m, H-
11), 2.94"2.43 (2H, m, H-10), 2.23"2.18 (3H, m, H-13), 1.80"1.40 (2H, m, H-3 & H-
7), 1.48"1.41 (9H, m, C(CH3)3), 1.30"1.25 (3H, m, , CH3CH2O), 1.17"1.09 (6H, m, 
tBuO2C
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H-5 &H-6); m/z (ESI): 387 [MNa+]; HRMS: calcd. for C21H32NaO5, 387.2142. 
Found: [MNa+], 387.2413 (0.1 ppm error). Note that the compound exists as a 
mixture of diastereoisomers, E/Z isomers and enol/keto tautomers, therefore 
assignment of the 13C NMR spectrum was complex and could not be assigned with 
confidence. 
 
(±)-(1S,2Z,5Z,7R)-Ethyl 4,4-dimethyl-7-(3-oxobutyl)cyclohepta-2,5-
dienecarboxylate (220) 
 
A stirred solution of 226 (1.00 g, 2.74 mmol) in toluene (100 
mL) was heated to 100 °C for 16 h. After being cooled to RT 
the solution was concentrated under reduced pressure. The 
resulting light yellow oil was dissolved in CH2Cl2 (50 mL) and 
stirred. TFA (2.8 mL) was then added and the reaction 
mixture was refluxed for a further 16 h before concentrating under reduced pressure. 
The resulting crude product was purified by flash column chromatography on silica 
gel, eluting with pet. ether:EtOAc (20:1) to afford the title compound 220 as a 
colourless oil (369 mg, 51%); Rf (20:1 pet. ether:EtOAc) 0.18; *max (thin film)/cm-1 
2954, 2930, 2858, 1745; 1H NMR (400 MHz; CDCl3) " 5.83 (1H, dd, J 11.5, 6.0, H-
2), 5.56 (1H, dd, J 12.0, 7.0, H-8), 5.50 (1H, dt, 11.5, 2.0, H-3), 5.33 (1H, d, 12.0, H-
7), 4.15 (2H, q, J 7.0, CH3CH2O), 3.67"3.58 (1H, m, H-1), 2.76"2.65 (1H, m, H-9), 
2.53"2.35 (2H, m, H-11), 2.11 (3H, s, H-13), 1.79-1.63 (2H, m, H-10), 1.26 (3H, t, J 
7.0, CH3CH2O), 1.13 (3H, s, H-5), 1.10 (3H, s, H-6); 13C NMR (101 MHz; CDCl3) # 
208.9 (C=O), 173.2 (CH3CH2OC=O), 139.9 (C-3), 139.2 (C-7), 128.7 (C-8), 123.2 
(C-2), 60.9 (CH3CH2O), 47.4 (C-1), 41.9 (C-11), 39.4 (C-4), 39.1 (C-9), 32.5 (C-5), 
29.9 (C-13), 29.5 (C-6), 27.0 (C-10), 14.4 (CH3CH2O); m/z (ESI): 287 [MNa+]; 
HRMS: calcd. for C16H24NaO3, 287.1618. Found: [MNa+], 287.1610 (2.0 ppm error). 
 
 
 
 
 
CO2Et
O 1
2
3
4 56
7
8
9
1011
12
13
 161 
(±)-(R,1E,5Z)-Ethyl 4,4-dimethyl-7-(3-oxobutyl)cyclohepta-1,5-dienecarboxylate 
(229) 
 
To a stirred solution of 220 (200 mg, 0.757 mmol) in degassed 
THF (8 mL) at 0 °C was added DBU (113 µL, 0.757 mmol). 
The reaction was heated to 60 °C and held at this temperature 
for 16 h. The reaction was then cooled to RT and the reaction 
mixture concentrated under reduced pressure. The resulting 
crude product was purified by flash column chromatography on silica gel, eluting with 
pet. ether:EtOAc (10:1) to afford the title compound 229 as a colourless oil (181 mg, 
91%) which was assigned tentatively using 1H NMR spectroscopy; Rf (10:1 pet. 
ether:EtOAc) 0.38; 1H NMR (400 MHz; CDCl3) " 7.13 (1H, dd, J 9.5, 6.0, H-2), 
5.43!5.36 (2H, m, H-8 & H-7), 4.21!4.15 (2H, m, CH3CH2O), 3.45"3.38 (1H, m, H-
9), 2.56"2.38 (2H, m, H-11), 2.13 (3H, s, H-13), 1.92"1.83 (2H, m, H-3), 1.29 (3H, t, 
J 7.0, CH3CH2O), 1.16"1.10 (2H, m, H-10), 1.05 (3H, s, H-6), 0.98 (3H, s, H-5). 
 
4-((R,2E,6Z)-2-(Hydroxymethyl)-5,5-dimethylcyclohepta-2,6-dienyl)butan-2-ol 
(232) 
 
To a stirred solution of 229 (84 mg, 0.318 mmol) in CH2Cl2 
(3 mL) at "78 °C was added DIBAL (1.27 mL, 1.27 mmol, 
1M in hexanes). After 1 h the reaction mixture was diluted 
with CH2Cl2 (5 mL) followed by the careful addition of 
MeOH (5 drops). The solution was warmed to RT and sat. 
aq. Rochelle’s salt (5 mL) was added. It was stirred for 2 h after which time, the 
organic layer was separated and the aqueous layer extracted with further portions of 
CH2Cl2 (3 ) 10 mL). The combined organic extracts were dried (MgSO4), filtered and 
concentrated under reduced pressure to afford the crude compound. The major 
diastereomer was isolated by flash column chromatography on silica gel, eluting with 
pet. ether:EtOAc (1:1) to afford the title compound 232 as a colourless oil (27 mg, 
38%). which was assigned tentatively using 1H NMR spectroscopy; Rf (1:1 pet. 
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ether:EtOAc) 0.18; 1H NMR (400 MHz; CDCl3) " 5.75 (1H, dd, J 8.5, 6.5, H-2), 
5.43 (1H, ddd, J 12.0, 6.5, 2.5, H-8), 5.33 (1H, d, J 12.0, H-7), 4.02!3.98 (2H, m, H-
14), 3.85!3.74 (1H, m, H-12), 2.74!2.65 (1H, m, H-9), 2.56!2.50 (1H, m, H-3a), 
1.95!1.84 (1H, m, H-3b), 1.82!1.43 (4H, m, H-10 & H-11), 1.20 (3H, d, J 6.0, H-13), 
1.00 (3H, s, H-5), 0.98 (3H, s, H-6). 
 
Cyclohex-2-enylmethanol (236)88 
 
n-BuLi (1.6 M in hexanes, 200 mL, 320 mmol) was added to a 
suspension of KOtBu (33.9 g, 302 mmol) in cyclohexene (270 mL, 2.7 
mol). The reaction mixture was kept below 15 °C for a period of 2 h, 
and then allowed to warm to RT over 16 h. The resultant suspension 
was cooled to 0 °C and (CH2O)n (9.98 g, 332 mmol) was added carefully. The 
reaction mixture was heated to 60 °C for 3 h, then cooled to 0 °C and quenched with 
sat. aq. NaHCO3 (200 mL). The mixture was extracted with CH2Cl2 (3 ) 200 mL). 
The combined organic extracts were washed sequentially with sat. aq. NaHCO3 (200 
mL) and brine (200 mL), dried and concentrated in vacuo. The resulting crude 
product was purified by flash column chromatography on silica gel, eluting with pet. 
ether:Et2O (1:1) to afford the title compound 236 as a pale yellow oil (25.5 g, 75%); 
Rf (1:1 pet. ether:Et2O) 0.19; 1H NMR (400 MHz; CDCl3) " 5.77"5.70 (1H, m, 
olefinic CH), 5.57"5.48 (1H, m, olefinic CH), 3.40 (2H, d, J 6.5, H-7), 2.25"2.17 
(1H, m, H-4), 1.92"1.86 (2H, m, CH2), 1.75"1.63 (2H, m, CH2), 1.53"1.47 (1H, m, 
CHa), 1.33"1.25 (1H, m, CHb). Data in agreement with those reported in the 
literature.88 
 
3-(Iodomethyl)cyclohex-1-ene (237)89 
 
To a stirred solution of cyclohex-2-enylmethanol 236 (20 g, 178 mmol) 
in CH2Cl2 (500 mL) at RT was added triphenylphosphine (69.8 g, 267 
mmol), imidazole (18.1 g, 267 mmol) and iodine (27.1 g, 214 mmol). 
After stirring for 50 mins Na2S2O3 (aq.) (250 mL) was added, the 
organic layer was separated and the aqueous layer extracted with further EtOAc (2 ) 
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300 mL). The resulting crude product was purified by flash column chromatography 
on silica gel, eluting with pet. ether:EtOAc (30:1) to afford the title compound 237 as 
a colourless oil (22.9 g, 58%); Rf (1:1 pet. ether:EtOAc) 0.81; 1H NMR (400 MHz; 
CDCl3) " 5.82"5.77 (1H, m, olefinic CH), 5.59"5.54 (1H, m, olefinic CH), 3.21"3.10 
(2H, m, H-7), 2.40"2.29 (1H, m, H-4), 2.00"1.83 (2H, m, CH2), 1.76"1.69 (2H, m, 
CH2), 1.61"1.50 (1H, m, CHa), 1.44"1.33 (1H, m, CHb); Data in agreement with 
those reported in the literature.89  
 
tert-Butyl 2-(cyclohex-2-enylmethyl)-3-oxobutanoate (238) 
 
To a stirring suspension of NaH (1.00 g, 26.9 mmol) in THF (135 
mL) at 0 °C was added t-butyl 3-oxobutanoate (3.62 mL, 22.5 
mmol). 237 (5 g, 22.5 mmol) in THF (135 mL) was added to the 
reaction mixture over 20 minutes before warming to RT over 1 h 
and heating for 16 h at 70 °C. The reaction was diluted with Et2O 
(500 mL), quenched with sat. NH4Cl (aq.) (300 mL) and the organic layer separated. 
The aqueous layer was extracted with further portions of Et2O (2 ) 200 mL). The 
combined organic extracts were dried (MgSO4), filtered and concentrated under 
reduced pressure. The resulting crude product was purified by flash column 
chromatography on silica gel, eluting with pet. ether:EtOAc (40:1) to afford the title 
compound 238 as a colourless oil and inseperable mixture of 2 diastereomers 238a & 
238b in a ratio ~ 1:1 (3.86 mg, 68%); Rf (20:1 pet. ether:EtOAc) 0.30; *max (thin 
film)/cm-1 2968, 2932, 2884, 1712, 1689; 1H NMR (400 MHz; CDCl3) " 5.76!5.66 
(1H, m, H-6A+B), 5.58!5.48 (1H, m, H-5A+B), 3.50!3.41 (1H, m, H-8A+B), 2.22 (3H, s, 
H-10A), 2.22 (3H, s, H-10B), 2.08"2.00 (1H, m, H-4A+B), 1.99"1.93 (2H, m, CH2A+B), 
1.93"1.67 (4H, m, 2 ) CH2A+B), 1.46 (9H, s, C(CH3)3A), 1.46 (9H, s, C(CH3)3B), 
1.30"1.13 (2H, m, CH2A+B); 13C NMR (101 MHz; CDCl3) # 203.8 (C=OA), 203.8 
(C=OB), 169.3 (t-BuOC=OA), 169.3 (t-BuOC=OB), 130.7 (C-5A), 130.3 (C-5B), 128.2 
(C-6A), 128.1 (C-6B), 82.0 (C(CH3)3A), 82.0 (C(CH3)3B) 58.7 (C-8A), 58.7 (C-8B), 34.4 
(C-7A), 34.4 (C-7B), 33.1 (C-4A), 33.1 (C-4B), 29.0 (CH2A), 28.7 (CH2B), 28.0 
(C(CH3)3A), 28.0 (C(CH3)3B), 25.4 (CH2A), 25.3 (CH2B), 21.2 (CH2A), 21.2 (CH2B); 
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m/z (ESI): 275 [MNa+]; HRMS (ESI): calcd. for C15H24NaO3, 275.1618 Found: 
[MNa+], 275.1606 (3.5 ppm error). 
 
4-(Cyclohex-2enyl)butan-2-one (239) 
 
To a stirred solution of 238 (1.00 g, 3.96 mmol) in benzene (1.5 
mL) was added p-TSA (160 mg, 0.802 mmol). This was refluxed for 
2.5h before the addition of sat. NaHCO3 (aq.) (50 mL) and Et2O (50 
mL). The organic layer was separated and the aqueous layer 
extracted with further portions of Et2O (2 ) 50 mL). The combined organic extracts 
were dried (MgSO4), filtered and concentrated under reduced pressure to afford the 
title compound 239 as a colourless oil (518 mg, 86%); Rf (20:1 pet. ether:Et2O) 0.28; 
*max (thin film)/cm-1 2971, 2884, 2817, 1759, 1670; 1H NMR (400 MHz; CDCl3) " 
5.72!5.66 (1H, m, H-6), 5.52 (1H, dd, J 10.0, 2.0, H-5), 2.47 (2H, t, J 8.0, H-8) 2.15 
(3H, s, H-10), 2.10"2.02 (1H, m, H-4), 2.00"1.92 (2H, m, CH2), 1.83"1.46 (4H, m, 2 
) CH2), 1.30"1.14 (2H, m, CH2); 13C NMR (101 MHz; CDCl3) # 208.9 (C-9), 131.1 
(C-5), 127.7 (C-6), 41.2 (C-8), 34.7 (C-4), 30.1 (C-10), 30.0 (CH2), 28.8 (CH2), 25.4 
(CH2), 21.4 (CH2); m/z (ESI): 175 [MNa+]; HRMS: calcd. for C10H16NaO2, 175.1093 
Found: [MNa+], 175.1094 (1.6 ppm error). 
 
Samarium diiodide solution in THF (0.1 M) 
 
To an oven dried RBF, equipped with a Teflon-coated magnetic stir bar, was added 
samarium metal (1.65 g, 11.0 mmol). This was left stirring at medium to high speed 
under a positive pressure of argon for 24 h. THF (45 mL) was added, followed by 
iodine (1.40 g, 5.5 mmol) dissolved in THF (10 mL). The reaction flask was heated at 
60 °C for 18 h. The stirring was turned off and the solution of SmI2 (0.1 M) was 
allowed to settle for 2 h. 
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tert-Butyl 1-hydroxy-1-methyloctahydro-1H-indene-2-carboxylate (241) 
 
To a solution of ester 238 (42 mg, 0.166 mmol), t-BuOH (32 µL, 
0.332 mmol), HMPA (1.01 mL, 5.81 mmol) in THF (37 mL) at 
"78 °C, was added SmI2 (4.9 mL, 0.1 M in THF, 0.498 mmol) 
dropwise. The reaction was stirred for 10 minutes before the 
addition of sat. aq. NaHCO3 (50 mL). The mixture was extracted 
with EtOAc (3 ) 25 mL). The combined organic extracts were dried (MgSO4) and 
concentrated in vacuo. The resulting crude product was purified by flash column 
chromatography on silica gel, eluting with pet. ether:EtOAc (10:1) to afford the title 
compound 241 as two isolated diastereomers 241a and 241b in a ratio of 1:0.8 (10 
mg, 24%) and (8mg, 19%); 241a; 1H NMR (400 MHz; CDCl3) " 2.7 (1H, t, J 9.0, H-
6), 2.52!2.37 (1H, m, H-8) 2.16!2.04 (1H, m, H-4), 2.00!1.90 (1H, br s, OH), 
1.86!1.76 (1H, m, CH2) 1.75!1.55 (5H, m, CH2), 1.46 (9H, s, C(CH3)3), 1.52!1.33 
(2H, m, CH2), 1.25 (3H, s, H-10), 1.19!1.06 (2H, m, CH2); 13C NMR (101 MHz; 
CDCl3) # 173.9 (C=O), 84.1 (C(CH3)3), 80.7 (C-7), 57.5 (C-6), 51.6 (C-8), 35.3 (C-4), 
30.6 (CH2), 28.3 (C(CH3)3), 26.9 (CH2), 25.1 (CH2), 22.7 (CH2), 22.3 (C-10), 20.9 
(CH2); m/z (ESI): 277 [MNa+]; HRMS: calcd. for C15H26NaO3, 277.1774 Found: 
[MNa+], 277.1772 (0.6 ppm error); 241b; 1H NMR (400 MHz; CDCl3) " 3.39 (1H, 
s, OH), 2.77 (1H, dd, J 11.5, 6.5, H-6), 2.04!2.1.76 (4H, m, H-8 & H-4 & CH2), 
1.71!1.56 (6H, m, CH2), 1.47 (9H, s, C(CH3)3), 1.29 (3H, s, H-10), 1.28!0.70 (2H, m, 
CH2); 13C NMR (101 MHz; CDCl3) # 175.1 (C=O), 83.1 (C(CH3)3), 81.2 (C-7), 58.6 
(C-6 or C-8), 51.1 (C-6 or C-8), 35.2 (C-4), 30.0 (CH2), 28.3 (C(CH3)3), 26.7 (CH2), 
25.0 (CH2), 25.0 (CH2), 23.3 (C-10), 20.7 (CH2); m/z (ESI): 277 [MNa+]; HRMS: 
calcd. for C15H26NaO3, 277.1774 Found: [MNa+], 277.1767 (0.4 ppm error). 
 
7.5 Procedures & Compound Characterisation (Chapter 5) 
 
(±)-Ethyl (2E)-3-[(1S,3R)-3-formyl-2,2-dimethylcyclopropyl]prop-2-enoate (253) 
 
To a stirred solution of 131 (259 mg, 1.31 mmol) in CHCl3 
(13 mL) was added manganese (IV) dioxide (1.13 g, 13.1 
O
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mmol) and 4Å molecular sieves (1.13 g). After 16 h the suspension was filtered 
through Celite, and washed with CHCl3 (50 mL). The filtrate was concentrated under 
reduced pressure to give the crude product. This was purified by flash column 
chromatography on silica gel, eluting with pet. ether:EtOAc (5:1) to afford the title 
compound 253 as a colourless oil (183 mg, 72%). Rf (5:1 pet. ether:EtOAc) 0.19; *max 
(thin film)/cm-1 2935, 2915, 2888, 1688, 1617; 1H NMR (400 MHz; CDCl3) " 9.62 
(1H, d, J 5.0, H-1), 7.19 (1H, dd, J 15.5, 10.5, H-7), 5.99 (1H, d, J 15.5, H-8), 4.17 
(2H, q, J 7.0, OCH2CH3), 2.14 (1H, dd, J 10.5, 8.5, H-6), 2.07 (1H, dd, J 8.5, 5.0, H-
2), 1.40 (3H, s, H-4), 1.26 (3H, t, J 7.0, OCH2CH3), 1.25 (3H, s, H-5); 13C NMR (101 
MHz; CDCl3) # 199.5 (C-1), 166.0 (CH3CH2OC=O), 142.9 (C-7), 123.6 (C-8), 60.4 
(CH3CH2O), 43.2 (C-2), 38.7 (C-6), 32.4 (C-3), 28.6 (C-5), 15.7 (C-4), 14.4 
(CH3CH2O); m/z (ESI) 219 [MNa+]; HRMS: calcd. for C11H16NaO3, 219.0992. 
Found: [MNa+], 219.0991 (0.5 ppm error).  
 
(±)-(E)-ethyl 3-((1R,3R)-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropyl)prop-2-
enoate (256) 
 
To a stirring solution of aldehyde 253 (2.04 g, 10.4 
mmol) in CH2Cl2 (100 mL) at 0 °C was added PPh3 
(15.0 g, 57.2 mmol) and CBr4 (5.17 g, 15.6 mmol). 
After 20 min the reaction mixture was filtered through a 
silica pad and washed through with Et2O (50 mL). The filtrate was concentrated under 
reduced pressure and the resulting crude product was purified by flash column 
chromatography on silica gel, eluting with pet. ether:EtOAc (60:1 & 40:1) to afford 
the title compound 256 as a colourless oil (1.76 g, 48%). Rf (10:1 pet. ether:EtOAc) 
0.44; *max (thin film)/cm-1 2934, 1712, 1638; 1H NMR (400 MHz; CDCl3) " 6.67 
(1H, dd, J 15.0, 10.5,  H-2), 6.27 (1H, d, J 8.0, H-8), 5.96 (1H, d, J 15.0, H-1), 4.17 
(2H, q, J 7.0, CH3CH2O), 1.89"1.77 (2H, m, H-3 & H-7), 1.27 (3H, t, J 7.0, 
CH3CH2O), 1.20 (3H, s, H-6), 1.17 (3H, s, H-5); 13C NMR (101 MHz; CDCl3) # 
166.2 (C=O), 145.5 (C-2), 134.1 (C-7), 122.9 (C-1), 90.6 (C-9), 60.3 (CH3CH2O), 
36.7 (C-3 or C-7), 34.1 (C-3 or C-7), 28.3 (C-5) 27.6 (C-4), 16.9 (C-6), 14.4 
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(CH3CH2O); m/z (ESI): 373 [MNa+]; HRMS: calcd. for C12H16Br2NaO2, 372.9409. 
Found: [MNa+], 372.9401 (1.0 ppm error). 
 
(±)-(E)-3-((1R,3R)-3-(2,2-Dibromovinyl)-2,2-dimethylcyclopropyl)prop-2-en-1-ol 
(259) 
 
To a stirred solution of 256 (50 mg, 0.142 mmol) in 
CH2Cl2 (2 mL) at "78 °C was added DIBAL (0.43 mL, 
0.426 mmol, 1M in hexanes). After 1 h the reaction 
mixture was diluted with CH2Cl2 (5 mL) followed by 
the careful addition of MeOH (2 drops). The solution was warmed to RT and sat. aq. 
Rochelle’s salt (2 mL) was added. It was stirred for 2 h after which time, the organic 
layer was separated and the aqueous layer extracted with further portions of CH2Cl2 
(3 ) 5 mL). The combined organic extracts were dried (MgSO4), filtered and 
concentrated under reduced pressure to afford the crude compound, which was 
purified by flash column chromatography on silica gel, eluting with pet. ether:EtOAc 
(20:1) to afford the title compound 259 as a colourless oil (32 mg, 74%) which was 
assigned tentatively using 1H NMR spectroscopy and HRMS; Rf (10:1 pet. 
ether:EtOAc) 0.34; 1H NMR (400 MHz; CDCl3) " 6.20 (1H, d, J 8.5, H-9), 5.83 (1H, 
dt, J 15.5, 6.5, H-2), 5.43 (1H, ddt, J 15.5, 9.0, 1.5 H-3), 4.14 (2H, dd, J 6.5, 1.5, H-
1), 1.32"1.04 (2H, m, H-4 & H-8), 1.17 (3H, s, H-6), 1.09 (3H, s, H-7); HRMS: 
calcd. for C10H14Br2NaO2, 330.9309. Found: [MNa+], 330.9305 (0.3 ppm error). 
 
(±)-tert-Butyl(((1S,3R)-2,2-dimethyl-3-((E)-3-(triisopropylsilyloxy)prop-1-
enyl)cyclopropyl)methoxy)dimethylsilane (261) 
 
To a stirring solution of alcohol 221 (594 mg, 2.01 
mmol) at 0 °C in CH2Cl2 (20 mL), was added lutidine 
(0.698 mL, 6.03 mmol) and TIPS sulfonate (616 mg, 
2.01 mmol). The reaction was warmed to RT and stirred for 10 min. The reaction 
mixture was diluted with CH2Cl2 (20 mL) and washed with sat. NH4Cl (aq.) (10 mL), 
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the organic layer separated and the aqueous layer extracted with further portions of 
CH2Cl2 (2 ) 20 mL). The combined organic extracts were dried (MgSO4), filtered and 
concentrated under reduced pressure. The resulting crude product was purified by 
flash column chromatography on silica gel, eluting with pet. ether:EtOAc (60:1) to 
afford the title compound 261 as a colourless oil (790 mg, 92%); Rf (60:1 pet. 
ether:EtOAc) 0.27; *max (thin film)/cm-1 2942, 2864; 1H NMR (400 MHz; CDCl3) " 
5.68 (1H, dt, J 15.0, 5.0, H-2), 5.46 (1H, ddt, J 15.0, 10.0, 1.5, H-3), 4.20 (2H, dd, J 
5.0, 1.5, H-1), 3.73 (1H, dd, J 11.0, 6.0, H-9a), 3.61 (1H, dd, J 11.0, 8.5, H-9b), 
1.11!1.02 (2H, m, H-4 &H-8), 1.09 (3H, s, H-6), 1.07 (18H, s, SiCH(CH3)2), 1.06 
(3H, s, H-7), 1.05 (3H, s, SiCH(CH3)2), 0.89 (9H, s, SiC(CH3)3), 0.04 (6H, s, SiCH3); 
13C NMR (101 MHz; CDCl3) # 130.5 (C-3), 126.8 (C-2), 64.1 (C-9), 60.7 (C-1), 32.1 
(C-4 or C-8), 30.0 (C-4 or C-8), 26.1 (SiC(CH3)3), 26.1 (C-6), 23.6 (SiCH(CH3)2), 
21.3 (C-5), 18.1 (SiC(CH3)3), 15.6 (C-7), 12.2 (SiCH(CH3)2), "5.0 (SiCH3), "5.0 
(SiCH3); m/z (ESI): 449 [MNa+]; HRMS: calcd. for C24H50NaO2Si2, 449.3242. Found: 
[MNa+], 449.3248 (1.0 ppm error). 
 
(±)-(E)-3-((1R,3S)-3-(Hydroxymethyl)-2,2-dimethylcyclopropyl)prop-2-en-1-ol 
(267) 
 
To a solution of 224 (731 mg, 2.70 mmol) in THF (30 
mL) at 0 °C was added TBAF (3.24 mL, 1 M in THF, 
3.24 mmol). After 2 h the reaction mixture was diluted 
with Et2O (30 mL) and washed with sat. NH4Cl (aq.) (30 mL), the organic layer 
separated and the aqueous layer extracted with further portions of Et2O (2 ) 30 mL). 
The combined organic extracts were dried (MgSO4), filtered and concentrated under 
reduced pressure. The resulting crude product was purified by flash column 
chromatography on silica gel, eluting with pet. ether:EtOAc (1:1) to afford the title 
compound 225 as a colourless oil (354 mg, 84%) which was assigned tentatively using 
1H NMR spectroscopy; Rf (1:1 pet. ether:EtOAc) 0.18; 1H NMR (400 MHz; CDCl3) 
" 5.84 (1H, dt, J 15.5, 6.0, H-2), 5.51 (1H, ddt, J 15.5, 9.0, 1.5, H-3), 4.12 (2H, dd, J 
6.0, 1.5, H-1), 3.77 (1H, dd, J 11.5, 7.5, H-9a), 3.68 (1H, dd, J 11.5, 8.0, H-9b), 
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1.60!1.49 (1H, m, H-4 or H-8), 1.23!1.15 (1H, m, H-4 or H-8), 1.15 (3H, s, H-6), 
1.11 (3H, s, H-7).  
 
(±)-tert-Butyl((E)-3-((1R,3S)-3-((tert-butyldimethylsilyloxy)methyl)-2,2-
dimethylcyclopropyl)allyloxy)dimethylsilane (269) 
 
To a solution of 267 (100 mg, 0.641 mmol) in CH2Cl2 
(5 mL) was added TBS chloride (96.6 mg, 0.641 
mmol) followed by imidazole (52.4 mg, 0.769 mmol). 
After 2 h the reaction mixture was diluted with CH2Cl2 (5 mL) and washed with sat. 
NH4Cl (aq.) (5 mL), the organic layer separated and the aqueous layer extracted with 
further portions of CH2Cl2 (2 ) 5 mL). The combined organic extracts were dried 
(MgSO4), filtered and concentrated under reduced pressure to afford a mixture of 267 
and the title compound 269 as a yellow oil (178 mg) in a ratio of 3:2 which was 
assigned tentatively using 1H NMR spectroscopy; 269; Rf (40:1 pet. ether:EtOAc) 
0.22; 1H NMR (400 MHz; CDCl3) " 5.98 (1H, dt, J 15.5, 6.5, H-2), 5.57 (1H, ddt, J 
15.5, 9.5, 1.5, H-3), 4.46 (2H, dd, J 6.5, 1.5, H-1), 3.99 (1H, dd, J 10.5, 7.0, H-9a), 
3.62 (1H, dd, J 10.5, 7.5, H-9b), 1.50!1.42 (1H, m, H-4 or H-8), 1.19!1.07 (1H, m, 
H-4 or H-8), 1.13 (3H, s, H-6), 1.10 (3H, s, H-7), 0.98 (9H, s, SiC(CH3)3),  0.95 (9H, 
s, SiC(CH3)3), 0.16 (6H, s, SiCH3), 0.03 (6H, s, SiCH3). 
 
(±)-((1S,3R)-3-((E)-3-(Benzyloxy)prop-1-enyl)-2,2-dimethylcyclopropyl)methanol 
(270) 
 
To a stirred solution of 221 (500 mg, 1.95 mmol) in 
THF (20 mL) at 0 °C was added NaH (117 mg, 2.93 
mmol, 60% dispersion in mineral oil). This was 
warmed to RT and allowed to stir for 45 mins. This was re-cooled to 0 °C, benzyl 
bromide (350 µL, 2.93 mmol) was added and the reaction mixture was allowed to stir 
at 40 °C for 18 h. The reaction mixture was diluted with Et2O (20 mL) and washed 
with sat. NH4Cl (aq.) (10 mL), the organic layer separated and the aqueous layer 
extracted with further portions of Et2O (2 ) 20 mL). The combined organic phases 
HO O
12
3
4
5
678
9 Ph
10
TBSO OTBS
1
2
3
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89
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were dried (MgSO4), filtered and concentrated under reduced pressure. The resulting 
crude product was dissolved in THF (20 mL) and the solution cooled to 0 °C before 
the addition of TBAF (2.93 mL, 1 M in THF). After 2 h the reaction mixture was 
diluted with Et2O (20 mL) and washed with sat. NH4Cl (aq.) (10 mL), the organic 
layer separated and the aqueous layer extracted with further portions of Et2O (2 ) 20 
mL). The combined organic extracts were dried (MgSO4), filtered and concentrated 
under reduced pressure. The resulting crude product was purified by flash column 
chromatography on silica gel, eluting with pet. ether:EtOAc (10:1) to afford the title 
compound 270 as a colourless oil (307 mg, 64%) which was assigned tentatively using 
1H NMR spectroscopy; Rf (2:1 pet. ether:EtOAc) 0.57; 1H NMR (400 MHz; CDCl3) 
" 7.38!7.26 (5H, m, Ar-CH), 5.79 (1H, dt, J 15.0, 6.5, H-3), 5.51 (1H, ddt, J 15.0, 
10.0, 1.5, H-4), 4.50 (2H, s, H-1), 3.98 (2H, dd, J 6.5, 1.5, H-2), 3.74 (1H, dd, J 11.5, 
7.5, H-10a), 3.67 (1H, dd, J 11.5, 8.0, H-10b), 1.48!1.43 (1H, m, H-5 or H-9), 
1.19!1.14 (1H, m, H-5 or H-9), 1.12 (3H, s, H-6), 1.11 (3H, s, H-8).  
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Appendix I 
1H- & 13C-NMR Spectra for cycloheptadienes 58a, 58b, 88a and 160-164 
 
Diethyl (1R,2S)-cyclohepta-3,6-diene-1,2-dicarboxylate (58a) 
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Diethyl (±)-(1S,2S)-cyclohepta-3,6-diene-1,2-dicarboxylate (58b) 
 
 
 174 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 175 
Diethyl (1R,2S)-5,5-dimethylcyclohepta-3,6-diene-1,2-dicarboxylate (88a) 
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Dimethyl (1R,2S)-5,5-dimethylcyclohepta-3,6-diene-1,2-dicarboxylate (160) 
 
 178 
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(±)-(3aR,8aS)-6,6-Dimethyl-3,3a,6,8a-tetrahydro-1H-cyclohepta[c]furan-1-one 
(161) 
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 181 
((1R,2S)-5,5-Dimethylcyclohepta-3,6-diene-1,2-diyl)dimethanol (162) 
 
 
 182 
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(±)-((1R,7S)-7-((tert-Butyldimethylsilyloxy)methyl)-4,4-dimethylcyclohepta-2,5-
dienyl)methanol (163)  
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 185 
((1R,2S)-5,5-Dimethylcyclohepta-3,6-diene-1,2- diyl)bis(methylene)bis(oxy)bis(tert-
butyldimethylsilane) (164) 
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The Cope rearrangement of gem-dimethyl substituted
divinylcyclopropanes†
Jonathan D. Osler, William P. Unsworth and Richard J. K. Taylor*
The reactivity of a range of substituted divinylcyclopropanes towards the thermal Cope rearrangement
has been examined. The eﬀects of gem-dimethyl substitution on the cyclopropane, the alkene geometry,
the relative stereochemistry of the cyclopropane and the steric and electronic eﬀects of a range of func-
tional groups were all examined, and the methods developed were used to synthesise a range of functio-
nalised 1,4-cycloheptadienes in high yields.
Introduction
The thermal Cope rearrangement of a divinylcyclopropane was
first described by Vogel in 1960 (Scheme 1).1 The rearrange-
ment normally proceeds via a [3,3]-sigmatropic rearrangement,
including ring-opening of the strained cyclopropane moiety,
leading to the convenient construction of 1,4-cycloheptadiene
scaﬀolds from relatively simple starting materials. Numerous
applications of this reaction have since appeared in the litera-
ture,2 but in the majority of examples the cyclopropane moiety
is substituted only with the two alkene groups involved in the
rearrangement.3,4 In this study we compare the reactivity of
gem-dimethyl substituted divinylcyclopropanes with their
unsubstituted analogues, examining the eﬀects of alkene geo-
metry, the relative stereochemistry of the cyclopropane and the
steric and electronic eﬀects of a range of functional groups.
Results
Our interest in the Cope rearrangements of divinylcyclopro-
panes arose as an extension to our work concerning the use of
tandem reaction sequences,5 particularly those involving
oxidation with manganese(IV) oxide.6 As part of these studies,
we reported the tandem oxidation and Wittig reaction of diol 3
that resulted in its conversion into E,E-diester 4a in a high
yielding, one-pot process.6d We have since discovered that
heating the resulting trans-divinylcyclopropane in xylene at
130 °C results in its smooth conversion into 1,4-cycloheptadiene
5a. The generally accepted mechanism for this process is pres-
ented (Scheme 2): a reversible epimerisation of trans-divinylcy-
clopropane 4a to the corresponding cis-divinylcyclopropane
takes place first, which is believed to proceed via a diradical
opening of the cyclopropane.2,7 The resulting cis-divinylcyclo-
propane then undergoes a thermal [3,3]-sigmatropic rearrange-
ment via a boat-like transition state 6.
Our group has also reported improved conditions for the
formation of gem-dimethylcyclopropanes using triisopropylsul-
foxonium tetrafluoroborate and sodium hydride.8 Thus, using
the reported procedure, dimethylcyclopropane 7 was syn-
thesised in high yield and subsequent reduction with lithium
aluminium hydride, followed by a tandem oxidation/Wittig
reaction resulted in the formation of E,E-diester 9a, as well as
a small amount E,Z-diester 9b. We then went on to attempt the
Cope reaction of 9a under the same conditions used for the
rearrangement of its non-methylated analogue 4a (130 °C in
Scheme 1 Vogel’s Cope rearrangement of divinylcyclopropane 1.
Scheme 2 The Cope rearrangement of diester 4a. Reagents and conditions:
(a) MnO2, CHCl3, Ph3PCHCO2Et, reﬂux, 75%,6d (b) xylene, 130 °C, 80%.
†Electronic supplementary information (ESI) available: For experimental
procedures, characterisation of compounds and NMR spectra. See DOI:
10.1039/c3ob41617h
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xylene) but no reaction ensued and the starting material 9a was
recovered cleanly upon evaporation of the solvent (Scheme 3).
This result is not altogether unexpected, as a review of the
related literature revealed that bulky substituents typically
inhibit the Cope rearrangements of divinyl cyclopropanes,9–11
by destabilising the previously invoked boat-like transition
state (see 11, Scheme 3). For example, it has been observed
that substitution on the vinyl groups can retard the reaction
significantly,9 and that this eﬀect is more pronounced for
Z-substituents than E-substituents, as the ensuing steric clash
with the cyclopropane moiety in the transition state is greater.9
Far less is known about the eﬀect of dimethyl substitution on
the cyclopropane, however; indeed, to the best of our knowl-
edge, there are no reports that directly compare the Cope
rearrangements of divinyl dimethylcyclopropanes with their
non-methylated analogues. The closest precedent was reported
by Sasaki et al.10 who found that methyl substitution on the
‘aza-divinylcyclopropanes’ 12 and 13 had a significant eﬀect
on their reactivity; the non-methylated variant 12 underwent
[3,3]-sigmatropic rearrangement at RT, whereas its methylated
analogue 13 required the far greater temperature of 144 °C
before rearrangement occurred (Scheme 4).11
The preceding example (Scheme 4) demonstrates the pro-
found eﬀect that dimethyl substitution can have on the [3,3]-sig-
matropic rearrangements of cyclopropane-containing systems.
However, we were surprised to discover that our study is the first
direct comparison of the Cope rearrangements of a divinyl
dimethylcyclopropane with its non-methylated analogue. In view
of this, we decided to investigate how dimethyl substitution
aﬀects such rearrangements, by synthesising all of the possible
stereoisomers (cis/trans and E,E/E,Z/Z,Z) of the diesters 4 and 9
and examining their propensity to undergo Cope rearrangement.
The syntheses of two of the required diesters (9a, 9b) are
described above (Scheme 3) and the Z,Z-diester 9c was readily
synthesised from diol 8, via oxidation with manganese(IV)
dioxide, followed by a Still–Gennari-modified Horner–
Wadsworth–Emmons (HWE) olefination (Scheme 5).12
The synthesis of diester 4a is described in Scheme 2. The
Z,Z-diester 4c was prepared from diol 3, via oxidation with
manganese(IV) dioxide, followed by a Still–Gennari-modified
Horner–Wadsworth–Emmons (HWE) olefination (Scheme 6).
The synthesis of E,Z-diester 4b began with mono-TBS protec-
tion of diol 3, and was followed by a tandem oxidation/Wittig
reaction to install the E-alkene portion, furnishing compound
17. Silyl cleavage using TBAF, manganese(IV) dioxide oxidation
and Still–Gennari olefination was then used to install the
Z-alkene and complete the synthesis (Scheme 6).
Similar reaction sequences were employed in the synthesis
of the dimethyl cis-cyclopropane diesters 9d, 9e, and 9f. To
begin, subjecting ethyl chrysanthemate13 to ozonolysis fol-
lowed by reduction with lithium aluminium hydride aﬀorded
a mixture of cis-cyclopropane diol 19 and its trans-analogue 8,
which were readily separated by column chromatography. On
all of the cis-cyclopropane diesters synthesised, the alkene
components were installed sequentially, to avoid competing
intramolecular cyclisation reactions. First, diol 19 was con-
verted into mono-silyl ether 20 under standard conditions14
and this common intermediate was then converted into either
E-alkene 21 using our standard tandem oxidation/Wittig con-
ditions or to Z-alkene 24 via oxidation and Still–Gennari olefi-
nation. Silyl cleavage of each of 21 and 24 using HF15 and
oxidation/olefination in the same way completed the syntheses
of the required cyclopropane diesters 9d, 9e and 9f (Scheme 7).
The syntheses of the non-methylated cis-cyclopropane di-
esters 4d, 4e, and 4f were completed using the same sequence
Scheme 4 The [3,3]-sigmatropic rearrangement of cyclopropanes 12 and 13
(no yields reported).10
Scheme 5 The synthesis of gem-dimethyl-trans-divinylcyclopropanes. Reagents
and conditions: (a) MnO2, CHCl3, reﬂux, 72%. (b) (F3CCH2O)2POCH2CO2Et,
KHMDS, 18-crown-6, THF, toluene, 35% (>20 : 1 Z : E).
Scheme 3 The formation of dimethylcyclopropanes 9a and 9b and the
attempted Cope rearrangement. Reagents and conditions: (a) i-Pr3SO+BF4−,
NaH, DMF, 73%. (b) LiAlH4, THF, 86%. (c) MnO2, Ph3PCHCO2Et, CHCl3, reﬂux,
9a 69%, 9b 4%, (d) xylene, 130 °C, 0%.
Scheme 6 The synthesis of trans-divinylcyclopropanes. Reagents and conditions:
(a) MnO2, CHCl3, reﬂux, 11%. (b) (F3CCH2O)2POCH2CO2Et, KHMDS, 18-crown-6,
THF, toluene, 63% (>20 : 1 Z : E). (c) NaH, TBSCl, THF, 69%. (d) MnO2,
Ph3PCHCO2Et, CHCl3, reﬂux, 85% (>10 : 1 E : Z; E-isomer was isolated by chrom-
atography). (e) TBAF, THF, 77%. (f ) (a) MnO2, CHCl3, reﬂux, 67%.
(g) (F3CCH2O)2POCH2CO2Et, KHMDS, 18-crown-6, THF, toluene, 46% (>20 : 1 Z : E).
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of steps described in Scheme 7, with the exception that diol 27
was accessed readily via the reduction of cyclic anhydride 26.
Otherwise, the syntheses proceeded as above until the final
step of the sequence; each of the target substrates 4d, 4e, or 4f
spontaneously undergo the Cope rearrangement at room temp-
erature as they are generated, hence cycloheptadiene 5a (from
4d and 4f ) and cycloheptadiene 5b (from 4e) were instead
obtained (Scheme 8).
With the requisite substrates, 4a–f and 9a–f, in hand their
propensity to undergo the Cope rearrangement was then exam-
ined. Each was stirred in xylene for 17 h at five diﬀerent temp-
eratures (RT, 40 °C, 70 °C, 100 °C, 130 °C) before removing the
solvent in vacuo. The reaction conversion into product was
then measured via analysis of the 1H NMR spectra of the
unpurified reaction mixtures as a ratio of product to starting
material (Table 1).
Scheme 8 The synthesis of cis-divinylcyclopropanes. Reagents and conditions:
(a) LiAlH4, THF, reﬂux, 79%. (b) NaH, TBSCl, THF 0 °C → RT, 100%. (c) MnO2,
CHCl3, reﬂux 75%. (d) Ph3PCHCO2Et, CHCl3, 63% (>10 : 1 E : Z; E-isomer was iso-
lated by chromatography). (e) HF, MeCN, 94%. (f ) MnO2, CHCl3, 81%.
(g) Ph3PCHCO2Et, CHCl3, RT, 79%. (h) (F3CCH2O)2POCH2CO2Et, KHMDS,
18-crown-6, THF, toluene 75%. (i) (F3CCH2O)2POCH2CO2Et, KHMDS, 18-crown-6,
THF, toluene 40% (>20 : 1 Z : E). ( j) HF, MeCN, 97%. (k) MnO2, CHCl3, reﬂux
53%. (l) (F3CCH2O)2POCH2CO2Et, KHMDS, 18-crown-6, THF, toluene 81%.
Table 1 The Cope rearrangement of divinylcyclopropane diesters
Entry Reagent Product
% Conversion (17 h)
Temperature (°C)
RT 40 70 100 130
1 0 0 0 20 100a
2 0 0 0 20 100a
3 0 0 0 0 80a
4 100b — — — —
5 100b — — — —
6 100b — — — —
7 0 0 0 0 0a
8 0 0 0 0 0a
9 0 0 0 0 0a
10 0 30 90 100c 100a
11 0 0 0 0 0a
12 0 0 0 0 0a
E = CO2Et. All reactions were carried out as 0.19 mol dm−3 solutions in
xylene. All reactions were carried out for 17 h. % Conversion was
determined via 1H NMR analysis of the unpurified reaction mixtures
as a ratio of product to starting material. a Some decomposition was also
evident. b The divinylcyclopropane could not be isolated at RT; the
cycloheptadiene shown was instead isolated during the attempted
preparation of the diene. c Compound 10a was isolated in 78% yield
after flash column chromatography.
Scheme 7 The synthesis of cis-gem-dimethyldivinylcyclopropanes. Reagents
and conditions: (a) O3, DCM, −78 °C then DMS, 97%. (b) LiAlH4, THF, 0 °C → RT,
19, 31%, 8, 49%. (c) NaH, TBSCl, THF 0 °C → RT, 84%. (d) MnO2, Ph3PCHCO2Et,
CHCl3, reﬂux, 78% (5 : 1 E : Z). (e) HF, MeCN, 75% (5 : 1 E : Z; E-isomer was iso-
lated by chromatography). (f ) MnO2, CHCl3, reﬂux, 46%. (g) Ph3PCHCO2Et,
CHCl3, RT, 47% (>10 : 1 E : Z; E-isomer was isolated by chromatography).
(h) (F3CCH2O)2POCH2CO2Et, KHMDS, 18-crown-6, THF, toluene, 52% (>20 : 1
Z : E). (i) MnO2, CHCl3, reﬂux, 55%. ( j) (F3CCH2O)2POCH2CO2Et, KHMDS,
18-crown-6, THF, toluene, 53% (>20 : 1 Z : E). (k) HF, MeCN, 85%. (l) MnO2, CHCl3,
reﬂux, 53%. (m) (F3CCH2O)2POCH2CO2Et, KHMDS, 18-crown-6, THF, toluene,
56% (>20 : 1 Z : E).
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A number of conclusions can be drawn from these experi-
ments. First, each of the unsubstituted trans-divinylcyclopro-
panes 4a, 4b, and 4c underwent the Cope rearrangement only
upon heating; a temperature of 130 °C was needed before the
trans-E,E and trans-E,Z-substrates 4a and 4b rearranged
(Table 1, entries 1–2) whereas only 80% conversion was
observed in the more sterically encumbered trans-Z,Z-system
4c under identical conditions (Table 1, entry 3). These results
are in stark contrast to those of their cis-analogues 4d, 4e, and
4f which rearrange spontaneously at room temperature during
their generation (Table 1, entries 4–6). A single stereoisomer of
product was observed in each case, with the stereochemical
outcomes being consistent with a simple concerted thermal
[3,3]-sigmatropic rearrangement in the cis-series of com-
pounds (Table 1, entries 4–6) and trans to cis-isomerisation,
followed by a concerted thermal [3,3]-sigmatropic rearrange-
ment, in the trans-series (Table 1, entries 1–3). Thus, the high
temperatures necessary to induce rearrangement in the trans-
series appear to be associated with overcoming the energy
barrier for trans to cis-epimerisation of the cyclopropane and
not with the energy of the transition state of the Cope
rearrangement itself.
The trans-dimethyl substrates 9a, 9b or 9c did not
rearrange, even at 130 °C (Table 1, entries 7–9) and, impor-
tantly, epimerisation to the corresponding cis-diesters was also
not observed. The cis-E,Z and cis-Z,Z-substrates 9e and 9f also
failed to react at 130 °C, with each remaining unchanged,
again with no evidence of cyclopropane epimerisation
(Table 1, entries 11–12). This suggests that the required tran-
sition state (11, Scheme 3) is too high in energy for the Cope
rearrangement to occur under the conditions screened, prob-
ably due to steric clashes, but also indicates that the cis/trans-
epimerisation occurs less readily than in the non-methylated
series of compounds. Interestingly, the cis-E,E-diester 9d was
significantly more reactive than either of compounds 9e or 9f;
this substrate began to rearrange at temperatures as low as
40 °C and the rearrangement was complete after 17 h at
100 °C (Table 1, entry 10). As before, a single stereoisomer of
product was observed with the stereochemical outcome con-
sistent with a concerted thermal [3,3]-sigmatropic rearrange-
ment. Of course, the rearrangement occurred less readily than
it did on the analogous desmethyl-cis-E,E substrate 4d
(Table 1, entry 4), as was expected, but the fact that it began to
rearrange at temperatures as low as 40 °C is significant, given
the dearth of examples on other divinyl dimethylcyclopropanes
in the literature. This result also sheds light on the reason why
our original dimethyl trans-E,E-diester 9a (Table 1, entry 7)
failed to react; given that the Cope rearrangement of cis-E,E-
diester 9d (Table 1, entry 10) proceeded at temperatures as low
as 40 °C, and that there was no evidence of any cis/trans-epi-
merisation in any of the diesters 9a–9f, this suggests that the
reaction of trans-E,E 9a failed at the cyclopropane epimerisation
stage, and not because of the high energy of the Cope
rearrangement transition state as originally thought.16 In
addition, the complete lack of cis to trans-epimerisation in any
of the dimethyl substituted diesters 9a–9f is in contrast to the
unsubstituted diesters 4a–4c (which must have epimerised
otherwise their Cope rearrangements would not have taken
place). Thus, we have shown that as well raising the energy of
the Cope rearrangement transition state, gem-dimethyl substi-
tution also retards the rate of cyclopropane epimerisation of
the trans-cyclopropane substrates screened.
It is clear that gem-dimethyl substitution significantly
retards the Cope rearrangements of divinylcyclopropanes.
However, it appears that its eﬀect on the trans to cis-isomerisa-
tion of the cyclopropane, and not its eﬀect on the [3,3]-sigma-
tropic rearrangement itself, is the most significant barrier to
reactivity. Pleasingly, from a synthetic viewpoint, the isomeri-
sation problem is easily negated by starting from a cis-oriented
divinylcyclopropane. To demonstrate this, we then went on to
synthesise a range of other dimethyl-cis-E,E-functionalised
cyclopropanes (Scheme 9). Cyclopropane 35 was prepared
using a tandem oxidation/Wittig reaction, followed by silyl
cleavage using HF.15 Another tandem oxidation/Wittig reaction
at RT aﬀorded the cis-E,E-functionalised cyclopropane 36. The
reduction of 36 using 2 equivalents of DIBAL gave a mixture of
monoester 37 and diol 38, and TBS protection of diol 38 using
1.5 equivalent of TBSCl generated a mixture of TBS com-
pounds 39 and 40. Finally, the hydrolysis of diester 36 aﬀorded
cyclopropane 41.
We were pleased to find that all of these substrates 36–41
undergo the Cope rearrangement upon heating, generating
1,4-cycloheptadienes in high yields (83–97%, Table 2), with
ester, alcohol, silyl ether and carboxylic acid substituents all
being well tolerated. The rearrangements do not appear to be
significantly aﬀected by electronic eﬀects, a point exemplified
by the near-identical reactivity of the electron-deficient ester-
substituted divinylcyclopropane 36 and the more electron-rich
alcohol-substituted divinylcyclopropane 38 (entries 1 and 3).
Note that the product isolated from the Cope rearrangement
of substrate 37 (entry 2) was a lactone, presumably, formed
via an intramolecular transesterification following the Cope
Scheme 9 The synthesis of a range of dimethyl cis-E,E divinylcyclopropanes.
Reagents and conditions: (a) MnO2, Ph3PCHCO2Me CHCl3, reﬂux 48% (>10 : 1
E : Z; E-isomer was isolated by chromatography). (b) HF, MeCN, 81%. (c) MnO2,
Ph3PCHCO2Me CHCl3, RT, 49% (>10 : 1 E : Z; E-isomer was isolated by chromato-
graphy). (d) NaOH, THF, H2O, RT, 100%. (e) DIBAL (2 eq.), CH2Cl2, 37, 9%, 38
33%. (f ) TBSCl (1.5 eq.), NaH, THF, 39 20%, 40, 35%.
Paper Organic & Biomolecular Chemistry
7590 | Org. Biomol. Chem., 2013, 11, 7587–7594 This journal is © The Royal Society of Chemistry 2013
Pu
bli
sh
ed
 on
 27
 Se
pte
mb
er 
20
13
. D
ow
nlo
ad
ed
 by
 U
niv
ers
ity
 of
 Y
ork
 on
 28
/08
/20
14
 11
:40
:02
. 
View Article Online
rearrangement. The size of the substituents appears to be
more significant; the addition of one 39 and then two 40 tert-
butyldimethyl silyl groups to diol 38 led to a decrease in
reactivity in each case (entries 3–5). Diacid-substituted
divinylcyclopropane 41 reacts more slowly still (entry 6),
but this reaction should not be compared directly to the
other entries as compound 41 was only sparingly soluble in
the reaction solvent.
Conclusions
The rate-retarding eﬀect of gem-dimethyl substitution on the
Cope rearrangements of divinylcyclopropanes has been
demonstrated directly for the first time. An examination of the
eﬀects of alkene geometry and the relative stereochemistry of
the cyclopropane have revealed that gem-dimethyl substitution
significantly inhibits the trans to cis-isomerisation about the
cyclopropyl ring, necessary for rearrangement to occur, relative
to unsubstituted analogues. Using the information accrued, a
series of ideal substrates (cis-oriented on the cyclopropane
with two E-alkenes) were synthesised and all underwent the
desired Cope rearrangement smoothly, aﬀording a range of
dimethylated substituted 1,4-cycloheptadienes in high yields.
Future work will focus on the application of this methodology
in the synthesis of natural products and pharmaceutically
important targets.
Experimental
General remarks
Experimental procedures and data for the characterisation of
Cope rearrangement products can be found below. Experi-
mental procedures and characterisation data of all other com-
pounds presented in this paper can be found in the ESI.† All
reagents were purchased from commercial sources and were
used without further purification. Where necessary, solvents
were dried on an MBraun SPS solvent purification system.
Anhydrous THF was obtained by distillation over sodium/
benzophenone. Xylene refers to a mixture of ortho, meta and
para-xylene and pet. ether refers to light petroleum ether, bp
40–60 °C. 1H NMR spectra were recorded on a JEOL ECX 400
(400 MHz) instrument. 13C NMR spectra were recorded on a
JEOL ECX 400 instrument at 100 MHz. Infrared spectra were
carried out on a Perkin Elmer FT-IR spectrometer UATR 2 or
on a ThermoNicolet IR100 spectrometer (recorded as a thin
film between NaCl discs). Mass spectra and accurate mass
measurements were recorded on a Bruker Daltonics, Micro-tof
spectrometer.
Table 2 Substrate scope in the Cope rearrangement of substituted gem-dimethyl divinylcyclopropanesa
Entry Reagent Product
% Conversion
Isolated
yield (%)
Temperature (°C)
40 70 100
1 30 100 100 83
2 0 100 100 92
3 30 90 100 83
4 30 70 100 86
5 0 30 100 88
6 0 10 100 97
a All reactions were carried out as 0.19 mol dm−3 solutions in xylene. All reactions were carried out for 17 h. % Conversion was determined via
analysis of the unpurified reaction mixtures. The isolated yields were obtained from the 100 °C experiments and include purification by column
chromatography in each example except for diacid 47.
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Diethyl (1R,2S)-cyclohepta-3,6-diene-1,2-dicarboxylate (5a)
Procedure 1: from diethyl (±)-(2E,2′E)-3,3′-(1R,2R)-cyclopro-
pane-1,2-diylbisprop-2-enoate 4a (Scheme 2). A stirred solution
of 4a (5.01 g, 21.0 mmol) in xylene (50 mL) was refluxed at
130 °C for 16 h. After being cooled to RT the solution was con-
centrated under reduced pressure to give the crude product.
This was purified by flash column chromatography on silica
gel, eluting with pet. ether–EtOAc (20 : 1) to aﬀord the title
compound 5a, as a colourless oil (3.96 g, 80%).
Procedure 2: from ethyl (±)-(2E)-3-[(1S,2S)-2-formylcyclopro-
pyl]prop-2-enoate 31 (Scheme 8). To a stirred solution of 31
(132 mg, 0.786 mmol) in CHCl3 (10 mL) at RT was
added (carbethoxymethylene)triphenylphosphorane (329 mg,
0.943 mmol). After 16 h the solution was concentrated under
reduced pressure at RT and the crude product purified by flash
column chromatography on silica gel, eluting with pet. ether–
EtOAc (20 : 1) to aﬀord the title compound 5a as a colourless
oil (148 mg, 79%).
Procedure 3: from ethyl (±)-(2Z)-3-[(1S,2S)-2-formylcyclopro-
pyl]prop-2-enoate (Scheme 8). To a solution of ethyl [bis(2,2,2-
trifluoroethoxy)phosphoryl]acetate (244 mg, 0.735 mmol) in
THF (7 mL) was added 18-crown-6 (433 mg, 1.64 mmol). The
solution was cooled to 0 °C and KHMDS (1.05 mL, 0.7 M in
toluene, 0.735 mmol) was added cautiously. After 15 min the
solution was cooled to −78 °C and ethyl (±)-(2Z)-3-[(1S,2S)-2-
formylcyclopropyl]prop-2-enoate (95 mg, 0.565 mmol) in THF
(7 mL) was added via cannula. After 2 h the reaction was
quenched with sat. NH4Cl (aq.) (10 mL), Et2O (20 mL) added
and the organic layer separated. The aqueous layer was
extracted with further portions of Et2O (2 × 20 mL) and the
combined organic extracts were dried (MgSO4), filtered and
concentrated under reduced pressure. The resulting crude
product was purified by flash column chromatography on
silica gel, eluting with pet. ether–EtOAc (20 : 1) to aﬀord the
title compound 5a as a colourless oil (109 mg, 81%). Rf (20 : 1
pet. ether–EtOAc) 0.19; νmax (thin film)/cm−1 2981, 2937, 1735;
1H NMR (400 MHz; CDCl3) δ 6.08–6.02 (2H, m), 5.82–5.76 (2H,
m), 4.20–4.11 (4H, m), 3.86–3.84 (2H, m), 3.08–2.98 (1H, m),
2.75–2.66 (1H, m), 1.25 (6H, t, J 7.0); 13C NMR (101 MHz;
CDCl3) δ 172.0, 129.4, 127.5, 61.1, 45.1, 28.3, 14.2; m/z (ESI)
239 [MH+]; HRMS: calcd for C13H19O4, 239.1278. Found:
[MH+], 239.1271 (2.4 ppm error).
Diethyl (±)-(1S,2S)-cyclohepta-3,6-diene-1,2-dicarboxylate (5b)
From ethyl (±)-(2E)-3-[(1S,2S)-2-formylcyclopropyl]prop-
2-enoate 31 (Scheme 8). To a solution of ethyl [bis(2,2,2-tri-
fluoroethoxy)phosphoryl]acetate (236 mg, 0.712 mmol) in THF
(7 mL) was added 18-crown-6 (420 mg, 1.59 mmol). The solu-
tion was cooled to 0 °C and KHMDS (1.02 mL, 0.7 M in
toluene, 0.712 mmol) was added cautiously. After 15 min the
solution was cooled to −78 °C and 31 (92 mg, 0.548 mmol) in
THF (7 mL) was added via cannula. After 2 h the reaction was
quenched with sat. NH4Cl (aq.) (10 mL), Et2O (20 mL) added
and the organic layer separated. The aqueous layer was
extracted with further portions of Et2O (2 × 20 mL) and the
combined organic extracts were dried (MgSO4), filtered and
concentrated under reduced pressure at RT. The resulting
crude product was purified by flash column chromatography
on silica gel, eluting with pet. ether–EtOAc (20 : 1) to aﬀord the
title compound 5b as a colourless oil (98 mg, 75%). Rf (10 : 1
pet. ether–EtOAc) 0.27; νmax (thin film)/cm−1 2978, 2936, 2893,
2862, 1710 1H NMR (400 MHz; CDCl3) δ 5.89–5.81 (2H, m),
5.66–5.60 (2H, m), 4.17 (2H, q, J 7.0), 4.16 (2H, q, J 7.0),
3.83–3.77 (2H, m), 2.91–2.84 (2H, m), 1.26 (6H, t, J 7.0); 13C
NMR (101 MHz; CDCl3) δ 173.3, 130.8, 127.0, 61.1, 45.1, 27.5,
14.3; m/z (ESI) 239 [MH+]; HRMS: calcd for C13H19O4,
239.1278. Found: [MH+], 239.1267 (3.8 ppm error).
General procedure for the Cope rearrangement
A solution of divinylcyclopropane in xylene (0.19 mol dm−3)
was heated to the temperature indicated and held at that temp-
erature for 17 h. The solution was then concentrated in vacuo.
The products in Table 2 were purified, by flash column chrom-
atography, except for diacid 47.
Diethyl (1R,2S)-5,5-dimethylcyclohepta-3,6-diene-
1,2-dicarboxylate (10a)
Synthesised from compound 9d using the general procedure
at 100 °C, aﬀording the title compound 10a as a colourless oil
(78%); Rf (10 : 1 pet. ether–EtOAc) 0.25; νmax (thin film)/cm−1
2961, 2920, 1735; 1H NMR (400 MHz; CDCl3) δ 5.93 (2H, dd, J
12.0, 6.0), 5.50 (2H, d, J 12.0), 4.12–4.18 (4H, m), 3.79 (2H, d, J
6.0), 1.25 (6H, t, J 7.0), 1.16 (3H, s), 1.13 (3H, s); 13C NMR
(101 MHz; CDCl3) δ 172.0, 140.0, 123.2, 61.1, 45.1, 39.1, 32.4,
29.3, 14.3; m/z (ESI): 289 [MNa+]; HRMS: calcd for C15H22NaO4,
289.1410. Found: [MNa+], 289.1411 (0.3 ppm error).
Dimethyl (1R,2S)-5,5-dimethylcyclohepta-3,6-diene-
1,2-dicarboxylate (42)
Synthesised from compound 36 using the general procedure at
100 °C, aﬀording the title compound 42 as a colourless oil
(36 mg, 83%); Rf (10 : 1 pet. ether–EtOAc) 0.23; νmax (thin film)/
cm−1 2974, 2912, 1718; 1H NMR (400 MHz; CDCl3) δ 5.93 (2H,
dd, J 11.5, 6.5), 5.50 (2H, d, J 11.5), 3.82 (2H, d, J 6.5), 3.70 (6H,
s), 1.16 (3H, s), 1.12 (3H, s); 13C NMR (101 MHz; CDCl3) δ
172.5, 140.1, 123.1, 52.3, 44.9, 39.1, 32.5, 29.3; m/z (ESI): 239
[MH+]; HRMS: calcd for C13H19O4, 239.1278. Found: [MH+],
239.1269 (3.2 ppm error).
(±)-(3aR,8aS)-6,6-Dimethyl-3,3a,6,8a-tetrahydro-1H-cyclohepta-[c]-
furan-1-one (43)
Synthesised from compound 37 using the general procedure at
100 °C, aﬀording the title compound 43 as a colourless oil
(32 mg, 84%); Rf (10 : 1 pet. ether–EtOAc) 0.25; νmax (thin film)/
cm−1 3528, 2961, 1770; 1H NMR (400 MHz; CDCl3) δ 5.69–5.59
(2H, m), 5.46 (2H, dd, J 12.0, 5.0), 5.31 (1H, dd, J 12.0, 4.0),
4.30 (1H, dd, J 8.5, 6.0), 4.12 (1H, dd, J 8.5, 4.5), 3.47–3.39 (2H,
m), 1.19 (3H, s), 1.15 (3H, s); 13C NMR (101 MHz; CDCl3) δ
176.9, 143.5, 142.6, 123.6, 118.6, 73.2, 44.0, 39.7, 38.3, 32.0,
30.2; m/z (ESI): 233 [MNa+]; HRMS: calcd for C11H14NaO2,
201.0891. Found: [MNa+], 201.0888 (1.2 ppm error).
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((1R,2S)-5,5-Dimethylcyclohepta-3,6-diene-1,2-diyl)dimethanol
(44)
Synthesised from compound 38 using the general procedure at
100 °C, aﬀording the title compound 44 as a colourless oil
(15 mg, 83%); Rf (EtOAc) 0.43; mp 42–44 °C; νmax (thin film)/
cm−1 3304, 3008, 2958, 2923, 2871; 1H NMR (400 MHz; CDCl3)
δ 5.57 (2H, dd, J 12.0, 6.5), 5.43 (2H, d, J 12.0), 3.72 (2H, dd, J
11.0, 7.0), 3.66 (2H, br s), 3.59 (2H, dd, J 11.0, 3.0), 2.81–2.76
(2H, m), 1.13 (3H, s), 1.08 (3H, s); 13C NMR (101 MHz; CDCl3)
δ 139.9, 126.0, 63.9, 43.8, 39.9, 32.9, 29.8; m/z (ESI): 205
[MNa+]; HRMS: calcd for C11H18NaO2, 205.1199. Found:
[MNa+], 205.1195 (0.7 ppm error).
(±)-((1R,7S)-7-((tert-Butyldimethylsilyloxy)methyl)-
4,4-dimethylcyclohepta-2,5-dienyl)methanol (45)
Synthesised from compound 39 using the general procedure at
100 °C, aﬀording the title compound 45 as a colourless oil
(10 mg, 86%); Rf (10 : 1 pet. ether–EtOAc) 0.52; νmax (thin film)/
cm−1 3373, 2962, 2911, 2885, 2815; 1H NMR (400 MHz; CDCl3)
δ 5.58 (1H, dd, J 11.5, 6.0), 5.50 (1H, dd, J 12.0, 6.5), 5.45–5.37
(2H, m), 3.74 (1H, dd, J 10.5, 8.0), 3.65 (1H, dd, J 11.5, 7.0),
3.57–3.51 (2H, m), 2.86–2.79 (1H, m), 2.75–2.68 (1H, m), 1.13
(3H, s), 1.08 (3H, s), 0.91 (9H, s), 0.10 (6H, s); 13C NMR
(101 MHz; CDCl3) δ 140.1, 139.5, 126.5, 125.9, 64.4, 64.3, 44.0,
44.0, 39.8, 33.0, 29.7, 26.0, 18.4, −5.4; m/z (ESI): 319 [MNa+];
HRMS: calcd for C17H32NaO2Si, 319.2064. Found: [MNa+],
319.2053 (2.4 ppm error).
((1R,2S)-5,5-Dimethylcyclohepta-3,6-diene-1,2-diyl)bis-
(methylene)bis(oxy)bis(tert-butyldimethylsilane) (46)
Synthesised from compound 40 using the general procedure at
100 °C, aﬀording the title compound 46 as a colourless oil
(17 mg, 88%); Rf (40 : 1 pet. ether–Et2O) 0.76; νmax (thin film)/
cm−1 2911, 2883, 2852, 2814; 1H NMR (400 MHz; CDCl3) δ 5.48
(2H, dd, J 11.5, 6.0), 5.35 (2H, d, J 11.5), 3.66 (2H, dd, J 10.0,
7.0), 3.58 (2H, dd, J 10.0, 7.0), 2.73 (2H, ddd, J 7.0, 7.0, 6.0),
1.14 (3H, s), 1.09 (3H, s), 0.88 (18H, s), 0.03 (12H, s); 13C NMR
(101 MHz; CDCl3) δ 139.1, 128.0, 65.5, 42.8, 39.8, 32.9, 29.9,
26.1, 18.5, −5.2; m/z (ESI): 411 [MH+]; HRMS: calcd for
C23H47O2Si2, 411.3109. Found: [MH+], 411.3100 (1.1 ppm
error).
(1R,2S)-5,5-Dimethylcyclohepta-3,6-diene-1,2-dicarboxylic
acid (47)
Synthesised from compound 41 using the general procedure at
100 °C, without chromatography, aﬀording the title compound
47 as a light brown solid (22 mg, 97%); mp 130–132 °C; νmax
(thin film)/cm−1 2963, 2927, 2600 (br), 1693; 1H NMR
(400 MHz; DMSO) δ 5.87–5.80 (2H, m), 5.40 (2H, d, J 12.0),
3.67 (2H, d, J 5.5), 1.12 (3H, s), 1.06 (3H, s); 13C NMR
(101 MHz; DMSO) δ 172.8, 138.4, 124.4, 44.1, 38.2, 32.1, 28.8;
m/z (ESI): 211 [MH+]; HRMS: calcd for C11H15O4, 211.0965.
Found: [MH+], 211.0971 (2.8 ppm error).
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Abbreviations 
 
Ac  acetate 
aq  aqueous 
bp  boiling point 
Bn  benzyl 
br  broad (NMR) 
CNS  central nervous system 
COSY  correlation spectroscopy 
d  doublet (NMR) 
!  chemical shift 
DBU  1,8-diazabicyclo[5.4.0]undec-7-ene 
DCM  dichloromethane 
DEPT  distortionless enhancement by polarization transfer 
DIBAL di-iso-butylaluminium hydride 
DMAP  4-dimethylaminopyridine 
DMF  N,N-dimethylformamide 
DMP  Dess"Martin periodinane 
DMSO  dimethyl sulfoxide 
eq.  equivalent 
ESI  electrospray ionization 
Et  ethyl 
EtOAc  ethyl acetate 
g  gram(s) 
h  hour(s) 
HRMS  high-resolution mass spectrometry 
HSQC  heteronuclear single quantum coherence 
HWE  Horner"Wadsworth"Emmons 
Hz  Hertz 
i  iso 
imid  imidazole 
IBX  2-iodoxybenzoic acid 
IPA  iso-propyl alcohol 
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IR  infrared 
K  Kelvin 
KHMDS potassium hexamethyldisilazide 
LDA  lithium diisopropylamide 
m  meta 
m  multiplet 
M  molarity 
mCPBA ‪meta-chloroperoxybenzoic acid‬ 
Me  methyl 
mg  milligram(s) 
min  minutes 
mL  milliliter 
mmol  millimoles 
mp  melting point 
Ms  methanesulfonyl 
MS  mass spectrometry 
MSA  methanesulfonic acid 
MTBD  7-methyl-1,5,7-triazabicyclo[4.4.0]dec-5-ene 
m/z  mass to charge ratio 
n  normal 
NMR  nuclear magnetic resonance 
n.O.e  nuclear Overhauser effect 
Nu  nucleophile 
p  para 
pet. ether petroleum ether (light petroleum ether, bp 40"60°C) 
Ph  phenyl 
PIDA  (diacetoxyiodo)benzene 
PMB  p-methoxybenzyl 
ppm  parts per million 
4-PPY  4-pyrrolidinopyridine 
Py  Pyridine 
p-TSA  p-toluenesulfonic acid 
q  quartet (NMR) 
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RCM  ring-closing metathesis 
Rf  retention factor 
ROESY rotating-frame Overhauser effect spectroscopy 
RT  room temperature 
s  second(s); singlet (NMR) 
sat.  saturated 
SN1  unimolecular nucleophilic substitution 
SN2  bimolecular nucleophilic substitution 
t  triplet (NMR) 
t  tert 
TBAF  tetra-n-butylammonium fluoride 
TBS  tert-butyldimethylsilyl 
TBDPS tert-butyldiphenylsilyl 
TEMPO 2,2,6,6-tetramethylpiperidinyloxy 
Tf  trifluoromethanesulfonyl 
TFA  trifluoroacetic acid 
THF  tetrahydrofuran 
TIPS  triisopropylsilyl 
tlc  thin layer chromatography 
TOP  tandem oxidation procedure 
UV  ultraviolet 
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